Also	O
chemokines	O
,	O
for	O
example	O
,	O
IL	O
-	O
8	O
,	O
a	O
cytokine	O
that	O
is	O
regulated	O
on	O
activation	O
with	O
normal	O
T	O
cell	O
expressed	O
and	O
secreted	O
(	O
RANTES	O
),	O
IFN	O
-	O
γ	O
-	O
inducible	O
protein	O
10	O
,	O
and	O
monokine	O
induced	O
by	O
IFN	O
-	O
γ	O
have	O
been	O
detected	O
in	O
breast	O
milk	O
[	O
66	O
,	O
67	O
].	O

At	O
the	O
earlier	O
time	O
point	O
,	O
34	O
.	O
5	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
;	O
at	O
the	O
later	O
time	O
point	O
,	O
29	O
.	O
1	O
%	O
did	O
.	O

Variables	O
included	O
in	O
the	O
PSM	O
model	O
that	O
could	O
explain	O
probability	O
of	O
receiving	O
vaccination	O
were	O
selected	O
a	O
priori	O
(	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
)	O
and	O
because	O
of	O
a	O
crude	O
association	O
with	O
vaccination	O
and	O
/	O
or	O
birth	O
outcomes	O
(	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
iron	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazole	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
calculated	O
from	O
height	O
and	O
weight	O
measurements	O
taken	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
).	O

The	O
results	O
of	O
the	O
LiST	O
analysis	O
found	O
that	O
84	O
%	O
of	O
premature	O
babies	O
(	O
more	O
than	O
921	O
,	O
000	O
lives	O
)	O
could	O
be	O
saved	O
in	O
2025	O
if	O
these	O
interventions	O
were	O
made	O
universally	O
available	O
(	O
95	O
%).	O

Therefore	O
,	O
the	O
adverse	O
effects	O
of	O
vitamin	O
D	O
restriction	O
during	O
kidney	O
development	O
need	O
further	O
exploration	O
.	O

Obesity	O
prevention	O
efforts	O
at	O
this	O
stage	O
of	O
development	O
have	O
typically	B
focused	O
on	O
encouraging	O
healthy	O
prenatal	O
nutrition	O
and	O
breast	O
-	O
feeding	O
;	O
however	O
,	O
interventions	O
to	O
reduce	O
maternal	O
obesity	O
during	O
pregnancy	O
have	O
been	O
limited	O
.	O

In	O
addition	O
,	O
3	O
-	O
month	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
not	O
closely	O
related	O
to	O
BMC	O
at	O
3	O
months	O
,	O
r	O
=	O
0	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
18	O
.	O

This	O
study	O
is	O
therefore	B
designed	O
to	O
investigate	O
pregnant	O
women	O
'	O
s	O
perception	O
of	O
quality	O
of	O
ANC	O
services	O
rendered	O
in	O
health	O
facilities	O
within	O
the	O
Buea	O
Health	O
District	O
area	O
.	O

Sunshine	O
in	O
not	O
adequate	O
in	O
many	O
parts	O
of	O
world	O
.	O

We	O
collected	O
baseline	O
demographics	O
using	O
a	O
questionnaire	O
including	O
race	O
/	O
ethnicity	O
and	O
education	O
obtained	O
data	O
from	O
the	O
medical	O
record	O
.	O

Additionally	O
,	O
16	O
(	O
6	O
.	O
1	O
%)	O
had	O
deficient	O
vitamin	O
D	O
concentrations	O
(<	O
35	O
nmol	O
/	O
L	O
).	O

INTRODUCTION	O
Diets	O
consumed	O
during	O
pregnancy	O
and	O
early	O
postnatal	O
life	O
shape	O
the	O
developmental	O
trajectory	O
of	O
the	O
offspring	O
.	O
1	O
,	O
2Although	O
vitamins	O
contribute	O
to	O
all	O
phases	O
of	O
development	O
,	O
3the	O
effects	O
of	O
multivitamin	O
consumption	O
above	O
requirements	O
(	O
but	O
at	O
non	O
-	O
toxic	O
levels	O
)	O
during	O
pregnancy	O
as	B
determinants	O
of	O
physiologic	O
phenotypes	O
of	O
the	O
offspring	O
have	O
received	O
little	O
attention	O
.	O

Though	O
consistent	O
with	O
studies	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
,	O
larger	O
prospective	O
studies	O
that	O
include	O
objective	O
measures	O
of	O
sleep	O
duration	O
,	O
sleep	O
quality	O
,	O
and	O
sleep	O
apnea	O
during	O
pregnancy	O
are	O
needed	O
to	O
confirm	O
our	O
findings	O
.	O

We	O
showed	O
that	O
gestational	O
exposure	O
to	O
phthalates	O
and	O
BPA	O
,	O
PCBs	O
,	O
PBDEs	O
or	O
OCPs	O
had	O
small	O
or	O
null	O
associations	O
with	O
differences	O
in	O
birth	O
weight	O
.	O

Other	O
potential	O
mechanism	O
that	O
would	O
explain	B
the	O
impairment	O
of	O
the	O
vagal	O
modulation	O
observed	O
in	O
children	O
with	O
low	O
birth	O
weight	O
could	O
be	O
mediated	O
by	O
renin	O
-	O
angiotensin	O
system	O
(	O
RAS	O
).	O

Thus	B
,	O
while	O
it	O
is	O
important	O
to	O
fully	O
characterize	O
the	O
hazard	O
,	O
further	O
studies	O
at	O
doses	O
and	O
routes	O
of	O
administration	O
similar	O
to	O
those	O
found	O
in	O
humans	O
are	O
necessary	O
for	O
determining	O
relevance	O
to	O
public	O
health	O
.	O

While	O
we	O
did	O
not	O
identify	O
statistically	O
or	O
clinically	O
significant	O
differences	O
in	O
neurodevelopment	O
at	O
6	O
-	O
months	O
of	O
age	O
using	O
a	O
reliable	O
screening	O
tool	O
,	O
ongoing	O
follow	O
-	O
up	O
of	O
participants	O
further	O
into	O
childhood	O
will	O
again	O
be	O
important	O
to	O
determine	O
whether	O
there	O
are	O
any	O
potential	O
benefits	O
of	O
improving	O
maternal	O
diet	O
and	O
physical	O
activity	O
during	O
pregnancy	O
on	O
childhood	O
neurodevelopment	O
.	O

The	O
human	O
endometrial	O
decidua	O
makes	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
the	O
placenta	O
synthesizes	O
only	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

Information	O
on	O
psychotic	O
-	O
like	O
symptoms	O
was	O
derived	O
from	O
a	O
follow	O
-	O
up	O
questionnaire	O
in	O
the	O
years	O
2002	O
/	O
03	O
.	O

PubMed	O
Central	O
:	O

A	O
number	O
of	O
techniques	O
have	O
been	O
described	O
in	O
the	O
assessment	O
of	O
early	O
infant	O
body	O
composition	O
.	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

However	O
,	O
long	O
-	O
term	O
studies	O
should	O
be	O
performed	O
to	O
investigate	O
this	O
possibility	O
.	O

All	O
samples	O
were	O
run	O
in	O
duplicates	O
and	O
the	O
entire	O
assay	O
was	O
performed	O
twice	O
.	O

Oral	O
iron	O
,	O
either	O
as	O
iron	O
sulphate	O
or	O
fumarate	O
,	O
is	O
the	O
most	O
commonly	O
used	O
preventive	O
treatment	O
for	O
iron	O
deficiency	O
and	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

Thus	B
,	O
it	O
is	O
very	O
necessary	O
to	O
promote	O
the	O
pregnant	O
women	O
to	O
take	O
proper	O
diet	O
i	O
.	O
e	O
.	O

The	O
greatest	O
risk	O
reduction	O
was	O
among	O
children	O
diagnosed	O
under	O
5	O
years	O
of	O
age	O
whose	O
mothers	O
used	O
supplements	O
during	O
all	O
three	O
trimesters	O
(	O
OR	O
0	O
.	O
5	O
,	O
CI	O
0	O
.	O
3	O
-	O
0	O
.	O
8	O
).	O

We	O
will	O
only	O
share	O
datasets	O
with	O
all	O
personally	O
identifiable	O
information	O
removed	O
,	O
and	O
every	O
reasonable	O
effort	O
to	O
keep	O
the	O
identification	O
of	O
study	O
subjects	O
in	O
the	O
strictest	O
confidence	O
.	O

Computer	O
software	O
IBM	O
SPSS	O
Statistics	O
version	O
22	O
.	O
0	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

In	O
addition	O
,	O
a	O
significant	O
percentage	O
of	O
infants	O
from	O
families	O
with	O
an	O
atopic	O
background	O
do	O
not	O
develop	O
atopy	O
during	O
childhood	O
.	O

These	O
figures	O
were	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
after	O
the	O
intervention	O
.	O

Maternal	O
pre	O
-	O
pregnancy	O
weight	O
was	O
the	O
only	O
significant	O
predictor	O
identified	O
(	O
p	O
=	O
0	O
.	O
015	O
).	O

This	O
study	O
points	O
towards	O
a	O
potential	O
gene	O
-	O
environment	O
interaction	O
that	O
could	O
be	O
of	O
predictive	O
value	O
for	O
fetal	O
weight	O
.	O

Radioactive	O
iodine	O
is	O
ineffective	O
because	O
I	O
-	O
131	O
uptake	O
by	O
MTC	O
cells	O
is	O
negligible	O
.	O

Although	O
a	O
person	O
is	O
at	O
risk	O
for	O
obesity	O
throughout	O
his	O
life	O
,	O
we	O
focus	O
on	O
specific	O
developmental	O
susceptibilities	O
for	O
obesity	O
from	O
gestation	O
through	O
adolescence	O
(	O
Table	O
).	O

MANAGEMENT	O
FACTORS	O
Several	O
management	O
factors	O
,	O
including	O
weaning	O
age	O
,	O
castration	O
,	O
slaughter	O
age	O
and	O
weight	O
,	O
nutrition	O
and	O
other	O
environmental	O
conditions	O
can	O
affect	O
IMF	O
deposition	O
.	O

Separate	O
analyses	O
were	O
carried	O
out	O
for	O
the	O
three	O
end	O
points	O
but	O
the	O
methodology	O
applied	O
did	O
not	O
allow	O
us	O
to	O
explore	O
the	O
specific	O
nature	O
of	O
causal	O
relationships	O
between	O
congenital	O
cryptorchidism	O
,	O
hypospadias	O
,	O
and	O
testicular	O
cancer	O
.	O

While	O
vitamin	O
A	O
restriction	O
improves	O
marbling	O
,	O
but	O
vitamin	O
D	O
restriction	O
did	O
not	O
significantly	O
affect	O
marbling	O
in	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

Lesions	O
of	O
testis	O
and	O
epididymis	O
associated	O
with	O
prenatal	O
diethylstilbestrol	O
exposure	O
.	O

Among	O
all	O
the	O
predicted	O
miRNAs	O
,	O
4	O
miRNAs	O
targeting	O
GR	O
were	O
quantitated	O
by	O
real	O
-	O
time	O
PCR	O
.	O

[	O
43	O
]	O
If	O
electing	O
to	O
test	O
vitamin	O
D	O
status	O
,	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
is	O
the	O
accepted	O
biomarker	O
to	O
be	O
offered	O
early	O
in	O
pregnancy	O
.	O

Harper	O
and	O
Pethick	O
[	O
23	O
]	O
recommended	O
that	O
producers	O
focus	O
on	O
individuals	O
with	O
high	O
genetic	O
capacity	O
to	O
create	O
more	O
preadipocytes	O
within	O
animal	O
muscle	O
.	O

Given	O
that	O
all	O
these	O
factors	O
significantly	O
influenced	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
linear	O
regression	O
model	O
,	O
it	O
was	O
unsurprising	O
that	O
vitamin	O
D	O
status	O
of	O
the	O
women	O
was	O
significantly	O
different	O
between	O
the	O
two	O
recruitment	O
sites	O
.	O

This	O
may	O
have	O
been	O
especially	O
relevant	O
in	O
our	O
measurement	O
of	O
maternal	O
tobacco	O
,	O
alcohol	O
,	O
and	O
prenatal	O
vitamin	O
use	O
and	O
could	O
have	O
potentially	O
introduced	O
a	O
bias	O
toward	O
the	O
null	O
.	O

In	O
such	O
instances	O
,	O
the	O
avoidance	O
of	O
peanuts	O
,	O
nuts	O
,	O
fish	O
,	O
eggs	O
,	O
and	O
sesame	O
during	O
the	O
last	O
3	O
months	O
of	O
pregnancy	O
may	O
have	O
a	O
protective	O
effect	O
[	O
106	O
].	O

Exposure	O
to	O
such	O
an	O
intra	O
-	O
uterine	O
environment	O
potentially	O
creates	O
a	O
vicious	O
cycle	O
in	O
which	O
the	O
propensity	O
to	O
obesity	O
is	O
perpetuated	O
,	O
with	O
major	O
adverse	O
public	O
health	O
implications	O
[	O
11	O
,	O
12	O
],	O
and	O
implications	O
for	O
the	O
health	O
of	O
successive	O
generations	O
[	O
13	O
].	O

Solid	O
gray	O
circles	O
and	O
solid	O
black	O
line	O
represent	O
MUSC	O
cohort	O
(	O
N	O
=	O
1064	O
)	O
and	O
open	O
circles	O
and	O
dashed	O
line	O
represent	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Based	O
on	O
these	O
scores	O
,	O
we	O
created	O
the	O
following	O
categories	O
of	O
nutritional	O
knowledge	O
:	O
low	O
level	O
(<	O
mean	O
–	O
standard	O
deviation	O
),	O
medium	O
level	O
(	O
mean	O
±	O
standard	O
deviation	O
)	O
and	O
high	O
level	O
(>	O
mean	O
+	O
standard	O
deviation	O
).	O

Among	O
primiparous	O
(	O
first	O
-	O
time	O
)	O
mothers	O
,	O
women	O
with	O
the	O
highest	O
estimated	O
serum	O
levels	O
of	O
DDE	O
at	O
delivery	O
breastfed	O
for	O
a	O
median	O
of	O
13	O
.	O
0	O
weeks	O
,	O
compared	O
with	O
a	O
median	O
of	O
30	O
.	O
3	O
weeks	O
for	O
women	O
with	O
the	O
lowest	O
levels	O
;	O
among	O
multiparous	O
mothers	O
—	O
women	O
who	O
had	O
given	O
birth	O
previously	O
—	O
these	O
numbers	O
were	O
13	O
.	O
0	O
and	O
21	O
.	O
7	O
weeks	O
,	O
respectively	O
.	O

Long	O
-	O
acting	O
insulin	O
analogs	O
,	O
particularly	O
glargine	O
,	O
are	O
increasingly	O
being	O
used	O
in	O
women	O
with	O
type	O
1	O
diabetes	O
,	O
and	O
they	O
are	O
often	O
continued	O
through	O
the	O
pregnancy	O
.	O

Hence	O
,	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
influences	O
pregnancy	O
health	O
.	O

Introduction	O
Perinatal	O
health	O
outcomes	O
vary	O
dramatically	O
by	O
race	O
in	O
the	O
United	O
States	O
.	O
1African	O
American	O
women	O
develop	O
preeclampsia	O
more	O
often	B
than	O
their	O
white	O
counterparts2and	O
are	O
more	O
likely	B
to	O
develop	O
preterm	O
labor	O
.	O
3The	O
result	O
is	O
that	O
black	O
infants	O
are	O
60	O
%	O
more	O
likely	B
be	I
preterm	O
and	O
four	O
times	O
more	O
likely	B
to	O
die	O
due	O
to	O
prematurity	O
than	O
white	O
infants	O
.	O
1Because	B
of	O
less	O
efficient	O
vitamin	O
D	O
synthesis	O
in	O
the	O
skin	O
of	O
darker	O
pigmented	O
individuals	O
,	O
African	O
Americans	O
are	O
at	O
higher	O
risk	O
than	O
white	O
Americans	O
of	O
vitamin	O
D	O
deficiency	O
.	O
4	O
,	O
5Black	O
women	O
are	O
also	O
more	O
likely	B
than	O
white	O
women	O
to	O
be	O
overweight	O
or	O
obese6which	O
is	O
of	O
concern	O
because	B
obesity	O
is	O
another	O
risk	O
factor	O
for	O
vitamin	O
D	O
deficiency5	O
,	O
7and	O
poor	O
perinatal	O
outcomes	O
.	O
8In	O
observational	O
studies	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
[	O
OH	O
]	O
D	O
)	O
levels	O
have	O
been	O
shown	O
to	O
be	O
associated	O
with	O
higher	O
risk	O
of	O
several	O
adverse	O
perinatal	O
outcomes	O
including	O
gestational	O
diabetes9	O
,	O
10	O
,	O
preeclampsia	O
,	O
11preterm	O
birth12and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
status	O
.	O
13	O
,	O
14	O
,	O
15	O
,	O
16	O
,	O
17Because	B
of	O
the	O
paucity	O
of	O
vitamin	O
D	O
trial	O
data	O
with	O
respect	O
to	O
perinatal	O
outcomes	O
,	O
whether	O
differences	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
explains	O
or	O
partially	O
explains	O
perinatal	O
disparities	O
is	O
plausible18but	O
remains	O
unknown	O
.	O

[	O
21	O
]	O
and	O
validated	O
in	O
a	O
young	O
adolescent	O
population	O
[	O
22	O
].	O

2006	O
;	O
Wynne	O
-	O
Davies	O
1975	O
)	O
and	O
twin	O
studies	O
(	O
Kesling	O
and	O
Reinker	O
1997	O
)	O
have	O
shown	O
that	O
the	O
cause	O
of	O
spinal	O
deformities	O
,	O
including	O
scoliosis	O
and	O
kyphosis	O
,	O
can	O
have	O
a	O
genetic	O
component	O
.	O

The	O
perinatal	O
mortality	O
rate	O
was	O
2	O
.	O
6	O
%	O
in	O
these	O
women	O
with	O
‘	O
mild	O
GDM	O
’	O
in	O
the	O
1970s	O
,	O
compared	O
to	O
0	O
.	O
7	O
%,	O
in	O
the	O
1980s	O
after	O
routine	O
treatment	O
had	O
been	O
introduced	O
for	O
this	O
group	O
.	O

In	O
vivo	O
testing	O
should	O
generally	B
be	O
postponed	O
until	O
after	O
pregnancy	O
,	O
unless	O
diagnosis	O
for	O
therapeutic	O
intervention	O
is	O
urgently	O
needed	O
.	O

demonstrated	O
no	O
adverse	O
effects	O
on	O
offspring	O
neurodevelopment	O
with	O
maternal	O
fish	O
consumption	O
during	O
pregnancy	O
equal	O
to	O
or	O
greater	O
than	O
once	O
per	O
week	O
.	O

The	O
lower	O
acceptance	O
to	O
novel	O
foods	O
has	O
been	O
found	O
in	O
animals	O
with	O
protein	O
deficiency	O
from	O
early	O
gestational	O
stages	O
(	O
Peregoy	O
et	O
al	O
.,	O
1972	O
;	O
Pettus	O
et	O
al	O
.,	O
1974	O
)	O
and	O
could	O
be	O
associated	O
with	O
abnormal	O
behaviors	O
in	O
adulthood	O
related	O
to	O
anxiety	O
(	O
Peleg	O
-	O
Raibstein	O
et	O
al	O
.,	O
2012	O
).	O

Although	O
no	O
causality	O
was	O
found	O
,	O
it	O
was	O
determined	O
that	O
prenatal	O
folic	O
acid	O
supplements	O
taken	O
during	O
pregnancy	O
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
autistic	O
disorder	O
.	O

2	O
.	O
9	O
.	O

Frequency	O
of	O
the	O
type	O
of	O
food	O
eaten	O
during	O
the	O
past	O
month	O
can	O
be	O
reported	O
by	O
the	O
mother	O
as	O
every	O
day	O
;	O
most	O
days	O
(	O
not	O
every	O
day	O
,	O
but	O
at	O
least	O
4	O
times	O
per	O
week	O
);	O
once	O
a	O
week	O
(	O
less	O
than	O
4	O
times	O
per	O
week	O
,	O
but	O
at	O
least	O
once	O
per	O
week	O
)	O
or	O
never	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
10	O
.	O
1186	O
/	O
s12884	O
-	O
018	O
-	O
1887	O
-	O
x	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
premise	O
that	O
modification	O
in	O
the	O
fetal	O
environment	O
could	O
alter	O
ANS	O
development	O
.	O

Using	O
image	O
analysis	O
with	O
an	O
LC	O
Evolution	O
camera	O
on	O
an	O
Olympus	O
BX51	O
microscope	O
running	O
Image	O
-	O
Pro	O
Plus	O
software	O
version	O
7	O
.	O
01	O
for	O
Windows	O
(	O
Media	O
Cybernetics	O
,	O
Silver	O
Spring	O
,	O
MD	O
,	O
USA	O
),	O
glomerular	O
size	O
(	O
mean	O
diameter	O
)	O
was	O
estimated	O
as	O
described	O
elsewhere	O
using	O
a	O
minimum	O
of	O
100	O
glomeruli	O
per	O
group	O
among	O
those	O
cut	O
equatorially	O
[	O
19	O
].	O

Analyses	O
were	O
performed	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
,	O
Mass	O
spectrometer	O
API	O
4000	O
)	O
by	O
the	O
clinical	O
chemistry	O
laboratory	O
in	O
Region	O
Skåne	O
,	O
Sweden	O
,	O
certified	O
by	O
the	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
[	O
15	O
].	O

In	O
the	O
study	O
,	O
steers	O
from	O
dams	O
fed	O
a	O
corn	O
-	O
based	O
diet	O
during	O
late	O
gestation	O
had	O
a	O
lower	O
MS	O
compared	O
with	O
progeny	O
from	O
dams	O
fed	O
diets	O
low	O
in	O
starch	O
(	O
grass	O
hay	O
or	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
).	O

Timmermann	O
and	O
colleagues	O
estimated	O
that	O
breastfeeding	O
was	O
1	O
.	O
4	O
months	O
shorter	O
when	O
women	O
’	O
s	O
serum	O
levels	O
of	O
PFOS	O
were	O
doubled	O
and	O
1	O
.	O
3	O
months	O
shorter	O
when	O
their	O
levels	O
of	O
PFOA	O
were	O
doubled	O
.	O

The	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
)	O
decreased	O
for	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
,	O
decreased	O
with	O
more	O
frequent	O
use	O
of	O
sunscreen	O
lotion	O
and	O
increased	O
for	O
smokers	O
and	O
women	O
who	O
reported	O
preference	O
for	O
shadow	O
.	O

Whatever	O
their	O
developmental	O
origin	O
,	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
seem	O
to	O
greatly	O
differ	O
in	O
their	O
function	O
.	O

Investigating	O
ways	O
to	O
improve	O
natural	O
immune	O
function	O
and	O
limit	O
the	O
number	O
of	O
infections	O
people	O
experience	O
is	O
of	O
great	O
importance	O
…	O
In	O
this	O
study	O
,	O
a	O
positive	O
correlation	O
between	O
age	O
and	O
cathelicidin	O
was	O
shown	O
.	O

All	O
five	O
assessments	O
were	O
successfully	O
completed	O
in	O
104	O
intervention	O
households	O
and	O
97	O
control	O
households	O
.	O

Training	O
of	O
trainers	O
involved	O
national	O
staff	O
training	O
staff	O
from	O
the	O
provincial	O
level	O
,	O
who	O
then	O
trained	O
district	O
,	O
commune	O
and	O
village	O
level	O
health	O
workers	O
.	O

Each	O
mouse	O
was	O
decapitated	O
,	O
and	O
the	O
kidneys	O
were	O
rapidly	O
removed	O
and	O
weighed	O
.	O

In	O
total	O
,	O
there	O
were	O
6	O
messages	O
related	O
to	O
risks	O
of	O
alcohol	O
consumption	O
,	O
spread	O
over	O
the	O
intervention	O
period	O
,	O
among	O
the	O
pregnancy	O
messages	O
delivered	O
.	O

110	O
Is	O
Pet	O
Ownership	O
Associated	O
with	O
Higher	O
Vitamin	O
D	O
?	O

However	O
,	O
due	B
to	I
recent	O
changes	O
in	O
national	O
health	O
policies	O
,	O
intake	O
of	O
vitamin	O
D	O
has	O
increased	O
resulting	O
in	O
decreasing	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
[	O
2	O
–	O
5	O
].	O

Symptoms	O
assessed	O
are	O
fever	O
,	O
diarrhoea	O
,	O
vomiting	O
,	O
nasal	O
discharge	O
,	O
coughing	O
,	O
diaper	O
and	O
other	O
rash	O
.	O

Results	O
from	O
several	O
studies	O
hint	O
that	O
non	O
-	O
genetic	O
factors	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
determination	O
of	O
handedness	O
.	O

Vitamin	O
D	O
may	O
act	O
as	B
an	O
anti	O
-	O
inflammatory	O
agent	O
in	O
the	O
brain	O
by	O
keeping	O
harmful	O
pro	O
-	O
inflammatory	O
cytokines	O
in	O
check	O
.	O

PubMed	O
Central	O
:	O

Effects	O
of	O
ethnicity	O
and	O
vitamin	O
D	O
supplementation	O
on	O
vitamin	O
D	O
status	O
and	O
changes	O
in	O
bone	O
mineral	O
content	O
in	O
infants	O
Abstract	O
Abstract	O
Background	O
To	O
evaluate	O
the	O
effects	O
on	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
bone	O
mineralization	O
of	O
supplementation	O
of	O
breast	O
-	O
fed	O
Hispanic	O
and	O
non	O
-	O
Hispanic	O
Caucasian	O
infants	O
with	O
vitamin	O
D	O
in	O
infants	O
in	O
Houston	O
,	O
Texas	O
.	O

However	O
,	O
if	O
the	O
mother	O
is	O
already	O
allergic	O
or	O
if	O
there	O
is	O
a	O
family	O
history	O
of	O
atopy	O
or	O
allergy	O
,	O
food	O
comprising	O
potential	O
allergens	O
should	O
be	O
avoided	O
.	O

These	O
processes	O
are	O
complex	O
and	O
normal	O
development	O
is	O
dependent	O
on	O
several	O
factors	O
.	O

All	O
the	O
investigators	O
will	O
have	O
the	O
right	O
to	O
analyse	O
and	O
publish	O
data	O
.	O

Women	O
at	O
their	O
first	O
pregnancy	O
and	O
those	O
with	O
a	O
high	O
level	O
of	O
education	O
were	O
more	O
likely	B
to	O
be	O
unsatisfied	O
with	O
the	O
ANC	O
services	O
they	O
received	O
at	O
their	O
attending	O
health	O
centres	O
.	O

With	O
thanks	O
to	O
Boston	O
Consulting	O
Group	O
.	O

In	O
conclusion	O
,	O
common	O
genetic	O
variation	O
is	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
in	O
pregnancy	O
and	O
the	O
response	O
to	O
antenatal	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
,	O
but	O
with	O
differing	O
SNPs	O
appearing	O
to	O
be	O
important	O
before	O
and	O
after	O
supplementation	O
.	O

For	O
continuous	O
outcomes	O
,	O
differences	O
in	O
means	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
linear	O
regression	O
.	O

In	O
addition	O
the	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
10	O
ng	O
/	O
ml	O
(	O
severe	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
severe	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
same	O
predictors	O
in	O
the	O
model	O
.	O

Intravenous	O
aminophylline	O
is	O
not	O
generally	B
recommended	O
in	O
the	O
emergency	O
management	O
of	O
acute	O
asthma	O
(	O
because	O
of	O
its	O
potentially	O
harmful	O
effects	O
)	O
but	O
may	O
be	O
used	O
in	O
pregnant	O
patients	O
hospitalized	O
for	O
acute	O
asthma	O
(	O
theophylline	O
levels	O
should	O
be	O
monitored	O
).	O

Women	O
with	O
missing	O
covariates	O
were	O
not	O
included	O
in	O
final	O
multivariable	O
models	O
.	O

After	O
controlling	O
for	O
potential	O
confounders	O
,	O
maternal	O
intake	O
of	O
free	O
sugar	O
was	O
positively	O
associated	O
with	O
atopy	O
(	O
OR	O
for	O
highest	O
versus	O
lowest	O
quintile	O
of	O
sugar	O
intake	O
1	O
.	O
38	O
,	O
95	O
%	O
CI	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
006	O
)	O
and	O
atopic	O
asthma	O
(	O
OR	O
2	O
.	O
01	O
,	O
95	O
%	O
CI	O
1	O
.	O
23	O
–	O
3	O
.	O
29	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
004	O
).	O

Data	O
from	O
the	O
feeding	O
response	O
to	O
AM251	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
treatment	O
and	O
diet	O
as	O
factors	O
.	O

Lipid	O
-	O
derived	O
immune	O
modulators	O
will	O
be	O
determined	O
with	O
LCMSMS	O
[	O
75	O
].	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

Authors	O
’	O
contributions	O
RS	O
:	O
Conception	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
drafting	O
of	O
article	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

BMI	O
,	O
defined	O
as	O
weight	O
in	O
kilograms	O
divided	O
by	O
height	O
in	O
meters	O
squared	O
,	O
was	O
calculated	O
.	O

Background	O
:	O
Since	O
classical	O
development	O
of	O
medicine	O
in	O
1920	O
,	O
Vitamin	O
D	O
(	O
cholecalciferol	O
,	O
VD	O
)	O
was	O
strongly	B
associated	O
with	O
rickets	O
,	O
after	O
observation	O
that	O
cod	O
liver	O
consumption	O
leads	B
to	O
a	O
regression	O
in	O
rickets	O
symptoms	O
[	O
3	O
].	O

Meanwhile	O
,	O
paternal	O
history	O
with	O
allergic	O
rhinitis	O
and	O
maternal	O
smoke	O
in	O
pregnancy	O
also	O
had	O
adverse	O
effect	O
on	O
lung	O
function	O
.	O

prematurity	O
[	O
21	O
,	O
22	O
],	O
impaired	O
fetal	O
growth	O
[	O
21	O
,	O
23	O
],	O
maternal	O
obesity	O
and	O
weight	O
gain	O
[	O
24	O
–	O
26	O
],	O
and	O
offspring	O
obesity	O
[	O
27	O
,	O
28	O
].	O

We	O
performed	O
secondary	O
analyses	O
restricting	O
to	O
women	O
who	O
initiated	O
PNV	O
use	O
before	O
pregnancy	O
only	O
and	O
after	O
pregnancy	O
only	O
and	O
compared	O
each	O
group	O
to	O
women	O
with	O
no	O
reported	O
PNV	O
use	O
.	O

Results	O
3	O
.	O
1	O
.	O

Volunteering	O
women	O
reporting	O
for	O
ANC	O
planned	O
visits	O
at	O
the	O
study	O
sites	O
were	O
sensitized	O
on	O
the	O
purpose	O
and	O
the	O
procedure	O
of	O
the	O
study	O
.	O

Our	O
findings	O
support	O
current	O
guidelines	B
to	O
begin	O
vitamin	O
D	O
supplementation	O
of	O
400	O
IU	O
/	O
day	O
to	O
all	O
breast	O
-	O
fed	O
infants	O
in	O
the	O
first	O
week	O
of	O
life	O
and	O
to	O
further	O
encourage	O
the	O
provision	O
of	O
adequate	O
vitamin	O
D	O
to	O
pregnant	O
women	O
.	O

The	O
visfatin	O
regulation	O
mechanism	O
in	O
human	O
fetal	O
blood	O
circulation	O
is	O
unknown	O
(	O
12	O
).	O

2	O
.	O
1	O
.	O

To	O
this	O
end	O
,	O
one	O
of	O
the	O
very	O
useful	O
tools	O
is	O
the	O
use	O
of	O
rodent	O
strains	O
with	O
different	O
sensitivities	O
to	O
diet	O
-	O
induced	O
obesity	O
and	O
insulin	O
resistance	O
.	O

Table	O
2presents	O
the	O
results	O
of	O
our	O
exploration	O
of	O
the	O
differences	O
in	O
the	O
measures	O
of	O
DNA	O
methylation	O
by	O
various	O
in	O
utero	O
exposures	O
.	O

Central	O
neck	O
and	O
upper	O
mediastinum	O
clearance	O
and	O
,	O
in	O
addition	O
,	O
mono	O
or	O
bilateral	O
node	O
dissection	O
(	O
depending	O
on	O
the	O
extent	O
of	O
nodal	O
involvement	O
)	O
is	O
also	O
advisable	O
.	O

This	O
study	O
reports	O
on	O
analysis	O
of	O
the	O
full	O
dataset	O
from	O
baseline	O
to	O
postpartum	O
follow	O
-	O
up	O
.	O

Materials	O
and	O
Methods	O
The	O
present	O
cohort	O
study	O
was	O
conducted	O
between	O
2013	O
and	O
2015	O
after	O
obtaining	O
approval	O
of	O
the	O
Research	O
Council	O
of	O
Tarbiat	O
Modares	O
University	O
,	O
Tehran	O
,	O
Iran	O
,	O
and	O
permission	O
from	O
the	O
Medical	O
Ethics	O
Committee	O
of	O
the	O
Faculty	O
of	O
Medical	O
Sciences	O
,	O
and	O
presenting	O
a	O
letter	O
of	O
introduction	O
from	O
the	O
university	O
to	O
selected	O
and	O
densely	O
populated	O
medical	O
centers	O
covered	O
by	O
Shahid	O
Beheshti	O
University	O
of	O
Medical	O
Sciences	O
in	O
the	O
north	O
,	O
east	O
,	O
and	O
Shemiranat	O
districts	O
of	O
Tehran	O
,	O
Iran	O
.	O

The	O
normal	O
BMI	O
range	O
is	O
18	O
.	O
5	O
–	O
25	O
kg	O
/	O
m2	O
,	O
although	O
the	O
range	O
may	O
vary	O
for	O
different	O
countries	O
.	O

The	O
model	O
allows	O
all	O
data	O
from	O
incomplete	O
families	O
to	O
be	O
used	O
.	O

There	O
were	O
1754	O
infants	O
who	O
were	O
assessed	O
at	O
6	O
months	O
of	O
age	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
.	O

Four	O
large	O
cohort	O
studies	O
conducted	O
across	O
Sweden	O
,	O
Australia	O
,	O
and	O
Denmark	O
found	O
that	O
an	O
Apgar	O
score	O
of	O
7	O
has	O
a	O
strong	O
predictive	O
value	O
of	O
autism	O
[	O
18	O
,	O
54	O
–	O
56	O
];	O
similar	O
findings	O
were	O
reported	O
by	O
Garderner	O
et	O
al	O
.	O

Primary	O
outcome	O
The	O
primary	O
outcome	O
was	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infant	O
age	O
and	O
sex	O
at	O
follow	O
-	O
up	O
[	O
27	O
].	O

Model	O
2	O
:	O
model	O
controlled	O
for	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
education	O
>	O
secondary	O
school	O
,	O
being	O
part	O
of	O
the	O
ROLO	O
study	O
intervention	O
group	O
,	O
early	O
-	O
pregnancy	O
energy	O
(	O
kcal	O
),	O
early	O
-	O
pregnancy	O
protein	O
(	O
g	O
),	O
early	O
-	O
pregnancy	O
fat	O
(	O
g	O
),	O
moderate	O
-	O
vigorous	O
activity	O
,	O
well	O
-	O
being	O
score	O
and	O
dietary	O
supplements	O
Post	O
-	O
hoc	O
analysis	O
-	O
exploring	O
potential	O
confounders	O
Dietary	O
intakes	O
,	O
lifestyle	O
behaviours	O
,	O
and	O
emotional	O
well	O
-	O
being	O
were	O
analysed	O
by	O
season	O
of	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Table	O
S2	O
).	O

IMF	O
contents	O
in	O
the	O
5	O
muscles	O
(	O
biceps	O
femoris	O
,	O
supraspinatus	O
,	O
semitendinosus	O
,	O
longissimus	O
lumborum	O
,	O
and	O
infraspinatus	O
)	O
also	O
increased	O
along	O
with	O
the	O
increase	O
of	O
HCW	O
at	O
5	O
slaughter	O
stages	O
in	O
Angus	O
(	O
from	O
114	O
.	O
8	O
to	O
459	O
.	O
1	O
kg	O
),	O
Hereford	O
(	O
from	O
114	O
.	O
0	O
to	O
452	O
.	O
2	O
kg	O
),	O
and	O
Wagyu	O
×	O
Angus	O
(	O
from	O
116	O
.	O
8	O
to	O
459	O
.	O
2	O
kg	O
)	O
[	O
30	O
].	O

We	O
found	O
no	O
significant	O
prenatal	O
predictors	O
of	O
change	O
in	O
WFA	O
z	O
-	O
scores	O
between	O
birth	O
and	O
6	O
months	O
.	O

We	O
also	O
found	O
a	O
sex	O
effect	O
on	O
the	O
gene	O
expression	O
of	O
Chrebp	O
,	O
Acaca	O
,	O
Acox1	O
,	O
Srebf1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Scd1	O
,	O
Cpt1b	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
.	O

In	O
the	O
first	O
trimester	O
,	O
daily	O
needs	O
decrease	O
due	O
to	O
the	O
absence	O
of	O
menstruation	O
;	O
thereby	O
saving	O
about	O
0	O
.	O
56	O
mg	O
of	O
iron	O
per	O
day	O
,	O
or	O
160	O
mg	O
for	O
the	O
pregnancy	O
[	O
15	O
].	O

Furthermore	O
,	O
not	O
only	O
the	O
F1	O
generation	O
but	O
also	O
the	O
F2	O
generation	O
was	O
affected	O
by	O
the	O
gestational	O
vitamin	O
D	O
deficiency	O
of	O
the	O
F0	O
generation	O
mice	O
.	O

BMI	O
—	O
child	O
age	O
5	O
There	O
was	O
a	O
strong	O
correlation	O
between	O
the	O
child	O
and	O
the	O
mother	O
,	O
similar	O
to	O
that	O
at	O
age	O
0	O
(	O
table	O
4	O
).	O

A	O
Danish	O
study	O
reported	O
that	O
adherence	O
with	O
an	O
iron	O
supplementation	O
regime	O
was	O
associated	O
with	O
maternal	O
age	O
(	O
over	O
20	O
years	O
),	O
primiparity	O
and	O
educational	O
level	O
[	O
18	O
].	O

Few	O
herb	O
users	O
discussed	O
use	O
with	O
their	O
providers	O
,	O
and	O
there	O
was	O
no	O
documentation	O
in	O
the	O
medical	O
record	O
.	O

A	O
further	O
limitation	O
is	O
that	O
the	O
OGTT	O
was	O
not	O
performed	O
on	O
all	O
mothers	O
,	O
and	O
a	O
slight	O
possibility	O
exists	O
that	O
the	O
actual	O
prevalence	O
of	O
GDM	O
might	O
be	O
underestimated	O
.	O

We	O
also	O
report	O
unadjusted	O
estimates	O
for	O
analyses	O
and	O
analyses	O
further	O
adjusted	O
for	O
infant	O
age	O
at	O
sample	O
collection	O
in	O
the	O
supplemental	O
information	O
.	O

The	O
Muslim	O
community	O
in	O
Houston	O
represents	O
about	O
3	O
%	O
of	O
the	O
population	O
,	O
and	O
therefore	O
,	O
mothers	O
were	O
asked	O
if	O
they	O
had	O
any	O
religious	O
or	O
cultural	O
practices	O
that	O
included	O
covering	O
their	O
head	O
and	O
bodies	O
with	O
clothing	O
in	O
the	O
context	O
that	O
this	O
may	O
affect	O
sunlight	O
exposure	O
and	O
therefore	O
cord	O
25	O
(	O
OHD	O
)	O
values	O
.	O

Additionally	O
,	O
there	O
is	O
a	O
high	O
correlation	O
between	O
vitamin	O
D	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
(	O
correlation	O
=	O
0	O
.	O
77	O
).	O

Critics	O
of	O
these	O
genetic	O
predisposition	O
argued	O
that	O
since	O
many	O
genes	O
are	O
involved	O
in	O
the	O
etiology	O
of	O
autism	O
,	O
the	O
role	O
of	O
any	O
single	O
gene	O
polymorphism	O
in	O
causing	O
autism	O
is	O
small	O
.	O

First	O
trimester	O
BMI	O
was	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
for	O
both	O
first	O
and	O
third	O
trimester	O
pregnant	O
women	O
.	O

The	O
calculation	O
was	O
based	O
on	O
a	O
small	O
effect	O
size	O
F2of	O
0	O
.	O
05	O
;	O
probability	O
of	O
error	O
(	O
alpha	O
)	O
of	O
5	O
%;	O
a	O
power	O
of	O
80	O
%	O
and	O
ten	O
predictors	O
on	O
the	O
birth	O
outcome	O
“	O
low	O
birth	O
weight	O
”.	O

A	O
Pearson	O
correlation	O
was	O
used	O
to	O
examine	O
the	O
correlation	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extents	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
show	O
that	O
low	O
cord	O
—	O
and	O
not	O
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	O
to	O
relatively	O
poor	O
lung	O
performance	O
at	O
6	O
months	O
of	O
age	O
.	O

The	O
increase	O
in	O
haemoglobin	O
concentration	O
in	O
the	O
intervention	O
group	O
relative	O
to	O
placebo	O
was	O
more	O
marked	O
in	O
women	O
who	O
were	O
anaemic	O
at	O
the	O
start	O
of	O
the	O
study	O
(	O
Figure	O
2	O
).	O

The	O
mean	O
kidney	O
mass	O
(	O
KM	O
;	O
mean	O
±	O
SEM	O
,	O
n	O
=	O
6	O
animals	O
each	O
group	O
)	O
varied	O
from	O
8	O
.	O
2	O
±	O
0	O
.	O
2	O
mg	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
10	O
.	O
3	O
±	O
0	O
.	O
4	O
mg	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
),	O
with	O
more	O
than	O
25	O
%	O
variation	O
between	O
the	O
groups	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

*	O
Note	O
that	O
Control	O
offspring	O
inFigure	O
3andFigure	O
4are	O
the	O
same	O
animals	O
.	O

Schools	O
'	O
food	O
policies	O
affect	O
student	O
BMI	O
;	O
in	O
1	O
study	O
,	O
as	B
the	O
number	O
of	O
school	O
food	O
policies	O
increased	O
,	O
students	O
'	O
mean	O
BMI	O
decreased	O
(	O
93	O
).	O

There	O
are	O
other	O
more	O
time	O
and	O
financially	O
economical	O
ways	O
in	O
which	O
lifetime	O
,	O
multigenerational	O
and	O
/	O
or	O
transgenerational	O
toxicity	O
could	O
be	O
assessed	O
,	O
for	O
example	O
using	O
zebrafish	O
models	O
,	O
both	O
respecting	O
the	O
3Rs	O
and	O
satisfying	O
sufficient	O
statistical	O
power	O
.	O

The	O
selective	O
knock	O
-	O
out	O
of	O
SIRT1	O
in	O
hypothalamic	O
AgRP	O
neurons	O
diminished	O
response	O
to	O
hunger	O
-	O
inducing	O
hormone	O
ghrelin	O
,	O
reduced	O
food	O
intake	O
,	O
consequently	B
causing	O
decreased	O
lean	O
mass	O
and	O
body	O
weight	O
(	O
23	O
).	O

The	O
association	O
of	O
later	O
life	O
health	O
with	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
environmental	O
factors	O
has	O
led	O
to	O
the	O
“	O
Developmental	O
Origins	O
of	O
Health	O
and	O
Disease	O
”	O
(	O
DOHaD	O
)	O
hypothesis	O
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

1999	O
).	O

The	O
differential	O
response	O
to	O
the	O
maternal	O
undernutrition	O
in	O
energy	O
balance	O
is	O
sexual	O
dimorphism	O
dependent	O
during	O
the	O
post	O
-	O
weaning	O
periods	O
.	O

Consequently	O
,	O
only	O
genes	O
whose	O
regulation	O
between	O
two	O
consecutive	O
ontogenetic	O
stages	O
(	O
period	O
I	O
:	O
94dpc	O
-	O
1dpn	O
;	O
period	O
II	O
:	O
1dpn	O
-	O
28dpn	O
;	O
period	O
III	O
:	O
28dpn	O
-	O
188dpn	O
)	O
was	O
private	O
to	O
either	O
the	O
LP	O
or	O
the	O
AP	O
group	O
were	O
analysed	O
(	O
Table1	O
).	O

We	O
considered	O
the	O
period	O
from	O
2010	O
to	O
2015	O
and	O
then	O
through	O
2025	O
to	O
allow	O
for	O
a	O
more	O
feasible	O
time	O
frame	O
to	O
scale	O
up	O
care	O
and	O
progress	O
on	O
the	O
prevention	O
agenda	O
.	O

Such	O
findings	O
will	O
be	O
used	O
to	O
implement	O
informative	O
interventional	O
programs	O
to	O
control	O
impaired	O
fetal	O
growth	O
and	O
develop	O
practical	O
policies	O
to	O
improve	O
the	O
diet	O
quality	O
among	O
pregnant	O
women	O
.	O

Lower	O
25OHD	O
in	O
early	O
pregnancy	O
was	O
only	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Gluckman	O
et	O
al	O
.	O

The	O
clinic	O
’	O
s	O
geographical	O
location	O
(	O
region	O
)	O
should	O
also	O
be	O
analyzed	O
,	O
because	B
the	O
midyear	O
UVB	O
intensity	O
and	O
VD	O
intake	O
in	O
diet	O
are	O
different	O
between	O
populations	O
.	O

Slaughter	O
weight	O
IMF	O
content	O
or	O
MS	O
generally	B
increases	O
with	O
slaughter	O
weight	O
in	O
several	O
cattle	O
breeds	O
.	O

There	O
is	O
also	O
evidence	O
that	O
decreased	O
parasympathetic	O
activity	O
is	O
correlated	O
with	O
high	O
blood	O
pressure	O
and	O
obesity	O
in	O
childhood	O
[	O
41	O
].	O

Because	B
of	O
its	O
steroid	O
structure	O
and	O
function	O
,	O
vitamin	O
D	O
plays	O
an	O
important	O
role	O
in	O
priming	O
cells	O
for	O
other	O
hormones	O
to	O
do	O
their	O
action	O
.	O

(	O
A	O
)	O
female	O
offspring	O
of	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

Further	O
,	O
a	O
cause	O
-	O
and	O
-	O
effect	O
relationship	O
can	O
not	O
be	O
concluded	O
from	O
this	O
study	O
.	O

The	O
fact	O
that	O
several	O
risk	O
factors	O
during	O
the	O
prenatal	O
and	O
labor	O
periods	O
are	O
implicated	O
in	O
autism	O
should	O
prompt	O
the	O
medical	O
community	O
to	O
focus	O
on	O
the	O
pregnancy	O
and	O
labor	O
periods	O
as	O
preventive	O
measures	O
to	O
curb	O
the	O
incidence	O
of	O
autism	O
.	O

The	O
ubiquitous	O
presence	O
of	O
vitamin	O
D	O
receptors	O
in	O
most	O
tissues	O
,	O
including	O
the	O
placenta	O
,	O
suggests	O
that	O
vitamin	O
D	O
may	O
have	O
other	O
roles	O
as	O
well	O
.	O

Should	O
Men	O
Take	O
Prenatal	O
Vitamins	O
?	O

Our	O
purpose	O
was	O
to	O
assess	O
if	O
there	O
are	O
any	O
similarities	O
in	O
BMI	O
patterns	O
within	O
families	O
and	O
whether	O
similarities	O
are	O
constant	O
over	O
the	O
three	O
time	O
points	O
and	O
across	O
generations	O
.	O

“	O
This	O
gives	O
us	O
more	O
confidence	O
that	O
the	O
association	O
is	O
not	B
due	I
to	O
reverse	O
causation	O
and	O
is	O
real	O
,”	O
says	O
Timmermann	O
.	O

However	O
,	O
adequate	O
maternal	O
intakes	O
of	O
zinc	O
and	O
vitamin	O
A	O
may	O
also	O
be	O
important	O
for	O
optimal	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
for	O
maternal	O
and	O
offspring	O
health	O
[	O
11	O
–	O
13	O
].	O

A	O
number	O
of	O
specific	O
actions	O
,	O
pursued	O
by	O
all	O
partners	O
and	O
applied	O
across	O
the	O
RMNCH	O
continuum	O
of	O
care	O
,	O
will	O
help	O
prevent	O
preterm	O
birth	O
and	O
associated	O
mortality	O
,	O
and	O
have	O
an	O
immediate	O
,	O
profound	O
and	O
sustained	O
impact	O
on	O
human	O
capital	O
.	O

Should	O
these	O
data	O
be	O
replicated	O
in	O
a	O
much	O
wider	O
cohort	O
,	O
given	B
the	O
simplicity	O
in	O
assessing	O
such	O
attitudes	O
and	O
the	O
feasibility	O
to	O
identify	O
the	O
homozygous	O
group	O
of	O
women	O
early	O
on	O
in	O
pregnancy	O
,	O
these	O
findings	O
may	O
have	O
significant	O
implications	O
for	O
public	O
health	O
and	O
prevention	O
.	O

However	O
this	O
current	O
practice	O
is	O
based	B
on	I
the	O
skeletal	O
actions	O
of	O
the	O
vitamin	O
and	O
may	O
not	O
be	O
applicable	O
for	O
its	O
non	O
-	O
classic	O
actions	O
.	O

If	O
the	O
delivery	O
is	O
induced	O
or	O
caesarean	O
section	O
conducted	O
,	O
the	O
reason	O
for	O
this	O
intervention	O
is	O
obtained	O
.	O

Measurement	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
Blood	O
was	O
collected	O
after	O
overnight	O
fasting	O
and	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
(	O
Molecular	O
weight	O
412	O
.	O
66	O
)	O
and	O
D3	O
(	O
Molecular	O
weight	O
400	O
.	O
63	O
)	O
levels	O
were	O
measured	O
by	O
using	O
LC	O
-	O
MS	O
/	O
MS	O
(	O
Waters	O
UPLC	O
,	O
AB	O
Sciex	O
4000QTRP	O
),	O
and	O
then	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
was	O
calculated	O
.	O

adjusted	O
for	O
paternal	O
IQ	O
but	O
not	O
the	O
home	O
environment	O
[	O
22	O
,	O
23	O
].	O

The	O
use	O
of	O
self	O
-	O
reported	O
snoring	O
as	O
a	O
tool	O
to	O
detect	O
sleep	O
disordered	O
breathing	O
is	O
well	B
established	I
.	O

Further	O
evidence	O
supporting	O
the	O
safety	O
of	O
glyburide	O
for	O
the	O
fetus	O
comes	O
from	O
a	O
study	O
using	O
an	O
in	O
vitro	O
perfusion	O
,	O
where	O
it	O
was	O
not	O
found	O
to	O
cross	O
the	O
placenta	O
in	O
significant	O
amounts	O
.	O
66However	O
,	O
another	O
in	O
vitro	O
study	O
has	O
found	O
transplacental	O
transfer	O
of	O
glyburide	O
.	O
67In	O
the	O
Langer	O
randomized	O
controlled	O
trial	O
,	O
glyburide	O
was	O
not	O
detected	O
in	O
the	O
cord	O
blood	O
of	O
the	O
neonates	O
and	O
cord	O
insulin	O
levels	O
were	O
similar	O
between	O
the	O
two	O
groups	O
.	O
57	O
Metformin	O
A	O
number	O
of	O
studies	O
have	O
provided	O
conflicting	O
information	O
regarding	O
the	O
safety	O
of	O
metformin	O
use	O
in	O
type	O
2	O
diabetic	O
pregnancy	O
.	O
68	O
–	O
70There	O
are	O
studies	O
which	O
have	O
used	O
metformin	O
during	O
pregnancy	O
in	O
women	O
with	O
polycystic	O
ovary	O
syndrome	O
,	O
without	O
any	O
noticeable	O
adverse	O
effects	O
on	O
the	O
fetus	O
.	O
71There	O
are	O
few	O
publications	O
of	O
its	O
use	O
in	O
GDM	O
,	O
and	O
these	O
are	O
dominated	O
by	O
the	O
Metformin	O
in	O
Gestational	O
Diabetes	O
(	O
MiG	O
)	O
Study	O
.	O

The	O
above	O
studies	O
provide	O
reassurance	B
that	O
moderate	O
intensity	O
activities	O
such	O
as	O
walking	O
for	O
20	O
–	O
30	O
minutes	O
each	O
day	O
,	O
and	O
attendance	O
at	O
antenatal	O
exercise	O
classes	O
can	O
be	O
safely	O
encouraged	O
,	O
and	O
that	O
modest	O
improvements	O
in	O
glycemic	O
control	O
might	O
be	O
achieved	O
.	O

In	O
contrast	O
,	O
the	O
RC	O
males	O
presented	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
whereas	O
RC	O
females	O
showed	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Faah	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Napepld	O
in	O
PAT	O
,	O
compared	O
to	O
those	O
of	O
their	O
respective	O
CC	O
offspring	O
(	O
Figures4B	O
,	O
C	O
).	O

PubMed	O
Central	O
:	O

Dietary	O
Reference	O
Intakes	O
for	O
macronutrients	O
Institute	O
of	O
Medicine	O
,	O
National	O
Academic	O
Press	O
,	O
Washington	O
:	O
2005	O
).	O

However	O
,	O
this	O
review	O
did	O
not	O
include	O
antenatal	O
iron	O
and	O
folic	O
acid	O
(	O
IFA	O
)	O
supplementation	O
for	O
pregnant	O
women	O
.	O

In	O
group	O
A	O
,	O
there	O
was	O
a	O
strong	O
positive	O
relationship	O
between	O
birth	O
head	O
circumference	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
054	O
,	O
r1	O
=	O
0	O
.	O
580	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
051	O
,	O
r2	O
=	O
0	O
.	O
530	O
).	O

When	O
analyses	O
were	O
restricted	O
to	O
overweight	O
women	O
,	O
we	O
noted	O
that	O
the	O
GDM	O
risk	O
was	O
reduced	O
by	O
24	O
%	O
for	O
each	O
sleep	O
hour	O
increment	O
(	O
RR	O
=	O
0	O
.	O
76	O
;	O
95	O
%	O
CI	O
0	O
.	O
57	O
-	O
1	O
.	O
00	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
),	O
but	O
again	O
the	O
association	O
was	O
not	O
statistically	O
significant	O
.	O

Other	O
disadvantages	O
of	O
intravenous	O
iron	O
supplementation	O
include	O
cost	O
and	O
invasiveness	O
of	O
the	O
procedure	O
.	O

It	O
would	O
not	O
be	O
possible	O
however	O
to	O
relate	O
such	O
levels	O
to	O
prenatal	O
exposure	O
.	O

The	O
results	O
of	O
this	O
study	O
to	O
address	O
these	O
hypotheses	O
are	O
presented	O
here	O
.	O

In	O
humans	O
,	O
a	O
unique	O
patient	O
suffering	O
from	O
extreme	O
diabetes	O
due	O
to	O
a	O
mutation	O
in	O
the	O
insulin	O
receptor	O
gene	O
had	O
to	O
undergo	O
total	O
thyroidectomy	O
because	O
of	O
the	O
presence	O
of	O
a	O
papillary	O
carcinoma	O
.	O

Serum	O
25OHD	O
,	O
fasting	O
glucose	O
,	O
insulin	O
and	O
insulin	O
resistance	O
(	O
HOMA	O
-	O
IR	O
)	O
were	O
measured	O
in	O
early	O
(	O
12	O
weeks	O
’	O
gestation	O
)	O
and	O
late	O
pregnancy	O
(	O
28	O
weeks	O
’	O
gestation	O
).	O

Another	O
possible	O
explanation	B
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	O
disadvantageous	O
in	O
higher	O
doses	O
.	O

Information	O
on	O
IUFD	O
was	O
collected	O
from	O
medical	O
records	O
from	O
the	O
obstetrics	O
care	O
.	O

Early	O
identification	O
of	O
pregnancy	O
In	O
the	O
intervention	O
clusters	O
,	O
trained	O
SS	O
will	O
identify	O
pregnant	O
women	O
through	O
systematic	O
door	O
-	O
to	O
-	O
door	O
visits	O
of	O
the	O
households	O
in	O
her	O
catchment	O
area	O
and	O
follow	O
-	O
up	O
with	O
all	O
women	O
of	O
reproductive	O
age	O
about	O
their	O
recent	O
history	O
of	O
missed	O
menstrual	O
periods	O
.	O

The	O
latter	O
goal	O
was	O
set	O
through	O
consultation	O
by	O
a	O
group	O
of	O
technical	O
experts	O
,	O
and	O
several	O
analyses	O
were	O
undertaken	O
to	O
inform	O
this	O
target	O
,	O
notably	O
(	O
1	O
)	O
projections	O
by	O
country	O
of	O
the	O
deaths	O
due	O
to	O
preterm	O
birth	O
from	O
now	O
until	O
2025	O
,	O
assuming	O
no	O
change	O
in	O
trends	O
and	O
assuming	O
expected	O
changes	O
in	O
Gross	O
National	O
Income	O
(	O
GNI	O
);	O
(	O
2	O
)	O
reduction	O
in	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
if	O
the	O
historical	O
trends	O
from	O
the	O
United	O
Kingdom	O
or	O
the	O
United	O
States	O
(	O
Figure4	O
)	O
were	O
applied	O
or	O
if	O
more	O
rapid	O
recent	O
reductions	O
in	O
middle	O
-	O
income	O
countries	O
were	O
applied	O
(	O
Figures5and6	O
);	O
(	O
3	O
)	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
reductions	O
predicted	O
based	O
on	O
coverage	O
changes	O
according	O
to	O
the	O
Lives	O
Saved	O
Tool	O
Modelling	O
(	O
Table2	O
).	O

We	O
found	O
a	O
significant	O
correlation	O
(	O
at	O
the	O
0	O
.	O
01	O
level	O
,	O
two	O
-	O
tailed	O
)	O
between	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
and	O
neonatal	O
birth	O
weight	O
.	O

Using	O
moderate	O
-	O
high	O
as	O
a	O
reference	O
(	O
standardised	O
vitamin	O
D	O
63	O
–	O
81	O
nmol	O
/	O
L	O
),	O
there	O
was	O
no	O
appreciable	O
effect	O
of	O
having	O
a	O
low	O
,	O
low	O
-	O
moderate	O
or	O
high	O
vitamin	O
D	O
with	O
the	O
risk	O
of	O
developing	O
any	O
pregnancy	O
complication	O
after	O
adjusting	O
for	O
confounders	O
.	O

The	O
20	O
µl	O
reactions	O
were	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
and	O
held	O
at	O
4	O
°	O
C	O
.	O

Similarly	O
,	O
rs10741657	O
(	O
CYP2R1	O
)	O
and	O
rs2282679	O
(	O
GC	O
)	O
were	O
associated	O
with	O
the	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
14	O
to	O
34	O
weeks	O
of	O
gestation	O
in	O
women	O
who	O
received	O
the	O
cholecalciferol	O
supplement	O
,	O
whereas	O
rs12785878	O
(	O
DHCR7	O
)	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
were	O
not	O
(	O
Fig	O
.	O

Conclusion	O
.	O

A	O
large	O
literature	O
primarily	O
focused	O
on	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
suggest	O
that	O
sleep	O
loss	O
adversely	O
affects	O
glucose	O
metabolism	O
and	O
increases	O
the	O
risk	O
of	O
type	O
2	O
diabetes	O
[	O
4	O
,	O
11	O
,	O
16	O
,	O
32	O
-	O
35	O
].	O

In	O
the	O
presence	O
of	O
adequate	O
concentrations	O
of	O
calcifediol	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
),	O
CYP27B1	O
leads	O
to	O
an	O
increase	O
synthesis	O
of	O
intracellular	O
calcitriol	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
).	O

Results	O
T1	O
25OHD	O
was	O
negatively	O
associated	O
with	O
pregnancy	O
loss	O
and	O
1	O
nmol	O
/	O
L	O
increase	O
in	O
25OHD	O
was	O
associated	O
with	O
1	O
%	O
lower	O
odds	O
of	O
pregnancy	O
loss	O
(	O
OR	O
0	O
.	O
99	O
,	O
p	O
=	O
0	O
.	O
046	O
).	O

Written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
parents	O
/	O
guardians	O
on	O
behalf	O
of	O
the	O
children	O
enrolled	O
in	O
this	O
study	O
.	O

However	O
,	O
we	O
were	O
not	O
able	O
take	O
environmental	O
factors	O
and	O
geographic	O
area	O
into	O
account	O
,	O
because	O
the	O
study	O
questionnaire	O
did	O
not	O
assess	O
the	O
origin	O
of	O
fish	O
,	O
such	O
as	O
the	O
Baltic	O
Sea	O
or	O
the	O
Atlantic	O
Ocean	O
.	O

They	O
concluded	O
that	O
the	O
TT	O
genotype	O
of	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
is	O
related	O
to	O
greater	O
IMF	O
than	O
the	O
CC	O
genotype	O
when	O
vitamin	O
A	O
is	O
restricted	O
,	O
and	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
could	O
be	O
a	O
genetic	O
marker	O
for	O
enhancing	O
marbling	O
in	O
feedlot	O
steers	O
.	O

Fourth	O
,	O
we	O
based	B
our	O
calculation	O
of	O
gestational	O
age	O
at	O
delivery	O
on	O
LMP	O
which	O
is	O
known	O
to	O
be	O
subject	O
to	O
recall	O
bias	O
and	O
could	O
have	O
introduced	O
errors	O
in	O
our	O
calculations	O
[	O
53	O
].	O

The	O
models	O
will	O
evaluate	O
the	O
impact	O
of	O
the	O
interventions	O
over	O
time	O
by	O
testing	O
for	O
an	O
interaction	O
between	O
time	O
and	O
intervention	O
group	O
.	O

We	O
will	O
conduct	O
analyses	O
to	O
identify	O
the	O
subgroups	O
(	O
based	O
on	O
household	O
wealth	O
,	O
sex	O
of	O
infant	O
and	O
maternal	O
education	O
)	O
that	O
modify	O
the	O
response	O
to	O
the	O
intervention	O
.	O

In	O
early	O
childhood	O
,	O
feeding	O
practices	O
,	O
taste	O
acquisition	O
,	O
and	O
eating	O
in	O
the	O
absence	O
of	O
hunger	O
must	O
be	O
considered	O
.	O

Morton	O
et	O
al	O
16indicate	O
that	O
population	O
strategies	O
aimed	O
at	O
optimising	O
size	O
at	O
birth	O
require	O
intergenerational	O
considerations	O
for	O
social	O
as	O
well	O
as	O
biological	O
reasons	O
.	O

We	O
will	O
use	O
sensitivity	O
analyses	O
of	O
the	O
findings	O
to	O
assess	O
uncertainty	O
in	O
key	O
parameters	O
.	O

Additionally	O
,	O
glucose	O
concentrations	O
were	O
statistically	O
significantly	O
elevated	O
among	O
women	O
who	O
snored	O
during	O
pregnancy	O
;	O
and	O
the	O
relative	O
risk	O
of	O
GDM	O
among	O
overweight	O
women	O
who	O
snored	O
,	O
compared	O
to	O
their	O
non	O
-	O
snoring	O
and	O
lean	O
counterparts	O
was	O
6	O
.	O
91	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

One	O
mechanism	O
the	O
infant	O
gut	O
microbiome	O
may	O
be	O
affected	O
by	O
maternal	O
diet	O
is	O
via	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
at	O
delivery	O
.	O

This	O
was	O
done	O
using	O
a	O
sequential	O
list	O
prepared	O
based	O
on	O
tables	O
of	O
random	O
numbers	O
.	O

Vitamin	O
and	O
mineral	O
supplements	O
are	O
recommended	O
for	O
women	O
with	O
multiple	O
pregnancy	O
,	O
those	O
who	O
misuse	O
alcohol	O
or	O
drugs	O
,	O
or	O
have	O
an	O
unbalanced	O
diet	O
[	O
32	O
].	O

Same	O
result	O
was	O
obtained	O
about	O
healthy	O
dietary	O
pattern	O
[	O
OR	O
3	O
.	O
70	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
72	O
-	O
17	O
.	O
86	O
),	O
P	O
=	O
0	O
.	O
52	O
].	O

It	O
will	O
be	O
valuable	O
to	O
utilise	O
our	O
clinical	O
and	O
biological	O
databases	O
to	O
explore	O
potential	O
pathways	O
whereby	O
maternal	O
obesity	O
contributes	O
to	O
childhood	O
outcomes	O
,	O
including	O
obesity	O
and	O
impaired	O
neurodevelopment	O
.	O

While	O
statistically	O
significant	O
,	O
the	O
clinical	O
significance	O
of	O
such	O
a	O
small	O
difference	O
is	O
questionable	O
,	O
the	O
findings	O
also	O
consistent	O
with	O
a	O
chance	O
occurrence	O
,	O
particularly	O
as	O
this	O
was	O
a	O
secondary	O
outcome	O
,	O
and	O
no	O
other	O
statistically	O
significant	O
differences	O
were	O
identified	O
between	O
the	O
treatment	O
groups	O
in	O
infant	O
BMI	O
,	O
abdominal	O
circumference	O
,	O
or	O
the	O
remainder	O
of	O
infant	O
anthropometric	O
measures	O
obtained	O
.	O

In	O
perinatal	O
piglets	O
(	O
stage	O
1	O
dpn	O
)	O
1	O
probe	O
-	O
set	O
differed	O
between	O
LP	O
offspring	O
and	O
AP	O
offspring	O
(	O
0	O
increased	O
).	O

2	O
.	O
4	O
.	O

We	O
used	O
PyNAST	O
alignment	O
[	O
37	O
]	O
with	O
Greengenes	O
core	O
reference	O
[	O
38	O
,	O
39	O
]	O
to	O
build	O
OTU	O
tables	O
and	O
assign	O
taxonomy	O
[	O
39	O
,	O
40	O
].	O

Given	O
the	O
very	O
high	O
levels	O
of	O
sugar	O
consumption	O
currently	O
in	O
the	O
West	O
,	O
where	O
childhood	O
allergy	O
and	O
asthma	O
are	O
so	O
prevalent	O
,	O
confirmation	O
of	O
a	O
causal	O
link	O
would	O
raise	O
exciting	O
prospects	O
for	O
the	O
primary	O
prevention	O
of	O
these	O
disorders	O
.	O

We	O
demultiplexed	O
and	O
divided	O
datasets	O
using	O
Illumina	O
MiSeq	O
Reporter	O
and	O
a	O
custom	O
Python	O
script	O
.	O

The	O
relative	O
quantification	O
method	O
was	O
performed	O
using	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
;	O
Cat	O
#	O
Rn99999916_s1	O
)	O
as	O
an	O
endogenous	O
control	O
,	O
which	O
was	O
selected	O
based	O
on	O
a	O
preliminary	O
screen	O
for	O
its	O
lowest	O
variation	O
.	O

Our	O
results	O
suggest	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
,	O
independently	O
of	O
sugar	O
intake	O
in	O
early	O
childhood	O
.	O

(	O
2015	O
)*	O
Kundakovic	O
et	O
al	O
.	O

Paradoxically	O
,	O
central	O
IL	O
-	O
6	O
delivery	O
was	O
shown	O
to	O
suppress	O
weight	O
gain	O
and	O
visceral	O
obesity	O
,	O
without	O
affecting	O
food	O
intake	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Our	O
results	O
further	O
show	O
different	O
metabolic	O
regulations	O
in	O
groups	O
A	O
and	O
B	O
,	O
which	O
may	O
be	O
due	B
to	I
differences	O
in	O
expression	O
of	O
SIRT1	O
,	O
glucose	O
transfer	O
or	O
insulin	O
resistance	O
as	O
a	O
result	O
of	O
resistance	O
to	O
glucose	O
entry	O
to	O
fetal	O
tissues	O
for	O
unknown	O
reasons	O
,	O
which	O
require	O
further	O
studies	O
.	O

Food	O
intake	O
was	O
recorded	O
daily	O
until	O
the	O
end	O
of	O
pregnancy	O
.	O

Materials	O
and	O
Methods	O
Ethics	O
Statement	O
All	O
animal	O
work	O
was	O
approved	O
by	O
the	O
Animal	O
Ethics	O
Committee	O
of	O
the	O
University	O
of	O
Auckland	O
.	O

All	O
calves	O
were	O
then	O
fed	O
the	O
same	O
diet	O
for	O
22	O
months	O
,	O
and	O
muscle	O
tissues	O
were	O
collected	O
by	O
biopsy	O
.	O

After	O
expert	O
review	O
,	O
the	O
final	O
questionnaire	O
used	O
had	O
29	O
items	O
(	O
see	O
Additional	O
file1	O
).	O

SGA	O
was	O
defined	O
as	O
weight	O
and	O
/	O
or	O
length	O
at	O
birth	O
<	O
2	O
SD	O
of	O
the	O
population	O
mean	O
and	O
LBW	O
as	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
<	O
37	O
+	O
0	O
gestational	O
weeks	O
and	O
pregnancy	O
loss	O
as	O
spontaneous	O
abortion	O
or	O
intrauterine	O
fetal	O
death	O
.	O

Part	O
of	O
an	O
adaptive	O
response	O
to	O
early	O
life	O
nutritional	O
challenge	O
might	O
therefore	B
be	O
expected	O
to	O
be	O
an	O
acceleration	O
in	O
the	O
age	O
of	O
reproductive	O
maturation	O
,	O
provided	O
that	O
the	O
organism	O
can	O
metabolically	O
sustain	O
earlier	O
reproduction	O
without	O
further	O
compromising	O
its	O
own	O
viability	O
.	O

Further	O
,	O
Gangwisch	O
et	O
al	O
,	O
in	O
their	O
analysis	O
of	O
data	O
from	O
the	O
first	O
National	O
Health	O
and	O
Nutrition	O
Examination	O
Survey	O
(	O
NHANES	O
I	O
)	O
noted	O
that	O
individuals	O
reporting	O
≤	O
5	O
hours	O
of	O
sleep	O
(	O
OR	O
=	O
1	O
.	O
47	O
;	O
95	O
%	O
CI	O
1	O
.	O
03	O
-	O
2	O
.	O
09	O
)	O
and	O
those	O
reporting	O
sleeping	O
≥	O
9	O
hours	O
(	O
OR	O
=	O
1	O
.	O
52	O
;	O
95	O
%	O
CI	O
1	O
.	O
06	O
-	O
2	O
.	O
18	O
)	O
had	O
increased	O
risks	O
of	O
developing	O
diabetes	O
as	O
compared	O
to	O
those	O
reporting	O
7	O
hours	O
of	O
sleep	O
[	O
34	O
].	O

Of	O
these	O
,	O
952	O
probe	O
-	O
sets	O
showed	O
higher	O
expression	O
and	O
1	O
,	O
132	O
probe	O
-	O
sets	O
showed	O
lower	O
expression	O
in	O
LP	O
than	O
in	O
AP	O
offspring	O
.	O

This	O
DSMB	O
is	O
responsible	O
for	O
assessing	O
the	O
interim	O
data	O
,	O
data	O
quality	O
,	O
data	O
completeness	O
,	O
adequacy	O
of	O
compliance	O
with	O
goals	O
for	O
recruitment	O
and	O
retention	O
,	O
and	O
factors	O
that	O
might	O
affect	O
the	O
study	O
outcome	O
or	O
compromise	O
the	O
confidentiality	O
of	O
the	O
trial	O
data	O
.	O

Due	O
to	O
the	O
normal	O
dietary	O
conditions	O
at	O
juvenile	O
and	O
adult	O
stages	O
the	O
alterations	O
found	O
here	O
can	O
be	O
regarded	O
as	O
fetal	O
nutritional	O
programming	O
.	O

We	O
recruited	O
385	O
consenting	O
pregnant	O
women	O
for	O
the	O
study	O
.	O

It	O
demonstrated	O
an	O
association	O
between	O
in	O
utero	O
exposure	O
to	O
both	O
SSRIs	O
and	O
nonselective	O
monoamine	O
reuptake	O
inhibitors	O
with	O
an	O
increased	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
,	O
particularly	O
without	O
intellectual	O
disability	O
.	O

Mean	O
haemoglobin	O
concentration	O
change	O
(	O
baseline	O
to	O
follow	O
-	O
up	O
)	O
was	O
compared	O
between	O
treatment	O
groups	O
with	O
analysis	O
of	O
covariance	O
.	O

Short	O
-	O
term	O
diets	O
comprised	O
solely	O
of	O
either	O
plant	O
or	O
animal	O
foods	O
have	O
been	O
shown	O
to	O
alter	O
the	O
human	O
gut	O
microbiome	O
[	O
3	O
].	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

Therefore	B
glyburide	O
has	O
the	O
potential	O
to	O
result	O
in	O
earlier	O
development	O
of	O
maternal	O
diabetes	O
,	O
and	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
mothers	O
are	O
needed	O
to	O
alleviate	O
this	O
concern	O
.	O

Limitations	O
Vitamin	O
D	O
consumption	O
by	O
mothers	O
was	O
merely	O
controlled	O
through	O
reminders	O
during	O
prenatal	O
care	O
visits	O
or	O
over	O
the	O
phone	O
.	O

Although	O
self	O
-	O
reported	O
alcohol	O
consumption	O
would	O
be	O
expected	O
to	O
be	O
lower	O
after	O
pregnancy	O
given	B
social	O
cues	O
and	O
available	O
information	O
about	O
health	O
risks	O
for	O
all	O
participants	O
,	O
the	O
dose	O
-	O
response	O
effect	O
among	O
text4baby	O
participants	O
was	O
pronounced	O
,	O
as	B
high	O
-	O
dose	O
participants	O
were	O
more	O
than	O
twice	O
as	O
likely	B
to	O
abstain	O
from	O
drinking	O
compared	O
to	O
low	O
-	O
dose	O
participants	O
.	O

W	O
Epidemiological	O
analyses	O
implicated	O
high	O
dietary	O
vitamin	O
D	O
intake	O
during	O
pregnancy	O
results	O
in	O
birth	O
of	O
syndromic	O
babies	O
.	O

Mice	O
fed	O
with	O
a	O
folate	O
deficient	O
diet	O
were	O
less	O
fertile	O
(	O
52	O
%	O
vs	O
.	O
85	O
%)	O
and	O
experienced	O
a	O
greater	O
post	O
-	O
implantation	O
loss	O
than	O
mice	O
fathered	O
by	O
mice	O
with	O
a	O
folate	O
sufficient	O
diet	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Evaluation	O
of	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
among	O
pregnant	O
women	O
by	O
trimester	O
of	O
vaccination	O
with	O
propensity	O
score	O
matching	O
(	O
PSM	O
)	O
analysis	O
*,	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
,	O
Nicaragua	O
.	O
Birth	O
outcomesInfluenza	O
vaccine	O
2014	O
seasonVaccinated	O
in	O
first	O
trimester	O
(	O
n	O
=	O
280	O
)	O
Vaccinated	O
in	O
second	O
trimester	O
(	O
n	O
=	O
1600	O
)	O
Vaccinated	O
in	O
third	O
trimester	O
(	O
n	O
=	O
1162	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
×	O
1000sim	O
***	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
0	O
.	O
90	O
(	O
0	O
.	O
40	O
;	O
2	O
.	O
03	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
86	O
;	O
1	O
.	O
17	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
55	O
;	O
1	O
.	O
25	O
)	O
Preterm	O
birth	O
**(	O
PTB	O
)	O
1	O
.	O
67	O
(	O
0	O
.	O
73	O
;	O
3	O
.	O
83	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
75	O
;	O
0	O
.	O
99	O
)	O
0	O
.	O
66	O
(	O
0	O
.	O
45	O
;	O
0	O
.	O
96	O
)	O
Low	O
birth	O
weight	O
(	O
LBW	O
)**	O
1	O
.	O
71	O
(	O
0	O
.	O
55	O
;	O
5	O
.	O
26	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
64	O
;	O
0	O
.	O
97	O
)	O
0	O
.	O
64	O
(	O
0	O
.	O
38	O
;	O
1	O
.	O
09	O
)	O
aOR	O
=	O
Adjusted	O
Odds	O
Ratio	O
.	O

Those	O
that	O
may	O
be	O
of	O
particular	O
interest	O
for	O
development	O
into	O
regulatory	O
strategies	O
/	O
procedures	O
are	O
presented	O
inTables	O
1and2	O
.	O

Further	O
research	O
should	O
investigate	O
variables	O
in	O
family	O
relationships	O
,	O
the	O
home	O
,	O
and	O
the	O
extended	O
environment	O
that	O
influence	O
eating	O
.	O

Genetics	O
and	O
breed	O
,	O
management	O
,	O
and	O
nutrition	O
affect	O
IMF	O
deposition	O
.	O

Only	O
one	O
stool	O
sample	O
showed	O
hookworm	O
infection	O
.	O

Amongst	O
them	O
,	O
15	O
mothers	O
leaved	O
the	O
study	O
,	O
because	O
their	O
depression	O
scores	O
were	O
higher	O
than	O
13	O
.	O

Vitamin	O
D	O
deficiency	O
was	O
not	O
significantly	O
associated	O
with	O
SGA	O
in	O
white	O
infants	O
.	O

Application	O
of	O
fetal	O
nutritional	O
programming	O
to	O
increase	O
IMF	O
deposition	O
of	O
progeny	O
in	O
later	O
life	O
is	O
reviewed	O
.	O

Otherwise	O
,	O
we	O
found	O
no	O
clear	O
published	O
evidence	O
for	O
times	O
at	O
which	O
maternal	O
or	O
other	O
caregiver	O
handwashing	O
may	O
prevent	O
pathogen	O
transfer	O
to	O
/	O
from	O
hands	O
in	O
low	O
-	O
income	O
settings	O
.	O

All	O
the	O
studies	O
shown	O
here	O
demonstrated	O
associations	O
among	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

Results	O
from	O
a	O
review	O
of	O
several	O
randomized	O
clinical	O
trials	O
of	O
PUFA	O
treatment	O
of	O
schizophrenia	O
were	O
inconclusive	O
,	O
although	O
,	O
it	O
seems	O
that	O
supplementation	O
of	O
especially	O
EPA	O
to	O
these	O
patients	O
may	O
have	O
a	O
positive	O
effect	O
on	O
their	O
schizophrenic	O
symptoms	O
[	O
17	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Selected	O
characteristics	O
of	O
participant	O
pregnant	O
women	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
AllVaccinatedUnvaccinatedp	O
-	O
value	O
†	O
n	O
=	O
3268n	O
=	O
1789n	O
=	O
1479n	O
(%)	O
n	O
(%)	O
n	O
(%)	O
Age	O
<	O
18	O
years415	O
(	O
13	O
)	O
232	O
(	O
13	O
)	O
183	O
(	O
12	O
)	O
0	O
.	O
80	O
18	O
–	O
34	O
years2620	O
(	O
80	O
)	O
1433	O
(	O
80	O
)	O
1187	O
(	O
80	O
)	O
≥	O
35	O
years233	O
(	O
7	O
)	O
124	O
(	O
7	O
)	O
109	O
(	O
7	O
)	O
Number	O
of	O
persons	O
in	O
household	O
2	O
–	O
4898	O
(	O
27	O
)	O
528	O
(	O
30	O
)	O
370	O
(	O
25	O
)	O
0	O
.	O
02	O
5	O
–	O
61070	O
(	O
33	O
)	O
580	O
(	O
32	O
)	O
490	O
(	O
33	O
)	O
7	O
–	O
8707	O
(	O
22	O
)	O
381	O
(	O
21	O
)	O
326	O
(	O
22	O
)	O
>	O
8593	O
(	O
18	O
)	O
300	O
(	O
17	O
)	O
293	O
(	O
20	O
)	O
Delivered	O
at	O
reference	O
*	O
obstetric	O
hospital1722	O
(	O
53	O
)	O
1083	O
(	O
61	O
)	O
639	O
(	O
43	O
)<	O
0	O
.	O
01Education	O
level	O
No	O
education	O
/	O
primary	O
school	O
incomplete421	O
(	O
13	O
)	O
231	O
(	O
13	O
)	O
190	O
(	O
13	O
)	O
0	O
.	O
01	O
Primary	O
school	O
complete337	O
(	O
10	O
)	O
195	O
(	O
11	O
)	O
142	O
(	O
10	O
)	O
Secondary	O
school	O
incomplete1372	O
(	O
42	O
)	O
771	O
(	O
43	O
)	O
601	O
(	O
41	O
)	O
Secondary	O
school	O
complete637	O
(	O
19	O
)	O
353	O
(	O
20	O
)	O
284	O
(	O
19	O
)	O
Technical	O
/	O
university	O
studies501	O
(	O
15	O
)	O
239	O
(	O
13	O
)	O
262	O
(	O
18	O
)	O
Received	O
at	O
least	O
one	O
dose	O
of	O
tetanus	O
vaccine2984	O
(	O
91	O
)	O
1759	O
(	O
98	O
)	O
1225	O
(	O
83	O
)<	O
0	O
.	O
01At	O
least	O
one	O
antenatal	O
visits3172	O
(	O
97	O
)	O
1786	O
(	O
100	O
)	O
1386	O
(	O
94	O
)<	O
0	O
.	O
01Four	O
or	O
more	O
antenatal	O
visits2549	O
(	O
78	O
)	O
1542	O
(	O
86	O
)	O
1007	O
(	O
68	O
)<	O
0	O
.	O
01Gestational	O
age	O
at	O
first	O
antenatal	O
visit	O
(	O
median	O
,	O
quantiles	O
in	O
weeks	O
)	O
12	O
(	O
9	O
,	O
19	O
)	O
12	O
(	O
9	O
,	O
17	O
)	O
13	O
(	O
9	O
,	O
22	O
)<	O
0	O
.	O
01	O
‡	O
Consumption	O
of	O
iron	O
and	O
folic	O
acid1485	O
(	O
45	O
)	O
805	O
(	O
45	O
)	O
680	O
(	O
46	O
)	O
0	O
.	O
59Consumption	O
of	O
albendazol703	O
(	O
22	O
)	O
482	O
(	O
27	O
)	O
221	O
(	O
15	O
)<	O
0	O
.	O
01Consumption	O
of	O
calcium1243	O
(	O
38	O
)	O
722	O
(	O
40	O
)	O
521	O
(	O
35	O
)<	O
0	O
.	O
01Consumption	O
of	O
aspirin938	O
(	O
29	O
)	O
600	O
(	O
34	O
)	O
338	O
(	O
23	O
)<	O
0	O
.	O
01	O
BMI	O
(	O
height	O
and	O
weight	O
measured	O
at	O
1st	O
antenatal	O
visit	O
)	O
Underweight	O
(<	O
18	O
.	O
5	O
)	O
315	O
(	O
10	O
)	O
116	O
(	O
6	O
)	O
199	O
(	O
13	O
)<	O
0	O
.	O
01	O
Normal	O
weight	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
)	O
1338	O
(	O
41	O
)	O
808	O
(	O
45	O
)	O
530	O
(	O
36	O
)	O
Overweight	O
(	O
25	O
–	O
29	O
.	O
9	O
)	O
928	O
(	O
28	O
)	O
510	O
(	O
29	O
)	O
418	O
(	O
28	O
)	O
Obesity	O
I	O
(	O
30	O
–	O
34	O
.	O
9	O
)	O
408	O
(	O
12	O
)	O
224	O
(	O
13	O
)	O
184	O
(	O
12	O
)	O
Obesity	O
II	O
(	O
35	O
–	O
39	O
.	O
9	O
)	O
163	O
(	O
5	O
)	O
87	O
(	O
5	O
)	O
76	O
(	O
5	O
)	O
Extreme	O
obesity	O
(>	O
40	O
)	O
88	O
(	O
3	O
)	O
41	O
(	O
2	O
)	O
47	O
(	O
3	O
)	O
Alcohol	O
consumption	O
before	O
pregnancy441	O
(	O
13	O
)	O
220	O
(	O
12	O
)	O
221	O
(	O
15	O
)	O
0	O
.	O
05Renal	O
Disease1266	O
(	O
39	O
)	O
734	O
(	O
41	O
)	O
532	O
(	O
36	O
)<	O
0	O
.	O
01Blood	O
Disease743	O
(	O
23	O
)	O
445	O
(	O
25	O
)	O
298	O
(	O
20	O
)<	O
0	O
.	O
01At	O
least	O
one	O
chronic	O
condition	O
**	O
1855	O
(	O
57	O
)	O
1069	O
(	O
60	O
)	O
786	O
(	O
53	O
)<	O
0	O
.	O
01	O
Number	O
of	O
parturitions	O
11519	O
(	O
46	O
)	O
879	O
(	O
49	O
)	O
640	O
(	O
43	O
)<	O
0	O
.	O
01	O
2	O
–	O
31447	O
(	O
44	O
)	O
768	O
(	O
43	O
)	O
679	O
(	O
46	O
)	O
>	O
3302	O
(	O
9	O
)	O
142	O
(	O
8	O
)	O
160	O
(	O
11	O
)	O
Female1585	O
(	O
49	O
)	O
804	O
(	O
45	O
)	O
781	O
(	O
53	O
)<	O
0	O
.	O
01Preterm	O
birth175	O
(	O
5	O
)	O
95	O
(	O
5	O
)	O
80	O
(	O
5	O
)	O
0	O
.	O
96Small	O
for	O
gestational	O
age343	O
(	O
10	O
)	O
198	O
(	O
11	O
)	O
145	O
(	O
10	O
)	O
0	O
.	O
26Low	O
birth	O
weight195	O
(	O
6	O
)	O
99	O
(	O
6	O
)	O
96	O
(	O
6	O
)	O
0	O
.	O
28	O
X2test	O
.	O

Harmon	O
and	O
McLeod	O
[	O
111	O
]	O
reported	O
that	O
starch	O
digestion	O
is	O
more	O
efficient	O
in	O
the	O
small	O
intestine	O
than	O
during	O
fermentation	O
in	O
the	O
rumen	O
:	O
the	O
total	O
energetic	O
efficiency	O
of	O
rumen	O
-	O
fermented	O
starch	O
was	O
about	O
73	O
%	O
that	O
of	O
small	O
intestine	O
-	O
digested	O
starch	O
.	O

Illicit	O
Drug	O
Exposure	O
,	O
Smoking	O
,	O
and	O
Pollutants	O
Drug	O
exposure	O
may	O
have	O
very	O
serious	O
complications	O
during	O
pregnancy	O
.	O

All	O
the	O
different	O
cell	O
types	O
that	O
comprise	O
the	O
new	O
individual	O
develop	O
from	O
this	O
zygote	O
and	O
so	O
contain	O
the	O
same	O
unique	O
genome	O
.	O

Follow	O
-	O
up	O
testing	O
was	O
recommended	O
between	O
24	O
–	O
28	O
weeks	O
and	O
prior	O
to	O
delivery	O
by	O
provider	O
request	O
.	O

This	O
assumption	O
is	O
based	O
on	O
the	O
fact	O
that	O
the	O
main	O
risk	O
factors	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
sun	O
exposure	O
and	O
/	O
or	O
ethnicity	O
)	O
are	O
common	O
to	O
many	O
European	O
countries	O
.	O

Results	O
The	O
prevalence	O
of	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
48	O
%	O
for	O
folic	O
acid	O
,	O
45	O
.	O
3	O
%	O
for	O
iron	O
and	O
68	O
%	O
for	O
multivitamins	O
.	O

Of	O
note	O
,	O
brain	O
tumors	O
are	O
known	O
to	O
contain	O
sex	O
steroid	O
receptors	O
(	O
e	O
.	O
g	O
.,	O
estrogen	O
,	O
androgen	O
,	O
progestin	O
)	O
[	O
198	O
],	O
and	O
sex	O
hormones	O
have	O
been	O
shown	O
to	O
promote	O
brain	O
tumors	O
in	O
animal	O
studies	O
[	O
199	O
,	O
200	O
].	O

Previous	O
studies	O
reported	O
that	O
unplanned	O
pregnancy	O
is	O
a	O
risk	O
factor	O
for	O
perinatal	O
depression	O
.	O

While	O
much	O
of	O
the	O
work	O
to	O
date	O
has	O
focused	O
on	O
rodent	O
models	O
,	O
there	O
is	O
also	O
some	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
other	O
mammalian	O
species	O
,	O
including	O
sheep	O
and	O
monkeys	O
(	O
Wu	O
et	O
al	O
.	O
2008	O
;	O
Begum	O
et	O
al	O
.	O
2013	O
;	O
Lie	O
et	O
al	O
.	O
2014a	O
,	O
2014b	O
).	O

The	O
strengths	O
of	O
this	O
study	O
include	O
the	O
large	O
sample	O
size	O
,	O
population	O
-	O
based	O
ascertainment	O
of	O
placenta	O
samples	O
,	O
quantitative	O
assessment	O
of	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
,	O
and	O
the	O
use	O
of	O
a	O
well	O
-	O
established	O
,	O
high	O
-	O
density	O
methylation	O
array	O
for	O
methylation	O
profiling	O
.	O

While	O
the	O
exact	O
mechanism	O
by	O
which	O
PFAS	O
impact	O
birth	O
weight	O
is	O
unknown	O
,	O
several	O
theories	O
have	O
been	O
proposed	O
.	O

Current	O
understanding	O
suggests	O
that	O
hypoxia	O
is	O
one	O
of	O
the	O
complications	O
of	O
prolonged	O
labor	O
,	O
along	O
with	O
infection	O
,	O
or	O
head	O
trauma	O
from	O
extended	O
pressure	O
.	O

In	O
our	O
study	O
,	O
maternal	O
vitamin	O
D	O
concentrations	O
were	O
similar	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
,	O
and	O
there	O
was	O
no	O
linear	O
association	O
between	O
vitamin	O
D	O
concentrations	O
and	O
OGTT	O
results	O
.	O

In	O
the	O
clinical	O
trials	O
,	O
compounds	O
from	O
the	O
venom	O
have	O
proven	O
beneficial	O
and	O
caused	O
no	O
apparent	O
side	O
effects	O
in	O
patients	O
with	O
advanced	O
liver	O
,	O
pancreatic	O
,	O
or	O
lung	O
cancer	O
.	O

MTRL	O
has	O
been	O
funded	O
by	O
a	O
FPU	O
predoctoral	O
fellowship	O
of	O
the	O
Spanish	O
Ministerio	O
de	O
Educación	O
,	O
Cultura	O
y	O
Deporte	O
(	O
AP	O
-	O
2009	O
-	O
0225	O
);	O
JS	O
holds	O
a	O
“	O
Miguel	O
Servet	O
”	O
research	O
contract	O
from	O
the	O
National	O
System	O
of	O
Health	O
,	O
ISCIII	O
(	O
grant	O
number	O
CP12	O
/	O
03109	O
).	O

Statistical	O
Analysis	O
Sample	O
size	O
determination	O
(	O
at	O
least	O
16	O
each	O
Hispanic	O
and	O
Caucasian	O
)	O
was	O
done	O
to	O
identify	O
a	O
one	O
standard	O
deviation	O
difference	O
in	O
the	O
change	O
in	O
bone	O
mineralization	O
between	O
one	O
week	O
of	O
age	O
and	O
three	O
months	O
of	O
age	O
by	O
ethnicity	O
.	O

[	O
20	O
]	O
and	O
defined	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
at	O
birth	O
as	O
WFA	O
z	O
-	O
scores	O
<	O
10th	O
percentile	O
and	O
large	O
for	O
gestational	O
age	O
as	O
WFA	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
.	O

Whatever	O
the	O
mechanism	O
,	O
the	O
relationship	O
between	O
smoking	O
during	O
pregnancy	O
and	O
children	O
'	O
s	O
overweight	O
is	O
well	O
documented	O
(	O
16	O
,	O
17	O
)	O
In	O
1	O
study	O
,	O
for	O
example	O
,	O
babies	O
born	O
to	O
mothers	O
who	O
smoked	O
during	O
pregnancy	O
weighed	O
less	O
than	O
did	O
babies	O
born	O
to	O
nonsmokers	O
(	O
18	O
).	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
and	O
RPMM	O
class	O
methylation	O
(	O
p	O
=	O
0	O
.	O
01	O
);	O
no	O
association	O
was	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
RPMM	O
class	O
methylation	O
.	O

Mean	O
(	O
SD	O
)	O
maternal	O
25OHD	O
at	O
T1	O
was	O
64	O
(	O
24	O
.	O
4	O
)	O
nmol	O
/	O
L	O
and	O
75	O
(	O
34	O
.	O
4	O
)	O
nmol	O
/	O
L	O
at	O
T3	O
.	O

For	O
Whites	O
,	O
but	O
not	O
African	O
Americans	O
,	O
having	O
no	O
pet	O
compared	O
to	O
1	O
or	O
>	O
1	O
pet	O
during	O
pregnancy	O
was	O
associated	O
with	O
lower	O
cord	O
blood	O
vitamin	O
D	O
concentrations	O
(	O
37	O
.	O
7	O
,	O
45	O
.	O
2	O
,	O
47	O
.	O
0	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
001	O
).	O

Lung	O
function	O
was	O
measured	O
by	O
spirometry	O
(	O
Vitalograph	O
2120	O
;	O
Vitalograph	O
,	O
Maids	O
Moreton	O
,	O
UK	O
)	O
at	O
age	O
8	O
.	O
5	O
years	O
after	O
withholding	O
short	O
-	O
acting	O
bronchodilators	O
for	O
at	O
least	O
6	O
h	O
and	O
long	O
-	O
acting	O
bronchodilators	O
and	O
theophyllines	O
for	O
at	O
least	O
24	O
h	O
.	O
The	O
best	O
of	O
three	O
reproducible	O
flow	O
–	O
volume	O
curves	O
was	O
used	O
to	O
measure	O
forced	O
expiratory	O
volume	O
in	O
1	O
s	O
(	O
FEV1	O
),	O
forced	O
vital	O
capacity	O
(	O
FVC	O
)	O
and	O
maximal	O
mid	O
-	O
expiratory	O
flow	O
(	O
forced	O
expiratory	O
flow	O
at	O
25	O
–	O
75	O
%	O
of	O
FVC	O
(	O
FEF25	O
–	O
75	O
)),	O
which	O
were	O
further	O
transformed	O
to	O
age	O
-,	O
height	O
-	O
and	O
sex	O
-	O
adjusted	O
standard	O
deviation	O
units	O
[	O
17	O
].	O

The	O
final	O
version	O
of	O
the	O
database	O
will	O
be	O
stored	O
under	O
protected	O
zipped	O
files	O
.	O

Over	O
the	O
past	O
several	O
decades	O
,	O
continuing	O
research	O
has	O
been	O
conducted	O
,	O
and	O
much	O
literature	O
has	O
been	O
published	O
that	O
has	O
supported	O
the	O
existence	O
of	O
the	O
links	O
between	O
autism	O
and	O
factors	O
that	O
relate	O
to	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
.	O

This	O
would	O
be	O
expected	O
as	B
subjects	O
who	O
are	O
iron	O
-	O
depleted	O
use	O
iron	O
more	O
effectively	O
than	O
those	O
who	O
are	O
iron	O
-	O
replete	O
(	O
Moriarty	O
-	O
Craige	O
et	O
al	O
2004	O
).	O

‡	O
Pearson	O
'	O
s	O
χ²	O
test	O
.	O

The	O
mechanism	O
of	O
PTH	O
reduction	O
is	O
that	O
an	O
increased	O
serum	O
vitamin	O
D	O
leads	O
to	O
a	O
decrease	O
in	O
PTH	O
gene	O
translation	O
,	O
and	O
thus	B
PTH	O
secretion	O
.	O

To	O
ensure	O
the	O
absence	O
of	O
a	O
DNA	O
contamination	O
within	O
the	O
isolated	O
RNA	O
a	O
PCR	O
amplification	O
with	O
the	O
porcine	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
gene	O
was	O
done	O
(	O
Forward	O
primer	O
:	O
aagcagggatgatgttctgg	O
;	O
Reverse	O
primer	O
:	O
atgcctcctgtaccaccaac	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Risk	O
factors	O
related	O
to	O
the	O
development	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
stratified	O
by	O
pre	O
-	O
pregnancy	O
Body	O
Mass	O
Index	O
(	O
PPBMI	O
)	O
classification	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
the	O
disease	O
,	O
Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

S1	O
.	O

For	O
example	O
,	O
rather	O
than	O
sorting	O
through	O
23	O
PCBs	O
to	O
identify	O
those	O
that	O
are	O
significant	O
,	O
we	O
simply	O
reported	O
the	O
average	O
association	O
of	O
all	O
23	O
PCBs	O
and	O
birth	O
weight	O
.	O

Thus	B
,	O
sufficient	O
evidence	O
is	O
lacking	O
at	O
this	O
time	O
to	O
recommend	O
routine	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
.	O
12However	O
,	O
identification	O
of	O
specific	O
risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
and	O
the	O
additive	O
effects	O
of	O
these	O
risk	O
factors	O
may	O
lead	O
to	O
opportunities	O
for	O
targeted	O
supplementation	O
with	O
improved	O
outcomes	O
.	O

As	B
insulin	O
therapy	O
is	O
effective	O
and	O
safe	O
,	O
it	O
is	O
considered	O
the	O
gold	O
standard	O
of	O
pharmacotherapy	O
for	O
gestational	O
diabetes	O
,	O
against	O
which	O
other	O
treatments	O
have	O
been	O
compared	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIG	O
3	O
Scatter	O
plots	O
showing	O
the	O
correlation	O
between	O
birth	O
weight	O
with	O
HF	O
,	O
parameter	O
of	O
the	O
frequency	O
domain	O
.	O

Nevertheless	O
,	O
the	O
statistically	O
significant	O
effect	O
and	O
the	O
size	O
of	O
differences	O
observed	O
between	O
mothers	O
with	O
negative	O
versus	O
positive	O
and	O
neutral	O
attitudes	O
in	O
the	O
Tht111	O
I	O
CC	O
polymorphism	O
group	O
suggest	O
that	O
this	O
effect	O
may	O
be	O
robust	O
.	O

Further	O
,	O
the	O
conversion	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
of	O
the	O
hormone	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
,	O
was	O
optimized	O
at	O
40	O
ng	O
/	O
mL	O
among	O
pregnant	O
women	O
[	O
13	O
].	O

Seventeen	O
vitamin	O
D	O
experts	B
recently	O
stated	O
,	O
‘	O
In	O
our	O
opinion	O
,	O
children	O
with	O
chronic	O
illnesses	O
such	O
as	O
autism	O
,	O
diabetes	O
and	O
/	O
or	O
frequent	O
infections	O
should	O
be	O
supplemented	O
with	O
higher	O
doses	O
of	O
sunshine	O
or	O
vitamin	O
D3	O
,	O
doses	O
adequate	O
to	O
maintain	O
their	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
the	O
mid	O
-	O
normal	O
of	O
the	O
reference	O
range	O
[	O
65	O
ng	O
/	O
mL	O
(	O
162	O
nmol	O
/	O
L	O
)]	O
–	O
and	O
should	O
be	O
so	O
supplemented	O
year	O
round	O
.’	O
(	O
22	O
)	O
Finally	O
,	O
if	O
true	B
,	O
a	O
darker	O
side	O
of	O
the	O
theory	O
emerges	O
.	O

Background	O
With	O
an	O
increasing	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
and	O
insufficiency	O
reported	O
both	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
as	O
well	O
as	O
worldwide	O
[	O
1	O
],	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
deficiency	O
may	O
influence	O
health	O
in	O
pregnancy	O
.	O

Lower	O
expression	O
of	O
the	O
anorexigenic	O
genes	O
in	O
the	O
offspring	O
of	O
dams	O
fed	O
the	O
multivamins	O
during	O
pregnancy	O
is	O
consistent	O
with	O
the	O
observed	O
increased	O
food	O
intake	O
.	O

Statistical	O
Analysis	O
Analysis	O
was	O
completed	O
using	O
the	O
cathelicidin	O
concentration	O
values	O
obtained	O
from	O
each	O
child	O
’	O
s	O
yearly	O
follow	O
-	O
up	O
visit	O
.	O

Then	O
they	O
compared	O
concentrations	O
of	O
these	O
compounds	O
in	O
mother	O
’	O
s	O
milk	O
to	O
outcomes	O
of	O
child	O
health	O
,	O
growth	O
,	O
and	O
development	O
.	O

The	O
questions	O
are	O
styled	O
in	O
a	O
'	O
Do	O
you	O
ever	O
feel	O
/	O
think	O
'	O
fashion	O
in	O
order	O
to	O
study	O
continuous	O
experiences	O
during	O
life	O
-	O
time	O
.	O

Objectives	O
:	O
We	O
examined	O
associations	O
between	O
in	O
utero	O
exposures	O
,	O
infant	O
growth	O
,	O
and	O
methylation	O
of	O
repetitive	O
elements	O
and	O
gene	O
-	O
associated	O
DNA	O
in	O
human	O
term	O
placenta	O
tissue	O
samples	O
.	O

The	O
Madigan	O
study	O
was	O
ambitious	O
in	O
that	O
it	O
followed	O
a	O
baseline	O
sample	O
of	O
nearly	O
1000	O
women	O
for	O
a	O
total	O
study	O
period	O
of	O
nearly	O
2	O
years	O
.	O

Less	O
than	O
half	O
the	O
participants	O
(	O
42	O
.	O
0	O
%)	O
declared	O
they	O
received	O
advice	O
on	O
diet	O
during	O
pregnancy	O
and	O
83	O
.	O
5	O
%	O
stated	O
they	O
were	O
advised	O
to	O
breastfeed	O
(	O
Table	O
1	O
).	O

Additionally	O
,	O
we	O
detected	O
interaction	O
between	O
time	O
and	O
diet	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
2	O
.	O
19	O
,	O
P	O
<	O
0	O
.	O
05	O
],	O
time	O
,	O
and	O
sex	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
13	O
.	O
28	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1	O
.	O
92	O
,	O
P	O
<	O
0	O
.	O
05	O
].	O

In	O
this	O
context	O
,	O
the	O
sheep	O
appears	O
to	O
be	O
a	O
very	O
good	O
model	O
,	O
because	O
as	O
for	O
humans	O
,	O
the	O
major	O
source	O
of	O
BAT	O
in	O
the	O
fetus	O
is	O
around	O
central	O
organs	O
and	O
is	O
replaced	O
by	O
WAT	O
after	O
birth	O
,	O
whereas	O
in	O
rodents	O
,	O
the	O
primary	O
BAT	O
depot	O
is	O
interscapular	O
and	O
it	O
remains	O
throughout	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

Maternal	O
dairy	O
intake	O
was	O
associated	O
with	O
an	O
increased	O
odds	O
of	O
infants	O
belonging	O
to	O
the	O
high	O
Clostridium	O
cluster	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
(	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
36	O
(	O
1	O
.	O
05	O
,	O
5	O
.	O
30	O
)).	O

PubMed	O
Central	O
:	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
use	O
of	O
supplements	O
and	O
socio	O
-	O
demographic	O
factors	O
,	O
pre	O
-	O
natal	O
care	O
and	O
nutritional	O
knowledge	O
Folic	O
acidIronVitamins	O
YES	O
YES	O
YES	O
N	O
%	O
pn	O
%	O
pn	O
%	O
p	O
Urban	O
environment13863	O
.	O
6	O
<	O
0	O
.	O
001	O
17178	O
.	O
80	O
.	O
1417178	O
.	O
8	O
<	O
0	O
.	O
001	O
Rural	O
environment5436	O
.	O
410155	O
.	O
210155	O
.	O
2Education	O
(	O
number	O
of	O
years	O
)	O
≤	O
8115	O
.	O
7	O
<	O
0	O
.	O
001	O
4524	O
.	O
9	O
<	O
0	O
.	O
001	O
4315	O
.	O
8	O
<	O
0	O
.	O
001	O
9	O
-	O
128242	O
.	O
77541	O
.	O
411040	O
.	O
4	O
>	O
129951	O
.	O
6	O
6133	O
.	O
7	O
11943	O
.	O
8	O
Age	O
(	O
years	O
old	O
)	O
<	O
1800	O
<	O
0	O
.	O
001	O
942	O
.	O
9	O
0	O
.	O
043	O
942	O
.	O
9	O
0	O
.	O
011	O
≥	O
1819250	O
.	O
726369	O
.	O
426369	O
.	O
4Number	O
of	O
births	O
≤	O
217352	O
.	O
624273	O
.	O
624273	O
.	O
6	O
>	O
21926	O
.	O
83042	O
.	O
33042	O
.	O
3Wanted	O
pregnancy17949	O
.	O
9	O
0	O
.	O
017	O
25470	O
.	O
8	O
0	O
.	O
009	O
25470	O
.	O
8	O
<	O
0	O
.	O
001	O
Unwanted	O
pregnancy1230	O
.	O
01742	O
.	O
51742	O
.	O
5	O
Married17654	O
.	O
5	O
<	O
0	O
.	O
001	O
23572	O
.	O
8	O
0	O
.	O
01	O
23572	O
.	O
8	O
<	O
0	O
.	O
001	O
Single1620	O
.	O
83748	O
.	O
13748	O
.	O
1Pregnancy	O
registration	O
General	O
practitioner	O
Yes18949	O
.	O
1	O
0	O
.	O
027	O
26769	O
.	O
40	O
.	O

However	O
,	O
dietary	O
protein	O
levels	O
do	O
not	O
affect	O
IMF	O
deposition	O
in	O
Angus	O
or	O
Shorthorn	O
steers	O
(	O
reviewed	O
in	O
Bindon	O
[	O
115	O
]).	O

One	O
of	O
the	O
studies	O
looked	O
at	O
serum	O
levels	O
in	O
samples	O
collected	O
from	O
Mexican	O
mothers	O
within	O
a	O
day	O
of	O
birth	O
,	O
17while	O
the	O
other	O
used	O
maternal	O
serum	O
samples	O
collected	O
during	O
the	O
second	O
trimester	O
from	O
Mexican	O
-	O
American	O
women	O
who	O
lived	O
in	O
California	O
’	O
s	O
Salinas	O
Valley	O
,	O
a	O
major	O
agricultural	O
region	O
.	O
18	O
Reverse	O
causality	O
is	O
a	O
major	O
concern	O
in	O
environmental	O
health	O
research	O
,	O
and	O
Amalie	O
Timmermann	O
,	O
a	O
research	O
assistant	O
in	O
the	O
Department	O
of	O
Environmental	O
Medicine	O
at	O
the	O
University	O
of	O
Southern	O
Denmark	O
,	O
points	O
it	O
out	O
as	B
a	O
potential	O
explanation	B
for	O
findings	O
in	O
studies	O
such	O
as	O
these	O
.	O

Correlations	O
between	O
continuous	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
insufficiency	O
was	O
significantly	O
lower	O
for	O
more	O
educated	O
women	O
and	O
for	O
persons	O
reporting	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
.	O

Also	O
no	O
association	O
was	O
also	O
found	O
between	O
a	O
children	O
’	O
s	O
vitamin	O
D	O
levels	O
and	O
their	O
lung	O
function	O
at	O
6	O
–	O
7	O
years	O
of	O
age	O
in	O
the	O
KOALA	O
birth	O
cohort	O
study	O
[	O
34	O
].	O

It	O
is	O
expressed	O
in	O
BAT	O
and	O
WAT	O
,	O
although	O
its	O
main	O
production	O
site	O
is	O
the	O
liver	O
(	O
Nishimura	O
et	O
al	O
.,	O
2000	O
;	O
Muise	O
et	O
al	O
.,	O
2008	O
;	O
Schulz	O
et	O
al	O
.,	O
2013	O
;	O
Zafrir	O
,	O
2013	O
).	O

The	O
close	O
relationships	O
between	O
weight	O
and	O
length	O
and	O
initial	O
BMC	O
imply	B
that	O
calcium	O
transfer	O
across	O
the	O
placenta	O
is	O
closely	O
related	O
to	O
overall	O
nutrient	O
transfer	O
and	O
not	O
to	O
vitamin	O
D	O
status	O
(	O
7	O
).	O

This	O
rule	O
,	O
the	O
first	O
of	O
its	O
kind	O
in	O
the	O
world	O
,	O
will	O
apply	O
mainly	O
to	O
personal	O
care	O
products	O
but	O
also	O
could	O
apply	O
to	O
other	O
categories	O
such	O
as	O
food	O
and	O
textiles	O
.	O

The	O
doses	O
for	O
adults	O
and	O
elderly	O
people	O
of	O
proper	O
body	O
weight	O
,	O
and	O
pregnant	O
and	O
lactating	O
women	O
should	O
not	O
exceed	O
4000	O
IU	O
daily	O
,	O
and	O
the	O
supplementation	O
dosage	O
recommended	O
for	O
pregnant	O
women	O
in	O
winter	O
and	O
less	O
sunny	O
countries	O
is	O
1500	O
–	O
4000	O
IU	O
per	O
day	O
(	O
37	O
.	O
5	O
–	O
50	O
.	O
0	O
μg	O
/	O
day	O
)	O
[	O
10	O
,	O
66	O
,	O
70	O
].	O

C	O
-	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

LASSO	O
(	O
Least	O
Absolute	O
Shrinkage	O
and	O
Selection	O
Operator	O
)	O
[	O
30	O
]	O
and	O
Elastic	O
Net	O
are	O
more	O
sophisticated	O
multivariable	O
linear	O
modeling	O
methods	O
that	O
have	O
been	O
used	O
for	O
analyzing	O
multiple	O
correlated	O
exposure	O
variables	O
.	O

In	O
the	O
case	O
of	O
asthma	O
,	O
the	O
risk	O
of	O
uncontrolled	O
severe	O
asthma	O
(	O
which	O
may	O
include	O
maternal	O
or	O
fetal	O
mortality	O
)	O
would	O
usually	O
be	O
the	O
greater	O
risk	O
,	O
suggesting	O
that	O
oral	O
corticosteroids	O
must	O
still	O
be	O
used	O
when	O
indicated	O
for	O
the	O
management	O
of	O
severe	O
gestational	O
asthma	O
.	O

Discussion	O
The	O
provision	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
a	O
weekly	O
basis	O
for	O
women	O
of	O
reproductive	O
age	O
is	O
aimed	B
at	O
improving	O
iron	O
stores	O
,	O
particularly	O
prior	O
to	O
pregnancy	O
and	O
during	O
the	O
first	O
trimester	O
before	O
women	O
access	O
ante	O
-	O
natal	O
care	O
.	O

However	O
,	O
as	O
the	O
effect	O
doesn	O
'	O
t	O
vary	O
by	O
cats	O
versus	O
dogs	O
,	O
differences	O
by	O
race	O
in	O
factors	O
correlated	O
with	O
pet	O
ownership	O
or	O
variations	O
in	O
pet	O
keeping	O
styles	O
may	O
be	O
more	O
important	O
.	O

On	O
the	O
other	O
hand	O
,	O
cytokines	O
are	O
messengers	O
produced	O
by	O
immune	O
cells	O
which	O
affect	O
all	O
tissues	O
,	O
including	O
brain	O
.	O

Manipulating	O
IMF	O
deposition	O
through	O
developmental	O
programming	O
via	O
metabolic	O
imprinting	O
is	O
a	O
recently	O
proposed	O
nutritional	O
method	O
to	O
change	O
potential	O
IMF	O
deposition	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
in	O
rodents	O
and	O
domestic	O
animals	O
.	O

Vitamin	O
D	O
during	O
the	O
pregnancy	O
is	O
important	O
to	O
both	O
maternal	O
skeletal	O
preservation	O
and	O
fetal	O
skeletal	O
formation	O
.	O

We	O
further	O
increased	O
the	O
desired	O
sample	O
to	O
200	O
per	O
arm	O
to	O
account	O
for	O
potential	O
loss	O
to	O
follow	O
-	O
up	O
,	O
and	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
maternal	O
or	O
neonatal	O
death	O
,	O
since	O
structured	O
observations	O
would	O
not	O
be	O
feasible	O
or	O
appropriate	O
in	O
such	O
cases	O
.	O

There	O
was	O
a	O
trend	O
for	O
lower	O
DopaR1	O
expression	O
in	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
HV	O
pup	O
diet	O
compared	O
to	O
the	O
RV	O
offspring	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
(	O
Figure	O
5b	O
).	O

These	O
data	O
have	O
a	O
few	O
girls	O
whose	O
mothers	O
have	O
a	O
very	O
high	O
BMI	O
and	O
these	O
values	O
appear	O
to	O
dilute	O
the	O
correlation	O
between	O
girls	O
and	O
mother	O
.	O

[	O
2	O
]	O
There	O
are	O
increasing	O
studies	O
worldwide	O
reporting	O
poor	O
vitamin	O
D	O
status	O
,	O
including	O
those	O
in	O
tropical	O
countries	O
.	O

The	O
researchers	O
checked	O
the	O
women	O
’	O
s	O
levels	O
of	O
hemoglobin	O
(	O
which	O
transports	O
oxygen	O
)	O
and	O
ferritin	O
every	O
four	O
weeks	O
through	O
the	O
end	O
of	O
pregnancy	O
.	O

However	O
,	O
the	O
girl	O
’	O
s	O
height	O
was	O
more	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
mother	O
than	O
father	O
.	O

Results	O
:	O
Forty	O
five	O
patients	O
including	O
24	O
with	O
the	O
mean	O
age	O
of	O
30	O
.	O
7	O
±	O
6	O
.	O
2	O
years	O
in	O
the	O
IG	O
and	O
21	O
with	O
the	O
mean	O
age	O
of	O
29	O
.	O
5	O
±	O
4	O
.	O
0	O
years	O
in	O
the	O
CG	O
participated	O
in	O
the	O
study	O
.	O

After	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
for	O
intake	O
of	O
omega	O
-	O
3	O
or	O
marine	O
fatty	O
acids	O
was	O
24	O
%	O
lower	O
in	O
the	O
third	O
quartile	O
compared	O
to	O
the	O
lowest	O
.	O

GR	O
alternative	O
splicing	O
might	O
also	O
influence	O
the	O
subsequent	O
activation	O
of	O
signalling	O
pathways	O
by	O
glucocorticoids	O
[	O
20	O
].	O

2	O
).	O

The	O
first	O
sign	O
is	O
a	O
rise	O
in	O
the	O
ratio	O
of	O
calcium	O
to	O
creatinine	O
in	O
the	O
urine	O
,	O
which	O
precedes	O
hypercalcemia	O
.	O

PubMed	O
Central	O
:	O

As	O
can	O
be	O
seen	O
in	O
Figure2b	O
,	O
the	O
frequency	O
distribution	O
of	O
women	O
with	O
post	O
-	O
50	O
gram	O
1	O
-	O
hour	O
glucose	O
concentration	O
≥	O
140	O
mg	O
/	O
dl	O
(	O
i	O
.	O
e	O
.,	O
the	O
threshold	O
for	O
screen	O
positive	O
for	O
glucose	O
intolerance	O
)	O
also	O
had	O
a	O
curvilinear	O
pattern	O
.	O

However	O
,	O
excluding	O
preeclampsia	O
cases	O
from	O
the	O
analysis	O
did	O
not	O
change	O
the	O
results	O
.	O

In	O
this	O
cohort	O
,	O
we	O
have	O
collected	O
detailed	O
information	O
on	O
social	O
and	O
environmental	O
influences	O
on	O
the	O
child	O
'	O
s	O
development	O
and	O
in	O
a	O
number	O
of	O
other	O
publications	O
address	O
this	O
question	O
,	O
including	O
cultural	O
and	O
familial	O
influences	O
.	O

Although	O
previous	O
small	O
surveys	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
common	O
in	O
Europe	O
[	O
29	O
],[	O
30	O
],	O
there	O
are	O
no	O
reliable	O
country	O
-	O
wide	O
estimates	O
of	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
European	O
countries	O
.	O

In	O
order	O
to	O
contribute	O
to	O
a	O
comprehensive	O
inventory	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
targets	O
of	O
nutritional	O
programming	O
initiated	O
during	O
fetal	O
life	O
,	O
we	O
applied	O
whole	O
-	O
genome	O
microarrays	O
for	O
expression	O
profiling	O
in	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

There	O
was	O
no	O
association	O
with	O
eczema	O
,	O
hay	O
fever	O
,	O
total	O
IgE	O
,	O
FEV1	O
,	O
FVC	O
or	O
FEF25	O
–	O
75	O
(	O
table	O
2and	O
supplementary	O
table	O
E2	O
).	O

Although	O
there	O
was	O
no	O
difference	O
in	O
the	O
rate	O
of	O
clinical	O
infection	O
diagnosis	O
between	O
the	O
two	O
arms	O
of	O
the	O
parent	O
trial	O
,	O
longitudinal	O
malaria	O
exposure	O
may	O
have	O
been	O
an	O
effect	O
modifier	O
or	O
confounding	O
variable	O
in	O
this	O
study	O
and	O
ought	O
to	O
be	O
assessed	O
formally	O
in	O
future	O
work	O
.	O

For	O
the	O
quantitative	O
PCR	O
,	O
the	O
following	O
equations	O
were	O
used	O
:	O
ΔCt	O
=	O
Ct	O
(	O
gene	O
of	O
interest	O
)−	O
Ct	O
(	O
house	O
keeping	O
gene	O
),	O
ΔΔCt	O
=	O
ΔCt	O
(	O
sample	O
)−	O
ΔCt	O
(	O
calibrator	O
),	O
and	O
Relative	O
Quantity	O
(	O
RQ	O
)	O
=	O
2	O
−	O
ΔΔCtas	O
previously	O
described	O
[	O
12	O
].	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;#/##/###	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
;$	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
RC	O
males	O
.	O

For	O
example	O
,	O
research	O
has	O
suggested	O
that	O
Alu	O
sequences	O
often	O
flank	O
CGIs	O
(	O
Graff	O
et	O
al	O
.	O

There	O
was	O
insufficient	O
case	O
information	O
available	O
to	O
assess	O
any	O
causal	O
association	O
between	O
the	O
allergic	O
reaction	O
and	O
the	O
fetal	O
loss	O
.	O

Participants	O
were	O
classified	O
into	O
three	O
predefined	O
levels	O
:	O
low	O
,	O
middle	O
and	O
high	O
frequency	O
of	O
symptoms	O
.	O

;	O
P	O
=	O
0	O
.	O
0001	O
)	O
and	O
at	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
19	O
.	O
6	O
%	O
versus	O
7	O
.	O
1	O
%;	O
P	O
=	O
.	O
001	O
;	O
Table	O
1	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Mapping	O
of	O
the	O
mutant	O
pedigrees	O
.	O

Low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
more	O
prevalent	O
in	O
individuals	O
with	O
female	O
gender	O
,	O
younger	O
age	O
and	O
urban	O
versus	O
rural	O
residence	O
in	O
Thailand	O
.	O

While	O
a	O
link	O
between	O
smoking	O
and	O
autism	O
could	O
not	O
be	O
established	O
,	O
air	O
pollution	O
may	O
have	O
a	O
role	O
.	O

Of	O
these	O
293	O
subjects	O
were	O
identified	O
and	O
recruited	O
(	O
Figure	O
1	O
).	O

The	O
serum	O
osmolality	O
was	O
356	O
mOsm	O
/	O
kg	O
;	O
urine	O
sodium	O
21	O
mEq	O
/	O
L	O
and	O
urine	O
osmolality	O
was	O
inappropriately	O
low	O
(	O
225	O
mOsm	O
/	O
kg	O
).	O

Thyroxin	O
therapy	O
should	O
be	O
started	O
immediately	O
after	O
surgery	O
because	O
untreated	O
hypothyroidism	O
may	O
expose	O
the	O
mother	O
to	O
a	O
higher	O
risk	O
of	O
disease	O
recurrence	O
and	O
may	O
have	O
an	O
adverse	O
effect	O
on	O
cognitive	O
function	O
and	O
regular	O
growth	O
of	O
the	O
offspring	O
.	O

In	O
this	O
case	O
,	O
the	O
optimum	O
slaughter	O
age	O
for	O
the	O
highest	O
profit	O
was	O
28	O
months	O
.	O

More	O
than	O
50	O
%	O
of	O
the	O
women	O
included	O
had	O
a	O
lower	O
education	O
level	O
,	O
which	O
means	O
only	O
completion	O
of	O
secondary	O
school	O
or	O
even	O
lower	O
education	O
.	O

Preventive	O
pharmacotherapy	O
and	O
immunotherapy	O
will	O
not	O
be	O
discussed	O
.	O

Insufficient	O
Exposure	O
to	O
Environmental	O
Bacteria	O
The	O
hygiene	O
hypothesis	O
states	O
that	O
low	O
exposure	O
of	O
the	O
mother	O
during	O
pregnancy	O
and	O
of	O
the	O
newborn	O
in	O
early	O
life	O
to	O
environmental	O
bacteria	O
contributes	O
to	O
a	O
Th2	O
-	O
biased	O
immune	O
response	O
.	O

Following	O
in	O
utero	O
exposure	O
to	O
a	O
gestational	O
low	O
protein	O
diet	O
at	O
1	O
dpn	O
we	O
could	O
not	O
find	O
significant	O
regulatory	O
changes	O
of	O
genes	O
of	O
any	O
molecular	O
route	O
in	O
porcine	O
perinatal	O
liver	O
.	O

The	O
ADA	O
states	O
that	O
all	O
women	O
should	O
receive	O
individualized	O
counseling	O
to	O
provide	O
adequate	O
calories	O
and	O
nutrients	O
to	O
meet	O
the	O
needs	O
of	O
pregnancy	O
and	O
consistent	O
with	O
the	O
blood	O
glucose	O
goals	O
(	O
fasting	O
≤	O
105	O
mg	O
/	O
dl	O
[	O
5	O
.	O
8	O
mmol	O
/	O
L	O
],	O
1	O
hr	O
≤	O
155	O
mg	O
/	O
dl	O
[	O
8	O
.	O
6	O
mmol	O
/	O
L	O
],	O
and	O
2	O
hrs	O
≤	O
130	O
mg	O
/	O
dl	O
[	O
7	O
.	O
2	O
mmol	O
/	O
L	O
]).	O

Eight	O
viable	O
fetuses	O
per	O
sow	O
were	O
collected	O
starting	O
at	O
the	O
tip	O
of	O
the	O
left	O
uterus	O
horn	O
and	O
alternating	O
between	O
left	O
and	O
right	O
horn	O
.	O

In	O
this	O
article	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
mutations	O
affecting	O
skeletal	O
morphology	O
,	O
skeletal	O
morphology	O
1	O
(	O
skm1	O
)	O
and	O
skeletal	O
morphology	O
2	O
(	O
Skm2	O
),	O
in	O
a	O
recessive	O
ENU	O
mutagenesis	O
screen	O
for	O
infectious	O
disease	O
susceptibility	O
.	O

These	O
data	O
will	O
supply	O
information	O
on	O
the	O
nutritional	O
status	O
of	O
women	O
early	O
in	O
their	O
pregnancy	O
.	O

1	O
)	O
in	O
a	O
crude	O
model	O
and	O
in	O
a	O
model	O
adjusted	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

Bonferrroni	O
analysis	O
indicated	O
that	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
).	O

Cont	O
–	O
control	O
pregnancies	O
;	O
UN	O
P	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
only	O
;	O
UN	O
L	O
–	O
dams	O
undernourished	O
during	O
lactation	O
only	O
;	O
UN	O
PL	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
and	O
lactation	O
.	O

Given	O
that	O
73	O
%	O
of	O
children	O
had	O
vitamin	O
D	O
deficiency	O
in	O
the	O
study	O
region	O
in	O
2005	O
,	O
12and	O
that	O
the	O
incidence	O
of	O
pneumonia	O
was	O
ten	O
-	O
times	O
higher	O
in	O
vitamin	O
D	O
deficient	O
children	O
than	O
in	O
children	O
without	O
a	O
deficiency	O
in	O
case	O
-	O
control	O
studies1	O
,	O
2we	O
postulated	O
that	O
there	O
would	O
be	O
at	B
least	I
a	O
35	O
%	O
reduction	O
in	O
pneumonia	O
incidence	O
in	O
the	O
vitamin	O
D	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Taken	O
together	O
,	O
the	O
observed	O
regulations	O
were	O
seen	O
as	O
a	O
clue	O
for	O
impairments	O
in	O
energy	O
metabolism	O
in	O
LP	O
offspring	O
during	O
ontogenesis	O
.	O

Women	O
of	O
Indian	O
origin	O
,	O
especially	O
pregnant	O
women	O
,	O
are	O
known	O
to	O
have	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
not	O
contraindicated	O
,	O
skin	O
prick	O
testing	O
should	O
be	O
postponed	O
until	O
after	O
birth	O
because	O
of	O
possible	O
,	O
although	O
rare	O
,	O
anaphylactic	O
reactions	O
to	O
skin	O
prick	O
testing	O
.	O

Subsequently	O
,	O
the	O
title	O
of	O
an	O
article	O
in	O
Scientific	O
American	O
recently	O
asked	O
,	O
‘	O
What	O
if	O
vitamin	O
D	O
deficiency	O
is	O
a	O
cause	O
of	O
autism	O
?’	O
(	O
3	O
)	O
Since	O
then	O
,	O
an	O
article	O
on	O
vitamin	O
D	O
and	O
autism	O
in	O
Acta	O
Paediatrica	O
(	O
4	O
)	O
and	O
the	O
accompanying	O
commentary	O
(	O
5	O
)	O
have	O
added	O
to	O
the	O
accelerating	O
suspicion	O
that	O
vitamin	O
D	O
deficiency	O
–	O
either	O
during	O
pregnancy	O
or	O
early	O
childhood	O
–	O
may	O
be	O
an	O
environmental	O
trigger	O
for	O
the	O
genetic	O
disease	O
of	O
autism	O
.	O

(	O
2011	O
)*	O
UrethaneMouseInjection	O
(	O
ip	O
)	O
(	O
1	O
mg	O
/	O
g	O
/	O
wk	O
)	O
Late	O
childhood	O
/	O
adolescence	O
+	O
early	O
adulthoodAdulthoodHepatic	O
tumorsHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsPandey	O
et	O
al	O
.	O

While	O
we	O
did	O
not	O
assess	O
caries	O
rates	O
,	O
all	O
children	O
with	O
S	O
-	O
ECC	O
had	O
multiple	O
cavitated	O
caries	O
lesions	O
necessitating	O
surgery	O
.	O

(	O
2015	O
)*/‡	O
Metals	O
:	O
Cadmium	O
(	O
Cd	O
)	O
Mouse	O
RatInjection	O
(	O
ip	O
)	O
(	O
20	O
nmol	O
/	O
kg	O
/	O
2	O
d	O
CdCl2	O
)	O
Adolescence	O
/	O
early	O
adulthoodLater	O
adulthoodHepatic	O
abnormalitiesDNA	O
methylationWang	O
et	O
al	O
.	O

Women	O
attending	O
ANC	O
for	O
their	O
subsequent	O
pregnancies	O
probably	B
had	O
a	O
notion	O
of	O
what	O
health	O
topics	O
were	O
discussed	O
during	O
clinic	O
sessions	O
and	O
so	O
their	O
objectives	O
at	O
ANC	O
were	O
not	O
only	O
aimed	O
at	O
acquiring	O
knowledge	O
about	O
diet	O
,	O
danger	O
signs	O
and	O
other	O
topics	O
but	O
also	O
in	O
the	O
state	O
of	O
their	O
babies	O
.	O

PcG	O
targets	O
are	O
a	O
family	O
of	O
developmentally	O
related	O
genes	O
that	O
can	O
remodel	O
chromatin	O
and	O
are	O
responsible	O
for	O
silencing	O
HOX	O
genes	O
,	O
which	O
are	O
critical	O
in	O
embryonic	O
development	O
as	O
well	O
as	O
potentially	O
hundreds	O
of	O
other	O
genes	O
involved	O
in	O
cellular	O
differentiation	O
(	O
Kirmizis	O
et	O
al	O
.	O

The	O
pills	O
were	O
produced	O
by	O
the	O
Jalinous	O
pharmaceutical	O
company	O
in	O
Iran	O
.	O

Comparisons	O
between	O
groups	O
were	O
performed	O
using	O
student	O
t	O
-	O
test	O
for	O
continuous	O
variables	O
,	O
and	O
Fisher	O
exact	O
test	O
for	O
categorical	O
variables	O
.	O

Dietary	O
therapy	O
It	O
is	O
generally	B
accepted	O
that	O
dietary	O
therapy	O
is	O
the	O
cornerstone	B
of	O
treatment	O
of	O
GDM	O
.	O

This	O
is	O
true	O
both	O
in	O
the	O
fetus	O
itself	O
and	O
in	O
the	O
placenta	O
,	O
where	O
changes	O
to	O
the	O
appropriate	O
methylation	O
patterning	O
have	O
been	O
linked	O
to	O
adverse	O
placental	O
morphology	O
and	O
birth	O
outcomes	O
(	O
Serman	O
et	O
al	O
.	O

Six	O
children	O
in	O
the	O
vitamin	O
D	O
and	O
four	O
in	O
the	O
placebo	O
group	O
died	O
of	O
septicaemia	O
or	O
pneumonia	O
.	O

Data	O
on	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
collected	O
from	O
obstetrics	O
charts	O
based	O
on	O
standardized	O
measures	O
.	O

Rules	O
will	O
include	O
logical	O
and	O
range	O
checks	O
,	O
uniqueness	O
check	O
and	O
skipping	O
rules	O
as	O
appropriate	O
.	O

Overall	O
,	O
lower	O
T1	O
25OHD	O
(	O
as	O
a	O
continuous	O
but	O
not	O
categorical	O
variable	O
)	O
was	O
associated	O
with	O
pregnancy	O
loss	O
(	O
Table3	O
).	O

To	O
exercise	O
the	O
delivery	O
of	O
services	O
Anganwadi	O
centres	O
(	O
AWCs	O
)	O
has	O
been	O
created	O
in	O
all	O
regions	O
of	O
the	O
country	O
.	O

)•	O
Create	O
and	O
implement	O
effective	O
community	O
-	O
based	O
approaches	O
(	O
e	O
.	O
g	O
.,	O
community	O
health	O
workers	O
home	O
visit	O
packages	O
,	O
women	O
'	O
s	O
'	O
groups	O
)	O
Typical	O
timeline	O
to	O
impactNear	O
-	O
term	O
to	O
Long	O
-	O
term	O
(	O
2	O
to	O
15	O
years	O
)	O
Long	O
-	O
term	O
(	O
5	O
to	O
15	O
years	O
)	O
Medium	O
-	O
term	O
(	O
5	O
to	O
10	O
years	O
)	O
Near	O
-	O
term	O
(	O
2	O
to	O
5	O
years	O
)	O
Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Therefore	O
,	O
no	O
significant	O
regulated	O
metabolic	O
pathway	O
was	O
determined	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
do	O
not	O
have	O
an	O
association	O
that	O
might	O
pose	O
a	O
conflict	O
of	O
interest	O
.	O

Undernourishment	O
in	O
utero	O
can	O
stress	O
the	O
foetus	O
in	O
ways	O
that	O
permanently	O
affect	O
physiological	O
growth	O
and	O
development	O
,	O
and	O
can	O
be	O
described	O
as	O
a	O
reprogramming	O
of	O
the	O
foetus	O
’	O
s	O
developing	O
phenotype	O
[	O
4	O
].	O

Cytokines	O
and	O
hepcidin	O
will	O
be	O
determined	O
using	O
ELISA	O
.	O

S1	O
).	O

Slight	O
modifications	O
to	O
the	O
standard	O
text4baby	O
messages	O
were	O
made	O
due	O
to	O
specific	O
health	O
care	O
resources	O
(	O
eg	O
,	O
toll	O
-	O
free	O
numbers	O
for	O
prenatal	O
health	O
information	O
)	O
available	O
to	O
military	O
women	O
[	O
23	O
,	O
25	O
].	O

Such	O
findings	O
have	O
been	O
echoed	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
in	O
recently	O
issued	O
warnings	O
suggesting	O
that	O
,	O
similar	O
to	O
SSRIs	O
,	O
antipsychotics	O
may	O
cause	O
PNA	O
syndrome	O
.	O
48In	O
the	O
present	O
study	O
,	O
82	O
.	O
6	O
%	O
of	O
neonates	O
admitted	O
to	O
the	O
NICU	O
were	O
exposed	O
to	O
polytherapy	O
,	O
mostly	O
with	O
SSRIs	O
.	O

Allergies	O
or	O
hyperreactivities	O
have	O
been	O
classified	O
by	O
Gells	O
and	O
Coombs	O
into	O
types	O
I	O
through	O
IV	O
,	O
with	O
types	O
I	O
,	O
II	O
,	O
and	O
III	O
being	O
mediated	O
by	O
antibodies	O
or	O
immune	O
complexes	O
and	O
type	O
IV	O
reactions	O
as	O
well	O
as	O
chronic	O
stages	O
of	O
allergic	O
diseases	O
being	O
mediated	O
by	O
T	O
cells	O
[	O
1	O
].	O

This	O
seems	O
to	O
be	O
important	O
because	O
allergen	O
-	O
specific	O
T	O
cells	O
transferred	O
from	O
1	O
mouse	O
mother	O
to	O
another	O
can	O
transmit	O
asthma	O
risk	O
to	O
the	O
offspring	O
of	O
the	O
recipient	O
mouse	O
mother	O
[	O
69	O
].	O

One	O
child	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
above	O
four	O
SD	O
from	O
the	O
mean	O
and	O
was	O
excluded	O
from	O
subsequent	O
analyses	O
.	O

We	O
used	O
the	O
R	O
package	O
‘	O
glmnet	O
’	O
[	O
42	O
],	O
and	O
included	O
the	O
BHLM	O
confounders	O
(	O
Table3	O
)	O
in	O
the	O
regression	O
as	O
unpenalized	O
variables	O
.	O

BMC	O
was	O
significantly	O
related	O
to	O
length	O
at	O
one	O
week	O
(	O
r	O
=	O
0	O
.	O
61	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
however	O
,	O
in	O
multivariate	O
analysis	O
including	O
weight	O
and	O
length	O
,	O
only	O
weight	O
was	O
significant	O
,	O
p	O
<	O
0	O
.	O
001	O
and	O
length	O
was	O
not	O
significant	O
,	O
p	O
=	O
0	O
.	O
87	O
.	O

We	O
are	O
describing	O
a	O
unique	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

Not	O
really	O
a	O
vitamin	O
,	O
D3is	O
a	O
pro	O
-	O
prehormone	O
made	O
in	O
the	O
skin	O
in	O
response	O
to	O
ultraviolet	O
-	O
B	O
light	O
exposure	O
.	O

PFAS	O
levels	O
were	O
similar	O
across	O
women	O
’	O
s	O
reported	O
reasons	O
for	O
ending	O
breastfeeding	O
,	O
and	O
the	O
researchers	O
saw	O
no	O
clear	O
differences	O
between	O
primiparous	O
and	O
multiparous	O
mothers	O
.	O
24	O
“	O
You	O
have	O
three	O
studies	O
telling	O
a	O
similar	O
story	O
from	O
different	O
parts	O
of	O
the	O
world	O
.	O

Adjusted	O
odd	O
ratios	O
(	O
aORs	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
)	O
were	O
first	O
determined	O
after	O
adjusting	O
for	O
the	O
number	O
of	O
prenatal	O
visits	O
,	O
then	O
after	O
adjusting	O
for	O
number	O
of	O
prenatal	O
visits	O
and	O
socio	O
-	O
demographic	O
factors	O
(	O
age	O
,	O
area	O
of	O
residence	O
,	O
level	O
of	O
education	O
).	O

Supplements	O
containing	O
vitamin	O
D	O
were	O
used	O
by	O
43	O
%	O
in	O
T1	O
and	O
39	O
%	O
in	O
T3	O
-	O
mainly	O
multivitamins	O
[	O
19	O
].	O

A	O
plot	O
of	O
gestational	O
age	O
at	O
birth	O
as	O
a	O
function	O
of	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
with	O
the	O
fitted	O
LOESS	O
curve	O
for	O
women	O
with	O
a	O
history	O
of	O
PTB	O
is	O
shown	O
inFig	O
3	O
.	O

Particularly	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
males	O
and	O
RC	O
females	O
did	O
not	O
displayed	O
higher	O
caloric	O
intake	O
compared	O
to	O
the	O
respective	O
CC	O
males	O
and	O
CC	O
females	O
.	O

Genomewide	O
DNA	O
methylation	O
profiles	O
were	O
obtained	O
in	O
a	O
subset	O
of	O
184	O
samples	O
using	O
the	O
Illumina	O
Infinium	O
HumanMethylation27	O
BeadArray	O
.	O

BAT	O
consists	O
in	O
brown	O
adipocytes	O
,	O
characterized	O
by	O
multiple	O
,	O
small	O
,	O
multilocular	O
lipid	O
droplets	O
with	O
a	O
central	O
nucleus	O
and	O
a	O
high	O
number	O
of	O
mitochondria	O
.	O

The	O
management	O
of	O
gestational	O
diabetes	O
Abstract	O
The	O
incidence	O
of	O
gestational	O
diabetes	O
is	O
increasing	O
.	O

Thus	B
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
Thai	O
people	O
is	O
generally	O
low	O
.	O

A	O
sufficient	O
maternal	O
vitamin	O
D	O
status	O
,	O
specified	O
as	B
25	O
(	O
OH	O
)	O
D	O
above	O
50	O
nmol	O
/	O
L	O
,	O
may	O
be	O
a	O
threshold	O
above	O
which	O
the	O
physiological	O
requirements	O
of	O
pregnancy	O
are	O
achieved	O
.	O

High	O
vitamin	O
D	O
status	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
was	O
associated	O
with	O
lower	O
odds	O
of	O
SGA	O
and	O
LBW	O
.	O

In	O
human	O
body	O
,	O
the	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
where	O
7	O
-	O
dehydrocholesterol	O
is	O
converted	O
to	O
vitamin	O
D3in	O
response	O
to	O
UV	O
exposure	O
.	O

Some	O
examples	O
include	O
technologies	O
for	O
ventilatory	O
support	O
,	O
novel	O
surfactant	O
formulations	O
,	O
safe	O
and	O
effective	O
intravenous	O
fluid	O
and	O
drug	O
administration	O
,	O
devices	O
for	O
testing	O
bilirubin	O
levels	O
for	O
jaundice	O
and	O
innovative	O
phototherapy	O
equipment	O
[	O
6	O
].	O

Most	O
pregnant	O
women	O
were	O
satisfied	O
with	O
the	O
level	O
of	O
care	O
received	O
during	O
ANC	O
in	O
public	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

We	O
drew	O
a	O
random	O
sample	O
of	O
all	O
women	O
meeting	O
criteria	O
at	O
the	O
Madigan	O
Obstetrics	O
and	O
Gynecology	O
Clinic	O
between	O
December	O
2011	O
and	O
January	O
2013	O
.	O

Indeed	O
,	O
without	O
the	O
genetic	O
tendency	O
for	O
autism	O
,	O
I	O
suspect	B
that	O
severe	O
maternal	O
or	O
early	O
childhood	O
vitamin	O
D	O
deficiency	O
may	O
cause	O
bone	O
abnormalities	O
,	O
as	O
referenced	O
above	O
,	O
with	O
no	O
evidence	O
autism	O
.	O

This	O
was	O
mediated	O
by	O
phosphorylation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
(	O
pSTAT3	O
).	O

This	O
increment	O
may	O
be	O
brought	O
about	O
largely	O
by	O
thyroid	O
stimulation	O
induced	O
by	O
human	O
chorionic	O
gonadotropin	O
(	O
HCG	O
)	O
through	O
its	O
structural	O
affinity	O
with	O
thyrotropin	O
(	O
TSH	O
).	O

Mothers	O
were	O
paid	O
$	O
25	O
for	O
attending	O
the	O
30	O
-	O
week	O
gestation	O
and	O
6	O
-	O
month	O
postpartum	O
assessments	O
.	O

Apart	O
from	O
the	O
inconvenience	O
of	O
taking	O
time	O
to	O
answer	O
the	O
research	O
questionnaire	O
,	O
participants	O
were	O
not	O
exposed	O
to	O
undue	O
risk	O
.	O

Our	O
findings	O
of	O
elevated	O
risks	O
of	O
incident	O
GDM	O
among	O
women	O
reporting	O
both	O
long	O
and	O
short	O
sleep	O
durations	O
in	O
early	O
pregnancy	O
are	O
consistent	O
with	O
these	O
earlier	O
reports	O
from	O
men	O
and	O
non	O
pregnant	O
women	O
.	O

Unplanned	O
pregnancy	O
was	O
more	O
frequent	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
group	O
.	O

Effect	O
of	O
weaning	O
age	O
has	O
been	O
studied	O
in	O
Shorthorn	O
calves	O
[	O
52	O
].	O

Premature	O
Ovarian	O
Failure	O
Premature	O
ovarian	O
failure	O
,	O
defined	O
as	O
starting	O
the	O
menopausal	O
period	O
before	O
the	O
40th	O
year	O
of	O
life	O
,	O
can	O
also	O
be	O
influenced	O
by	O
VD	O
level	O
.	O

These	O
sensory	O
and	O
biological	O
considerations	O
shed	O
light	O
on	O
why	O
lifestyle	O
changes	O
are	O
difficult	O
for	O
young	O
children	O
to	O
make	O
.	O

The	O
number	O
of	O
mature	O
glomeruli	O
was	O
20	O
%	O
lower	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1VitD	O
-	O
mice	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
the	O
number	O
of	O
mature	O
glomeruli	O
between	O
the	O
F2	O
-	O
VitD	O
-	O
and	O
F2	O
-	O
SC	O
mice	O
at	O
this	O
age	O
.	O

Epigenetics	O
thus	B
offers	O
an	O
opportunity	O
for	O
improved	O
chemical	O
regulation	O
and	O
public	O
health	O
protection	O
.	O

Frequent	O
regular	O
follow	O
-	O
up	O
visits	O
to	O
or	O
by	O
health	O
professionals	O
skilled	O
in	O
managing	O
asthma	O
are	O
essential	O
to	O
ensure	O
optimal	O
success	O
and	O
safety	O
of	O
asthma	O
management	O
during	O
pregnancy	O
.	O

The	O
differing	O
outcomes	O
between	O
each	O
of	O
the	O
perinatal	O
undernutrition	O
approaches	O
reported	O
here	O
are	O
likely	B
to	O
reflect	O
these	O
confounders	O
of	O
severity	O
and	O
timing	O
.	O

The	O
day	O
before	O
the	O
test	O
,	O
all	O
animals	O
were	O
food	O
-	O
deprived	O
for	O
20	O
h	O
.	O
Then	O
AM251	O
or	O
vehicle	O
was	O
intraperitoneally	O
administered	O
(	O
3	O
mg	O
/	O
mL	O
).	O

Vitamin	O
D	O
is	O
linked	O
with	O
other	O
non	O
-	O
bone	O
health	O
outcomes	O
,	O
but	O
the	O
few	O
completed	O
and	O
adequately	O
powered	O
trials	O
assessing	O
the	O
effect	O
of	O
supplementation	O
have	O
mixed	O
findings	O
in	O
improving	O
outcomes	O
—	O
ie	O
,	O
cancers	O
,	O
vascular	O
disease	O
,	O
and	O
diabetes	O
.	O

In	O
contrast	O
for	O
white	O
women	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
significantly	O
higher	O
seasonally	O
-	O
adjusted	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
early	O
(	O
OR	O
3	O
.	O
5	O
,	O
95	O
%	O
CI	O
2	O
.	O
1	O
,	O
5	O
.	O
8	O
)	O
(	O
Interaction	O
P	O
value	O
0	O
.	O
01	O
).	O

Environmentally	O
induced	O
epigenetic	O
changes	O
in	O
the	O
sperm	O
or	O
egg	O
prior	O
to	O
conception	O
could	O
,	O
therefore	B
,	O
affect	O
embryo	O
viability	O
and	O
development	O
and	O
the	O
subsequent	O
future	O
health	O
and	O
fertility	O
of	O
the	O
next	O
generation	O
.	O

One	O
study	O
reported	O
that	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3inhibited	O
lipid	O
accumulation	O
by	O
inhibiting	O
key	O
adipogenic	O
factors	O
such	O
as	O
PPARG	O
[	O
143	O
].	O

Design	O
:	O
Within	O
-	O
randomization	O
group	O
analysis	O
of	O
the	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
trial	O
of	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

Studies	O
in	O
which	O
BMI	O
of	O
children	O
is	O
documented	O
at	O
repeated	O
times	O
show	O
strong	O
tracking	O
patterns	O
with	O
age	O
,	O
6	O
–	O
9but	O
this	O
has	O
not	O
been	O
reported	O
in	O
relation	O
to	O
family	O
lineages	O
including	O
grandparents	O
.	O

While	O
this	O
large	O
body	O
of	O
work	O
also	O
provides	O
some	O
comprehensive	B
evidence	O
for	O
,	O
and	O
specific	O
mechanisms	O
of	O
,	O
epigenetic	O
toxicity	O
,	O
it	O
was	O
considered	O
outside	O
the	O
scope	O
of	O
this	O
review	O
.	O

We	O
further	O
the	O
study	O
for	O
analyses	O
of	O
miRNAs	O
targeting	O
porcine	O
GR	O
.	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Box	O
2	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
.	O

Promotion	O
of	O
handwashing	O
with	O
soap	O
before	O
umbilical	O
cord	O
care	O
should	O
be	O
emphasized	O
in	O
antenatal	O
and	O
neonatal	O
care	O
messaging	O
,	O
given	B
existing	O
evidence	O
supporting	O
prevention	O
of	O
umbilical	O
cord	O
infections	O
by	O
caregiver	O
handwashing	O
.	O

Factors	O
affecting	O
BAT	O
function	O
and	O
energy	O
metabolism	O
improve	O
overall	O
metabolism	O
In	O
rodents	O
,	O
brown	O
adipocytes	O
are	O
found	O
in	O
discrete	O
areas	O
,	O
such	O
as	O
interscapular	O
,	O
cervical	O
,	O
peri	O
-	O
aortic	O
,	O
peri	O
-	O
renal	O
,	O
intercostal	O
and	O
mediastinal	O
depots	O
(	O
Cinti	O
,	O
2001	O
),	O
which	O
are	O
referred	O
to	O
as	O
“	O
classical	O
”	O
BAT	O
depots	O
.	O

Also	O
,	O
future	O
adequately	O
powered	O
randomized	O
clinical	O
trials	O
are	O
needed	O
to	O
determine	O
whether	O
modifying	O
maternal	O
prenatal	O
behaviors	O
and	O
GWG	O
can	O
prevent	O
offspring	O
obesity	O
.	O

The	O
resulting	O
gene	O
lists	O
were	O
compared	O
between	O
LP	O
and	O
AP	O
offspring	O
at	O
the	O
corresponding	O
ontogenetic	O
periods	O
.	O

A	O
subgroup	O
of	O
infants	O
from	O
the	O
MIG	O
Study	O
are	O
currently	O
being	O
followed	O
up	O
.	O
72It	O
may	O
be	O
circumspect	O
to	O
await	O
the	O
findings	O
from	O
this	O
follow	O
-	O
up	O
study	O
before	O
metformin	O
can	O
be	O
considered	O
safe	O
for	O
the	O
routine	O
treatment	O
of	O
GDM	O
.	O

While	O
some	O
tests	O
in	O
the	O
OECD	O
Conceptual	O
Framework	O
do	O
cover	O
exposure	O
during	O
critical	O
periods	O
of	O
development	O
in	O
utero	O
,	O
to	O
date	O
,	O
they	O
may	O
not	O
address	O
effects	O
that	O
might	O
be	O
induced	O
by	O
exposure	O
during	O
neonatal	O
or	O
pubertal	O
development	O
,	O
and	O
/	O
or	O
emerge	O
during	O
later	O
life	O
stages	O
.	O

There	O
was	O
also	O
no	O
significant	O
difference	O
in	O
multivitamin	O
usage	O
between	O
the	O
groups	O
(	O
76	O
with	O
S	O
-	O
ECC	O
vs	O
.	O
67	O
caries	O
-	O
free	O
,	O
p	O
=	O
0	O
.	O
73	O
).	O

Lab	O
and	O
questionnaire	O
data	O
were	O
entered	O
into	O
an	O
Excel	O
(	O
Microsoft	O
Office	O
)	O
spreadsheet	O
and	O
analyzed	O
using	O
Number	O
Cruncher	O
Statistical	O
Software	O
(	O
NCSS	O
)	O
version	O
7	O
.	O
0	O
(	O
Kaysville	O
,	O
Utah	O
).	O

There	O
was	O
an	O
association	O
also	O
with	O
each	O
parent	O
and	O
their	O
own	O
mother	O
.	O

The	O
commonly	O
used	O
organophospate	O
pesticide	O
chlorpyrifos	O
(	O
CPF	O
)	O
is	O
known	O
to	O
specifically	O
target	O
the	O
immature	O
brain	O
,	O
from	O
the	O
early	O
embryonic	O
stage	O
to	O
the	O
postweaning	O
period	O
,	O
and	O
it	O
causes	O
a	O
host	O
of	O
irreversible	O
changes	O
to	O
developing	O
brain	O
cells	O
[	O
39	O
].	O

Severe	O
maternal	O
anaemia	O
increases	O
the	O
risk	O
of	O
maternal	O
and	O
neonatal	O
mortality	O
and	O
morbidity	O
while	O
less	O
severe	O
anaemia	O
and	O
iron	O
deficiency	O
have	O
been	O
linked	O
to	O
sub	O
-	O
optimal	O
fetal	O
growth	O
,	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
,	O
as	O
well	O
as	O
iron	O
deficiency	O
in	O
infants	O
[	O
2	O
]–[	O
4	O
]	O
which	O
may	O
impair	O
cognitive	O
development	O
[	O
5	O
].	O

We	O
will	O
also	O
collect	O
information	O
on	O
exposure	O
to	O
household	O
air	O
pollution	O
and	O
out	O
of	O
pocket	O
expenses	O
for	O
any	O
antenatal	O
and	O
postnatal	O
care	O
seeking	O
(	O
Table1	O
).	O

Gestational	O
exposure	O
to	O
endocrine	O
disrupting	O
chemicals	O
in	O
relation	O
to	O
infant	O
birth	O
weight	O
:	O
a	O
Bayesian	O
analysis	O
of	O
the	O
HOME	O
Study	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
exposed	O
to	O
a	O
mixture	O
of	O
endocrine	O
disrupting	O
chemicals	O
(	O
EDCs	O
).	O

Shea	O
et	O
al	O
studied	O
2500	O
elderly	O
adults	O
and	O
found	O
that	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
vitamin	O
D	O
insufficiency	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
in	O
both	O
black	O
(	O
5	O
.	O
2	O
(	O
95	O
%	O
CI	O
:	O
3	O
.	O
5	O
,	O
7	O
.	O
7	O
))	O
and	O
white	O
participants	O
(	O
OR	O
2	O
.	O
6	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
0	O
,	O
3	O
.	O
2	O
),	O
however	O
these	O
subjects	O
were	O
much	O
older	O
and	O
not	O
pregnant	O
.	O
26A	O
small	O
Turkish	O
study	O
of	O
79	O
pregnant	O
women	O
showed	O
significantly	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
among	O
women	O
reporting	O
PNV	O
use	O
in	O
the	O
third	O
trimester	O
,	O
27but	O
this	O
study	O
did	O
not	O
include	O
women	O
of	O
African	O
descent	O
and	O
did	O
not	O
have	O
the	O
power	O
to	O
address	O
potential	O
interaction	O
by	O
BMI	O
.	O

Q	O
:	O
quintile	O
.#:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

As	B
S	O
-	O
ECC	O
is	O
influenced	O
by	O
the	O
social	O
determinants	O
of	O
health	O
,	O
there	O
were	O
differences	O
in	O
parental	O
education	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
household	O
income	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
between	O
groups	O
,	O
with	O
lower	O
levels	O
of	O
both	O
education	O
and	O
household	O
income	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

Our	O
findings	O
represent	O
an	O
important	O
key	O
point	O
to	O
understand	O
the	O
complexity	O
of	O
the	O
fetal	O
programming	O
process	O
and	O
might	O
be	O
particularly	O
useful	O
in	O
the	O
searching	O
of	O
efficient	O
therapies	O
against	O
a	O
malprogramming	O
.	O

Whereas	O
the	O
frequency	O
of	O
handwashing	O
with	O
water	O
alone	O
was	O
similar	O
in	O
the	O
two	O
groups	O
(	O
mean	O
1	O
.	O
6	O
events	O
in	O
intervention	O
arm	O
,	O
1	O
.	O
5	O
events	O
in	O
control	O
arm	O
),	O
mothers	O
in	O
the	O
intervention	O
arm	O
washed	O
their	O
hands	O
with	O
soap	O
with	O
a	O
mean	O
of	O
0	O
.	O
82	O
times	O
(	O
SD	O
1	O
.	O
2	O
)	O
during	O
the	O
3	O
-	O
hour	O
observation	O
period	O
,	O
compared	O
to	O
0	O
.	O
20	O
times	O
by	O
mothers	O
in	O
the	O
control	O
arm	O
(	O
RD	O
0	O
.	O
61	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
37	O
–	O
0	O
.	O
86	O
)	O
(	O
Table	O
2	O
).	O

However	O
,	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
bone	O
-	O
related	O
outcomes	O
in	O
supplemented	O
infants	O
provides	O
information	O
about	O
the	O
effects	O
of	O
these	O
cord	O
levels	O
and	O
vitamin	O
D	O
supplementation	O
in	O
early	O
infancy	O
.	O

Any	O
unexpected	O
test	O
result	O
and	O
any	O
symptoms	O
that	O
change	O
over	O
time	O
should	O
be	O
reevaluated	O
after	O
pregnancy	O
.	O

2	O
.	O
2	O
.	O

It	O
is	O
unknown	O
whether	O
this	O
reflects	O
differences	O
in	O
brain	O
size	O
or	O
in	O
skull	O
bones	O
’	O
structure	O
,	O
and	O
needs	O
to	O
be	O
explored	O
in	O
future	O
studies	O
.	O

For	O
more	O
information	O
on	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
prevention	O
of	O
allergy	O
,	O
readers	O
are	O
referred	O
to	O
the	O
document	O
,	O
"	O
Prevention	O
of	O
Allergy	O
and	O
Allergic	O
Asthma	O
,"	O
an	O
article	O
based	O
on	O
findings	O
presented	O
at	O
the	O
World	O
Health	O
Organization	O
/	O
World	O
Allergy	O
Organization	O
meeting	O
in	O
January	O
2002	O
[	O
120	O
].	O

On	O
evaluation	O
of	O
this	O
recurrence	O
,	O
a	O
0	O
.	O
8	O
-	O
×	O
0	O
.	O
9	O
-	O
cm	O
friable	O
erythematous	O
papule	O
was	O
noted	O
under	O
the	O
onycholytic	O
distal	O
right	O
great	O
toenail	O
and	O
extended	O
distal	O
to	O
the	O
onychodermal	O
band	O
(	O
Fig	O
1	O
).	O

With	O
respect	O
to	O
public	O
health	O
,	O
however	O
,	O
this	O
is	O
mere	O
semantics	O
;	O
both	O
could	O
have	O
far	O
-	O
reaching	O
consequences	O
for	O
the	O
present	O
and	O
future	O
health	O
of	O
human	O
populations	O
.	O

The	O
same	O
researcher	O
blinded	O
to	O
the	O
clinical	O
data	O
conducted	O
the	O
assessment	O
of	O
all	O
children	O
.	O

Mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
significantly	O
lower	O
among	O
children	O
with	O
S	O
-	O
ECC	O
than	O
caries	O
-	O
free	O
controls	O
(	O
68	O
.	O
9	O
±	O
28	O
.	O
0	O
nmol	O
/	O
L	O
vs	O
.	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Table	O
2	O
).	O

This	O
was	O
followed	O
by	O
incubation	O
for	O
1	O
hr	O
with	O
antibodies	O
against	O
GR	O
α	O
at	O
a	O
1	O
:	O
200	O
dilution	O
in	O
1	O
%	O
BSA	O
/	O
PBS	O
.	O

Therefore	B
,	O
these	O
potential	O
limitations	O
should	O
be	O
considered	O
in	O
the	O
interpretation	O
of	O
our	O
results	O
.	O

Various	O
human	O
studies	O
are	O
done	O
so	O
far	O
involving	O
pharmacological	O
doses	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
.	O

A	O
detailed	O
description	O
of	O
the	O
follow	O
-	O
up	O
study	O
and	O
exposure	O
assessment	O
has	O
been	O
described	O
elsewhere	O
[	O
21	O
].	O

Also	O
,	O
few	O
maternal	O
psychosocial	O
predictors	O
of	O
offspring	O
weight	O
status	O
were	O
observed	O
within	O
both	O
overweight	O
/	O
obese	O
and	O
normal	O
weight	O
mothers	O
.	O

Despite	O
small	O
cell	O
sizes	O
,	O
it	O
should	O
be	O
noted	O
that	O
all	O
of	O
the	O
children	O
with	O
low	O
calcium	O
concentrations	O
belonged	O
to	O
the	O
S	O
-	O
ECC	O
group	O
.	O

Data	O
were	O
analyzed	O
using	O
the	O
PROC	O
MIXED	O
,	O
including	O
effects	O
of	O
diet	O
,	O
sex	O
,	O
mother	O
,	O
birth	O
weight	O
and	O
interaction	O
between	O
diet	O
and	O
sex	O
(	O
SAS	O
version	O
9	O
.	O
1	O
;	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
).	O

Infections	O
were	O
defined	O
as	O
discrete	O
events	O
that	O
were	O
documented	O
in	O
the	O
medical	O
record	O
and	O
/	O
or	O
the	O
primary	O
health	O
care	O
record	O
.	O

The	O
plasma	O
levels	O
of	O
LDL	O
were	O
significantly	O
increased	O
in	O
RC	O
males	O
and	O
females	O
.	O

However	O
,	O
the	O
previous	O
study	O
was	O
based	O
on	O
cortical	O
and	O
hippocampal	O
tissue	O
from	O
adult	O
female	O
animals	O
,	O
whereas	O
the	O
current	O
study	O
was	O
based	O
on	O
tissue	O
from	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
male	O
animals	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
.	O

As	B
15	O
%	O
of	O
the	O
women	O
in	O
the	O
Diabetes	O
Prevention	O
Program	O
and	O
Diabetes	O
Prevention	O
Study	O
had	O
GDM	O
,	O
similar	O
measures	O
should	O
be	O
recommended	O
to	O
women	O
after	O
they	O
have	O
had	O
GDM	O
.	O

Ethical	O
approval	O
was	O
granted	O
from	O
the	O
local	O
ethics	O
authority	O
.	O

The	O
highest	O
profit	O
in	O
this	O
steer	O
group	O
was	O
for	O
a	O
slaughter	O
age	O
of	O
31	O
months	O
.	O

Only	O
a	O
small	O
proportion	O
of	O
white	O
infants	O
were	O
SGA	O
,	O
and	O
this	O
may	O
have	O
limited	O
our	O
ability	O
to	O
detect	O
significant	O
associations	O
between	O
vitamin	O
D	O
and	O
SGA	O
among	O
white	O
infants	O
.	O

Maternal	O
Diet	O
The	O
maternal	O
dietary	O
component	O
consumed	O
during	O
gestation	O
could	O
influence	O
the	O
immune	O
status	O
of	O
the	O
child	O
.	O

could	O
be	O
replicated	O
in	O
the	O
general	O
obstetrical	O
population	O
at	O
MUSC	O
.	O

Reactive	O
oxygen	O
species	O
are	O
also	O
proposed	O
to	O
stimulate	O
the	O
production	O
of	O
alpha	O
-	O
ketoglutarate	O
,	O
a	O
co	O
-	O
substrate	O
for	O
TETs	O
and	O
one	O
of	O
the	O
two	O
main	O
classes	O
of	O
histone	O
demethylases	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

The	O
corresponding	O
null	O
distribution	O
,	O
signifying	O
a	O
lack	O
of	O
association	O
between	O
repetitive	O
element	O
methylation	O
and	O
autosomal	O
CpG	O
methylation	O
,	O
was	O
obtained	O
by	O
randomly	O
permuting	O
each	O
repetitive	O
element	O
methylation	O
marker	O
with	O
respect	O
to	O
aggregate	O
methylation	O
values	O
of	O
the	O
RPMM	O
and	O
bioinformatic	O
classes	O
.	O

We	O
acknowledge	O
that	O
measurement	O
of	O
GR	O
polymorphisms	O
posed	O
certain	O
limitations	O
,	O
for	O
example	O
,	O
the	O
use	O
of	O
cell	O
lines	O
as	O
in	O
vitro	O
experimental	O
models	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
as	O
the	O
main	O
precursor	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
has	O
a	O
circulating	O
half	O
-	O
life	O
of	O
2	O
–	O
3	O
weeks	O
.	O

At	O
baseline	O
,	O
using	O
Pearson	O
’	O
s	O
correlation	O
coefficient	O
,	O
no	O
relations	O
were	O
observed	O
between	O
the	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
and	O
depression	O
scores	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

Kolmogro	O
-	O
Smirnov	O
test	O
was	O
used	O
to	O
determine	O
the	O
distribution	O
of	O
quantitative	O
data	O
.	O

Doses	O
of	O
L	O
-	O
thyroxine	O
greater	O
than	O
150	O
/	O
200	O
μg	O
(	O
at	B
least	I
2	O
μg	O
/	O
kg	O
/	O
day	O
)	O
are	O
usually	O
needed	O
to	O
maintain	O
maternal	O
serum	O
-	O
free	O
thyroxin	O
concentrations	O
within	O
the	O
upper	O
third	O
of	O
the	O
reference	O
range	O
and	O
to	O
suppress	O
TSH	O
levels	O
.	O

A	O
more	O
recent	O
study	O
examined	O
the	O
peer	O
effects	O
on	O
adolescent	O
BMI	O
by	O
using	O
the	O
National	O
Longitudinal	O
Study	O
of	O
Adolescent	O
Health	O
(	O
98	O
).	O

Black	O
line	O
represents	O
fitted	O
LOESS	O
curve	O
.	O

[	O
18	O
]	O
both	O
found	O
changes	O
in	O
birth	O
weight	O
associated	O
with	O
increased	O
OCP	O
exposure	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2458	O
/	O
13	O
/	O
1105	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Nutritional	O
knowledge	O
questionnaire	O
.	O

The	O
quality	O
and	O
accuracy	O
of	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
analysis	O
is	O
validated	O
on	O
an	O
ongoing	O
basis	O
by	O
participation	O
in	O
the	O
vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
(	O
DEQAS	O
,	O
Charing	O
Cross	O
Hospital	O
,	O
London	O
,	O
UK	O
).	O

©	O
2009	O
Dove	O
Medical	O
Press	O
Limited	O
.	O

Chart	O
reviews	O
were	O
conducted	O
to	O
determine	O
whether	O
the	O
PTBs	O
were	O
spontaneous	O
(	O
occurring	O
after	O
preterm	O
labor	O
with	O
intact	O
membranes	O
or	O
preterm	O
pre	O
-	O
labor	O
rupture	O
of	O
the	O
fetal	O
membranes	O
)	O
or	O
indicated	O
.	O

Providing	O
quality	O
care	O
involves	O
doing	O
the	O
right	O
thing	O
at	O
the	O
right	O
time	O
.	O

In	O
this	O
way	O
free	O
sugar	O
intake	O
was	O
estimated	O
.	O

Weight	O
at	O
the	O
last	O
clinic	O
visit	O
was	O
objectively	O
measured	O
using	O
a	O
calibrated	O
digital	O
or	O
balance	O
beam	O
scale	O
by	O
research	O
assistant	O
or	O
clinic	O
staff	O
.	O

The	O
evaluation	O
team	O
will	O
consist	O
of	O
135	O
data	O
collectors	O
,	O
five	O
field	O
supervisors	O
and	O
five	O
field	O
research	O
officers	O
.	O

The	O
following	O
narrative	O
review	O
aims	O
to	O
better	O
understand	O
the	O
existing	O
evidence	O
for	O
perinatal	O
and	O
labor	O
-	O
related	O
associations	O
with	O
autism	O
.	O

Postoperatively	O
,	O
the	O
mother	O
continued	O
to	O
be	O
hypernatremic	O
despite	O
IV	O
infusion	O
of	O
hypotonic	O
fluids	O
.	O

Maternal	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
closest	O
to	O
delivery	O
were	O
plotted	O
against	O
gestational	O
age	O
at	O
birth	O
and	O
locally	O
weighted	O
regression	O
(	O
LOESS	O
)	O
was	O
used	O
to	O
explore	O
the	O
relationship	O
in	O
more	O
detail	O
and	O
compare	O
to	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

However	O
,	O
a	O
few	O
studies	O
present	O
conflicting	O
data	O
about	O
the	O
correlation	O
between	O
birth	O
weight	O
and	O
the	O
impairment	O
of	O
cardiac	O
autonomic	O
modulation	O
.	O

Years	O
of	O
life	O
saved	O
will	O
be	O
based	O
on	O
any	O
difference	O
in	O
survival	O
of	O
mothers	O
and	O
infants	O
observed	O
during	O
the	O
trial	O
and	O
estimated	O
using	O
current	O
life	O
expectancy	O
in	O
Bangladesh	O
.	O

Malaria	O
blood	O
films	O
were	O
prepared	O
and	O
stained	O
with	O
giemsa	O
stain	O
and	O
100	O
microscopic	O
fields	O
examined	O
to	O
determine	O
parasite	O
count	O
.	O

While	O
dental	O
surgery	O
targets	O
the	O
visible	O
signs	O
of	O
the	O
disease	O
,	O
our	O
understanding	O
of	O
the	O
systemic	O
influence	O
of	O
S	O
-	O
ECC	O
on	O
overall	O
health	O
is	O
limited	O
.	O

(	O
a	O
)	O
SC	O
offspring	O
and	O
(	O
b	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F1	O
generation	O
;	O
(	O
c	O
)	O
SC	O
offspring	O
and	O
(	O
d	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F2	O
generation	O
;	O
(	O
arrows	O
)	O
clusters	O
with	O
comma	O
-	O
shaped	O
and	O
S	O
-	O
shaped	O
glomerular	O
structures	O
at	O
the	O
cortex	O
;	O
(	O
open	O
arrows	O
)	O
vascularized	O
glomerular	O
structures	O
in	O
the	O
inner	O
region	O
.	O

They	O
are	O
also	O
complicated	O
by	O
the	O
fact	O
that	O
the	O
biological	O
material	O
under	O
study	O
,	O
often	B
blood	O
cells	O
,	O
is	O
not	O
from	O
the	O
target	O
organ	O
/	O
tissue	O
.	O

2	O
.	O

The	O
rapid	O
acting	O
analogs	O
lispro	O
and	O
aspart	O
are	O
considered	O
safe	O
,	O
but	O
the	O
safety	O
of	O
the	O
long	O
-	O
acting	O
analogs	O
are	O
yet	O
to	O
be	O
determined	O
.	O

Those	O
who	O
participated	O
gave	O
written	O
informed	O
consent	O
.	O

Regarding	O
the	O
potential	O
relation	O
between	O
ECS	O
and	O
fetal	O
undernutrition	O
,	O
a	O
few	O
studies	O
have	O
demonstrated	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
calorie	O
-	O
restricted	O
diet	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
could	O
decrease	O
the	O
hypothalamic	O
endocannabinoids	O
and	O
/	O
or	O
acylethanolamines	O
in	O
offspring	O
(	O
Matias	O
et	O
al	O
.,	O
2003	O
;	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

None	O
of	O
the	O
other	O
variables	O
listed	O
in	O
Table1were	O
found	O
to	O
be	O
confounders	O
.	O

Overall	O
,	O
snoring	O
was	O
associated	O
with	O
a	O
1	O
.	O
86	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
1	O
.	O
86	O
;	O
95	O
%	O
CI	O
0	O
.	O
88	O
-	O
3	O
.	O
94	O
).	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
.	O

Blood	O
samples	O
were	O
collected	O
and	O
a	O
questionnaire	O
was	O
completed	O
face	O
-	O
to	O
-	O
face	O
.	O

The	O
cost	O
per	O
woman	O
treated	O
(	O
defined	O
as	O
consuming	O
at	O
least	O
75	O
%	O
of	O
the	O
recommended	O
intake	O
)	O
was	O
USD0	O
.	O
76	O
per	O
annum	O
.	O

It	O
is	O
possible	O
that	O
the	O
increased	O
energy	O
,	O
protein	O
and	O
fat	O
observed	O
in	O
our	O
study	O
during	O
extended	O
summer	O
could	O
be	O
due	O
to	O
changes	O
in	O
dietary	O
habits	O
during	O
the	O
summer	O
holidays	O
.	O

The	O
decision	O
whether	O
to	O
use	O
a	O
first	O
-	O
generation	O
or	O
second	O
-	O
generation	O
antihistamine	O
for	O
a	O
particular	O
patient	O
must	O
be	O
individualized	O
.	O

Methods	O
Study	O
design	O
and	O
subjects	O
This	O
retrospective	O
study	O
was	O
conducted	O
at	O
University	O
of	O
Cincinnati	O
Medical	O
Center	O
in	O
Cincinnati	O
,	O
OH	O
,	O
USA	O
.	O

Results	O
Figure	O
1shows	O
the	O
trial	O
profile	O
.	O

Follow	O
-	O
up	O
schedule	O
Each	O
infant	O
was	O
assessed	O
by	O
a	O
research	O
assistant	O
,	O
blinded	O
to	O
the	O
allocated	O
treatment	O
group	O
.	O

By	O
identifying	O
and	O
contributing	O
to	O
the	O
knowledge	O
gaps	O
PHE	O
,	O
and	O
similar	O
organizations	O
worldwide	O
,	O
can	O
ensure	O
that	O
they	O
stay	O
fully	O
aware	O
of	O
the	O
current	O
situation	O
and	O
are	O
in	O
the	O
best	O
position	O
to	O
give	O
advice	O
and	O
put	O
forward	O
any	O
necessary	O
recommendations	O
and	O
policies	O
to	O
protect	O
public	O
health	O
against	O
such	O
toxicity	O
.	O

Such	O
barriers	O
may	O
include	O
lack	O
of	O
prenatal	O
education	O
about	O
breastfeeding	O
,	O
inadequate	O
lactation	O
support	O
from	O
healthcare	O
providers	O
after	O
delivery	O
,	O
disapproval	O
from	O
spouses	O
or	O
family	O
members	O
,	O
short	O
maternity	O
leave	O
,	O
and	O
few	O
opportunities	O
to	O
pump	O
at	O
work	O
.	O

Specifically	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
males	O
also	O
displayed	O
higher	O
body	O
weight	O
than	O
CC	O
males	O
in	O
several	O
weeks	O
of	O
the	O
post	O
-	O
weaning	O
period	O
that	O
comprise	O
the	O
adulthood	O
(	O
postnatal	O
weeks	O
15	O
–	O
18	O
and	O
postnatal	O
week	O
19	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Approximately	O
three	O
-	O
quarters	O
of	O
the	O
women	O
were	O
immigrants	O
(	O
75	O
%),	O
primarily	O
from	O
Mexico	O
and	O
Honduras	O
.	O

Programmatic	O
costs	O
included	O
cost	O
of	O
supplements	O
,	O
which	O
were	O
originally	O
distributed	O
in	O
tamper	O
-	O
proof	O
bottles	O
(	O
UNICEF	O
,	O
Copenhagen	O
),	O
and	O
after	O
12	O
months	O
sourced	O
domestically	O
in	O
blister	O
packs	O
consisting	O
of	O
6	O
tear	O
-	O
off	O
strips	O
of	O
5	O
tablets	O
,	O
each	O
strip	O
enough	O
for	O
one	O
month	O
(	O
Nam	O
Ha	O
Pharmaceutical	O
Company	O
,	O
Nam	O
Dinh	O
,	O
Vietnam	O
).	O

Therefore	B
,	O
vitamin	O
D	O
supplementation	O
in	O
high	O
doses	O
has	O
been	O
recommended	O
,	O
and	O
oral	O
doses	O
of	O
20000	O
or	O
40000	O
IU	O
were	O
associated	O
with	O
positive	O
outcomes	O
.	O
6	O
,	O
14Moreover	O
,	O
higher	O
oral	O
dose	O
of	O
(	O
6400	O
IU	O
per	O
day	O
)	O
to	O
lactating	O
mothers	O
significantly	O
increased	O
vitamin	O
D	O
status	O
in	O
mothers	O
as	O
well	O
as	O
the	O
vitamin	O
D	O
content	O
and	O
antirachitic	O
activity	O
of	O
their	O
milk	O
.	O
14Therefore	B
,	O
high	O
doses	O
of	O
vitamin	O
D	O
,	O
either	O
orally	O
or	O
through	O
injection	O
,	O
has	O
recently	O
been	O
recommended	O
.	O
15	O
-	O
24	O
A	O
single	O
dose	O
of	O
vitamin	O
D	O
,	O
administered	O
parenterally	O
,	O
would	O
be	O
more	O
effective	O
,	O
because	O
it	O
is	O
not	O
associated	O
with	O
the	O
noncompliance	O
associated	O
with	O
an	O
oral	O
dose	O
.	O

The	O
mean	O
number	O
of	O
glomeruli	O
varied	O
from	O
10897	O
±	O
614	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
14064	O
±	O
308	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
30	O
%	O
difference	O
;	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
10466	O
±	O
867	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
12015	O
±	O
785	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Maternal	O
iron	O
deficiency	O
and	O
anemia	O
early	O
in	O
gestation	O
can	O
result	O
in	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

PubMed	O
Central	O
:	O

Briefly	O
,	O
maternal	O
stress	O
/	O
maternal	O
attitudes	O
towards	O
their	O
pregnancy	O
were	O
assessed	O
in	O
the	O
3rd	O
trimester	O
,	O
using	O
a	O
questionnaire	O
approach	O
.	O

The	O
thermogenic	O
activity	O
of	O
BAT	O
is	O
mainly	O
controlled	O
by	O
the	O
sympathetic	O
nervous	O
system	O
.	O

Influenza	O
vaccination	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
risk	O
of	O
influenza	O
virus	O
disease	O
and	O
its	O
complications	O
among	O
pregnant	O
women	O
and	O
their	O
infants	O
[	O
5	O
],[	O
6	O
],[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],[	O
12	O
],[	O
13	O
],[	O
14	O
],[	O
15	O
].	O

Women	O
with	O
known	O
metabolic	O
bone	O
disease	O
,	O
renal	O
stones	O
,	O
hyperparathyroidism	O
or	O
hypercalciuria	O
,	O
those	O
taking	O
medication	O
known	O
to	O
interfere	O
with	O
fetal	O
growth	O
,	O
fetal	O
anomalies	O
on	O
ultrasonography	O
,	O
and	O
women	O
already	O
using	O
>	O
400	O
IU	O
/	O
d	O
vitamin	O
D	O
supplementation	O
were	O
excluded	O
.	O

Insulin	O
therapy	O
for	O
gestational	O
diabetes	O
When	O
treatment	O
targets	O
are	O
not	O
achieved	O
by	O
dietary	O
means	O
,	O
then	O
insulin	O
is	O
required	O
.	O

The	O
duration	O
of	O
supplementation	O
in	O
these	O
studies	O
was	O
short	O
,	O
different	O
MMN	O
formulations	O
were	O
used	O
and	O
sample	O
sizes	O
were	O
smaller	O
than	O
in	O
the	O
present	O
study	O
.	O

However	O
,	O
as	B
there	O
was	O
no	O
evaluation	O
of	O
glycemic	O
control	O
early	O
in	O
pregnancy	O
,	O
and	O
more	O
women	O
on	O
metformin	O
had	O
pre	O
-	O
existing	O
type	O
2	O
diabetes	O
,	O
the	O
groups	O
do	O
not	O
appear	O
to	O
be	O
well	O
matched	O
.	O

Differences	O
in	O
ferritin	O
and	O
haemoglobin	O
between	O
these	O
groups	O
has	O
previously	O
been	O
reported	O
in	O
this	O
sample	O
[	O
12	O
].	O

Neuronal	O
membranes	O
are	O
largely	O
made	O
up	O
of	O
phospholipids	O
,	O
and	O
the	O
brain	O
phospholipids	O
are	O
rich	O
in	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
).	O

In	O
rodents	O
,	O
many	O
studies	O
reported	O
an	O
impact	O
of	O
maternal	O
low	O
protein	O
diets	O
on	O
expression	O
and	O
affinity	O
of	O
the	O
glucocorticoid	O
receptor	O
and	O
its	O
signaling	O
molecules	O
[	O
8	O
,	O
48	O
,	O
59	O
-	O
61	O
].	O

Overall	O
the	O
data	O
support	O
the	O
hypothesis	O
that	O
the	O
cause	O
of	O
the	O
phenotype	O
of	O
HV	O
offspring	O
fed	O
RV	O
diets	O
may	O
be	O
accounted	B
for	I
by	O
its	O
effects	O
in	O
utero	O
on	O
development	O
of	O
hypothalamic	O
pathways	O
of	O
intake	O
regulation	O
,	O
leading	O
to	O
excess	O
food	O
intake	O
,	O
and	O
consequently	B
increased	O
body	O
weight	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
.	O
4Offspring	O
born	O
to	O
dams	O
fed	O
the	O
HV	O
diet	O
during	O
pregnancy	O
had	O
lower	O
expression	O
of	O
POMC	O
and	O
BDNF	O
,	O
which	O
are	O
anorexigenic	O
(	O
appetite	O
-	O
suppressing	O
)	O
genes	O
,	O
20	O
,	O
21compared	O
to	O
those	O
born	O
to	O
dams	O
on	O
the	O
RV	O
diet	O
.	O

Antenatal	O
vitamin	O
D	O
supplementation	O
is	O
now	O
recommended	O
for	O
all	O
pregnant	O
women	O
in	O
many	O
national	O
guidelines	B
(	O
1	O
–	O
3	O
)	O
as	B
severe	O
maternal	O
vitamin	O
D	O
deficiency	O
can	O
result	O
in	O
symptomatic	O
neonatal	O
hypocalcemia	O
(	O
4	O
).	O

As	O
early	O
development	O
progresses	O
and	O
the	O
embryonic	O
genome	O
is	O
activated	O
,	O
miRNA	O
expression	O
increases	O
and	O
piRNA	O
and	O
esiRNA	O
expression	O
decreases	O
,	O
so	O
that	O
the	O
pattern	O
of	O
sncRNA	O
expression	O
is	O
reversed	O
(	O
Ohnishi	O
et	O
al	O
.	O
2010	O
;	O
Suh	O
&	O
Blelloch2011	O
).	O

In	O
these	O
sessions	O
,	O
71	O
maneuvers	O
of	O
tidal	O
breathing	O
analysis	O
,	O
65	O
maneuvers	O
of	O
respiratory	O
mechanics	O
,	O
and	O
59	O
maneuvers	O
of	O
tidal	O
forced	O
expiration	O
were	O
eligible	O
for	O
the	O
final	O
analysis	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Study	O
flow	O
chart	O
.	O

Although	O
some	O
studies	O
have	O
found	O
evidence	O
of	O
a	O
correlation	O
between	O
low	O
birth	O
weight	O
and	O
autonomic	O
dysfunction	O
,	O
the	O
results	O
remain	O
inconclusive	O
.	O

Previous	O
studies	O
have	O
shown	O
a	O
positive	O
association	O
between	O
socioeconomic	O
status	O
and	O
vitamin	O
D	O
in	O
both	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
[	O
36	O
,	O
37	O
].	O

From	O
birth	O
to	O
PND	O
22	O
(	O
lactation	O
),	O
three	O
-	O
way	O
repeated	O
measures	O
ANOVA	O
showed	O
a	O
main	O
and	O
significant	O
effect	O
of	O
time	O
on	O
body	O
weight	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
675	O
.	O
53	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
Figure2B	O
].	O

Development	O
of	O
robust	O
,	O
fit	O
-	O
for	O
-	O
purpose	O
equipment	O
,	O
is	O
a	O
critical	O
next	O
frontier	O
for	O
referral	O
care	O
for	O
premature	O
babies	O
in	O
the	O
settings	O
where	O
most	O
die	O
,	O
especially	O
for	O
care	O
in	O
hospitals	O
[	O
6	O
].	O

[	O
20	O
]	O
report	O
autonomic	O
dysfunction	O
in	O
adults	O
with	O
low	O
birth	O
weight	O
,	O
characterized	O
by	O
increased	O
sympathetic	O
activity	O
and	O
reduced	O
parasympathetic	O
activity	O
and	O
baroreflex	O
sensitivity	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
clarify	O
and	O
strengthen	O
the	O
role	O
of	O
BMP	O
proteins	O
in	O
the	O
regulation	O
of	O
BAT	O
or	O
“	O
brite	O
”	O
cells	O
and	O
their	O
consequences	O
on	O
metabolic	O
homeostasis	O
.	O

We	O
will	O
use	O
population	O
average	O
Poisson	O
model	O
for	O
other	O
outcomes	O
including	O
preterm	O
,	O
small	O
for	O
gestation	O
and	O
low	O
birth	O
weights	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
between	O
vitamin	O
D	O
status	O
in	O
pregnancy	O
with	O
birth	O
size	O
and	O
pregnancy	O
loss	O
(	O
adjusted	O
logistic	O
regression	O
analysis	O
)	O
Small	O
for	O
gestational	O
ageaPreterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
bLow	O
birth	O
weight	O
(<	O
2500	O
g	O
)	O
cPregnancy	O
lossdORCI	O
95	O
%	O
ORCI	O
95	O
%	O
ORCI	O
95	O
%	O
ORCI	O
95	O
%	O
T1	O
25OHDe	O
Continuous	O
nmol	O
/	O
L1	O
.	O
0030	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
9960	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
9990	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
989	O
*	O
0	O
.	O
98	O
–	O
1	O
.	O
00	O
<	O
30	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
01	O
.	O
0	O
30	O
–	O
49	O
.	O
91	O
.	O
0780	O
.	O
44	O
–	O
2	O
.	O
661	O
.	O
6470	O
.	O
63	O
–	O
4	O
.	O
332	O
.	O
5490	O
.	O
88	O
–	O
7	O
.	O
381	O
.	O
0300	O
.	O
44	O
–	O
2	O
.	O
41	O
50	O
–	O
74	O
.	O
91	O
.	O
6320	O
.	O
69	O
–	O
3	O
.	O
851	O
.	O
2600	O
.	O
47	O
–	O
3	O
.	O
362	O
.	O
2870	O
.	O
77	O
–	O
6	O
.	O
830	O
.	O
6880	O
.	O
29	O
–	O
1	O
.	O
62	O
75	O
–	O
99	O
-	O
91	O
.	O
2920	O
.	O
51	O
–	O
3	O
.	O
271	O
.	O
3320	O
.	O
48	O
–	O
3	O
.	O
731	O
.	O
6650	O
.	O
51	O
–	O
5	O
.	O
490	O
.	O
8090	O
.	O
33	O
–	O
1	O
.	O
96	O
≥	O
1001	O
.	O
2940	O
.	O
38	O
–	O
4	O
.	O
420	O
.	O
5020	O
.	O
09	O
–	O
2	O
.	O
721	O
.	O
2550	O
.	O
22	O
–	O
7	O
.	O
270	O
.	O
000fT3	O
25OHDe	O
<	O
30	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
0	O
30	O
–	O
49	O
.	O
90	O
.	O
7710	O
.	O
34	O
–	O
1	O
.	O
750	O
.	O
3020	O
.	O
08	O
–	O
1	O
.	O
140	O
.	O
071	O
*	O
0	O
.	O
01	O
–	O
0	O
.	O
63	O
50	O
–	O
74	O
.	O
90	O
.	O
6230	O
.	O
27	O
–	O
1	O
.	O
450	O
.	O
9330	O
.	O
31	O
–	O
2	O
.	O
790	O
.	O
5840	O
.	O
17	O
–	O
1	O
.	O
98	O
75	O
–	O
99	O
-	O
90	O
.	O
6570	O
.	O
27	O
–	O
1	O
.	O
610	O
.	O
6140	O
.	O
18	O
–	O
2	O
.	O
140	O
.	O
2370	O
.	O
06	O
–	O
1	O
.	O
01	O
≥	O
1000	O
.	O
318	O
*	O
0	O
.	O
11	O
–	O
0	O
.	O
900	O
.	O
4460	O
.	O
11	O
–	O
1	O
.	O
760	O
.	O
215	O
*	O
0	O
.	O
05	O
–	O
0	O
.	O
97Δ25OHDg	O
Large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
0	O
Small	O
increase	O
(	O
0	O
–	O
30	O
nmol	O
/	O
L	O
)	O
2	O
.	O
564	O
*	O
1	O
.	O
16	O
–	O
5	O
.	O
672	O
.	O
905	O
*	O
1	O
.	O
01	O
–	O
8	O
.	O
343	O
.	O
1220	O
.	O
97	O
–	O
10	O
.	O
09	O
Decrease	O
(<	O
0	O
nmol	O
/	O
L	O
)	O
3	O
.	O
679	O
**	O
1	O
.	O
60	O
–	O
8	O
.	O
442	O
.	O
8940	O
.	O
95	O
–	O
8	O
.	O
854	O
.	O
722	O
*	O
1	O
.	O
37	O
–	O
16	O
.	O
28	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
*	O
p	O
<	O
0	O
.	O
05	O
**	O
p	O
<	O
0	O
.	O
01	O
aModels	O
include	O
92	O
(	O
T1	O
)	O
and	O
80	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
small	O
for	O
gestational	O
age	O
bModels	O
include	O
77	O
(	O
T1	O
)	O
and	O
43	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
preterm	O
delivery	O
cModels	O
include	O
57	O
(	O
T1	O
)	O
and	O
31	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
low	O
birth	O
weight	O
dModels	O
include	O
96	O
cases	O
of	O
pregnancy	O
loss	O
eAdjusted	O
for	O
education	O
,	O
origin	O
,	O
season	O
of	O
conception	O
and	O
BMI	O
at	O
T1	O
.	O

Similarly	O
,	O
seasonal	O
occurrence	O
has	O
been	O
observed	O
for	O
chicken	O
pox	O
,	O
measles	O
,	O
influenza	O
and	O
many	O
other	O
common	O
childhood	O
infectious	O
diseases	O
[	O
7	O
,	O
142	O
].	O

It	O
should	O
be	O
noted	O
,	O
however	O
,	O
that	O
,	O
from	O
a	O
stand	O
-	O
alone	O
perspective	O
,	O
each	O
of	O
the	O
factors	O
(	O
as	O
listed	O
above	O
)	O
that	O
link	O
autism	O
with	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
does	O
not	O
correlate	O
consistently	O
as	B
the	O
incidence	O
of	O
autism	O
is	O
reviewed	O
in	O
terms	O
of	O
its	O
cross	O
-	O
reference	O
amongst	O
various	O
research	O
studies	O
.	O

First	O
,	O
it	O
provides	B
a	O
randomized	O
trial	O
of	O
text4baby	O
with	O
a	O
large	O
sample	O
over	O
the	O
full	O
course	O
of	O
the	O
prenatal	O
texting	O
module	O
.	O

Randomisation	O
was	O
by	O
use	O
of	O
a	O
computer	O
-	O
generated	O
list	O
.	O

It	O
was	O
hypothesized	O
that	O
(	O
1	O
)	O
total	O
current	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
would	O
be	O
positively	O
correlated	O
with	O
cathelicidin	O
in	O
children	O
;	O
(	O
2	O
)	O
children	O
with	O
higher	O
plasma	O
cathelicidin	O
concentrations	O
would	O
have	O
had	O
fewer	O
infections	O
than	O
children	O
with	O
lower	O
cathelicidin	O
concentrations	O
;	O
and	O
(	O
3	O
)	O
cathelicidin	O
concentration	O
would	O
increase	O
with	O
advancing	O
age	O
.	O

Results	O
Participant	O
characteristics	O
-	O
demographics	O
Half	O
of	O
the	O
participants	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
(	O
November	O
–	O
April	O
)	O
(	O
n	O
=	O
166	O
[	O
49	O
.	O
7	O
%]).	O

From	O
murine	O
studies	O
,	O
it	O
may	O
be	O
expected	O
that	O
the	O
sensitization	O
of	O
a	O
mother	O
to	O
a	O
(	O
food	O
)	O
allergen	O
will	O
also	O
bias	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
toward	O
Th2	O
[	O
39	O
,	O
40	O
].	O

The	O
medical	O
management	O
of	O
gestational	O
diabetes	O
is	O
still	O
evolving	O
,	O
and	O
recent	O
randomized	O
controlled	O
trials	O
have	O
added	O
considerably	O
to	O
our	O
knowledge	O
in	O
this	O
area	O
.	O

For	O
41	O
.	O
7	O
%	O
of	O
the	O
women	O
this	O
was	O
their	O
first	O
pregnancy	O
(	O
unknown	O
for	O
0	O
.	O
4	O
%	O
of	O
the	O
women	O
),	O
while	O
for	O
45	O
.	O
6	O
%	O
of	O
the	O
women	O
this	O
would	O
be	O
their	O
first	O
child	O
(	O
status	O
not	O
known	O
for	O
1	O
.	O
4	O
%	O
of	O
the	O
women	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Skeletal	O
abnormalities	O
in	O
skeletal	O
morphology	O
mutant	O
(	O
Skm	O
)	O
mice	O
.	O

At	O
weaning	O
(	O
28	O
dpn	O
)	O
offspring	O
of	O
the	O
LP	O
group	O
showed	O
slight	O
but	O
significant	O
higher	O
fat	O
content	O
and	O
adipocyte	O
size	O
,	O
and	O
still	O
lower	O
muscle	O
fibre	O
numbers	O
.	O

These	O
districts	O
are	O
Netrokona	O
,	O
Kishoreganj	O
,	O
Mymensingh	O
,	O
Sherpur	O
,	O
and	O
Gazipur	O
,	O
with	O
a	O
total	O
number	O
of	O
47	O
Upazila	O
(	O
subdistricts	O
)	O
and	O
a	O
combined	O
population	O
of	O
20	O
million	O
.	O

Preeclampsia	O
occurred	O
less	O
frequently	O
in	O
the	O
intervention	O
group	O
(	O
12	O
%	O
vs	O
18	O
%,	O
adjusted	O
risk	O
reduction	O
0	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

In	O
terms	O
of	O
the	O
polymorphic	O
study	O
,	O
our	O
study	O
provides	B
a	O
novel	O
insight	O
into	O
the	O
involvement	O
of	O
GR	O
polymorphisms	O
in	O
pregnancy	O
outcome	O
.	O

Other	O
allergic	O
diseases	O
that	O
may	O
complicate	O
pregnancy	O
include	O
conjunctivitis	O
,	O
acute	O
urticaria	O
,	O
anaphylaxis	O
,	O
food	O
allergy	O
,	O
and	O
drug	O
allergy	O
.	O

There	O
are	O
also	O
high	O
preterm	O
birth	O
rates	O
in	O
many	O
high	O
-	O
income	O
countries	O
,	O
including	O
the	O
United	O
States	O
.	O

In	O
either	O
design	O
,	O
contamination	O
of	O
the	O
control	O
group	O
would	O
be	O
a	O
potential	O
concern	O
.	O

Furthermore	O
,	O
women	O
were	O
asked	O
a	O
validated	O
,	O
single	O
-	O
item	O
question	O
on	O
food	O
insufficiency	O
–“	O
How	O
many	O
days	O
in	O
the	O
past	O
week	O
have	O
you	O
gone	O
hungry	O
?	O

Those	O
receiving	O
standard	O
care	O
were	O
unaware	O
that	O
they	O
had	O
GDM	O
.	O

These	O
in	O
vitro	O
and	O
in	O
vivo	O
observations	O
together	O
are	O
highly	B
suggestive	O
of	O
a	O
functional	O
link	O
between	O
stress	O
and	O
this	O
ncRNA	O
.	O

Second	O
,	O
the	O
fallow	O
up	O
of	O
mothers	O
and	O
infants	O
was	O
short	O
-	O
term	O
.	O

Independent	O
t	O
-	O
tests	O
were	O
used	O
to	O
examine	O
the	O
relationship	O
between	O
continuous	O
variables	O
and	O
each	O
outcome	O
.	O

injection	O
of	O
1	O
.	O
25	O
mg	O
propionyl	O
-	O
promazine	O
(	O
0	O
.	O
2	O
ml	O
Combelen	O
,	O
Bayer	O
AG	O
,	O
Leverkusen	O
,	O
Germany	O
)	O
and	O
50	O
mg	O
ketamine	O
(	O
Ursotamin	O
,	O
Serumwerk	O
Bernburg	O
AG	O
,	O
Germany	O
).	O

Associations	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
and	O
pregnancy	O
loss	O
were	O
also	O
studied	O
.	O

Methods	O
The	O
GraviD	O
study	O
is	O
a	O
prospective	O
cohort	O
study	O
,	O
conducted	O
in	O
parts	O
of	O
the	O
Västra	O
Götaland	O
region	O
in	O
the	O
southwest	O
of	O
Sweden	O
,	O
at	O
latitude	O
57	O
–	O
58	O
°	O
N	O
[	O
3	O
].	O

Chailurkit	O
et	O
al	O
.	O

Asthma	O
and	O
allergic	O
disorders	O
can	O
affect	O
the	O
course	O
and	O
outcome	O
of	O
the	O
pregnancy	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
25	O
(	O
OH	O
)	O
D	O
,	O
Calcium	O
,	O
Albumin	O
,	O
and	O
PTH	O
status	O
by	O
S	O
-	O
ECC	O
and	O
caries	O
-	O
free	O
groupVariableOverall	O
valueCaries	O
statusP	O
valueS	O
-	O
ECCCaries	O
-	O
FreeN	O
(%)	O
95	O
%	O
CIN	O
(%)	O
95	O
%	O
CI25	O
(	O
OH	O
)	O
D	O
status	O
Mean	O
(	O
nmol	O
/	O
L	O
)†	O
75	O
.	O
4	O
±	O
30	O
.	O
268	O
.	O
9	O
±	O
27	O
.	O
9	O
/	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
/	O
<	O
0	O
.	O
001Optimal	O
*	O
(≥	O
75	O
nmol	O
/	O
L	O
)	O
Yes12556	O
(	O
44	O
.	O
8	O
)	O
36	O
.	O
1	O
,	O
53	O
.	O
569	O
(	O
55	O
.	O
2	O
)	O
46	O
.	O
0	O
,	O
64	O
.	O
00	O
.	O
006No13684	O
(	O
61	O
.	O
8	O
)	O
53	O
.	O
6	O
,	O
69	O
.	O
952	O
(	O
38	O
.	O
2	O
)	O
30	O
.	O
1	O
,	O
46	O
.	O
4	O
Adequate	O
*	O
(≥	O
50	O
nmol	O
/	O
L	O
)	O
Yes218111	O
(	O
50	O
.	O
9	O
)	O
44	O
.	O
3	O
,	O
57	O
.	O
6107	O
(	O
49	O
.	O
1	O
)	O
42	O
.	O
4	O
,	O
55	O
.	O
70	O
.	O
05No4329	O
(	O
67	O
.	O
4	O
)	O
53	O
.	O
4	O
,	O
81	O
.	O
414	O
(	O
32	O
.	O
6	O
)	O
18	O
.	O
6	O
,	O
46	O
.	O
6	O
Deficient	O
*	O
(<	O
35	O
nmol	O
/	O
L	O
)	O
Yes1612	O
(	O
75	O
.	O
0	O
)	O
53	O
.	O
8	O
,	O
96	O
.	O
24	O
(	O
25	O
.	O
0	O
)	O
3	O
.	O
8	O
,	O
46	O
.	O
20	O
.	O
12aNo245128	O
(	O
52	O
.	O
2	O
)	O
46	O
.	O
0	O
,	O
58	O
.	O
5117	O
(	O
47	O
.	O
8	O
)	O
41	O
.	O
5	O
,	O
54	O
.	O
0	O
Calcium	O
status	O
Mean	O
(	O
mmol	O
/	O
L	O
)†	O
2	O
.	O
3	O
±	O
0	O
.	O
12	O
.	O
2	O
±	O
0	O
.	O
1	O
/	O
2	O
.	O
4	O
±	O
0	O
.	O
1	O
/<	O
0	O
.	O
001Low	O
calcium	O
*	O
Yes1010	O
(	O
100	O
.	O
0	O
)	O
100	O
,	O
1000	O
(	O
0	O
.	O
0	O
)	O
0	O
,	O
00	O
.	O
002aNo248130	O
(	O
52	O
.	O
4	O
)	O
46	O
.	O
2	O
,	O
58	O
.	O
6118	O
(	O
47	O
.	O
6	O
)	O
41	O
.	O
4	O
,	O
53	O
.	O
8	O
Low	O
calcium	O
(	O
Corrected	O
)*	O
Yes66	O
(	O
100	O
)	O
100	O
,	O
1000	O
(	O
0	O
.	O
0	O
)	O
0	O
,	O
0	O
No252134	O
(	O
53	O
.	O
2	O
)	O
47	O
.	O
0	O
,	O
59	O
.	O
3118	O
(	O
46	O
.	O
8	O
)	O
41	O
.	O
0	O
,	O
53	O
.	O
00	O
.	O
03aPTH	O
status	O
Mean	O
(	O
ng	O
/	O
L	O
)†	O
47	O
.	O
3	O
±	O
22	O
.	O
059	O
.	O
1	O
±	O
21	O
.	O
8	O
/	O
32	O
.	O
9	O
±	O
10	O
.	O
8	O
/<	O
0	O
.	O
001Elevated	O
PTH	O
*	O
Yes9285	O
(	O
92	O
.	O
4	O
)	O
87	O
.	O
0	O
,	O
97	O
.	O
87	O
(	O
7	O
.	O
6	O
)	O
2	O
.	O
2	O
,	O
13	O
.	O
0	O
<	O
0	O
.	O
001No16255	O
(	O
34	O
.	O
0	O
)	O
26	O
.	O
7	O
,	O
41	O
.	O
2107	O
(	O
66	O
.	O
0	O
)	O
58	O
.	O
7	O
,	O
73	O
.	O
3	O
Albumin	O
status	O
Mean	O
(	O
g	O
/	O
L	O
)†	O
38	O
.	O
4	O
±	O
3	O
.	O
736	O
.	O
8	O
±	O
3	O
.	O
1	O
/	O
40	O
.	O
3	O
±	O
3	O
.	O
5	O
/<	O
0	O
.	O
001Low	O
albumin	O
*	O
Yes3326	O
(	O
78	O
.	O
8	O
)	O
64	O
.	O
8	O
,	O
92	O
.	O
77	O
(	O
21	O
.	O
2	O
)	O
7	O
.	O
3	O
,	O
35	O
.	O
20	O
.	O
002No225114	O
(	O
50	O
.	O
7	O
)	O
44	O
.	O
1	O
,	O
57	O
.	O
2111	O
(	O
49	O
.	O
3	O
)	O
43	O
.	O
0	O
,	O
56	O
.	O
0	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

All	O
estimates	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
.	O

As	O
sensitivity	O
analyses	O
,	O
we	O
repeated	O
analyses	O
after	O
exclusion	O
of	O
mothers	O
with	O
implausible	O
energy	O
intakes	O
(<	O
2500	O
or	O
>	O
25	O
000	O
kJ	O
·	O
day	O
−	O
1	O
[	O
34	O
])	O
and	O
after	O
exclusion	O
of	O
mothers	O
with	O
diabetes	O
(	O
whose	O
offspring	O
will	O
have	O
experienced	O
high	O
fetal	O
exposure	O
to	O
glucose	O
).	O

The	O
research	O
that	O
ensued	O
found	O
significantly	O
different	O
results	O
between	O
population	O
-	O
based	O
studies	O
and	O
clinic	O
based	O
studies	O
.	O

A	O
step	O
in	O
this	O
direction	O
will	O
go	O
a	O
long	O
way	O
to	O
consolidate	O
the	O
improvement	O
in	O
health	O
care	O
delivery	O
sought	O
by	O
Cameroon	O
in	O
the	O
framework	O
of	O
the	O
MDGs	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Determinants	O
of	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
vitamins	O
Folic	O
acidIronVitamins	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
Urban	O
environment	O
1	O
.	O
47	O
(	O
1	O
.	O
18	O
;	O
1	O
.	O
48	O
)	O
1	O
.	O
46	O
(	O
0	O
.	O
83	O
;	O
2	O
.	O
54	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
55	O
;	O
1	O
.	O
34	O
)	O
0	O
.	O
72	O
(	O
0	O
.	O
44	O
;	O
1	O
.	O
19	O
)	O
1	O
.	O
66	O
(	O
1	O
.	O
01	O
;	O
2	O
.	O
73	O
)	O
1	O
.	O
58	O
(	O
0	O
.	O
90	O
;	O
2	O
.	O
78	O
)	O
Age	O
(	O
yrs	O
)	O
≤	O
1911111119	O
-	O
342	O
.	O
061	O
.	O
271	O
.	O
050	O
.	O
931	O
.	O
551	O
.	O
18	O
(	O
0	O
.	O
66	O
;	O
6	O
.	O
47	O
)(	O
0	O
.	O
39	O
;	O
4	O
.	O
19	O
)(	O
0	O
.	O
47	O
;	O
2	O
.	O
37	O
)(	O
0	O
.	O
41	O
;	O
2	O
.	O
14	O
)	O
0	O
.	O
67	O
;	O
3	O
.	O
580	O
.	O
50	O
;	O
2	O
.	O
78	O
≥	O
353	O
.	O
111	O
.	O
590	O
.	O
760	O
.	O
640	O
.	O
790	O
.	O
50	O
(	O
0	O
.	O
84	O
;	O
11	O
.	O
46	O
)(	O
0	O
.	O
41	O
;	O
6	O
.	O
17	O
)(	O
0	O
.	O
28	O
;	O
2	O
.	O
08	O
)(	O
0	O
.	O
23	O
;	O
1	O
.	O
79	O
)	O
0	O
.	O
28	O
;	O
2	O
.	O
250	O
.	O
17	O
;	O
1	O
.	O
47Schooling	O
(	O
grades	O
)	O
≤	O
8	O
9	O
-	O
12	O
11	O
1111	O
4	O
.	O
764	O
.	O
01	O
1	O
.	O
141	O
.	O
341	O
.	O
631	O
.	O
640	O
>	O
12	O
(	O
2	O
.	O
28	O
;	O
9	O
.	O
97	O
)(	O
1	O
.	O
88	O
;	O
8	O
.	O
56	O
)	O
(	O
0	O
.	O
66	O
;	O
1	O
.	O
98	O
)(	O
0	O
.	O
75	O
;	O
2	O
.	O
37	O
)(	O
0	O
.	O
93	O
;	O
2	O
.	O
88	O
)(	O
0	O
.	O
908	O
;	O
2	O
.	O
964	O
)	O
8	O
.	O
125	O
.	O
21	O
1	O
.	O
54	O
2	O
.	O
303	O
.	O
543	O
.	O
372	O
(	O
3	O
.	O
67	O
;	O
17	O
.	O
96	O
)(	O
2	O
.	O
12	O
;	O
12	O
.	O
82	O
)	O
(	O
0	O
.	O
82	O
;	O
2	O
.	O
90	O
)	O
(	O
1	O
.	O
08	O
;	O
4	O
.	O
86	O
)(	O
1	O
.	O
68	O
;	O
7	O
.	O
43	O
)(	O
1	O
.	O
432	O
;	O
7	O
.	O
940	O
)	O
Married	O
2	O
.	O
68	O
1	O
.	O
931	O
.	O
300	O
.	O
741	O
.	O
491	O
.	O
330	O
(	O
1	O
.	O
34	O
;	O
5	O
.	O
36	O
)	O
(	O
0	O
.	O
93	O
;	O
4	O
.	O
01	O
)(	O
0	O
.	O
75	O
;	O
2	O
.	O
25	O
)(	O
0	O
.	O
45	O
;	O
1	O
.	O
22	O
)(	O
0	O
.	O
83	O
;	O
2	O
.	O
68	O
)(	O
0	O
.	O
712	O
;	O
2	O
.	O
487	O
)	O
Wanted	O
pregnancy0	O
.	O
960	O
.	O
821	O
.	O
611	O
.	O
480	O
.	O
961	O
.	O
49	O
(	O
0	O
.	O
40	O
;	O
2	O
.	O
30	O
)(	O
0	O
.	O
32	O
;	O
2	O
.	O
08	O
)(	O
0	O
.	O
78	O
;	O
3	O
.	O
33	O
)(	O
0	O
.	O
71	O
;	O
3	O
.	O
09	O
)(	O
0	O
.	O
40	O
;	O
2	O
.	O
30	O
)(	O
0	O
.	O
68	O
;	O
3	O
.	O
26First	O
birth1	O
.	O
3540	O
.	O
9470	O
.	O
9130	O
.	O
8982	O
.	O
0361	O
.	O
79	O
(	O
0	O
.	O
706	O
;	O
2	O
.	O
599	O
)(	O
0	O
.	O
474	O
;	O
1	O
.	O
891	O
)(	O
0	O
.	O
519	O
;	O
1	O
.	O
604	O
)(	O
0	O
.	O
506	O
;	O
1	O
.	O
593	O
)(	O
1	O
.	O
128	O
;	O
3	O
.	O
673	O
)(	O
0	O
.	O
98	O
;	O
3	O
.	O
26	O
)≤	O
4	O
pregnancy	O
registration	O
3	O
.	O
763	O
.	O
41	O
1	O
.	O
070	O
.	O
920	O
.	O
482	O
.	O
02	O
(	O
1	O
.	O
19	O
;	O
11	O
.	O
89	O
)(	O
1	O
.	O
05	O
;	O
11	O
.	O
14	O
)	O
(	O
0	O
.	O
52	O
;	O
2	O
.	O
24	O
)(	O
0	O
.	O
48	O
;	O
1	O
.	O
93	O
)(	O
0	O
.	O
22	O
;	O
1	O
.	O
05	O
)(	O
0	O
.	O
91	O
;	O
4	O
.	O
46	O
)	O
No	O
.	O

Whenever	O
possible	O
,	O
surgery	O
should	O
be	O
carried	O
out	O
during	O
the	O
second	O
trimester	O
or	O
after	O
delivery	O
,	O
as	O
for	O
newly	O
diagnosed	O
thyroid	O
cancer	O
.	O

RA	O
,	O
JD	O
,	O
PR	O
,	O
and	O
JS	O
did	O
both	O
,	O
the	O
biochemical	O
and	O
statistical	O
analysis	O
.	O

The	O
lack	O
of	O
differentiation	O
of	O
underlying	O
complications	O
in	O
pregnancy	O
,	O
which	O
lead	O
to	O
eventual	O
use	O
of	O
induction	O
,	O
could	O
be	O
the	O
cause	O
of	O
these	O
conflicting	O
findings	O
[	O
51	O
].	O

The	O
eight	O
eligible	O
studies	O
were	O
graded	O
as	O
negative	O
,	O
neutral	O
or	O
positive	O
overall	O
based	O
on	O
NHMRC	O
guidelines	O
for	O
scientific	O
literature	O
reviews	O
[	O
16	O
].	O

At	O
present	O
,	O
it	O
is	O
impossible	O
to	O
conclusively	O
state	O
that	O
a	O
particular	O
dietary	O
pattern	O
or	O
food	O
will	O
alter	O
AM	O
risk	O
in	O
infants	O
.	O

Celery	O
and	O
citrus	O
fruits	O
seem	O
to	O
increase	O
the	O
risk	O
of	O
food	O
sensitization	O
,	O
whereas	O
vegetable	O
oils	O
,	O
raw	O
sweet	O
pepper	O
,	O
and	O
again	O
citrus	O
fruit	O
increase	O
sensitization	O
to	O
respiratory	O
antigens	O
[	O
79	O
].	O

Autism	O
and	O
autism	O
spectrum	O
disorders	O
(	O
ASDs	O
),	O
including	O
Asperger	O
'	O
s	O
syndrome	O
and	O
pervasive	O
developmental	O
disorder	O
,	O
have	O
become	O
increasingly	O
diagnosed	O
over	O
the	O
past	O
decade	O
.	O

Infant	O
outcomes	O
other	O
than	O
z	O
-	O
scores	O
were	O
additionally	O
adjusted	O
for	O
gender	O
and	O
actual	O
age	O
at	O
assessment	O
.	O

The	O
central	O
team	O
will	O
comprise	O
of	O
three	O
research	O
fellows	O
,	O
one	O
medical	O
officer	O
and	O
one	O
research	O
investigator	O
and	O
one	O
BRAC	O
national	O
manager	O
.	O

Critical	O
monthly	O
adjustment	O
of	O
levothyroxine	O
therapy	O
:	O
maintain	O
fT4	O
in	O
the	O
upper	O
third	O
of	O
reference	O
range	O
.	O

Continuous	O
variables	O
Serum	O
total	O
IgE	O
(	O
kU	O
·	O
L	O
−	O
1	O
)	O
was	O
measured	O
by	O
fluoroimmunoassay	O
using	O
the	O
Pharmacia	O
UNICAP	O
system	O
(	O
Pharmacia	O
and	O
Upjohn	O
Diagnostics	O
,	O
Uppsala	O
,	O
Sweden	O
).	O

The	O
researchers	O
of	O
independent	O
subjects	O
and	O
dizygotic	O
twins	O
found	O
that	O
activation	O
of	O
receptors	O
with	O
either	O
polymorphism	O
has	O
been	O
link	O
with	O
increased	O
signaling	O
,	O
secondary	O
to	O
decreased	O
downregulation	O
of	O
the	O
β	O
2	O
adrenergic	O
receptor	O
gene	O
.	O

The	O
recommended	O
dose	O
of	O
400	O
IU	O
(	O
10	O
micrograms	O
)	O
daily	O
for	O
infants	O
was	O
established	O
based	B
on	I
typical	O
amounts	O
in	O
a	O
teaspoon	O
of	O
cod	O
liver	O
oil	O
[	O
1	O
].	O

Further	O
study	O
is	O
needed	O
to	O
confirm	O
this	O
.	O

General	O
Characteristics	O
and	O
Dietary	O
Intakes	O
of	O
Study	O
Participants	O
According	O
to	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
812	O
subjects	O
with	O
mean	O
(	O
SD	O
)	O
maternal	O
age	O
of	O
29	O
.	O
4	O
(	O
4	O
.	O
85	O
)	O
remained	O
for	O
the	O
current	O
analysis	O
.	O

The	O
expression	O
of	O
the	O
RAS	O
and	O
podocin	O
proteins	O
was	O
also	O
altered	O
.	O

Maternal	O
diet	O
may	O
influence	O
the	O
infant	O
gut	O
microbiome	O
through	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
during	O
vaginal	O
delivery	O
and	O
breastfeeding	O
.	O

The	O
GM	O
of	O
phthalate	O
and	O
BPA	O
concentrations	O
ranged	O
from	O
2	O
.	O
4	O
ng	O
/	O
ml	O
(	O
MCPP	O
)	O
to	O
41	O
.	O
3	O
ng	O
/	O
ml	O
(	O
MECPP	O
).	O

Most	O
studies	O
on	O
breastfeeding	O
over	O
the	O
past	O
few	O
decades	O
have	O
focused	O
on	O
the	O
advantages	O
of	O
breastfeeding	O
and	O
how	O
to	O
get	O
more	O
women	O
to	O
breastfeed	O
their	O
babies	O
.	O

PubMed	O
Central	O
:	O

Another	O
study	O
was	O
organized	O
to	O
determine	O
ASD	O
in	O
children	O
born	O
preterm	O
and	O
the	O
role	O
of	O
exposure	O
to	O
perinatal	O
inflammation	O
.	O

All	O
offspring	O
was	O
nursed	O
by	O
foster	O
sows	O
receiving	O
standard	O
diets	O
.	O

Epigenetic	O
programing	O
via	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNAs	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

Recurrent	O
acral	O
angioosteoma	O
cutis	O
in	O
a	O
pregnant	O
patient	O
Introduction	O
Googe	O
et	O
al	O
in	O
2006	O
first	O
described	O
11	O
cases	O
of	O
acral	O
angioosteoma	O
cutis	O
(	O
AAOC	O
),	O
characterized	O
by	O
benign	O
vascular	O
and	O
osseous	O
lesions	O
on	O
acral	O
skin	O
.	O
1Since	O
then	O
,	O
there	O
have	O
been	O
only	O
3	O
additional	O
cases	O
reported	O
.	O
2	O
,	O
3	O
,	O
4This	O
friable	O
erythematous	O
exophytic	O
papule	O
has	O
clinical	O
resemblance	O
to	O
pyogenic	O
granuloma	O
(	O
PG	O
)	O
but	O
has	O
distinct	O
histologic	O
features	O
.	O

We	O
have	O
previously	O
shown	O
that	O
higher	O
vitamin	O
D	O
status	O
in	O
late	O
pregnancy	O
and	O
larger	O
increase	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
preeclampsia	O
[	O
3	O
].	O

This	O
association	O
was	O
not	O
significant	O
for	O
fish	O
consumption	O
in	O
early	O
pregnancy	O
(	O
15	O
weeks	O
gestation	O
)	O
suggesting	O
that	O
fish	O
consumption	O
may	O
be	O
of	O
more	O
benefit	O
during	O
the	O
third	O
trimester	O
[	O
21	O
].	O

Results	O
Of	O
the	O
506	O
non	O
-	O
Hispanic	O
white	O
and	O
black	O
infants	O
,	O
438	O
with	O
available	O
data	O
on	O
vitamin	O
D	O
status	O
,	O
BMI	O
at	O
delivery	O
,	O
prenatal	O
vitamin	O
use	O
and	O
pre	O
-	O
eclampsia	O
/	O
pregnancy	O
-	O
induced	O
hypertension	O
(	O
PIH	O
)	O
history	O
were	O
included	O
in	O
final	O
analyses	O
.	O

AMH	O
is	O
produced	O
by	O
ovary	O
granulosa	O
cells	O
irrespective	O
of	O
stimulation	O
with	O
gonadotropins	O
,	O
but	O
,	O
as	O
stated	O
above	O
,	O
it	O
may	O
be	O
triggered	O
by	O
VD	O
supplementation	O
.	O

We	O
excluded	O
stillbirths	O
,	O
those	O
who	O
declined	O
to	O
participate	O
,	O
those	O
with	O
obstetric	O
pathology	O
,	O
or	O
psychiatric	O
,	O
cognitive	O
or	O
other	O
disease	O
that	O
might	O
adversely	O
affect	O
understanding	O
of	O
the	O
study	O
objectives	O
or	O
the	O
ability	O
to	O
provide	O
accurate	O
information	O
.	O

Study	O
design	O
We	O
conducted	O
follow	O
-	O
up	O
of	O
infants	O
born	O
to	O
women	O
who	O
participated	O
in	O
the	O
LIMIT	O
randomised	O
trial	O
6	O
-	O
months	O
after	O
birth	O
.	O

Meticulous	O
observation	O
should	O
include	O
seasonal	O
and	O
regional	O
patterns	O
.	O

The	O
metabolism	O
of	O
choline	O
and	O
other	O
methyl	O
group	O
vitamins	O
(	O
ie	O
.	O

Low	O
birth	O
weight	O
infants	O
are	O
susceptible	O
to	O
higher	O
risk	O
of	O
developing	O
iron	O
deficiency	O
anemia	O
leading	O
to	O
impaired	O
development	O
and	O
altered	O
longer	O
term	O
neurodevelopment	O
[	O
3	O
].	O

Soon	O
after	O
,	O
the	O
Association	O
of	O
State	O
and	O
Territorial	O
Health	O
Officials	O
(	O
ASTHO	O
)	O
joined	O
with	O
the	O
March	O
of	O
Dimes	O
to	O
ask	O
state	O
health	O
officials	O
to	O
pledge	O
to	O
reduce	O
preterm	O
birth	O
rates	O
in	O
their	O
states	O
,	O
and	O
the	O
pledge	O
was	O
incorporated	O
into	O
Report	O
Cards	O
.	O

When	O
analysing	O
separately	O
the	O
interaction	O
effect	O
between	O
education	O
and	O
prenatal	O
care	O
,	O
the	O
probability	B
of	O
using	O
folic	O
acid	O
,	O
iron	O
and	O
vitamins	O
supplements	O
was	O
increasing	O
with	O
the	O
level	O
of	O
formal	O
education	O
and	O
number	O
of	O
prenatal	O
visits	O
(	O
Table	O
4	O
).	O

A	O
possible	O
association	O
between	O
fetal	O
sex	O
,	O
vitamin	O
D	O
status	O
and	O
GDM	O
provides	O
further	O
questions	O
and	O
encourages	O
continual	O
research	O
and	O
discussion	O
into	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
,	O
particularly	O
in	O
vitamin	O
D	O
replete	O
populations	O
.	O

Interestingly	O
the	O
risk	O
for	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
lower	O
among	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

Much	O
less	O
is	O
known	O
about	O
the	O
mechanisms	O
of	O
DNA	O
demethylation	O
.	O

They	O
suggest	O
that	O
VD	O
changes	O
AMH	O
production	O
patterns	O
in	O
ovarian	O
granulose	O
cells	O
and	O
alters	O
follicle	O
stimulating	O
hormone	O
(	O
FHS	O
)	O
sensitivity	O
,	O
possibly	O
playing	O
a	O
role	O
in	O
ovarian	O
follicle	O
development	O
.	O

Three	O
analyses	O
informed	O
this	O
target	O
:	O
historical	O
change	O
in	O
high	O
income	O
countries	O
,	O
recent	O
progress	O
in	O
best	O
performing	O
countries	O
,	O
and	O
modelling	O
of	O
mortality	O
reduction	O
with	O
high	O
coverage	O
of	O
existing	O
interventions	O
.	O

For	O
62	O
.	O
0	O
%	O
of	O
them	O
the	O
multivitamin	O
contained	O
vitamin	O
D	O
.	O
In	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
the	O
percentage	O
of	O
women	O
taking	O
a	O
multivitamin	O
containing	O
vitamin	O
D	O
was	O
52	O
.	O
6	O
%	O
and	O
72	O
.	O
3	O
%	O
respectively	O
.	O

Those	O
receiving	O
advice	O
were	O
more	O
likely	B
to	O
have	O
accurate	O
personal	O
weight	O
gain	O
targets	O
,	O
whereas	O
those	O
women	O
who	O
did	O
not	O
receive	O
professional	O
advice	O
were	O
more	O
likely	B
to	O
have	O
low	O
or	O
high	O
personal	O
weight	O
gain	O
targets	O
(	O
Table	O
4	O
).	O
The	O
concordance	O
of	O
mothers	O
’	O
weight	O
gain	O
targets	O
with	O
IOM	O
recommendations	O
did	O
not	O
vary	O
by	O
language	O
preference	O
,	O
years	O
in	O
the	O
US	O
,	O
maternal	O
education	O
,	O
or	O
WIC	O
status	O
.	O

1	O
.	O

5	O
.	O

Three	O
independent	O
reports	O
have	O
observed	O
a	O
peak	O
risk	O
for	O
winter	O
births	O
[	O
16	O
–	O
18	O
],	O
while	O
no	O
seasonal	O
variation	O
for	O
risk	O
was	O
noted	O
in	O
two	O
other	O
epidemiologic	O
studies	O
[	O
19	O
,	O
20	O
].	O

Sustained	O
effort	O
by	O
healthcare	O
leaders	O
and	O
advocates	O
at	O
all	O
levels	O
,	O
inside	O
and	O
outside	O
of	O
government	O
,	O
has	O
elevated	O
the	O
issue	O
of	O
preterm	O
birth	O
on	O
the	O
nation	O
'	O
s	O
health	O
agenda	O
,	O
contributing	O
to	O
an	O
announcement	O
of	O
new	O
federal	O
resources	O
to	O
test	O
promising	B
practices	O
in	O
February	O
2012	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Potential	O
side	O
effects	O
of	O
any	O
drug	O
taken	O
during	O
pregnancy	O
by	O
the	O
mother	O
must	O
be	O
balanced	O
againts	O
the	O
risk	O
of	O
the	O
mother	O
of	O
the	O
infant	O
suffering	O
from	O
inadequately	O
treated	O
symptoms	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

Scenario	O
1	O
:	O
"	O
Business	O
as	O
usual	O
"	O
Should	O
governments	O
and	O
the	O
global	O
community	O
take	O
no	O
further	O
direct	O
action	O
to	O
address	O
deaths	O
due	O
to	O
preterm	O
birth	O
,	O
mortality	O
will	O
decline	O
by	O
24	O
%	O
by	O
2025	O
according	O
to	O
an	O
analysis	O
of	O
regional	O
trends	O
over	O
the	O
past	O
decade	O
and	O
forward	O
projection	O
(	O
or	O
16	O
%,	O
if	O
the	O
projection	O
is	O
based	O
on	O
forecasted	O
GNI	O
change	O
)	O
(	O
Figure4	O
).	O

We	O
computed	O
the	O
relative	O
abundance	O
for	O
each	O
OTU	O
by	O
dividing	O
the	O
read	O
count	O
in	O
each	O
cell	O
by	O
the	O
total	O
number	O
of	O
reads	O
in	O
the	O
sample	O
and	O
filtered	O
out	O
OTUs	O
with	O
zero	O
or	O
near	O
-	O
zero	O
variance	O
using	O
the	O
caret	O
package	O
in	O
R	O
.	O
This	O
results	O
in	O
624	O
OTUs	O
.	O

With	O
bold	O
significant	O
OR	O
for	O
p	O
<	O
0	O
.	O
005	O
.	O

Methods	O
Study	O
population	O
.	O

increase	O
in	O
corticosterone	O
levels	O
,	O
suppression	O
of	O
physical	O
activity	O
,	O
alteration	O
in	O
circadian	O
behavior	O
)	O
(	O
Bookout	O
et	O
al	O
.,	O
2013	O
).	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	O
that	O
feed	O
that	O
has	O
a	O
high	O
glycemic	O
index	O
to	O
allow	O
rapid	O
glucose	O
absorption	O
and	O
concomitant	O
high	O
insulin	O
levels	O
through	O
either	O
grain	O
feeding	O
instead	O
of	O
grass	O
finishing	O
or	O
grain	O
processing	O
provides	O
increased	O
net	O
energy	O
levels	O
for	O
FA	O
synthesis	O
.	O

The	O
timing	O
and	O
dosage	O
of	O
oral	O
iron	O
are	O
also	O
controversial	O
as	B
most	O
studies	O
have	O
focused	O
on	O
preventive	O
treatment	O
from	O
midpregnancy	O
,	O
at	O
or	O
before	O
20	O
weeks	O
gestation	O
[	O
4	O
].	O

We	O
need	O
facilities	O
equipped	O
with	O
life	O
-	O
saving	O
commodities	O
,	O
and	O
girls	O
,	O
and	O
women	O
who	O
are	O
educated	O
,	O
and	O
enabled	O
,	O
can	O
protect	O
their	O
own	O
health	O
,	O
and	O
that	O
of	O
their	O
babies	O
.	O

has	O
described	O
that	O
pregnancy	O
is	O
a	O
transformative	O
moment	O
in	O
a	O
woman	O
'	O
s	O
life	O
,	O
at	O
which	O
time	O
she	O
is	O
reenvisioning	O
her	O
role	O
of	O
herself	O
as	O
well	O
as	O
creating	O
and	O
reacting	O
to	O
the	O
expectancies	O
of	O
her	O
pregnancy	O
outcome	O
(	O
i	O
.	O
e	O
.,	O
the	O
new	O
baby	O
she	O
will	O
care	O
for	O
)	O
[	O
15	O
].	O

Seasonal	O
variations	O
in	O
the	O
number	O
of	O
pregnancies	O
have	O
already	O
been	O
noted	O
both	O
in	O
spontaneous	O
reproduction	O
and	O
in	O
IVF	O
.	O

Differences	O
in	O
the	O
distributions	O
of	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
by	O
race	O
were	O
evident	O
(	O
Figure	O
1	O
),	O
with	O
a	O
higher	O
proportion	O
of	O
vitamin	O
D	O
-	O
deficient	O
samples	O
found	O
in	O
the	O
black	O
population	O
.	O

Though	O
compliance	O
with	O
weekly	O
dosage	O
may	O
be	O
better	O
than	O
daily	O
regimen	O
because	O
of	O
reduced	O
side	O
effects	O
,	O
it	O
is	O
desirable	O
to	O
conduct	O
further	O
field	O
randomized	O
controlled	O
trials	O
in	O
order	O
to	O
establish	O
the	O
efficacy	O
of	O
weekly	O
supplementation	O
compared	O
to	O
daily	O
regimen	O
.	O

We	O
recruited	O
from	O
49	O
villages	O
in	O
the	O
study	O
area	O
,	O
which	O
were	O
not	O
receiving	O
any	O
active	O
maternal	O
and	O
child	O
health	O
or	O
nutrition	O
interventions	O
.	O

A	O
strong	O
negative	O
correlation	O
was	O
separately	O
found	O
between	O
the	O
second	O
trimester	O
visfatin	O
level	O
and	O
infant	O
’	O
s	O
head	O
circumference	O
(	O
p2	O
=	O
0	O
.	O
05	O
,	O
r2	O
=-	O
0	O
.	O
392	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

Their	O
mean	O
depression	O
score	O
changed	O
to	O
8	O
.	O
54	O
±	O
3	O
.	O
84	O
.	O

When	O
comparing	O
cathelicidin	O
concentrations	O
of	O
children	O
who	O
were	O
deficient	O
with	O
those	O
who	O
were	O
sufficient	O
,	O
(	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
20	O
ng	O
/	O
mL	O
),	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
.	O

Numerous	O
studies	O
have	O
also	O
reported	O
the	O
expression	O
of	O
different	O
GR	O
splice	O
variants	O
in	O
different	O
cell	O
and	O
tissue	O
types	O
[	O
3	O
–	O
6	O
].	O

Symptoms	O
usually	O
develop	O
over	O
a	O
few	O
days	O
and	O
include	O
polyuria	O
,	O
polydipsia	O
,	O
fatigue	O
,	O
nausea	O
,	O
weight	O
loss	O
,	O
and	O
decreased	O
skin	O
turgor	O
.	O

The	O
smallest	O
and	O
the	O
heaviest	O
fetus	O
within	O
one	O
litter	O
were	O
selected	O
for	O
transcriptome	O
analysis	O
.	O

However	O
,	O
among	O
Gardener	O
et	O
al	O
.	O

American	O
Wagyu	O
steers	O
fed	O
a	O
high	O
-	O
corn	O
diet	O
had	O
greater	O
fat	O
accumulation	O
than	O
did	O
animals	O
fed	O
a	O
hay	O
-	O
based	O
diet	O
[	O
120	O
].	O

Inflammatory	O
responses	O
also	O
may	O
favor	O
tumor	O
development	O
[	O
93	O
].	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

The	O
mean	O
visfatin	O
and	O
adiponectin	O
levels	O
were	O
significantly	O
higher	O
in	O
the	O
macrosomia	O
group	O
compared	O
with	O
the	O
AGA	O
group	O
.	O

Extending	O
the	O
time	O
between	O
two	O
consecutive	O
episodes	O
of	O
pneumonia	O
to	O
30	O
days	O
to	O
define	O
a	O
new	O
repeat	O
episode	O
of	O
pneumonia	O
(	O
used	O
by	O
the	O
WHO	O
Vaccine	O
Trials	O
group	O
),	O
19gave	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

At	O
3	O
months	O
,	O
they	O
were	O
mated	O
with	O
males	O
to	O
give	O
birth	O
to	O
the	O
F2	O
generation	O
.	O

1	O
.	O

Therefore	B
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
carry	O
out	O
the	O
first	O
national	O
representative	O
random	O
sample	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
in	O
a	O
European	O
country	O
and	O
to	O
assess	O
the	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Mothers	O
were	O
of	O
Caucasian	O
origin	O
,	O
and	O
infants	O
were	O
born	O
at	O
term	O
with	O
normal	O
birth	O
weight	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
first	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
(	O
Table	O
3	O
).	O

Renin	O
expression	O
was	O
significantly	O
higher	O
at	O
6	O
months	O
of	O
age	O
than	O
at	O
weaning	O
in	O
both	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
offspring	O
(	O
P	O
=	O
0	O
.	O
0003	O
,	O
Fig	O
.	O

The	O
infants	O
were	O
born	O
between	O
37	O
+	O
0	O
and	O
42	O
+	O
0	O
weeks	O
of	O
gestation	O
,	O
and	O
newborn	O
’	O
s	O
birth	O
weight	O
was	O
appropriate	O
for	O
gestational	O
age	O
(	O
SD	O
-	O
score	O
[	O
SDS	O
]	O
between	O
−	O
2	O
.	O
0	O
and	O
+	O
2	O
.	O
0	O
).	O

Gestational	O
OPP	O
,	O
Pb	O
,	O
and	O
PFAS	O
exposures	O
were	O
most	O
strongly	O
associated	O
with	O
lower	O
birth	O
weight	O
.	O

Results	O
A	O
total	O
of	O
1754	O
infants	O
were	O
assessed	O
at	O
age	O
6	O
months	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
(	O
n	O
=	O
2136	O
).	O

This	O
study	O
examined	O
the	O
relationship	O
between	O
mothers	O
'	O
stress	O
levels	O
and	O
attitude	O
towards	O
their	O
pregnancies	O
,	O
placental	O
GR	O
and	O
GAS5	O
expression	O
,	O
and	O
the	O
status	O
of	O
GR	O
polymorphism	O
,	O
with	O
their	O
infants	O
'	O
birth	O
weights	O
.	O

Response	O
to	O
Antenatal	O
Cholecalciferol	O
Supplementation	O
Is	O
Associated	O
With	O
Common	O
Vitamin	O
D	O
–	O
Related	O
Genetic	O
Variants	O
Abstract	O
Context	O
:	O
Single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
genes	O
related	O
to	O
vitamin	O
D	O
metabolism	O
have	O
been	O
associated	O
with	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentration	O
,	O
but	O
these	O
relationships	O
have	O
not	O
been	O
examined	O
following	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

Vitamin	O
D	O
supplementation	O
reduces	O
preeclampsia	O
risk	O
,	O
compared	O
to	O
unsupplemented	O
controls	O
.	O

Eligible	O
studies	O
were	O
those	O
with	O
healthy	O
pregnant	O
women	O
,	O
full	O
term	O
births	O
and	O
offspring	O
with	O
no	O
anomalies	O
or	O
diseases	O
.	O

We	O
acknowledge	O
the	O
following	O
limitations	O
.	O

List	O
of	O
abbreviations	O
used	O
KMC	O
:	O
Kangaroo	O
Mother	O
Care	O
;	O
PMNCH	O
:	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
;	O
pPROM	O
:	O
Prelabour	O
premature	O
rupture	O
of	O
membranes	O
;	O
RMNCH	O
:	O
Reproductive	O
,	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
;	O
STI	O
:	O
Sexually	O
Transmitted	O
Infection	O
;	O
WHO	O
:	O
World	O
Health	O
Organization	O
.	O

Although	O
some	O
of	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	O
(	O
table	O
4	O
),	O
it	O
appears	O
that	O
polytherapy	O
with	O
SGAs	O
and	O
other	O
psychotropic	O
medications	O
may	O
be	O
associated	O
with	O
a	O
higher	O
risk	O
for	O
adverse	O
pregnancy	O
outcomes	O
,	O
compared	O
with	O
SGA	O
monotherapy	O
.	O

They	O
do	O
,	O
however	O
,	O
agree	O
with	O
previously	O
published	O
studies	O
[	O
14	O
,	O
39	O
,	O
45	O
,	O
46	O
].	O

Maternal	O
vitamin	O
D	O
deficiency	O
is	O
accompanied	O
by	O
changes	O
in	O
the	O
renal	O
expression	O
of	O
podocin	O
,	O
renin	O
and	O
AT1	O
receptors	O
,	O
and	O
it	O
delays	O
the	O
maturity	O
of	O
the	O
glomeruli	O
,	O
by	O
extending	O
nephrogenesis	O
.	O

In	O
juvenile	O
piglets	O
(	O
stage	O
28	O
dpn	O
)	O
483	O
probe	O
-	O
sets	O
differed	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

Gardener	O
et	O
al	O
.	O

Oka	O
et	O
al	O
[	O
134	O
]	O
recommended	O
selective	O
restriction	O
of	O
dietary	O
vitamin	O
A	O
from	O
14	O
to	O
22	O
or	O
25	O
months	O
of	O
age	O
to	O
improve	O
MS	O
and	O
QG	O
without	O
adverse	O
health	O
effects	O
(	O
blindness	O
,	O
arthritis	O
,	O
and	O
muscular	O
edema	O
),	O
given	O
the	O
effect	O
of	O
vitamin	O
A	O
restriction	O
from	O
23	O
months	O
of	O
age	O
in	O
improving	O
MS	O
is	O
minimal	O
.	O

For	O
instance	O
,	O
greater	O
fish	O
consumption	O
is	O
associated	O
with	O
child	O
development	O
outcomes	O
including	O
decreased	O
risk	O
of	O
asthma	O
and	O
improved	O
cognition	O
[	O
13	O
,	O
14	O
].	O

People	O
residing	O
near	O
the	O
equator	O
should	O
have	O
lower	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
people	O
living	O
at	O
high	O
latitudes	O
.	O

This	O
measure	O
is	O
widely	O
used	O
in	O
South	O
Africa	O
to	O
describe	O
the	O
socio	O
-	O
economic	O
status	O
of	O
the	O
population	O
[	O
33	O
].	O

We	O
also	O
lacked	O
data	O
on	O
vitamin	O
D	O
binding	O
protein	O
which	O
may	O
differ	O
by	O
race	O
/	O
ethnicity	O
and	O
could	O
affect	O
the	O
association	O
between	O
PNV	O
use	O
and	O
25	O
(	O
OH	O
)	O
D	O
measured	O
in	O
the	O
plasma	O
.	O

The	O
fixed	O
effects	O
are	O
chosen	O
to	O
account	O
for	O
different	O
mean	O
levels	O
of	O
BMI	O
for	O
the	O
sexes	O
and	O
for	O
different	O
generations	O
.	O

3	O
.	O

Abbreviations	O
:	O
SC	O
,	O
standard	O
chow	O
;	O
VitD	O
−,	O
vitamin	O
D	O
restricted	O
diet	O
.	O

It	O
is	O
also	O
relevant	O
to	O
note	O
that	O
Hibbeln	O
et	O
al	O
.	O

Although	O
the	O
importance	O
of	O
IFA	O
supplements	O
to	O
prevent	O
maternal	O
anaemia	O
and	O
mortality	O
is	O
widely	O
accepted	O
,	O
most	O
antenatal	O
IFA	O
supplements	O
distribution	O
programs	O
are	O
of	O
low	O
priority	O
.	O

A	O
secondary	O
aim	O
is	O
to	O
prevent	O
excessive	O
maternal	O
weight	O
gain	O
,	O
particularly	O
in	O
women	O
who	O
are	O
overweight	O
or	O
have	O
gained	O
excess	O
weight	O
in	O
pregnancy	O
.	O

Indoor	O
exposures	O
to	O
these	O
agents	O
frequently	O
occur	O
[	O
29	O
,	O
30	O
].	O

However	O
,	O
none	O
of	O
these	O
covariates	O
change	O
the	O
estimates	O
substantially	O
,	O
and	O
was	O
therefore	B
not	O
included	O
in	O
the	O
final	O
multivariate	O
model	O
cAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
cod	O
-	O
type	O
fish	O
and	O
shellfish	O
dAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
salmon	O
-	O
type	O
fish	O
and	O
shellfish	O
eAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
salmon	O
-	O
type	O
fish	O
and	O
cod	O
-	O
type	O
fish	O
fAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
and	O
alcohol	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
all	O
fish	O
and	O
seafood4	O
.	O
1Relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
evaluated	O
by	O
multinomial	O
logistic	O
regression	O
,	O
adjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
and	O
alcohol	O
.	O
2The	O
group	O
with	O
no	O
or	O
low	O
level	O
of	O
psychotic	O
symptoms	O
was	O
used	O
as	O
reference	O
group	O
.	O
3Participants	O
categorized	O
into	O
levels	O
;	O
no	O
/	O
low	O
,	O
middle	O
,	O
high	O
frequency	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O
4Total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
were	O
grouped	O
into	O
six	O
categories	O
;	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
.	O

293	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
.	O

There	O
was	O
the	O
assumption	O
that	O
in	O
utero	O
exposure	O
represents	O
the	O
most	O
vulnerable	O
period	O
in	O
an	O
individual	O
’	O
s	O
life	O
with	O
respect	O
to	O
their	O
future	O
development	O
.	O

During	O
pregnancy	O
,	O
the	O
mother	O
'	O
s	O
thyroid	O
physiology	O
undergoes	O
many	O
well	O
-	O
defined	O
changes	O
,	O
leading	O
to	O
an	O
increase	O
in	O
thyroid	O
volume	O
which	O
is	O
often	B
associated	O
with	O
higher	O
urinary	O
iodine	O
excretion	O
.	O

Data	O
suggest	O
that	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
aids	O
implantation	O
and	O
maintains	O
normal	O
pregnancy	O
,	O
supports	O
fetal	O
growth	O
through	O
delivery	O
of	O
calcium	O
,	O
controls	O
secretion	O
of	O
multiple	O
placental	O
hormones	O
,	O
and	O
limits	O
production	O
of	O
proinflammatory	O
cytokines	O
.	O

However	O
,	O
few	O
obesity	O
interventions	O
show	O
clinically	O
or	O
statistically	O
significant	O
weight	O
loss	O
beyond	O
the	O
intervention	O
period	O
(	O
100	O
),	O
which	O
suggests	O
that	O
new	O
and	O
more	O
comprehensive	O
interventions	O
are	O
needed	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
incidence	O
of	O
first	O
or	O
only	O
pneumonia	O
between	O
the	O
vitamin	O
D	O
(	O
0	O
·	O
145	O
per	O
child	O
per	O
year	O
,	O
95	O
%	O
CI	O
0	O
·	O
129	O
–	O
0	O
·	O
164	O
)	O
and	O
the	O
placebo	O
group	O
(	O
0	O
.	O
137	O
,	O
0	O
·	O
121	O
–	O
0	O
·	O
155	O
);	O
the	O
incidence	O
rate	O
ratio	O
was	O
1	O
·	O
06	O
(	O
95	O
%	O
CI	O
0	O
·	O
89	O
–	O
1	O
·	O
27	O
).	O

Third	O
,	O
we	O
did	O
not	O
power	O
the	O
sample	O
size	O
to	O
analyze	O
effects	O
by	O
trimester	O
of	O
vaccination	O
and	O
so	B
may	O
have	O
missed	O
important	O
effects	O
.	O

In	O
a	O
sensitivity	O
analysis	O
,	O
the	O
effect	O
of	O
maternal	O
fruit	O
consumption	O
on	O
the	O
infant	O
gut	O
microbiome	O
in	O
babies	O
born	O
vaginally	O
persisted	O
when	O
restricted	O
to	O
infants	O
who	O
were	O
exclusively	O
breastfed	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
022	O
;	O
Table	O
2	O
)	O
.	O

Data	O
sources	O
for	O
Afghanistan	O
,	O
India	O
,	O
Brazil	O
,	O
and	O
Russia	O
from	O
Child	O
Health	O
Epidemiology	O
Reference	O
Group	O
/	O
World	O
Health	O
Organization	O
cause	O
of	O
death	O
estimates	O
for	O
2010	O
from	O
Liu	O
et	O
al	O
.,	O
2012	O
[	O
50	O
].	O

Primordial	O
germ	O
cells	O
(	O
PGCs	O
)	O
undergo	O
a	O
second	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
to	O
ensure	O
correct	O
imprinting	O
and	O
development	O
of	O
mature	O
germ	O
cells	O
according	O
to	O
the	O
gender	O
of	O
the	O
embryo	O
,	O
and	O
enable	O
the	O
successful	O
production	O
of	O
subsequent	O
generations	O
in	O
a	O
continuous	O
cycle	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Integrated	O
service	O
delivery	O
packages	O
for	O
maternal	O
,	O
newborn	O
and	O
child	O
health	O
.	O

Drug	O
Allergy	O
There	O
is	O
a	O
lack	O
of	O
data	O
on	O
the	O
prevalence	O
of	O
adverse	O
drug	O
reactions	O
during	O
pregnancy	O
.	O

Four	O
major	O
adipose	O
tissue	O
depots	O
exist	O
in	O
animals	O
:	O
ab	O
dominal	O
,	O
subcutaneous	O
,	O
intermuscular	O
,	O
and	O
intramuscular	O
.	O

To	O
examine	O
how	O
repetitive	O
element	O
methylation	O
was	O
related	O
to	O
gene	O
-	O
associated	O
methylation	O
,	O
we	O
restricted	O
our	O
analysis	O
to	O
placentas	O
for	O
which	O
we	O
had	O
both	O
repetitive	O
element	O
and	O
gene	O
-	O
associated	O
(	O
array	O
)	O
methylation	O
data	O
for	O
the	O
26	O
,	O
486	O
CpG	O
autosomal	O
loci	O
(	O
n	O
=	O
184	O
).	O

This	O
was	O
independent	O
of	O
diet	O
and	O
lifestyles	O
factors	O
including	O
BMI	O
and	O
SEI	O
and	O
highlights	O
the	O
difficulty	O
in	O
understanding	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
in	O
human	O
cohort	O
studies	O
.	O

Exclusion	O
criteria	O
for	O
the	O
newborns	O
were	O
:	O
nasal	O
continuous	O
positive	O
airway	O
pressure	O
treatment	O
>	O
one	O
day	O
,	O
intravenous	O
glucose	O
infusion	O
,	O
seizures	O
,	O
duration	O
of	O
phototherapy	O
>	O
three	O
days	O
and	O
need	O
for	O
nasogastric	O
tube	O
>	O
one	O
day	O
.	O

Mothers	O
were	O
instructed	O
to	O
continue	O
the	O
supplements	O
as	O
long	O
as	O
they	O
were	O
breastfeeding	O
.	O

After	O
baseline	O
survey	O
completion	O
,	O
participants	O
were	O
assigned	O
to	O
the	O
text4baby	O
(	O
plus	O
usual	O
care	O
)	O
or	O
to	O
control	O
(	O
usual	O
care	O
only	O
)	O
groups	O
.	O

analysed	O
11	O
,	O
538	O
pregnancies	O
,	O
and	O
found	O
a	O
51	O
%	O
increase	O
in	O
gestational	O
diabetes	O
diagnosed	O
by	O
OGTT	O
in	O
the	O
months	O
of	O
June	O
to	O
July	O
(	O
summer	O
),	O
compared	O
to	O
other	O
months	O
[	O
25	O
].	O

Based	O
on	O
estimated	O
productivity	O
gains	O
for	O
adult	O
women	O
,	O
the	O
benefit	O
:	O
cost	O
ratio	O
is	O
6	O
.	O
7	O
∶	O
1	O
.	O

purports	O
that	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
carries	O
an	O
increased	O
risk	O
of	O
developing	O
ASD	O
[	O
8	O
].	O

We	O
ascertained	O
causes	O
of	O
death	O
through	O
scrutiny	O
of	O
hospital	O
notes	O
,	O
and	O
verbal	O
autopsy	O
interviews	O
with	O
the	O
WHO	O
standard	O
questionnaire	O
and	O
review	O
of	O
the	O
interview	O
data	O
by	O
two	O
physicians	O
independently	O
.	O

She	O
described	O
the	O
pain	O
as	O
continuous	O
,	O
10	O
/	O
10	O
in	O
severity	O
,	O
worsened	O
with	O
movement	O
and	O
breathing	O
,	O
and	O
relieved	O
by	O
nothing	O
.	O

Distribution	O
and	O
storage	O
USD3	O
,	O
597	O
:	O
source	O
Yen	O
Bai	O
People	O
'	O
s	O
Committee	O
financial	O
recordsPromotional	O
material	O
development	O
and	O
production	O
:	O
amortized	O
over	O
5	O
years	O
.	O

Relationships	O
between	O
repetitive	O
element	O
and	O
gene	O
associated	O
methylation	O
.	O

While	O
the	O
possibility	O
of	O
residual	O
confounding	O
cannot	O
be	O
ruled	O
out	O
,	O
the	O
null	O
findings	O
for	O
maternal	O
and	O
paternal	O
free	O
sugar	O
intakes	O
after	O
pregnancy	O
make	O
confounding	O
by	O
unmeasured	O
familial	O
behaviours	O
linked	O
to	O
sugar	O
intake	O
and	O
asthma	O
risk	O
a	O
less	O
likely	B
explanation	O
.	O

New	O
OB	O
patients	O
were	O
offered	O
a	O
free	O
bottle	O
of	O
Bio	O
-	O
Tech	O
Pharmacal	O
,	O
Inc	O
.	O
(	O
Fayetteville	O
,	O
AR	O
)	O
vitamin	O
D	O
supplements	O
(	O
5000	O
IU	O
per	O
capsule	O
)	O
at	O
their	O
first	O
visit	O
and	O
personalized	O
dosing	O
recommendations	O
were	O
provided	O
based	O
on	O
the	O
result	O
of	O
their	O
initial	O
25	O
(	O
OH	O
)	O
D	O
test	O
using	O
an	O
algorithm	O
of	O
existing	O
dose	O
-	O
response	O
data	O
[	O
11	O
].	O

Substantial	O
racial	O
disparities	O
in	O
PTB	O
rates	O
have	O
also	O
been	O
found	O
in	O
the	O
United	O
States	O
:	O
18	O
%	O
among	O
African	O
Americans	O
,	O
12	O
%	O
among	O
Hispanics	O
,	O
and	O
11	O
%	O
among	O
whites	O
in	O
2009	O
[	O
2	O
].	O

We	O
will	O
obtain	O
written	O
,	O
witnessed	O
informed	O
consent	O
from	O
all	O
participants	O
.	O

The	O
mean	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
levels	O
in	O
case	O
and	O
control	O
groups	O
were	O
compared	O
with	O
independent	O
t	O
test	O
.	O

Data	O
Analysis	O
Stata	O
version	O
12	O
(	O
StataCorp	O
LP	O
,	O
College	O
Station	O
,	O
TX	O
,	O
USA	O
)	O
was	O
used	O
in	O
all	O
analyses	O
.	O

Being	O
synthesized	O
from	O
the	O
placenta	O
,	O
higher	O
enzyme	O
concentrations	O
were	O
observed	O
in	O
twin	O
and	O
triple	O
pregnancies	O
.	O

This	O
slurry	O
was	O
frequently	O
stored	O
in	O
large	O
,	O
unlined	O
ponds	O
,	O
says	O
Chris	O
Shuey	O
,	O
an	O
environmental	O
health	O
specialist	O
with	O
the	O
Southwest	O
Research	O
and	O
Information	O
Center	O
in	O
Albuquerque	O
,	O
who	O
has	O
spent	O
the	O
last	O
three	O
decades	O
working	O
with	O
Navajo	O
communities	O
affected	O
by	O
uranium	O
mining	O
and	O
milling	O
.	O

Multivariable	O
logistic	O
regression	O
analysis	O
of	O
the	O
outcome	O
pregnancy	O
loss	O
was	O
also	O
performed	O
with	O
25OHD	O
at	O
T1	O
(	O
continuous	O
and	O
categorical	O
)	O
as	O
independent	O
variable	O
.	O

In	O
addition	O
,	O
nutritional	O
restriction	O
during	O
early	O
and	O
mid	O
gestation	O
reduced	O
ovarian	O
characteristics	O
(	O
wet	O
ovary	O
weight	O
,	O
luteal	O
tissue	O
weight	O
)	O
of	O
heifers	O
,	O
indicating	O
negative	O
effects	O
of	O
fetal	O
programming	O
on	O
productive	O
efficiency	O
of	O
replacement	O
heifers	O
.	O

Model	O
2	O
of	O
the	O
multiple	O
linear	O
regression	O
analysis	O
was	O
additionally	O
controlled	O
for	O
change	O
in	O
25OHD	O
from	O
early	O
to	O
late	O
pregnancy	O
(	O
Additional	O
file1	O
:	O
Table	O
S3	O
).	O

An	O
adapted	O
questionnaire	O
previously	O
used	O
in	O
the	O
South	O
African	O
context	O
is	O
used	O
[	O
58	O
].	O

Of	O
total	O
,	O
89	O
%	O
achieved	O
vitamin	O
D	O
concentration	O
of	O
higher	O
than	O
20	O
ng	O
/	O
mL	O
and	O
56	O
%	O
achieved	O
vitamin	O
D	O
concentration	O
of	O
higher	O
than	O
32	O
ng	O
/	O
mL	O
[	O
57	O
].	O

The	O
composition	O
of	O
UNIMMAP	O
is	O
shown	O
inTable	O
1	O
(	O
UNICEF	O
/	O
WHO	O
/	O
UNU	O
1999	O
).	O

The	O
aim	O
of	O
this	O
review	O
was	O
to	O
critically	O
appraise	O
literature	O
investigating	O
fish	O
intake	O
in	O
pregnant	O
women	O
to	O
assess	O
the	O
hypothesis	O
that	O
fish	O
consumption	O
during	O
pregnancy	O
positively	O
influences	O
foetal	O
neurodevelopment	O
.	O

An	O
increase	O
in	O
25OHD	O
from	O
early	O
to	O
late	O
pregnancy	O
was	O
not	O
associated	O
with	O
markers	O
of	O
glucose	O
metabolism	O
.	O

The	O
2009	O
survey	O
identified	O
that	O
it	O
took	O
women	O
an	O
average	O
of	O
17	O
minutes	O
to	O
access	O
the	O
distribution	O
point	O
for	O
weekly	O
supplements	O
.	O

Each	O
data	O
collector	O
will	O
be	O
responsible	O
for	O
one	O
cluster	O
.	O

Implementation	O
research	O
from	O
low	O
-	O
and	O
middle	O
-	O
income	O
settings	O
is	O
critical	O
to	O
inform	O
and	O
accelerate	O
the	O
scale	O
up	O
of	O
high	O
-	O
impact	O
care	O
,	O
such	O
as	O
KMC	O
and	O
neonatal	O
resuscitation	O
[	O
19	O
,	O
21	O
,	O
40	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Subject	O
characteristics	O
by	O
delivery	O
mode	O
(	O
n	O
=	O
145	O
)	O
n	O
(%)	O
or	O
mean	O
[	O
range	O
]	O
p	O
value1All	O
(	O
n	O
=	O
145	O
)	O
Vaginal	O
(	O
n	O
=	O
97	O
)	O
Cesarean	O
(	O
n	O
=	O
48	O
)	O
Maternal	O
characteristics	O
Maternal	O
age31	O
.	O
9	O
[	O
22	O
–	O
44	O
]	O
31	O
.	O
8	O
[	O
22	O
–	O
44	O
]	O
32	O
.	O
2	O
[	O
23	O
–	O
42	O
]	O
0	O
.	O
65	O
Education	O
level0	O
.	O
14	O
Less	O
than	O
11th	O
grade1	O
(	O
0	O
.	O
7	O
)	O
1	O
(	O
1	O
.	O
0	O
)	O
0	O
(	O
0	O
.	O
0	O
)	O
High	O
school	O
graduate	O
or	O
equivalent15	O
(	O
10	O
.	O
3	O
)	O
7	O
(	O
7	O
.	O
2	O
)	O
8	O
(	O
16	O
.	O
7	O
)	O
Junior	O
college	O
graduate	O
or	O
some	O
college25	O
(	O
17	O
.	O
2	O
)	O
16	O
(	O
16	O
.	O
5	O
)	O
9	O
(	O
18	O
.	O
8	O
)	O
College	O
graduate54	O
(	O
37	O
.	O
2	O
)	O
34	O
(	O
35	O
.	O
1	O
)	O
20	O
(	O
41	O
.	O
7	O
)	O
Any	O
post	O
-	O
graduate	O
schooling50	O
(	O
34	O
.	O
5	O
)	O
39	O
(	O
40	O
.	O
2	O
)	O
11	O
(	O
22	O
.	O
9	O
)	O
Relationship	O
status0	O
.	O
29	O
Married133	O
(	O
91	O
.	O
7	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
42	O
(	O
87	O
.	O
5	O
)	O
Separated	O
or	O
divorced3	O
(	O
2	O
.	O
1	O
)	O
1	O
(	O
1	O
.	O
0	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
Single	O
and	O
never	O
married9	O
(	O
6	O
.	O
2	O
)	O
5	O
(	O
5	O
.	O
2	O
)	O
4	O
(	O
8	O
.	O
3	O
)	O
Smoking0	O
.	O
43	O
No138	O
(	O
95	O
.	O
2	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
47	O
(	O
97	O
.	O
9	O
)	O
Yes7	O
(	O
4	O
.	O
8	O
)	O
6	O
(	O
6	O
.	O
2	O
)	O
1	O
(	O
2	O
.	O
1	O
)	O
Parity0	O
.	O
8	O
[	O
0	O
–	O
4	O
]	O
0	O
.	O
9	O
[	O
0	O
–	O
4	O
]	O
0	O
.	O
7	O
[	O
0	O
–	O
2	O
]	O
0	O
.	O
07	O
Maternal	O
BMI25	O
.	O
6	O
[	O
17	O
.	O
4	O
–	O
47	O
.	O
8	O
]	O
26	O
.	O
0	O
[	O
17	O
.	O
4	O
–	O
47	O
.	O
8	O
]	O
24	O
.	O
7	O
[	O
18	O
.	O
4	O
–	O
42	O
.	O
1	O
]	O
0	O
.	O
22	O
Gestational	O
diabetes20	O
.	O
58	O
No121	O
(	O
83	O
.	O
4	O
)	O
84	O
(	O
86	O
.	O
6	O
)	O
37	O
(	O
77	O
.	O
1	O
)	O
Yes16	O
(	O
11	O
.	O
0	O
)	O
10	O
(	O
10	O
.	O
3	O
)	O
6	O
(	O
12	O
.	O
5	O
)	O
Dietary	O
factors	O
(	O
servings	O
/	O
day	O
)	O
3	O
aMED	O
score3	O
.	O
67	O
[	O
0	O
–	O
7	O
]	O
3	O
.	O
8	O
[	O
0	O
–	O
7	O
]	O
3	O
.	O
5	O
[	O
0	O
–	O
7	O
]	O
0	O
.	O
32	O
Dairy3	O
.	O
6	O
[	O
0	O
.	O
0	O
–	O
8	O
.	O
5	O
]	O
3	O
.	O
7	O
[	O
0	O
.	O
0	O
–	O
8	O
.	O
5	O
]	O
3	O
.	O
5	O
[	O
0	O
.	O
8	O
–	O
6	O
.	O
8	O
]	O
0	O
.	O
40	O
Fruit2	O
.	O
3	O
[	O
0	O
.	O
0	O
–	O
5	O
.	O
9	O
]	O
2	O
.	O
3	O
[	O
0	O
.	O
2	O
–	O
5	O
.	O
9	O
]	O
2	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
5	O
.	O
6	O
]	O
0	O
.	O
52	O
Vegetables3	O
.	O
3	O
[	O
0	O
.	O
0	O
–	O
9	O
.	O
6	O
]	O
3	O
.	O
3	O
[	O
0	O
.	O
5	O
–	O
9	O
.	O
6	O
]	O
3	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
7	O
.	O
6	O
]	O
0	O
.	O
78	O
Whole	O
grains1	O
.	O
0	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
1	O
]	O
1	O
.	O
2	O
[	O
0	O
.	O
1	O
–	O
4	O
.	O
1	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
3	O
.	O
1	O
]	O
0	O
.	O
03	O
Fish	O
and	O
seafood0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
1	O
.	O
0	O
]	O
0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
1	O
.	O
0	O
]	O
0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
56	O
Nuts	O
,	O
legumes	O
,	O
and	O
soy0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
5	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
3	O
.	O
1	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
5	O
]	O
1	O
.	O
00	O
Red	O
and	O
processed	O
meat0	O
.	O
8	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
7	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
0	O
]	O
0	O
.	O
8	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
21	O
Polyunsaturated	O
fat	O
(	O
g	O
/	O
day	O
)	O
13	O
.	O
9	O
[	O
8	O
.	O
67	O
–	O
23	O
.	O
7	O
]	O
13	O
.	O
6	O
[	O
8	O
.	O
7	O
–	O
21	O
.	O
0	O
]	O
14	O
.	O
5	O
[	O
9	O
.	O
2	O
–	O
23	O
.	O
7	O
]	O
0	O
.	O
12	O
EPA	O
(	O
g	O
/	O
day	O
)	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
28	O
DHA	O
(	O
g	O
/	O
day	O
)	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
79	O
Monounsaturated	O
:	O
saturated	O
fatty	O
acid	O
ratio1	O
.	O
1	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
3	O
]	O
1	O
.	O
1	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
1	O
]	O
1	O
.	O
2	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
35Infant	O
characteristics	O
Sex0	O
.	O
38	O
Female62	O
(	O
42	O
.	O
8	O
)	O
44	O
(	O
45	O
.	O
4	O
)	O
18	O
(	O
37	O
.	O
5	O
)	O
Male83	O
(	O
57	O
.	O
2	O
)	O
53	O
(	O
54	O
.	O
6	O
)	O
30	O
(	O
62	O
.	O
5	O
)	O
Birth	O
weight	O
(	O
g	O
)	O
43427	O
.	O
4	O
[	O
1960	O
–	O
4710	O
]	O
3466	O
.	O
3	O
[	O
2030	O
–	O
4565	O
]	O
3348	O
.	O
9	O
[	O
1960	O
–	O
4710	O
]	O
0	O
.	O
18	O
Gestational	O
age	O
(	O
weeks	O
)	O
39	O
.	O
3	O
[	O
30	O
.	O
4	O
–	O
43	O
.	O
4	O
]	O
39	O
.	O
5	O
[	O
30	O
.	O
4	O
–	O
42	O
.	O
1	O
]	O
39	O
.	O
1	O
[	O
33	O
.	O
4	O
–	O
43	O
.	O
4	O
]	O
0	O
.	O
21	O
Feeding	O
method0	O
.	O
04	O
Exclusively	O
breastfed102	O
(	O
70	O
.	O
3	O
)	O
74	O
(	O
76	O
.	O
3	O
)	O
28	O
(	O
58	O
.	O
3	O
)	O
Combination37	O
(	O
25	O
.	O
5	O
)	O
21	O
(	O
21	O
.	O
7	O
)	O
16	O
(	O
33	O
.	O
3	O
)	O
Exclusively	O
formula	O
fed6	O
(	O
4	O
.	O
1	O
)	O
2	O
(	O
2	O
.	O
1	O
)	O
4	O
(	O
8	O
.	O
3	O
)	O
Antibiotics	O
by	O
4	O
months	O
old50	O
.	O
66	O
No135	O
(	O
93	O
.	O
1	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
44	O
(	O
91	O
.	O
7	O
)	O
Yes5	O
(	O
3	O
.	O
5	O
)	O
3	O
(	O
3	O
.	O
1	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
1p	O
value	O
determined	O
by	O
two	O
-	O
sided	O
Welch	O
’	O
s	O
t	O
test	O
or	O
Fisher	O
’	O
s	O
exact	O
test	O
2Missing	O
data	O
on	O
eight	O
subjects	O
3All	O
dietary	O
factors	O
are	O
standardized	O
to	O
a	O
2000	O
cal	O
/	O
day	O
diet	O
,	O
excluding	O
aMED	O
score	O
and	O
monounsaturated	O
:	O
saturated	O
fatty	O
acid	O
ratio	O
4Missing	O
data	O
on	O
three	O
subjects	O
5Missing	O
data	O
on	O
five	O
subjects	O
Microbial	O
community	O
composition	O
and	O
maternal	O
dietary	O
factors	O
We	O
identified	O
11	O
,	O
029	O
,	O
093	O
bacterial	O
sequences	O
in	O
145	O
6	O
-	O
week	O
infant	O
stool	O
samples	O
passing	O
quality	O
control	O
.	O

The	O
obvious	O
explanations	B
to	O
the	O
higher	O
body	O
weight	O
found	O
in	O
RC	O
males	O
after	O
weaning	O
could	O
be	O
as	O
a	O
consequence	O
of	O
an	O
increased	O
food	O
intake	O
,	O
decreased	O
energy	O
expenditure	O
or	O
higher	O
metabolic	O
efficiency	O
.	O

Height	O
—	O
child	O
age	O
5	O
This	O
correlation	O
in	O
the	O
nuclear	O
family	O
became	O
stronger	O
at	O
age	O
5	O
.	O

Current	O
Thinking	O
on	O
Low	O
Milk	O
Production	O
Standard	O
lactation	O
support	O
guidelines3are	B
based	B
on	I
the	O
assumption	O
that	O
virtually	B
any	O
woman	O
can	O
breastfeed	O
normally	B
.	O

In	O
addition	O
the	O
current	O
vitamin	O
D	O
content	O
of	O
multivitamins	O
for	O
pregnancy	O
,	O
400	O
IU	O
,	O
do	O
not	O
even	O
comply	O
with	O
the	O
current	O
Belgian	O
recommendations	O
of	O
800	O
IU	O
per	O
day	O
,	O
therefore	B
a	O
prudent	O
step	O
should	O
at	B
least	I
be	O
to	O
increase	O
the	O
vitamin	O
D	O
content	O
in	O
multivitamins	O
for	O
pregnant	O
women	O
to	O
800	O
IU	O
.	O

However	O
,	O
a	O
multi	O
-	O
centre	O
study	O
might	O
have	O
resulted	O
in	O
a	O
wider	O
variety	O
of	O
socio	O
-	O
economic	O
backgrounds	O
.	O

Moreover	O
,	O
the	O
majority	O
of	O
these	O
47	O
studies	O
represent	O
exploratory	O
in	O
vivo	O
high	O
(	O
often	B
single	O
)	O
dose	O
range	O
experiments	O
,	O
many	O
orders	O
of	O
magnitude	O
above	O
likely	B
human	O
exposures	O
.	O

There	O
were	O
no	O
apparent	O
differences	O
in	O
the	O
intake	O
of	O
foods	O
containing	O
vitamin	O
D	O
between	O
the	O
S	O
-	O
ECC	O
and	O
caries	O
-	O
free	O
groups	O
,	O
including	O
the	O
frequency	O
of	O
milk	O
consumption	O
(	O
data	O
not	O
shown	O
).	O

At	O
the	O
time	O
of	O
the	O
lung	O
function	O
testing	O
,	O
the	O
mean	O
body	O
weight	O
was	O
8	O
.	O
3	O
±	O
1	O
.	O
0	O
kg	O
,	O
and	O
the	O
mean	O
body	O
length	O
was	O
68	O
.	O
6	O
±	O
3	O
.	O
0	O
cm	O
.	O

In	O
order	O
to	O
minimize	O
the	O
estrous	O
cycle	O
-	O
related	O
variability	O
,	O
the	O
female	O
rats	O
were	O
closely	O
housed	O
in	O
adjacent	O
cages	O
and	O
randomly	O
distributed	O
among	O
the	O
different	O
experimental	O
groups	O
(	O
McClintock	O
,	O
1978	O
,	O
1984	O
).	O

The	O
infant	O
is	O
weighed	O
on	O
a	O
calibrated	O
scale	O
with	O
minimum	O
of	O
clothing	O
,	O
namely	O
only	O
a	O
vest	O
,	O
and	O
without	O
a	O
nappy	O
;	O
and	O
recorded	O
to	O
the	O
nearest	O
5	O
g	O
.	O
Recumbent	O
length	O
of	O
the	O
infants	O
is	O
taken	O
by	O
means	O
of	O
an	O
infantometer	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
.	O

Only	O
POU2F1	O
was	O
found	O
to	O
be	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
.	O

A	O
developmental	O
perspective	O
considers	B
family	O
,	O
school	O
,	O
and	O
community	O
context	O
.	O

However	O
,	O
research	O
in	O
recent	O
years	O
has	O
been	O
challenging	O
those	O
ideas	O
on	O
what	O
is	O
enough	O
,	O
and	O
what	O
is	O
too	O
much	O
.	O

Data	O
from	O
a	O
review	O
of	O
the	O
literature	O
and	O
the	O
authors	O
'	O
own	O
experience	O
show	O
that	O
in	O
patients	O
undergoing	O
either	O
suppressive	O
or	O
substitutive	O
thyroxine	O
therapy	O
foetal	O
thyroid	O
growth	O
is	O
normal	O
at	O
ultrasound	O
study	O
,	O
newborn	O
thyroid	O
status	O
is	O
normal	O
,	O
and	O
the	O
incidence	O
of	O
maternal	O
morbidity	O
is	O
not	O
influenced	O
by	O
the	O
pregnancy	O
.	O

Both	O
higher	O
late	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
gestational	O
vitamin	O
D	O
status	O
trajectory	O
can	O
be	O
suspected	B
to	O
play	O
a	O
role	O
in	O
healthy	O
pregnancy	O
.	O

Women	O
with	O
a	O
higher	O
level	O
of	O
nutritional	O
knowledge	O
used	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
more	O
frequently	O
(	O
Table	O
2	O
).	O

The	O
nucleus	O
accumbens	O
(	O
NAc	O
)	O
were	O
sampled	O
from	O
all	O
animals	O
according	O
to	O
boundaries	O
determined	O
from	O
a	O
standard	O
rat	O
brain	O
atlas	O
[	O
22	O
].	O

Animal	O
models	O
of	O
vitamin	O
D	O
deficiency	O
have	O
shown	O
just	O
how	O
important	O
adequate	O
nutritional	O
intakes	O
of	O
vitamin	O
D	O
are	O
to	O
skeletal	O
,	O
cardiovascular	O
,	O
and	O
neurologic	O
development	O
in	O
experimental	O
animals	O
.	O

There	O
are	O
few	O
large	O
intervention	O
trials	O
of	O
multiple	O
micronutrient	O
supplementation	O
in	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
and	O
none	O
have	O
been	O
conducted	O
in	O
Africa	O
.	O

Primers	O
used	O
were	O
obtained	O
based	O
on	O
TaqMan	O
®	O
Gene	O
Expression	O
Assays	O
and	O
the	O
FAM	O
™	O
dye	O
label	O
format	O
(	O
ThermoFisher	O
;	O
TableS1	O
).	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Cincinnati	O
and	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
Institutional	O
Review	O
Boards	O
.	O

2008	O
),	O
we	O
offer	O
the	O
following	O
observations	O
regarding	O
the	O
scope	O
of	O
our	O
study	O
and	O
limitations	O
of	O
the	O
methodology	O
applied	O
.	O

Under	O
the	O
key	O
words	O
“	O
vitamin	O
D	O
,	O
fertility	O
”,	O
129	O
articles	O
were	O
found	O
in	O
the	O
PubMed	O
database	O
,	O
for	O
“	O
vitamin	O
D	O
,	O
infertility	O
”,	O
another	O
106	O
were	O
located	O
(	O
March	O
15th	O
,	O
2015	O
).	O

However	O
,	O
the	O
reality	O
is	O
that	O
medications	O
must	O
be	O
considered	O
for	O
pregnant	O
patients	O
with	O
medical	O
disorders	O
,	O
based	O
on	O
a	O
thorough	O
appreciation	O
of	O
the	O
potential	O
deleterious	O
effects	O
of	O
untreated	O
disease	O
.	O

IFA	O
supplements	O
have	O
also	O
been	O
found	O
to	O
reduce	O
the	O
preterm	O
delivery	O
rate	O
and	O
neonatal	O
mortality	O
attributable	O
to	O
prematurity	O
and	O
birth	O
asphyxia	O
[	O
7	O
].	O

In	O
contrast	O
,	O
when	O
bred	O
under	O
thermoneutral	O
conditions	O
(	O
29	O
°	O
C	O
),	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
enhanced	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
(	O
Feldmann	O
et	O
al	O
.,	O
2009	O
).	O

Subjects	O
who	O
attended	O
this	O
visit	O
were	O
considered	O
enrolled	O
.	O

Bonferroni	O
analysis	O
indicated	O
a	O
significant	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Cnr2	O
in	O
the	O
hypoyhalamus	O
of	O
RC	O
male	O
offspring	O
compared	O
to	O
CC	O
ones	O
(	O
Figure4A	O
).	O

The	O
main	O
food	O
sources	O
of	O
Vitamin	O
D3	O
are	O
dairy	O
,	O
egg	O
,	O
fish	O
and	O
meat	O
.	O

There	O
was	O
no	O
correlation	O
between	O
BMI	O
at	O
the	O
time	O
of	O
the	O
visit	O
and	O
cathelicidin	O
in	O
this	O
population	O
,	O
nor	O
was	O
there	O
a	O
correlation	O
between	O
percent	O
fat	O
and	O
cathelicidin	O
concentration	O
.	O

Candidate	O
genes	O
were	O
prioritized	O
based	B
on	I
reported	O
phenotypes	O
and	O
natriuretic	O
peptide	O
receptor	O
C	O
(	O
Npr3	O
)	O
was	O
selected	O
for	O
sequencing	O
based	B
on	I
the	O
existence	O
of	O
seven	O
known	B
alleles	O
(	O
spontaneous	O
and	O
generated	O
)	O
with	O
phenotypes	O
similar	O
to	O
those	O
of	O
the	O
Skm1	O
mice	O
.	O

A	O
similar	O
analysis	O
was	O
undertaken	O
for	O
BMI	O
difference	O
in	O
the	O
child	O
.	O

Thus	B
,	O
preventive	O
treatment	O
with	O
iron	O
supplements	O
has	O
always	O
been	O
given	O
in	O
combination	O
with	O
folic	O
acid	O
and	O
this	O
has	O
been	O
included	O
as	O
part	O
of	O
routine	O
antenatal	O
care	O
provided	O
to	O
pregnant	O
women	O
at	O
every	O
visit	O
in	O
developing	O
countries	O
[	O
26	O
].	O

The	O
role	O
of	O
radiotherapy	O
is	O
controversial	O
as	B
MTC	O
is	O
generally	B
not	O
believed	O
to	O
be	O
radio	O
-	O
sensitive	O
.	O

By	O
clustering	O
,	O
we	O
hoped	O
to	O
uncover	O
biologically	O
meaningful	O
groups	O
of	O
CpG	O
loci	O
,	O
with	O
similar	O
methylation	O
patterns	O
,	O
which	O
may	O
share	O
biological	O
characteristics	O
such	O
as	O
comparable	O
functionality	O
in	O
certain	O
developmental	O
pathways	O
or	O
location	O
in	O
similar	O
genomic	O
regions	O
.	O

BMI	O
Table	O
3displays	O
raw	O
BMI	O
correlations	O
for	O
the	O
index	O
child	O
with	O
family	O
members	O
together	O
with	O
the	O
sample	O
size	O
.	O

A	O
further	O
limitation	O
of	O
our	O
study	O
is	O
that	O
it	O
was	O
not	O
feasible	O
to	O
undertake	O
biochemical	O
assessment	O
of	O
the	O
supplements	O
or	O
assess	O
serum	O
concentrations	O
in	O
all	O
participants	O
after	O
each	O
and	O
between	O
supplementation	O
.	O

found	O
a	O
59	O
%	O
lower	O
risk	O
of	O
PTB	O
for	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
concentrations	O
≤	O
20	O
ng	O
/	O
mL	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
[	O
12	O
].	O

Our	O
findings	O
represent	O
the	O
largest	O
,	O
most	O
extensive	O
,	O
and	O
most	O
complete	O
follow	O
-	O
up	O
of	O
infants	O
to	O
6	O
months	O
of	O
age	O
who	O
were	O
born	O
to	O
overweight	O
and	O
obese	O
women	O
following	O
the	O
conduct	O
of	O
the	O
largest	O
randomised	O
trial	O
to	O
date	O
evaluating	O
the	O
provision	O
of	O
a	O
comprehensive	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
.	O

Our	O
goal	O
was	O
to	O
identify	O
specific	O
high	O
-	O
risk	O
subsets	O
of	O
pregnant	O
women	O
who	O
may	O
benefit	O
from	O
vitamin	O
D	O
supplementation	O
in	O
order	O
to	O
mitigate	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

This	O
leaves	O
the	O
important	O
question	O
of	O
exact	O
dosage	O
and	O
timing	O
of	O
delivery	O
requirements	O
for	O
future	O
studies	O
.	O

These	O
numbers	O
for	O
control	O
group	O
were	O
9	O
(	O
18	O
%),	O
22	O
(	O
44	O
%),	O
19	O
(	O
38	O
%),	O
respectively	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
the	O
STATA	O
version	O
10	O
.	O
0	O
Results	O
Characteristics	O
of	O
study	O
participants	O
Baseline	O
characteristics	O
of	O
the	O
study	O
participants	O
are	O
presented	O
in	O
Table1	O
.	O

Of	O
course	O
,	O
any	O
strategies	O
to	O
prolong	O
labour	O
,	O
including	O
delaying	O
caesarean	O
birth	O
,	O
must	O
be	O
evaluated	O
against	O
the	O
potential	O
risk	O
of	O
continued	O
exposure	O
of	O
woman	O
and	O
foetus	O
to	O
sub	O
-	O
optimal	O
conditions	O
that	O
may	O
result	O
in	O
harmful	O
effects	O
.	O

For	O
boys	O
,	O
there	O
was	O
a	O
positive	O
change	O
associated	O
with	O
the	O
BMI	O
of	O
the	O
mother	O
,	O
p	O
=	O
0	O
.	O
002	O
,	O
but	O
no	O
association	O
with	O
other	O
family	O
members	O
.	O

Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
[	O
25	O
].	O

The	O
actions	O
identified	O
aim	O
to	O
support	O
the	O
goals	O
of	O
the	O
Global	O
Strategy	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
launched	O
by	O
the	O
United	O
Nations	O
(	O
UN	O
)	O
Secretary	O
-	O
General	O
Ban	O
Ki	O
-	O
moon	O
in	O
September	O
2010	O
to	O
further	O
advance	O
progress	O
for	O
the	O
Millennium	O
Development	O
Goal	O
4	O
for	O
child	O
survival	O
and	O
the	O
Every	O
Woman	O
Every	O
Child	O
movement	O
to	O
mobilise	O
action	O
and	O
resources	O
for	O
these	O
goals	O
[	O
7	O
].	O

Primiparous	O
women	O
were	O
eligible	O
if	O
the	O
following	O
criteria	O
were	O
met	O
:	O
Woman	O
planned	O
to	O
remain	O
in	O
the	O
study	O
area	O
for	O
at	O
least	O
one	O
month	O
before	O
and	O
one	O
month	O
after	O
delivery	O
.	O

This	O
can	O
improve	O
after	O
dental	O
surgery	O
under	O
GA	O
[	O
3	O
,	O
9	O
].	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
inversely	O
related	O
to	O
primary	O
cesarean	O
section	O
in	O
nulliparous	O
women	O
,	O
an	O
unexpected	O
and	O
unexplained	O
maternal	O
outcome	O
recently	O
identified	O
.	O

In	O
a	O
previous	O
genome	O
-	O
wide	O
association	O
study	O
(	O
GWAS	O
),	O
we	O
demonstrated	O
that	O
a	O
number	O
of	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
or	O
near	O
to	O
genes	O
encoding	O
key	O
components	O
of	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
are	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
8	O
).	O

The	O
following	O
search	O
terms	O
were	O
used	O
:	O
prevalence	O
,	O
burden	O
,	O
iron	O
deficiency	O
,	O
anaemia	O
in	O
pregnancy	O
,	O
preventive	O
treatments	O
,	O
and	O
developing	O
countries	O
.	O

However	O
,	O
in	O
countries	O
at	O
northern	O
latitudes	O
,	O
such	O
as	O
Ireland	O
(	O
51	O
–	O
55	O
°	O
N	O
),	O
production	O
reduces	O
substantially	O
from	O
October	O
to	O
March	O
[	O
1	O
,	O
2	O
]	O
with	O
striking	O
seasonal	O
variation	O
observed	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
)	O
in	O
pregnant	O
and	O
non	O
-	O
pregnant	O
populations	O
[	O
3	O
–	O
5	O
].	O

Ninety	O
-	O
three	O
per	O
cent	O
of	O
the	O
exposed	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
born	O
to	O
mothers	O
receiving	O
psychotropic	O
polytherapy	O
,	O
and	O
53	O
%	O
of	O
these	O
neonates	O
were	O
prenatally	O
exposed	O
to	O
a	O
selective	O
serotonin	O
reuptake	O
inhibitor	O
(	O
SSRI	O
).	O

Although	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
do	O
correlate	O
to	O
maternal	O
levels	O
,	O
factors	O
that	O
affect	O
fetal	O
growth	O
may	O
not	O
be	O
uniform	O
throughout	O
pregnancy	O
and	O
this	O
difference	O
in	O
timing	O
could	O
affect	O
study	O
findings	O
.	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6In	O
addition	O
,	O
maternal	O
characteristics	O
such	O
as	O
obesity	O
or	O
pre	O
-	O
eclampsia	O
could	O
also	O
affect	O
results	O
that	O
may	O
not	O
have	O
been	O
seen	O
if	O
vitamin	O
D	O
samples	O
were	O
obtained	O
during	O
early	O
pregnancy	O
.	O

Methods	O
This	O
case	O
–	O
control	O
study	O
was	O
conducted	O
from	O
2009	O
to	O
2011	O
in	O
the	O
city	O
of	O
Winnipeg	O
,	O
Manitoba	O
,	O
Canada	O
.	O

In	O
the	O
ventromedial	O
hypothalamic	O
nucleus	O
,	O
dopamine	O
release	O
is	O
required	O
to	O
initiate	O
a	O
meal	O
,	O
and	O
is	O
positively	O
associated	O
with	O
meal	O
number	O
and	O
duration	O
.	O
27	O
,	O
28By	O
possibly	O
reducing	O
dopamine	O
signaling	O
,	O
the	O
HV	O
pup	O
diet	O
may	O
have	O
provided	O
some	O
protection	O
against	O
excess	O
food	O
intake	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
.	O

Funding	O
This	O
study	O
was	O
supported	O
by	O
theCenters	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
United	O
States	O
(	O
CDC	O
)	O
(	O
Grant	O
No	O
.	O

Therapy	O
with	O
long	O
-	O
acting	O
somatostatin	O
analogues	O
has	O
been	O
tested	O
in	O
metastatic	O
disease	O
,	O
with	O
some	O
positive	O
benefots	O
in	O
most	O
patients	O
.	O

The	O
women	O
who	O
contacted	O
Motherisk	O
tended	O
to	O
be	O
middle	O
to	O
upper	O
middle	O
class	O
,	O
whereas	O
a	O
smaller	O
proportion	O
of	O
callers	O
came	O
from	O
the	O
lower	O
socioeconomic	O
and	O
/	O
or	O
immigrant	O
population	O
;	O
however	O
,	O
this	O
may	O
not	O
affect	O
the	O
generalisability	O
of	O
the	O
results	O
,	O
as	B
their	O
outcomes	O
may	O
be	O
confounded	O
by	O
other	O
factors	O
unrelated	O
to	O
the	O
drug	O
effect	O
.	O

To	O
this	O
end	O
,	O
we	O
recommend	O
a	O
cue	O
to	O
be	O
taken	O
from	O
new	O
approaches	O
to	O
iron	O
fortification	O
technology	O
development	O
whereby	O
iron	O
-	O
mediated	O
undesirable	O
taste	O
and	O
appearance	O
are	O
prevented	O
while	O
its	O
stability	O
and	O
bioavailability	O
are	O
preserved	O
[	O
60	O
].	O

[	O
44	O
]	O
Controversy	O
exists	O
regarding	O
the	O
optimum	O
concentration	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
for	O
defining	O
vitamin	O
D	O
deficiency	O
,	O
especially	O
in	O
pregnancy	O
.	O

Due	O
to	O
the	O
high	O
iron	O
requirements	O
for	O
pregnancy	O
,	O
it	O
is	O
highly	O
prevalent	O
and	O
severe	O
in	O
pregnant	O
women	O
[	O
4	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Means	O
age	O
and	O
depression	O
score	O
,	O
sun	O
exposure	O
and	O
seasons	O
in	O
the	O
participants	O
with	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
and	O
≥	O
20	O
ng	O
/	O
mLVariablesSerum	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
ml	O
)	O
p	O
-	O
value	O
<	O
20	O
≥	O
20Age	O
(	O
years	O
),	O
mean	O
±	O
sd28	O
.	O
45	O
±	O
4	O
.	O
6225	O
.	O
32	O
±	O
4	O
.	O
390	O
.	O
31Depression	O
score	O
at	O
baseline	O
,	O
mean	O
±	O
sd8	O
.	O
34	O
±	O
3	O
.	O
829	O
.	O
37	O
±	O
3	O
.	O
940	O
.	O
31Sun	O
exposure	O
,	O
N	O
(%)<	O
0	O
.	O
001	O
<	O
60	O
m105	O
(	O
89	O
.	O
7	O
%)	O
8	O
(	O
44	O
.	O
4	O
%)	O
≥	O
60	O
m12	O
(	O
10	O
.	O
3	O
%)	O
10	O
(	O
55	O
.	O
6	O
%)	O
Season	O
,	O
N	O
(%)	O
0	O
.	O
05	O
Spring24	O
(	O
75	O
%)	O
8	O
(	O
25	O
%)	O
Summer16	O
(	O
88	O
.	O
9	O
%)	O
2	O
(	O
11	O
.	O
1	O
%)	O
Winter94	O
(	O
91	O
.	O
3	O
%)	O
9	O
(	O
8	O
.	O
7	O
%)	O
At	O
childbirth	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
had	O
a	O
mean	O
value	O
of	O
14	O
.	O
64	O
±	O
8	O
.	O
60	O
,	O
with	O
a	O
minimum	O
and	O
maximum	O
value	O
4	O
and	O
51	O
.	O
10	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

This	O
illustrates	O
the	O
importance	O
of	O
previous	O
contact	O
with	O
a	O
facility	O
to	O
determine	O
further	O
use	O
.	O

Fine	O
needle	O
aspiration	O
shows	O
a	O
mixture	O
of	O
round	O
,	O
polyhedral	O
and	O
spindle	O
-	O
shaped	O
cells	O
that	O
may	O
seem	O
undifferentiated	O
,	O
and	O
look	O
like	O
a	O
variable	O
amount	O
of	O
extra	O
-	O
cellular	O
amyloid	O
.	O

In	O
this	O
study	O
,	O
we	O
observed	O
marginal	O
sex	O
-	O
specific	O
differences	O
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
where	O
by	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
male	O
fetus	O
was	O
moderately	O
associated	O
with	O
decreasing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

Courtesy	O
U	O
.	O
S	O
.	O
National	O
Archives	O
There	O
are	O
other	O
reasons	B
why	O
reported	O
associations	O
may	O
not	O
actually	O
reveal	O
much	O
about	O
environmental	O
impacts	O
on	O
lactation	O
.	O

Likewise	O
,	O
non	O
-	O
vaccination	O
status	O
was	O
corroborated	O
if	O
no	O
information	O
on	O
vaccination	O
including	O
specific	O
date	O
for	O
vaccination	O
was	O
identified	O
from	O
these	O
sources	O
.	O

Delivery	O
and	O
neonatal	O
outcomes	O
All	O
instrumental	O
deliveries	O
were	O
performed	O
in	O
the	O
polytherapy	O
-	O
exposed	O
group	O
(	O
12	O
.	O
3	O
%	O
vs	O
0	O
%).	O

However	O
,	O
our	O
data	O
indicated	O
a	O
lower	O
preference	O
for	O
a	O
novel	O
highly	O
-	O
palatable	O
food	O
(	O
chocolate	O
mixture	O
)	O
than	O
the	O
familiar	O
standard	O
diet	O
in	O
RC	O
females	O
when	O
they	O
were	O
exposed	O
for	O
4	O
days	O
.	O

Positional	O
cloning	O
of	O
the	O
Skm	O
mutants	O
The	O
Skm	O
mutations	O
originally	O
generated	O
on	O
a	O
129S1	O
background	O
were	O
segregated	O
on	O
a	O
mixed	O
genetic	O
background	O
of	O
129S1	O
,	O
129X1	O
,	O
and	O
DBA	O
/	O
2J	O
.	O

Growth	O
arrest	O
-	O
specific	O
transcript	O
5	O
(	O
GAS5	O
)	O
encodes	O
a	O
single	O
strand	O
noncoding	O
RNA	O
(	O
ncRNA	O
)	O
and	O
,	O
as	O
its	O
name	O
suggests	O
,	O
can	O
accumulate	O
in	O
growth	O
-	O
arrested	O
cells	O
[	O
7	O
].	O

However	O
,	O
recent	O
studies	O
suggest	O
that	O
allergen	O
exposure	O
may	O
be	O
necessary	O
to	O
induce	O
tolerance	O
,	O
and	O
moreover	O
,	O
a	O
balanced	O
diet	O
prevents	O
malnutrition	O
of	O
both	O
mother	O
and	O
child	O
[	O
82	O
].	O

Sustained	O
advocacy	O
in	O
tackling	O
micronutrient	O
deficiencies	O
at	O
national	O
and	O
international	O
policy	O
levels	O
is	O
also	O
a	O
prerequisite	O
to	O
the	O
attainment	O
of	O
Millennium	O
Development	O
Goals	O
4	O
and	O
5	O
.	O

Mouse	O
models	O
have	O
contributed	O
greatly	O
to	O
our	O
understanding	O
of	O
molecular	O
embryonic	O
development	O
,	O
including	O
vertebral	O
formation	O
and	O
segmentation	O
(	O
Sparrow	O
et	O
al	O
.	O

To	O
examine	O
predictors	O
within	O
the	O
polytherapy	O
subgroup	O
only	O
,	O
unadjusted	O
logistic	O
regression	O
models	O
(	O
due	O
to	O
the	O
small	O
sample	O
size	O
)	O
were	O
subsequently	O
tested	O
.	O

Note	O
:	O
Analysis	O
is	O
for	O
countries	O
with	O
NMR	O
of	O
more	O
than	O
5	O
per	O
1	O
,	O
000	O
live	O
births	O
;	O
other	O
countries	O
are	O
excluded	O
.	O

To	O
determine	O
the	O
effect	O
of	O
birth	O
weight	O
on	O
HRV	O
parameters	O
,	O
we	O
perform	O
multivariate	O
linear	O
regression	O
analysis	O
adjusted	O
for	O
potentially	O
confounding	O
factors	O
(	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
).	O

examined	O
the	O
relationships	O
between	O
16	O
chemicals	O
(	O
6	O
phthalates	O
,	O
8	O
PFAS	O
,	O
2	O
PCBs	O
and	O
1	O
OCP	O
)	O
and	O
birth	O
weight	O
using	O
Elastic	O
Net	O
Regression	O
analyses	O
;	O
2	O
phthalates	O
,	O
1	O
PFAS	O
,	O
and	O
1	O
OCP	O
were	O
associated	O
with	O
lower	O
birth	O
weight	O
[	O
18	O
].	O

Education	O
about	O
asthma	O
and	O
its	O
interaction	O
with	O
pregnancy	O
reduces	O
anxiety	O
and	O
improves	O
compliance	O
.	O

The	O
mechanisms	O
protecting	O
specific	O
genomic	O
regions	O
from	O
epigenetic	O
re	O
-	O
programing	O
are	O
not	O
yet	O
well	O
-	O
understood	O
.	O

In	O
the	O
second	O
experiment	O
(	O
EXP2	O
)	O
offspring	O
selected	O
for	O
the	O
postnatal	O
time	O
points	O
was	O
born	O
to	O
primiparous	O
sows	O
after	O
prostaglandin	O
induction	O
of	O
parturition	O
as	O
described	O
[	O
15	O
]	O
and	O
farrowed	O
after	O
mean	O
pregnancy	O
duration	O
of	O
115	O
days	O
.	O

Geographical	O
accessibility	O
was	O
the	O
main	O
reason	O
for	O
choosing	O
an	O
ANC	O
site	O
,	O
followed	O
by	O
perceived	O
quality	O
of	O
care	O
provided	O
.	O

Results	O
The	O
initial	O
search	O
identified	O
279	O
articles	O
after	O
duplicates	O
were	O
removed	O
,	O
eight	O
of	O
which	O
were	O
suitable	O
for	O
inclusion	O
.	O

Twice	O
as	O
many	O
women	O
exposed	O
to	O
polytherapy	O
experienced	O
hypertension	O
and	O
gestational	O
diabetes	O
comorbidities	O
.	O

To	O
estimate	O
the	O
total	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
we	O
combined	O
the	O
intake	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
.	O

The	O
findings	O
of	O
the	O
formative	O
study	O
suggested	O
that	O
introduction	O
of	O
IFA	O
supplements	O
early	O
in	O
pregnancy	O
is	O
feasible	B
with	O
support	O
from	O
BRAC	O
or	O
government	O
community	O
health	O
workers	O
.	O

Initiating	O
these	O
changes	O
can	O
start	O
to	O
move	O
countries	O
toward	O
their	O
goal	O
of	O
preterm	O
mortality	O
reduction	O
while	O
also	O
preventing	O
death	O
due	O
to	O
other	O
causes	O
of	O
newborn	O
death	O
,	O
as	O
well	O
as	O
maternal	O
deaths	O
and	O
stillbirths	O
,	O
through	O
shared	O
interventions	O
such	O
as	O
skilled	O
care	O
at	O
birth	O
.	O

The	O
use	O
of	O
opium	O
,	O
bread	O
and	O
tea	O
could	O
not	O
be	O
assessed	O
in	O
the	O
retrospective	O
framework	O
.	O

Methods	O
Study	O
population	O
This	O
study	O
utilised	O
data	O
collected	O
from	O
the	O
multi	O
-	O
centre	O
,	O
prospective	O
cohort	O
Screening	O
for	O
Pregnancy	O
Endpoints	O
(	O
SCOPE	O
)	O
study	O
[	O
28	O
].	O

There	O
are	O
randomized	O
controlled	O
trials	O
which	O
have	O
demonstrated	O
efficacy	O
of	O
the	O
oral	O
agents	O
glyburide	O
and	O
metformin	O
.	O

Effects	O
of	O
dietary	O
energy	O
(	O
TDN	O
:	O
70	O
%,	O
80	O
%;	O
DM	O
basis	O
)	O
and	O
protein	O
levels	O
(	O
crude	O
protein	O
[	O
CP	O
]:	O
11	O
.	O
9	O
%,	O
14	O
.	O
3	O
%;	O
DM	O
basis	O
)	O
on	O
growth	O
performance	O
,	O
carcass	O
characteristics	O
and	O
meat	O
quality	O
were	O
examined	O
in	O
F1	O
Angus	O
×	O
Chinese	O
Xiangxi	O
yellow	O
cattle	O
[	O
125	O
].	O

Of	O
the	O
routine	O
antianaphylaxis	O
medications	O
,	O
epinephrine	O
and	O
diphenhydramine	O
have	O
been	O
implicated	O
in	O
causing	O
fetal	O
malformations	O
.	O

Innovate	O
•	O
Promote	O
the	O
discovery	O
,	O
development	O
and	O
delivery	O
of	O
affordable	O
and	O
essential	O
medicines	O
,	O
new	O
technologies	O
and	O
novel	O
models	O
for	O
training	O
and	O
services	O
to	O
prevent	O
preterm	O
birth	O
and	O
improve	O
care	O
of	O
premature	O
babies	O
.	O

However	O
,	O
in	O
that	O
study	O
neurodevelopment	O
was	O
assessed	O
when	O
the	O
infant	O
was	O
only	O
three	O
days	O
old	O
.	O

Thus	O
,	O
the	O
caloric	O
restriction	O
finished	O
at	O
GD	O
20	O
(	O
2	O
days	O
before	O
birth	O
),	O
and	O
all	O
dams	O
and	O
their	O
offspring	O
were	O
fed	O
ad	O
libitum	O
with	O
the	O
standard	O
chow	O
along	O
the	O
remaining	O
experimental	O
periods	O
(	O
lactation	O
and	O
postweaning	O
periods	O
).	O

Innovate	O
•	O
Advance	O
policy	O
development	O
by	O
improving	O
the	O
metrics	O
for	O
impairment	O
outcomes	O
as	O
well	O
as	O
preterm	O
birth	O
rates	O
,	O
and	O
link	O
to	O
other	O
pregnancy	O
outcomes	O
,	O
reporting	O
on	O
trends	O
and	O
emerging	O
issues	O
relating	O
to	O
preterm	O
births	O
.	O

Furthermore	O
,	O
associations	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
loss	O
were	O
studied	O
.	O

Results	O
For	O
a	O
10	O
-	O
fold	O
increase	O
in	O
chemical	O
concentration	O
,	O
the	O
mean	O
differences	O
in	O
birth	O
weights	O
(	O
95	O
%	O
credible	O
intervals	O
(	O
CI	O
))	O
were	O
1	O
g	O
(-	O
20	O
,	O
23	O
)	O
for	O
phthalates	O
,	O
-	O
11	O
g	O
(-	O
52	O
,	O
34	O
)	O
for	O
PFAS	O
,	O
0	O
.	O
2	O
g	O
(-	O
9	O
,	O
10	O
)	O
for	O
PCBs	O
,	O
-	O
4	O
g	O
(-	O
30	O
,	O
22	O
)	O
for	O
PBDEs	O
,	O
and	O
7	O
g	O
(-	O
25	O
,	O
40	O
)	O
for	O
OCPs	O
.	O

Questionnaires	O
regarding	O
maternal	O
stress	O
/	O
maternal	O
attitudes	O
as	O
well	O
as	O
anthropometric	O
data	O
were	O
collected	O
as	O
previously	O
described	O
[	O
12	O
,	O
13	O
].	O

We	O
conducted	O
the	O
key	O
informant	O
interviews	O
to	O
understand	O
the	O
community	O
norms	O
around	O
IFA	O
supplementation	O
,	O
and	O
challenges	O
and	O
successes	O
of	O
the	O
existing	O
programme	O
.	O

All	O
these	O
mechanisms	O
play	O
critical	O
roles	O
throughout	O
normal	O
mammalian	O
development	O
,	O
particularly	O
during	O
early	O
embryo	O
and	O
germ	O
cell	O
development	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Beaujean2014	O
;	O
Dean2014	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
;	O
Luk	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Mukherjee	O
et	O
al	O
.	O
2014	O
;	O
O	O
'	O
Doherty	O
&	O
McGettigan2014	O
;	O
Grote	O
&	O
Herrmann2015	O
;	O
Hogg	O
&	O
Western2015	O
;	O
Marcho	O
et	O
al	O
.	O
2015	O
).	O

Omnibus	O
tests	O
for	O
the	O
overall	O
association	O
between	O
each	O
repetitive	O
methylation	O
and	O
class	O
methylation	O
were	O
obtained	O
by	O
permutation	O
test	O
,	O
using	O
a	O
test	O
analogous	O
to	O
a	O
Kolmogorov	O
–	O
Smirnov	O
test	O
.	O

Methods	O
are	O
currently	O
available	O
to	O
quantify	O
the	O
contribution	O
of	O
endogenous	O
vitamin	O
D	O
synthesis	O
resulting	O
from	O
sun	O
exposure	O
,	O
but	O
serious	O
limitations	O
remain	O
in	O
accurately	O
estimating	O
dietary	O
vitamin	O
D	O
intake	O
because	O
of	O
the	O
incompleteness	O
of	O
nutrient	O
databases	O
for	O
both	O
vitamin	O
D	O
-	O
fortified	O
food	O
and	O
vitamin	O
D	O
supplements	O
.	O

There	O
were	O
no	O
associations	O
between	O
the	O
predictor	O
T1	O
25OHD	O
and	O
the	O
outcomes	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
(	O
Table	O
3	O
).	O

More	O
research	O
with	O
larger	O
sample	O
sizes	O
and	O
frequent	O
assessments	O
of	O
diet	O
is	O
needed	O
to	O
inform	O
the	O
impact	O
of	O
timing	O
of	O
nutrient	O
exposures	O
on	O
offspring	O
weight	O
status	O
.	O

This	O
study	O
concluded	O
that	O
abnormal	O
maternal	O
gestational	O
weight	O
indirectly	O
caused	O
an	O
increased	O
chance	O
of	O
developing	O
ASD	O
[	O
49	O
].	O

The	O
concordance	O
of	O
mothers	O
’	O
personal	O
weight	O
gain	O
target	O
with	O
IOM	O
recommendations	O
varied	O
by	O
their	O
pre	O
-	O
pregnancy	O
weight	O
status	O
:	O
Normal	O
weight	O
mothers	O
were	O
more	O
likely	B
to	O
have	O
low	O
weight	O
gain	O
targets	O
,	O
whereas	O
overweight	O
and	O
obese	O
women	O
were	O
more	O
likely	B
to	O
have	O
high	O
weight	O
gain	O
targets	O
(	O
Table	O
3	O
).	O

Pepsin	O
(	O
0	O
.	O
01	O
%	O
in	O
0	O
.	O
01	O
M	O
HCl	O
)	O
was	O
used	O
to	O
treat	O
the	O
tissue	O
for	O
5	O
minutes	O
at	O
37	O
°	O
C	O
,	O
and	O
a	O
brief	O
rinse	O
in	O
DEPC	O
treated	O
H2O	O
followed	O
.	O

Participants	O
took	O
an	O
average	O
of	O
12	O
minutes	O
to	O
complete	O
the	O
questionnaire	O
.	O

As	O
reported	O
previously	O
[	O
16	O
],	O
the	O
intervention	O
reduced	O
excessive	O
GWG	O
in	O
normal	O
weight	O
but	O
not	O
overweight	O
/	O
obese	O
women	O
.	O

[	O
37	O
–	O
39	O
]	O
The	O
concept	O
that	O
maternal	O
nutritional	O
status	O
influences	O
the	O
risk	O
of	O
chronic	O
disorders	O
in	O
the	O
offspring	O
has	O
attracted	O
interest	O
over	O
the	O
past	O
2	O
decades	O
.	O

One	O
participant	O
assigned	O
to	O
the	O
intervention	O
arm	O
and	O
two	O
in	O
the	O
control	O
arm	O
were	O
later	O
found	O
to	O
be	O
ineligible	O
because	O
another	O
woman	O
residing	O
in	O
the	O
same	O
household	O
compound	O
had	O
previously	O
been	O
enrolled	O
in	O
the	O
study	O
;	O
data	O
collection	O
was	O
discontinued	O
upon	O
identification	O
of	O
the	O
ineligibility	O
criteria	O
.	O

When	O
juvenile	O
and	O
young	O
adult	O
pigs	O
(	O
period	O
III	O
)	O
are	O
compared	O
,	O
1	O
,	O
549	O
probe	O
-	O
sets	O
differed	O
significantly	O
(	O
697	O
188	O
dpn	O
≻	O
28	O
dpn	O
)	O
in	O
AP	O
offspring	O
.	O

GDM	O
cases	O
were	O
older	O
,	O
and	O
heavier	O
than	O
women	O
who	O
did	O
not	O
develop	O
the	O
disorder	O
.	O

Girls	O
who	O
ranked	O
themselves	O
at	O
the	O
low	O
end	O
of	O
school	O
social	O
status	O
were	O
69	O
%	O
more	O
likely	B
to	O
have	O
a	O
BMI	O
2	O
kg	O
/	O
m2higher	O
than	O
that	O
of	O
girls	O
of	O
higher	O
subjective	O
social	O
status	O
.	O

The	O
results	O
of	O
several	O
meta	O
-	O
analyses	O
reinforce	O
the	O
beneficial	O
role	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
during	O
pregnancy	O
in	O
reducing	O
the	O
prevalence	O
of	O
neural	O
tube	O
defects	O
,	O
low	O
-	O
birth	O
weight	O
babies	O
,	O
small	O
for	O
gestational	O
age	O
newborns	O
and	O
maternal	O
anaemia	O
[	O
7	O
-	O
9	O
].	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
association	O
between	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
levels	O
and	O
S	O
-	O
ECC	O
.	O

Interactions	O
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
34	O
.	O
005	O
,	O
P	O
<	O
0	O
.	O
01	O
],	O
and	O
diet	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
4	O
.	O
58	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
were	O
found	O
.	O

DNA	O
sequence	O
analysis	O
of	O
Flnb	O
revealed	O
a	O
T	O
-	O
to	O
-	O
C	O
transition	O
at	O
nucleotide	O
position	O
481	O
converting	O
a	O
serine	O
residue	O
to	O
a	O
proline	O
residue	O
(	O
S96P	O
),	O
resulting	O
in	O
a	O
missense	O
mutation	O
(	O
Figure	O
3A	O
,	O
right	O
panel	O
)	O
within	O
the	O
actin	O
-	O
binding	O
domain	O
of	O
FLNB	O
(	O
Figure	O
3C	O
,	O
bottom	O
panel	O
).	O

Although	O
not	O
prespecified	O
,	O
we	O
also	O
generated	O
rate	O
ratios	O
to	O
compare	O
the	O
proportion	O
of	O
intervention	O
-	O
recommended	O
times	O
at	O
which	O
hands	O
were	O
washed	O
in	O
the	O
two	O
study	O
arms	O
;	O
we	O
used	O
log	O
binomial	O
regression	O
,	O
accounting	O
for	O
repeated	O
measures	O
at	O
the	O
caregiver	O
level	O
to	O
adjust	O
standard	O
errors	O
.	O

Since	O
we	O
completed	O
structured	O
observations	O
at	O
the	O
end	O
of	O
the	O
neonatal	O
period	O
during	O
postnatal	O
days	O
30	O
–	O
32	O
,	O
we	O
cannot	O
know	O
whether	O
handwashing	O
was	O
more	O
common	O
or	O
less	O
common	O
during	O
the	O
early	O
days	O
of	O
the	O
newborn	O
period	O
,	O
when	O
babies	O
may	O
have	O
been	O
perceived	O
to	O
be	O
particularly	O
vulnerable	O
but	O
mothers	O
may	O
have	O
been	O
particularly	O
fatigued	O
or	O
getting	O
adjusted	O
to	O
the	O
new	O
household	O
routine	O
following	O
the	O
birth	O
.	O

Additionally	O
,	O
the	O
discordance	O
of	O
handedness	O
in	O
twin	O
studies	O
illustrates	O
that	O
genetics	O
alone	O
cannot	O
explain	O
the	O
development	O
of	O
handedness	O
[	O
202	O
–	O
207	O
].	O

Is	O
any	O
part	O
of	O
the	O
life	O
cycle	O
particularly	O
more	O
sensitive	O
to	O
an	O
exposure	O
than	O
others	O
?	O

Also	O
,	O
weekly	O
supplements	O
may	O
be	O
better	O
tolerated	O
,	O
with	O
less	O
frequent	O
side	O
-	O
effects	O
thereby	B
increasing	O
acceptance	O
and	O
compliance	O
.	O

A	O
10	O
-	O
fold	O
increase	O
in	O
Pb	O
exposure	O
was	O
associated	O
with	O
a	O
45	O
g	O
birth	O
weight	O
reduction	O
(	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
),	O
while	O
increased	O
exposure	O
to	O
DMP	O
was	O
associated	O
with	O
a	O
-	O
57	O
g	O
(	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
))	O
change	O
in	O
birth	O
weight	O
.	O

On	O
the	O
basis	O
of	O
these	O
criteria	O
,	O
we	O
controlled	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

In	O
addition	O
,	O
smoking	O
is	O
a	O
cause	O
of	O
reflux	O
and	O
should	O
be	O
avoided	O
.	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

Exposure	O
to	O
the	O
sun	O
during	O
week	O
and	O
weekend	O
days	O
,	O
and	O
consumption	O
of	O
milk	O
and	O
dairy	O
products	O
were	O
not	O
associated	O
with	O
either	O
severe	O
or	O
normal	O
vitamin	O
D	O
deficiency	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t005	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
in	O
Belgium	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
)	O
(	O
n	O
=	O
1121	O
),	O
results	O
of	O
multiple	O
logistic	O
regressions	O
.	O
N	O
of	O
subjectsN	O
of	O
severe	O
deficient	O
casesOR	O
[	O
95	O
%	O
Conf	O
Interval	O
]	O
p	O
Trimester	O
of	O
pregnancy	O
first	O
trimester633741	O
.	O
000third	O
trimester665841	O
.	O
7511	O
.	O
1282	O
.	O
7190	O
.	O
013	O
Season	O
Winter470891	O
.	O
000Spring384350	O
.	O
2830	O
.	O
1680	O
.	O
477	O
<	O
0	O
.	O
001Summer930Autumn351340	O
.	O
3240	O
.	O
1910	O
.	O
551	O
<	O
0	O
.	O
001	O
Smoking	O
Yes219331	O
.	O
000No10781250	O
.	O
4630	O
.	O
2680	O
.	O
8010	O
.	O
006	O
Alcohol	O
consumption	O
Yes264131	O
.	O
000No10221432	O
.	O
3701	O
.	O
1624	O
.	O
8340	O
.	O
018	O
Use	O
of	O
multivitamins	O
containing	O
vitamin	O
D	O
No4891151	O
.	O
000Yes809430	O
.	O
1210	O
.	O
0750	O
.	O
193	O
<	O
0	O
.	O
001	O
Ethnicity	O
Caucasian	O
,	O
white955691	O
.	O
000Asiatic3396	O
.	O
6562	O
.	O
41318	O
.	O
359	O
<	O
0	O
.	O
001African	O
,	O
black64132	O
.	O
6051	O
.	O
1515	O
.	O
8960	O
.	O
022African	O
,	O
north174638	O
.	O
1744	O
.	O
71214	O
.	O
177	O
<	O
0	O
.	O
001	O
Frequency	O
fatty	O
fish	O
consumption	O
Never192181	O
.	O
000Less	O
than	O
once	O
a	O
month188242	O
.	O
2051	O
.	O
0104	O
.	O
8160	O
.	O
0471	O
–	O
3	O
days	O
a	O
month498591	O
.	O
4810	O
.	O
7552	O
.	O
9040	O
.	O
2541	O
day	O
per	O
week291351	O
.	O
3910	O
.	O
6712	O
.	O
8850	O
.	O
3752	O
–	O
4	O
days	O
a	O
week	O
or	O
more	O
frequent128221	O
.	O
5130	O
.	O
6593	O
.	O
4720	O
.	O
328	O
Use	O
of	O
sunscreen	O
lotion	O
Yes	O
,	O
much	O
of	O
the	O
time644361	O
.	O
000Yes	O
,	O
sometimes281342	O
.	O
0871	O
.	O
1713	O
.	O
7220	O
.	O
013No368883	O
.	O
2631	O
.	O
9355	O
.	O
504	O
<	O
0	O
.	O
001	O
Preference	O
sun	O
/	O
shadow	O
Sun476531	O
.	O
000Shadow497701	O
.	O
9831	O
.	O
2253	O
.	O
2100	O
.	O
005Does	O
not	O
matter321351	O
.	O
2060	O
.	O
6912	O
.	O
1040	O
.	O
510	O
OR	O
Odds	O
ratio	O
.	O

Women	O
presenting	O
for	O
other	O
services	O
than	O
ANC	O
visits	O
were	O
excluded	O
on	O
the	O
grounds	O
that	O
they	O
did	O
not	O
have	O
any	O
experience	O
of	O
a	O
particular	O
health	O
centre	O
and	O
so	O
could	O
not	O
give	O
an	O
opinion	O
on	O
the	O
ANC	O
services	O
.	O

Tobacco	O
use	O
and	O
vitamin	O
D	O
supplement	O
use	O
were	O
also	O
investigated	O
as	O
potential	O
confounders	O
but	O
did	O
not	O
show	O
any	O
confounding	O
effect	O
and	O
were	O
thus	B
not	O
included	O
in	O
the	O
final	O
models	O
.	O

The	O
findings	O
will	O
provide	O
a	O
concrete	O
way	O
for	O
the	O
researchers	O
to	O
give	O
back	O
to	O
the	O
community	O
.	O

Biomarkers	O
with	O
<	O
90	O
%	O
detection	O
level	O
or	O
that	O
were	O
only	O
examined	O
in	O
a	O
subset	O
of	O
the	O
participants	O
were	O
excluded	O
from	O
analysis	O
to	O
preserve	O
sample	O
size	O
(	O
Table2	O
).	O

This	O
is	O
the	O
next	O
step	O
to	O
find	O
out	O
how	O
it	O
’	O
s	O
really	O
happening	O
on	O
the	O
molecular	O
level	O
.”	O
Uranium	O
’	O
s	O
Toxic	O
Legacy	O
Human	O
and	O
animal	O
studies	O
elsewhere	O
have	O
indicated	O
the	O
health	O
legacy	O
of	O
uranium	O
exposure	O
may	O
extend	O
to	O
the	O
children	O
of	O
exposed	O
parents	O
.	O

Conclusion	O
:	O
Maternal	O
serum	O
visfatin	O
level	O
shows	O
a	O
relationship	O
with	O
fetal	O
and	O
infant	O
anthropometric	O
indicators	O
,	O
with	O
different	O
effects	O
in	O
the	O
two	O
groups	O
,	O
suggesting	O
visfatin	O
dysfunction	O
in	O
the	O
overweight	O
group	O
before	O
pregnancy	O
.	O

Additionally	O
,	O
the	O
initial	O
test	O
was	O
not	O
automated	O
until	O
May	O
2016	O
so	B
many	O
women	O
who	O
delivered	O
during	O
the	O
early	O
study	O
time	O
period	O
did	O
not	O
have	O
a	O
25	O
(	O
OH	O
)	O
D	O
measurement	O
and	O
therefore	B
could	O
not	O
be	O
included	O
in	O
this	O
analysis	O
.	O

Prior	O
to	O
ACHOIS	O
,	O
a	O
large	O
number	O
of	O
other	O
studies	O
had	O
been	O
performed	O
to	O
ascertain	O
if	O
treatment	O
of	O
GDM	O
is	O
of	O
benefit	O
.	O

If	O
this	O
approach	O
is	O
vulgarized	O
,	O
it	O
might	O
increase	O
the	O
uptake	O
of	O
ANC	O
services	O
and	O
improve	O
on	O
the	O
quality	O
of	O
health	O
care	O
.	O

Also	O
,	O
vitamin	O
D	O
supplements	O
were	O
used	O
by	O
almost	O
half	O
of	O
the	O
women	O
but	O
most	O
(	O
88	O
%)	O
used	O
multivitamins	O
containing	O
5	O
–	O
10	O
μg	O
of	O
vitamin	O
D3	O
.	O

N	O
-	O
nitroso	O
compounds	O
are	O
a	O
potent	O
inducer	O
of	O
cancer	O
and	O
brain	O
tumors	O
in	O
various	O
animal	O
species	O
[	O
159	O
,	O
160	O
],	O
and	O
fetal	O
exposure	O
produces	O
more	O
tumors	O
than	O
postnatal	O
exposure	O
[	O
161	O
].	O

Inform	O
•	O
Improve	O
systems	O
for	O
collecting	O
,	O
evaluating	O
and	O
disseminating	O
data	O
on	O
preterm	O
birth	O
rates	O
,	O
mortality	O
,	O
disability	O
,	O
quality	O
of	O
life	O
and	O
equitable	O
coverage	O
of	O
evidence	O
-	O
based	O
interventions	O
to	O
track	O
progress	O
towards	O
MDGs	O
4	O
and	O
5	O
for	O
maternal	O
and	O
child	O
survival	O
.	O

Nutritional	O
education	O
is	O
considered	O
an	O
important	O
tool	O
for	O
promoting	O
a	O
healthy	O
lifestyle	O
,	O
but	O
has	O
not	O
been	O
studied	O
as	O
a	O
determinant	O
for	O
maternal	O
use	O
of	O
supplements	O
during	O
pregnancy	O
,	O
especially	O
in	O
Romania	O
,	O
where	O
evidence	O
about	O
pregnancy	O
and	O
nutrition	O
is	O
scarce	O
.	O

Glucose	O
intolerance	O
and	O
gestational	O
diabetes	O
risk	O
in	O
relation	O
to	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
:	O
a	O
pilot	O
study	O
Abstract	O
Background	O
Insufficient	O
sleep	O
and	O
poor	O
sleep	O
quality	O
,	O
considered	O
endemic	O
in	O
modern	O
society	O
,	O
are	O
associated	O
with	O
obesity	O
,	O
impaired	O
glucose	O
tolerance	O
and	O
diabetes	O
.	O

We	O
observed	O
consistent	O
associations	O
between	O
maternal	O
DHA	O
and	O
EPA	O
intake	O
and	O
infant	O
gut	O
microbiota	O
.	O

Familial	O
cases	O
account	B
for	I
about	O
30	O
%	O
of	O
MTCs	O
.	O

Given	B
that	O
pregnant	O
women	O
,	O
particularly	O
those	O
in	O
the	O
first	O
trimester	O
,	O
are	O
known	O
to	O
require	O
30	O
-	O
45	O
more	O
minutes	O
of	O
sleep	O
per	O
night	O
than	O
their	O
non	O
-	O
pregnant	O
counterparts	O
[	O
25	O
-	O
27	O
],	O
we	O
a	O
priori	O
defined	O
those	O
women	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
as	O
the	O
reference	O
group	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1472	O
-	O
6874	O
/	O
10	O
/	O
17	O
/	O
prepub	O
PubMed	O
Central	O
:	O

These	O
alterations	O
are	O
primarily	B
the	O
result	O
of	O
hormonal	O
effects	O
.	O

In	O
accordance	O
to	O
a	O
guideline	B
by	O
Holick	O
et	O
al	O
.,	O
6	O
–	O
8	O
weeks	O
consumption	O
of	O
a	O
high	O
dose	O
vitamin	O
D	O
supplement	O
are	O
essential	O
to	O
obtain	O
an	O
adequate	O
blood	O
reserves	O
of	O
vitamin	O
D	O
[	O
19	O
].	O

Therefore	B
,	O
nutritionally	O
-	O
induced	O
accelerated	O
reproductive	O
maturation	O
following	O
high	O
fat	O
exposure	O
may	O
not	O
be	O
limited	O
to	O
one	O
distinct	O
critical	O
developmental	O
window	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
vs	O
.	O
respective	O
vehicle	O
males	O
;#/##	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
(	O
vehicle	O
)	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
;§	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
AM251	O
-	O
treated	O
CC	O
females	O
.	O

Such	O
a	O
relation	O
has	O
been	O
attributed	O
to	O
special	O
receptors	O
for	O
vitamin	O
D	O
in	O
pancreatic	O
betacells	O
.	O
9Moreover	O
,	O
vitamin	O
D	O
was	O
shown	O
to	O
have	O
positive	O
effects	O
on	O
insulin	O
sensitivity	O
,	O
and	O
its	O
deficiency	O
to	O
have	O
negative	O
effects	O
on	O
the	O
function	O
of	O
betacells	O
.	O
11In	O
agreement	O
with	O
this	O
,	O
cohort	O
studies	O
revealed	O
that	O
vitamin	O
D	O
had	O
a	O
protective	O
effect	O
against	O
diabetes	O
type	O
II	O
.	O
8	O
,	O
11Also	O
,	O
serum	O
concentration	O
of	O
vitamin	O
D	O
during	O
24	O
-	O
29thweek	O
of	O
pregnancy	O
in	O
women	O
suffering	O
from	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
was	O
lower	O
than	O
that	O
in	O
women	O
without	O
the	O
disease	O
.	O
12	O
The	O
study	O
of	O
vitamin	O
D	O
status	O
and	O
improving	O
it	O
in	O
the	O
lactating	O
mothers	O
with	O
previous	O
GDM	O
is	O
of	O
conspicuous	O
value	O
.	O
4	O
,	O
13	O
Due	O
to	O
the	O
limited	O
exposure	O
to	O
sunshine	O
and	O
inadequate	O
intake	O
,	O
the	O
level	O
of	O
vitamin	O
D	O
is	O
reduced	O
in	O
the	O
milk	O
of	O
lactating	O
mothers	O
.	O

Authorship	O
eligibility	O
will	O
be	O
based	O
on	O
recommendation	O
from	O
International	O
committee	O
for	O
medical	O
journals	O
editors	O
(	O
ICMJE	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

,	O
2008	O
[	O
21	O
]	O
Type	O
of	O
studyObservational	O
cohort	O
(	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
-	O
ALSPAC	O
)	O
Prospective	O
cohort	O
(	O
Project	O
Viva	O
)	O
Observational	O
cohort	O
(	O
ALSPAC	O
)	O
Observational	O
cohortNHMRC	O
Level	O
of	O
evidence	O
[	O
20	O
]	O
Level	O
III	O
-	O
3Level	O
III	O
-	O
3Level	O
III	O
-	O
3Level	O
III	O
-	O
3PopulationPregnant	O
women	O
living	O
in	O
Bristol	O
&	O
surrounds	O
,	O
United	O
Kingdom	O
(	O
UK	O
).	O
Pregnant	O
women	O
recruited	O
in	O
Massachusetts	O
,	O
United	O
States	O
of	O
America	O
(	O
USA	O
)	O
Pregnant	O
women	O
in	O
Bristol	O
&	O
surrounds	O
,	O
UK	O
.	O
Pregnant	O
women	O
recruited	O
in	O
Southampton	O
,	O
UK	O
.	O

Mothers	O
in	O
several	O
low	O
-	O
income	O
countries	O
have	O
indicated	O
that	O
their	O
responsibilities	O
increase	O
in	O
the	O
postnatal	O
period	O
,	O
often	O
without	O
increased	O
support	O
for	O
household	O
or	O
child	O
care	O
activities	O
from	O
others	O
[	O
12	O
].	O

On	O
the	O
one	O
hand	O
,	O
this	O
matter	O
may	O
be	O
related	O
to	O
mitochondrial	O
impairments	O
which	O
may	O
happen	O
due	O
to	O
the	O
LP	O
diet	O
,	O
as	O
has	O
been	O
suggested	O
previously	O
[	O
57	O
,	O
58	O
].	O

Detailed	O
data	O
collection	O
procedures	O
have	O
been	O
published	O
elsewhere	O
[	O
23	O
].	O

Pregnancy	O
loss	O
was	O
defined	O
as	O
both	O
spontaneous	O
abortions	O
from	O
gestational	O
week	O
4	O
and	O
intrauterine	O
fetal	O
death	O
(	O
IUFD	O
).	O

Therefore	B
,	O
examining	O
childhood	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
is	O
warranted	O
.	O

These	O
findings	O
are	O
compatible	O
with	O
a	O
previous	O
report	O
of	O
early	O
puberty	O
following	O
high	O
fat	O
nutrition	O
during	O
pregnancy	O
[	O
57	O
].	O

Innovate	O
Conduct	O
multi	O
-	O
country	O
collaborative	O
research	O
on	O
the	O
:	O
•	O
Etiology	O
of	O
preterm	O
birth	O
,	O
advancing	O
the	O
understanding	O
of	O
strategies	O
to	O
prevent	O
and	O
treat	O
maternal	O
health	O
conditions	O
associated	O
with	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
pre	O
-	O
eclampsia	O
and	O
gestational	O
diabetes	O
)	O
and	O
improving	O
identification	O
of	O
diagnostic	O
markers	O
and	O
related	O
screening	O
tools	O
.	O

Currently	O
,	O
the	O
venom	O
-	O
based	O
treatment	O
is	O
administered	O
by	O
injection	O
,	O
but	O
the	O
Texas	O
researchers	O
hope	O
to	O
develop	O
a	O
pill	O
form	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
in	O
intervention	O
and	O
control	O
groups25	O
-	O
OH	O
VitD2	O
(	O
nmol	O
/	O
L	O
)	O
25	O
-	O
OH	O
VitD2	O
detection	O
rate25	O
-	O
OH	O
VitD3	O
(	O
nmol	O
/	O
L	O
)	O
Total25	O
-	O
OH	O
VitD	O
(	O
nmol	O
/	O
L	O
)	O
Deficiency	O
rate	O
(%)	O
Intervention	O
(	O
n	O
=	O
84	O
)	O
11	O
.	O
61	O
±	O
6	O
.	O
7122	O
.	O
6	O
%	O
71	O
.	O
77	O
±	O
26	O
.	O
7874	O
.	O
35	O
±	O
26	O
.	O
13	O
*	O
17	O
.	O
9	O
%	O
Control	O
(	O
n	O
=	O
14	O
)	O
00060	O
.	O
45	O
±	O
23	O
.	O
6335	O
.	O
7	O
%	O
Note	O
:	O
*	O
Compared	O
with	O
control	O
group	O
,	O
p	O
<	O
0	O
.	O
05	O
Seasonal	O
changes	O
of	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
pregnant	O
women	O
with	O
GDM	O
Blood	O
samples	O
were	O
taken	O
between	O
October	O
2013	O
and	O
July	O
2015	O
,	O
twenty	O
-	O
one	O
cases	O
were	O
collected	O
in	O
winter	O
,	O
forty	O
-	O
three	O
cases	O
in	O
Spring	O
,	O
twenty	O
two	O
cases	O
in	O
Summer	O
,	O
and	O
twelve	O
cases	O
in	O
Autumn	O
.	O

Our	O
study	O
revealed	O
that	O
a	O
single	O
high	O
dose	O
injection	O
of	O
vitamin	O
D	O
is	O
more	O
economic	O
and	O
effective	O
particularly	O
in	O
lactating	O
mothers	O
who	O
refrain	O
from	O
consuming	O
oral	O
daily	O
doses	O
due	O
to	O
postpartum	O
care	O
,	O
unwillingness	O
or	O
depression	O
.	O

*	O
Note	O
that	O
Control	O
offspring	O
inFigure	O
3andFigure	O
4are	O
the	O
same	O
animals	O
.	O

Albrecht	O
et	O
al	O
[	O
24	O
]	O
reported	O
that	O
hyperplasia	O
of	O
preadipocytes	O
also	O
plays	O
an	O
important	O
role	O
in	O
marbling	O
formation	O
during	O
postnatal	O
growth	O
of	O
IMF	O
because	O
new	O
marbling	O
flecks	O
appear	O
after	O
recruitment	O
and	O
filling	O
with	O
preadipocytes	O
.	O

We	O
have	O
,	O
for	O
instance	O
,	O
established	O
dietary	O
associations	O
between	O
nuclear	O
family	O
members	O
and	O
have	O
shown	O
that	O
maternal	O
pregnancy	O
diet	O
is	O
associated	O
with	O
a	O
number	O
of	O
outcomes	O
,	O
including	O
child	O
'	O
s	O
risk	O
of	O
asthma	O
,	O
overweight	O
and	O
obesity	O
.	O
22	O
There	O
are	O
powerful	O
environmental	O
influences	O
at	O
play	O
in	O
familial	O
studies	O
.	O

Vitamin	O
D	O
receptors	O
are	O
present	O
in	O
most	O
cells	O
and	O
tissues	O
in	O
the	O
body	O
[	O
152	O
],	O
including	O
the	O
brain	O
[	O
148	O
],	O
so	O
this	O
hormone	O
is	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
disease	O
management	O
and	O
cancer	O
prevention	O
as	O
a	O
modulator	O
of	O
immune	O
system	O
activity	O
[	O
148	O
,	O
153	O
–	O
155	O
].	O

We	O
examined	O
the	O
relationship	O
of	O
maternal	O
diet	O
during	O
pregnancy	O
with	O
the	O
infant	O
stool	O
microbiome	O
in	O
6	O
-	O
week	O
-	O
old	O
infants	O
and	O
identified	O
associations	O
within	O
delivery	O
mode	O
groups	O
.	O

They	O
found	O
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
levels	O
in	O
the	O
second	O
trimester	O
were	O
a	O
risk	O
factor	O
for	O
postnatal	O
depression	O
.	O

Liver	O
samples	O
were	O
obtained	O
and	O
RNA	O
was	O
isolated	O
.	O

The	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
was	O
10	O
.	O
5	O
%,	O
compared	O
to	O
3	O
.	O
7	O
%	O
for	O
insulin	O
and	O
25	O
%	O
for	O
glyburide	O
(	O
p	O
=	O
0	O
.	O
07	O
).	O

Measures	O
The	O
study	O
questionnaire	O
was	O
administered	O
by	O
trained	O
study	O
personnel	O
in	O
Spanish	O
or	O
English	O
in	O
participants	O
’	O
homes	O
.	O

Most	O
of	O
them	O
recommended	O
an	O
improvement	O
in	O
the	O
nurses	O
’	O
skills	O
.	O

This	O
project	O
will	O
determine	O
if	O
antenatal	O
IFA	O
supplements	O
commenced	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
rather	O
than	O
later	O
,	O
will	O
significantly	O
reduce	O
neonatal	O
deaths	O
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
if	O
this	O
approach	O
is	O
cost	O
-	O
effective	O
.	O

However	O
,	O
very	O
few	O
studies	O
have	O
been	O
in	O
position	O
to	O
examine	O
this	O
association	O
directly	O
in	O
animals	O
.	O

In	O
the	O
second	O
piece	O
of	O
research	O
,	O
VD	O
supplementation	O
was	O
proven	O
to	O
increase	O
serum	O
levels	O
of	O
pro	O
-	O
inflammatory	O
advanced	O
glycation	O
end	O
products	O
receptor	O
(	O
sRAGE	O
),	O
a	O
particle	O
binding	O
those	O
glycation	O
end	O
products	O
(	O
AGEs	O
),	O
which	O
are	O
known	O
to	O
be	O
one	O
of	O
PCOS	O
triggers	O
(	O
p	O
=	O
0	O
.	O
03	O
).	O

Differences	O
between	O
regions	O
,	O
trimesters	O
and	O
age	O
groups	O
were	O
explored	O
using	O
two	O
-	O
sample	O
Wilcoxon	O
rank	O
-	O
sum	O
test	O
or	O
Kruskal	O
-	O
Wallis	O
equality	O
-	O
of	O
-	O
populations	O
rank	O
test	O
.	O

We	O
didn	O
’	O
t	O
consider	O
placebo	O
because	O
WHO	O
and	O
Government	O
of	O
Bangladesh	O
have	O
a	O
recommendation	O
that	O
pregnant	O
women	O
should	O
receive	O
60	O
mg	O
of	O
iron	O
supplementation	O
.	O

Improving	O
the	O
vitamin	O
D	O
status	O
of	O
women	O
with	O
underlying	O
conditions	O
may	O
avert	O
the	O
need	O
for	O
a	O
medically	O
indicated	O
preterm	O
delivery	O
.	O

When	O
studied	O
under	O
thermoneutral	O
conditions	O
,	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
increased	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
.	O

All	O
categorical	O
outcomes	O
were	O
analysed	O
using	O
Pearson	O
'	O
s	O
χ²	O
or	O
Fisher	O
'	O
s	O
exact	O
tests	O
.	O

Black	O
infants	O
with	O
vitamin	O
D	O
deficiency	O
had	O
2	O
.	O
4	O
greater	O
odds	O
of	O
SGA	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
0	O
,	O
5	O
.	O
8	O
)	O
after	O
adjusting	O
for	O
maternal	O
history	O
of	O
PIH	O
and	O
maternal	O
BMI	O
,	O
two	O
significant	O
confounding	O
variables	O
in	O
our	O
model	O
(	O
Table	O
3	O
).	O

Therefore	B
meconium	O
aspiration	O
syndrome	O
cannot	O
be	O
the	O
cause	O
of	O
autistic	O
disorder	O
in	O
children	O
,	O
but	O
it	O
can	O
be	O
a	O
contributing	O
factor	O
[	O
57	O
].	O

In	O
this	O
way	O
,	O
hundreds	O
of	O
thousands	O
of	O
lives	O
could	O
be	O
saved	O
with	O
the	O
application	O
of	O
current	O
knowledge	O
.	O

In	O
other	O
words	O
,	O
this	O
system	O
might	O
not	O
be	O
effective	O
unless	O
there	O
is	O
existing	O
infection	O
with	O
pathogens	O
when	O
vitamin	O
D	O
supplementation	O
is	O
given	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
frequency	O
of	O
daily	O
“	O
between	O
-	O
meal	O
”	O
snacking	O
between	O
the	O
groups	O
(	O
93	O
.	O
8	O
%	O
S	O
-	O
ECC	O
vs	O
.	O
96	O
.	O
7	O
%	O
caries	O
-	O
free	O
,	O
p	O
=	O
0	O
.	O
39	O
,	O
Fisher	O
’	O
s	O
Exact	O
Test	O
).	O

Iron	O
fortification	O
of	O
foods	O
might	O
be	O
particularly	O
useful	O
and	O
cost	O
effective	O
in	O
settings	O
where	O
the	O
logistics	O
of	O
oral	O
iron	O
supplementation	O
among	O
pregnant	O
women	O
are	O
highly	O
challenging	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Experimental	O
design	O
.	O

The	O
importance	O
of	O
effective	O
3	O
-	O
way	O
communication	O
among	O
the	O
patient	O
,	O
asthma	O
specialist	O
,	O
and	O
obstetrician	O
cannot	O
be	O
overemphasized	O
.	O

The	O
influence	O
of	O
the	O
educational	O
level	O
of	O
respondents	O
is	O
predominant	O
here	O
as	O
it	O
is	O
noticed	O
that	O
those	O
at	O
a	O
high	O
educational	O
level	O
are	O
more	O
likely	B
to	O
be	O
critical	O
about	O
care	O
received	O
and	O
defer	O
a	O
positive	O
satisfaction	O
.	O

A	O
strength	O
of	O
the	O
present	O
study	O
lies	O
in	O
the	O
recruitment	O
of	O
subjects	O
,	O
which	O
took	O
place	O
in	O
a	O
single	O
hospital	O
,	O
enabled	O
standardised	O
data	O
collection	O
and	O
covered	O
all	O
seasons	O
.	O

Microbiome	O
profiling	O
To	O
identify	O
microbial	O
population	O
structure	O
profiles	O
,	O
we	O
used	O
full	O
-	O
length	O
amplicon	O
sequences	O
for	O
the	O
rRNA	O
gene	O
V4	O
-	O
V5	O
hypervariable	O
regions	O
.	O

On	O
admission	O
,	O
her	O
blood	O
pressure	O
was	O
108	O
/	O
60	O
mmHg	O
,	O
pulse	O
95	O
beats	O
/	O
minute	O
,	O
temperature	O
97	O
°	O
F	O
,	O
respiratory	O
rate	O
of	O
17	O
breaths	O
/	O
min	O
,	O
and	O
saturating	O
98	O
%	O
on	O
ambient	O
air	O
.	O

These	O
authors	O
estimate	O
that	O
the	O
productivity	O
gains	O
for	O
an	O
individual	O
removed	O
from	O
anaemia	O
are	O
5	O
%	O
in	O
manual	O
occupations	O
(	O
70	O
%	O
of	O
employment	O
in	O
a	O
country	O
such	O
as	O
Viet	O
Nam	O
),	O
and	O
17	O
%	O
in	O
heavy	O
manual	O
occupations	O
(	O
which	O
form	O
12	O
.	O
7	O
%	O
of	O
employment	O
in	O
manual	O
occupations	O
in	O
Viet	O
Nam	O
:	O
the	O
share	O
of	O
agriculture	O
in	O
GDP	O
is	O
22	O
.	O
1	O
%)[	O
16	O
].	O

For	O
this	O
purpose	O
,	O
we	O
searched	O
the	O
current	O
literature	O
on	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
and	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
rodent	O
models	O
in	O
PubMed	O
using	O
the	O
terms	O
in	O
Supplementary	O
Table	O
1	O
;	O
defining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
as	O
environmental	O
factors	O
(	O
chemicals	O
,	O
radiation	O
and	O
lifestyle	O
factors	O
(	O
including	O
alcohol	O
,	O
nutrition	O
and	O
smoking	O
))	O
that	O
induce	O
adverse	O
effects	O
(	O
growth	O
retardation	O
,	O
fertility	O
problems	O
,	O
hormonal	O
changes	O
,	O
reproductive	O
and	O
/	O
or	O
other	O
organ	O
-	O
and	O
system	O
-	O
specific	O
abnormalities	O
(	O
including	O
immune	O
disorders	O
,	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
))	O
and	O
are	O
associated	O
with	O
epigenetic	O
mechanisms	O
(	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
,	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
and	O
other	O
epigenetic	O
machinery	O
(	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
)).	O

Thus	O
,	O
to	O
estimate	O
the	O
required	O
sample	O
size	O
for	O
measuring	O
the	O
impact	O
of	O
handwashing	O
promotion	O
on	O
maternal	O
handwashing	O
behavior	O
,	O
we	O
assumed	B
that	O
the	O
probability	O
of	O
observed	O
handwashing	O
with	O
soap	O
after	O
a	O
fecal	O
contact	O
event	O
would	O
be	O
0	O
.	O
20	O
in	O
the	O
control	O
arm	O
[	O
20	O
]	O
and	O
that	O
the	O
probability	O
would	O
increase	O
to	O
0	O
.	O
40	O
in	O
the	O
intervention	O
arm	O
.	O

All	O
patients	O
should	O
undergo	O
neck	O
ultrasound	O
and	O
serum	O
assay	O
for	O
HTG	O
,	O
HTG	O
antibodies	O
,	O
fT4	O
and	O
TSH	O
.	O

In	O
the	O
United	O
States	O
,	O
median	O
values	O
for	O
25	O
(	O
OH	O
)	O
D	O
in	O
a	O
northern	O
setting	O
in	O
the	O
first	O
days	O
of	O
life	O
were	O
17	O
ng	O
/	O
mL	O
with	O
58	O
%	O
of	O
infants	O
<	O
20	O
ng	O
/	O
mL	O
,	O
results	O
very	O
similar	O
to	O
those	O
seen	O
in	O
our	O
study	O
[	O
13	O
].	O

Regular	O
supply	O
of	O
IFA	O
supplements	O
and	O
counselling	O
Upon	O
receiving	O
the	O
consent	O
icddr	O
,	O
b	O
study	O
staff	O
(	O
Field	O
Implementers	O
or	O
FI	O
)	O
will	O
hand	O
over	O
the	O
first	O
two	O
months	O
of	O
supply	O
of	O
iron	O
-	O
folic	O
acid	O
capsules	O
,	O
each	O
containing	O
60	O
mg	O
of	O
elemental	O
iron	O
and	O
400μg	O
of	O
folic	O
acid	O
.	O

Women	O
who	O
had	O
attended	O
antenatal	O
visits	O
in	O
their	O
previous	O
pregnancy	O
thought	O
that	O
it	O
was	O
beneficial	O
to	O
start	O
ANC	O
early	O
in	O
pregnancy	O
unlike	O
those	O
who	O
did	O
not	O
have	O
this	O
experience	O
and	O
who	O
opted	O
for	O
third	O
trimester	O
enrollment	O
.	O

A	O
follow	O
-	O
up	O
study	O
among	O
overweight	O
men	O
also	O
found	O
higher	O
weight	O
loss	O
using	O
Internet	O
and	O
mobile	O
phone	O
[	O
15	O
].	O

However	O
,	O
these	O
studies	O
have	O
been	O
limited	O
by	O
the	O
relatively	O
low	O
rates	O
of	O
assessment	O
[	O
18	O
–	O
20	O
].	O

Although	O
potentially	O
complex	O
,	O
the	O
use	O
of	O
a	O
systems	O
biology	O
approach	O
,	O
incorporating	O
genome	O
-	O
wide	O
analysis	O
at	O
multiple	O
levels	O
(	O
histone	O
code	O
,	O
methylome	O
,	O
non	O
-	O
coding	O
RNA	O
expression	O
,	O
transcriptome	O
,	O
proteome	O
and	O
metabolome	O
)	O
would	O
provide	O
comprehensive	B
analysis	O
of	O
epigenetic	O
changes	O
and	O
associated	O
phenotypic	O
outcomes	O
.	O

In	O
another	O
study	O
,	O
20	O
,	O
000	O
and	O
40	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
week	O
were	O
given	O
to	O
the	O
obese	O
and	O
overweight	O
people	O
for	O
one	O
year	O
.	O

Du	O
et	O
al	O
[	O
17	O
]	O
suggested	O
that	O
a	O
shift	O
in	O
development	O
of	O
mesenchymal	O
stem	O
cells	O
from	O
myogenesis	O
to	O
adipogenesis	O
may	O
increase	O
IMF	O
deposition	O
later	O
in	O
life	O
.	O

Intensively	O
promoting	O
handwashing	O
with	O
soap	O
resulted	O
in	O
increased	O
availability	O
of	O
soap	O
and	O
water	O
at	O
handwashing	O
places	O
,	O
but	O
only	O
a	O
modest	O
increase	O
in	O
maternal	O
handwashing	O
with	O
soap	O
.	O

(	O
2014	O
)*/†	O
Nutrition	O
:	O
High	O
fat	O
dietMouse	O
RatOral	O
(	O
diet	O
)	O
(	O
60	O
%	O
fat	O
)	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
to	O
lactation	O
Early	O
adulthoodAdulthood	O
F0	O
-	O
F1generationsWeight	O
-,	O
glucose	O
-	O
and	O
lipid	O
-	O
related	O
metabolic	O
and	O
food	O
preference	O
abnormalitiesDNA	O
methylation	O
miRNAsBaselga	O
-	O
Escudero	O
et	O
al	O
.	O

Season	O
and	O
vitamin	O
D	O
status	O
are	O
independently	O
associated	O
with	O
glucose	O
homeostasis	O
in	O
pregnancy	O
Abstract	O
Background	O
Vitamin	O
D	O
status	O
and	O
season	O
are	O
intrinsically	O
linked	O
,	O
and	O
both	O
have	O
been	O
proposed	O
to	O
be	O
associated	O
with	O
glucose	O
homeostasis	O
in	O
pregnancy	O
,	O
with	O
conflicting	O
results	O
.	O

Glyburide	O
(	O
Glibenclamide	O
)	O
American	O
authors	O
have	O
stated	O
that	O
glyburide	O
has	O
replaced	O
insulin	O
as	O
first	B
line	I
pharmacological	O
treatment	O
of	O
GDM	O
in	O
many	O
practices	O
.	O
56This	O
has	O
largely	O
occurred	O
on	O
the	O
basis	O
of	O
a	O
randomized	O
controlled	O
trial	O
where	O
404	O
women	O
with	O
GDM	O
were	O
treated	O
with	O
glyburide	O
(	O
up	O
to	O
20	O
mg	O
/	O
day	O
)	O
or	O
insulin57In	O
this	O
study	O
,	O
the	O
level	O
of	O
glycemic	O
control	O
achieved	O
was	O
the	O
same	O
in	O
both	O
groups	O
(	O
mean	O
glucose	O
concentration	O
during	O
treatment	O
with	O
glyburide	O
5	O
.	O
9	O
±	O
0	O
.	O
9	O
mmol	O
/	O
L	O
compared	O
to	O
5	O
.	O
9	O
±	O
1	O
.	O
0	O
mmol	O
/	O
L	O
in	O
insulin	O
group	O
).	O

Methods	O
:	O
Placental	O
tissues	O
and	O
associated	O
demographic	O
and	O
clinical	O
data	O
were	O
obtained	O
from	O
subjects	O
delivering	O
at	O
Women	O
and	O
Infants	O
Hospital	O
in	O
Providence	O
,	O
Rhode	O
Island	O
(	O
USA	O
).	O

The	O
intervention	O
resulted	O
in	O
greater	O
maintenance	O
of	O
handwashing	O
materials	O
in	O
locations	O
where	O
mothers	O
are	O
cocooned	O
with	O
neonate	O
.	O

Providers	O
may	O
need	O
to	O
re	O
-	O
emphasize	O
their	O
recommendations	O
with	O
overweight	O
and	O
obese	O
patients	O
to	O
help	O
align	O
their	O
personal	O
weight	O
gain	O
targets	O
with	O
current	O
clinical	O
recommendations	O
.	O

Indeed	O
,	O
resistance	O
to	O
the	O
development	O
of	O
obesity	O
has	O
at	B
least	I
partly	O
been	O
attributed	O
to	O
elevated	O
recruitment	O
of	O
brown	O
adipocytes	O
in	O
skeletal	O
muscle	O
or	O
WAT	O
(	O
Guerra	O
et	O
al	O
.,	O
1998	O
;	O
Almind	O
et	O
al	O
.,	O
2007	O
;	O
Veyrat	O
-	O
Durebex	O
et	O
al	O
.,	O
2009	O
;	O
Harms	O
and	O
Seale	O
,	O
2013	O
).	O

Pearson	O
Chi	O
-	O
square	O
test	O
,	O
analysis	O
of	O
variance	O
and	O
Kruskal	O
-	O
Wallis	O
were	O
employed	O
.	O

F1	O
females	O
were	O
separated	O
at	O
21	O
days	O
from	O
the	O
SC	O
and	O
VitD	O
-	O
groups	O
to	O
produce	O
the	O
F2	O
generation	O
(	O
n	O
=	O
10	O
females	O
per	O
group	O
).	O

To	O
stay	O
consistent	O
with	O
typical	O
handwashing	O
promotion	O
messages	O
,	O
we	O
also	O
recommended	O
handwashing	O
with	O
soap	O
before	O
food	O
preparation	O
.	O

Vitamins	O
Several	O
vitamins	O
,	O
including	O
vitamins	O
A	O
,	O
D	O
,	O
and	O
C	O
,	O
are	O
implicated	O
in	O
regulating	O
IMF	O
deposition	O
.	O

This	O
might	O
be	O
a	O
reason	B
why	O
we	O
failed	O
to	O
report	O
a	O
significant	O
positive	O
association	O
between	O
high	O
adherence	O
to	O
healthy	O
dietary	O
pattern	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

While	O
the	O
risk	O
factors	O
outlined	O
in	O
this	O
review	O
do	O
not	O
conflict	O
with	O
our	O
current	O
understanding	O
of	O
the	O
natural	O
history	O
of	O
cancer	O
or	O
glioma	O
specifically	O
,	O
the	O
evidence	O
in	O
support	O
of	O
a	O
causal	O
relationship	O
has	O
not	O
been	O
consistent	O
.	O

Women	O
who	O
suffered	O
a	O
stillbirth	O
or	O
neonatal	O
death	O
,	O
or	O
who	O
withdrew	O
from	O
participation	O
in	O
ongoing	O
follow	O
-	O
up	O
were	O
excluded	O
.	O

Additionally	O
,	O
to	O
better	O
understand	O
the	O
impact	O
of	O
the	O
BHLM	O
shrinkage	O
on	O
the	O
regression	O
coefficients	O
,	O
we	O
re	O
-	O
analyzed	O
the	O
data	O
using	O
both	O
LASSO	O
and	O
Elastic	O
Net	O
.	O

Birth	O
by	O
Cesarean	O
Delivery	O
The	O
delivery	O
of	O
a	O
baby	O
by	O
cesarean	O
delivery	O
has	O
been	O
suggested	O
to	O
be	O
associated	O
with	O
increased	O
risk	O
of	O
allergies	O
and	O
atopic	O
diseases	O
in	O
the	O
child	O
,	O
most	O
probably	B
because	O
of	O
a	O
lower	O
bacterial	O
exposure	O
for	O
the	O
child	O
.	O

Maternal	O
pregnancy	O
-	O
specific	O
stress	O
may	O
be	O
a	O
more	O
powerful	O
contributor	O
to	O
birth	O
outcomes	O
than	O
general	O
stress	O
[	O
1	O
].	O

Interestingly	O
,	O
maternal	O
prenatal	O
stress	O
could	O
have	O
negative	O
effects	O
on	O
fetal	O
ANS	O
[	O
46	O
].	O

In	O
addition	O
,	O
participating	O
women	O
were	O
surveyed	O
to	O
assess	O
their	O
estimate	O
of	O
costs	O
involved	O
in	O
accessing	O
the	O
supplements	O
.	O

In	O
order	O
to	O
further	O
investigate	O
the	O
effect	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
we	O
performed	O
a	O
compulsive	O
feeding	O
test	O
in	O
the	O
adult	O
offspring	O
.	O

These	O
include	O
not	O
only	O
the	O
in	O
vitro	O
endocrine	O
TGs	O
and	O
in	O
vivo	O
reproductive	O
and	O
developmental	O
TGs	O
(	O
Greally	O
&	O
Jacobs2013	O
)	O
but	O
also	O
a	O
newly	O
revised	O
genotoxicity	O
TG	O
(	O
TG	O
483	O
)	O
where	O
spermatogonal	O
samples	O
could	O
be	O
further	O
utilized	O
for	O
RNA	O
analyzes	O
(	O
Linschooten	O
et	O
al	O
.	O
2009	O
;	O
Marczylo	O
et	O
al	O
.	O
2012	O
;	O
Metzler	O
-	O
Guillemain	O
et	O
al	O
.	O
2015	O
).	O

All	O
women	O
received	O
prenatal	O
care	O
in	O
their	O
dominant	O
language	O
(	O
Spanish	O
/	O
English	O
)	O
(	O
Table	O
2	O
).	O

Exposure	O
to	O
winter	O
in	O
early	O
pregnancy	O
was	O
not	O
associated	O
with	O
glucose	O
challenge	O
test	O
results	O
,	O
however	O
it	O
was	O
associated	O
with	O
increased	O
fasting	O
glucose	O
and	O
insulin	O
resistance	O
at	O
28	O
weeks	O
.	O

Correlations	O
between	O
expression	O
values	O
of	O
microarray	O
and	O
qRT	O
-	O
PCR	O
of	O
positive	O
validated	O
transcripts	O
ranged	O
between	O
0	O
.	O
47	O
and	O
0	O
.	O
86	O
and	O
were	O
highly	O
significant	O
.	O

According	O
to	O
these	O
results	O
,	O
visfatin	O
can	O
have	O
a	O
major	O
role	O
in	O
regulating	O
neonatal	O
obesity	O
after	O
birth	O
.	O

All	O
participants	O
gave	O
informed	O
consent	O
to	O
participate	O
in	O
the	O
study	O
and	O
ethical	O
approval	O
was	O
granted	O
by	O
the	O
local	O
ethics	O
committee	O
of	O
the	O
hospital	O
.	O

Furthermore	O
,	O
genetic	O
variations	O
in	O
vitamin	O
-	O
D	O
-	O
related	O
and	O
other	O
genes	O
might	O
influence	O
the	O
effects	O
of	O
vitamin	O
D	O
on	O
the	O
immune	O
system	O
.	O

(	O
2012	O
)¶/†	O
Leu	O
et	O
al	O
.	O

If	O
the	O
vitamin	O
D	O
theory	O
is	O
true	B
,	O
autism	O
should	O
be	O
more	B
common	I
in	O
richer	O
well	O
-	O
educated	O
mothers	O
,	O
who	O
are	O
more	O
likely	B
than	O
other	O
mothers	O
to	O
practice	O
sun	O
avoidance	O
and	O
use	O
sunblock	O
(	O
1	O
,	O
2	O
).	O

Unexpectedly	O
,	O
the	O
intake	O
of	O
fatty	O
fish	O
(	O
salmon	O
,	O
herring	O
and	O
mackerel	O
)	O
or	O
shellfish	O
more	O
than	O
twice	O
a	O
week	O
increased	O
the	O
risk	O
of	O
being	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Neither	O
of	O
these	O
results	O
changed	O
after	O
adjustment	O
for	O
tobacco	O
use	O
and	O
vitamin	O
D	O
supplementation	O
at	O
T3	O
or	O
after	O
excluding	O
cases	O
of	O
preeclampsia	O
.	O

Peptide	O
mass	O
maps	O
of	O
tryptic	O
peptides	O
were	O
generated	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
/	O
ionisation	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
using	O
an	O
Applied	O
Biosystems	O
Q	O
-	O
STAR	O
Pulsar	O
with	O
MALDI	O
source	O
(	O
APAF	O
,	O
University	O
of	O
Sydney	O
).	O

A	O
growing	O
body	O
of	O
evidence	O
links	O
hypertension	O
,	O
32heart	O
disease	O
,	O
33and	O
autoimmune	O
diseases34to	O
markers	O
of	O
inflammation	O
such	O
as	O
C	O
-	O
reactive	O
protein	O
and	O
assorted	O
chemokines	O
.	O
35Erdei	O
hypothesizes	O
that	O
uranium	O
exposure	O
might	O
contribute	O
to	O
these	O
diseases	O
through	O
effects	O
on	O
inflammation	O
.	O

Wells	O
,	O
in	O
a	O
recent	O
commentary	O
,	O
indicates	O
the	O
need	O
for	O
such	O
cross	O
-	O
generational	O
grandparental	O
data	O
to	O
understand	O
more	O
fully	O
the	O
influence	O
of	O
maternal	O
and	O
paternal	O
lineages	O
on	O
growth	O
and	O
development	O
.	O
19	O
In	O
a	O
previous	O
study	O
employing	O
primarily	O
self	O
-	O
reported	O
data	O
,	O
we	O
showed	O
that	O
BMI	O
appeared	O
to	O
be	O
strongly	O
familial	O
in	O
the	O
maternal	O
line	O
,	O
23and	O
we	O
have	O
shown	O
that	O
familial	O
dietary	O
patterns	O
are	O
also	O
stronger	O
in	O
the	O
maternal	O
line	O
.	O
2425The	O
present	O
analysis	O
of	O
BMI	O
has	O
extended	O
this	O
to	O
include	O
both	O
birth	O
weight	O
and	O
data	O
when	O
the	O
children	O
were	O
aged	O
9	O
years	O
and	O
shows	O
this	O
strong	O
maternal	O
pattern	O
consistently	B
for	O
children	O
while	O
height	O
,	O
by	O
comparison	O
,	O
is	O
heritable	O
across	O
lineages	O
.	O

the	O
same	O
association	O
(	O
s	O
)	O
reported	O
in	O
multiple	O
independent	O
cohorts	O
or	O
multiple	O
association	O
(	O
s	O
)	O
that	O
contribute	O
to	O
the	O
same	O
biological	O
pathway	O
),	O
and	O
are	O
,	O
therefore	B
,	O
included	O
in	O
Supplementary	O
Table	O
2	O
.	O

Pairwise	O
comparisons	O
showed	O
that	O
the	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
,	O
4	O
and	O
8	O
weeks	O
postpartum	O
were	O
significantly	O
lower	O
than	O
the	O
baseline	O
depression	O
scores	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
brief	O
,	O
text	O
-	O
based	O
intervention	O
format	O
of	O
text4baby	O
is	O
consistent	O
with	O
other	O
brief	O
prenatal	O
alcohol	O
interventions	O
found	O
to	O
be	O
effective	O
in	O
recent	O
studies	O
[	O
42	O
].	O

For	O
simplicity	O
of	O
language	O
we	O
abbreviated	O
'	O
relative	O
risk	O
ratio	O
'	O
to	O
'	O
relative	O
risk	O
'	O
(	O
RR	O
).	O

Anaemia	O
prevalence	O
was	O
almost	O
halved	O
in	O
supplemented	O
women	O
and	O
anaemic	O
women	O
showed	O
the	O
greatest	O
increase	O
in	O
haemoglobin	O
concentration	O
following	O
supplementation	O
(+	O
1	O
.	O
2g	O
/	O
dL	O
).	O

Calbindin	O
is	O
strongly	O
induced	O
by	O
vitamin	O
D	O
[	O
29	O
],	O
and	O
thus	B
it	O
is	O
feasible	B
that	O
the	O
reduction	O
in	O
this	O
protein	O
may	O
be	O
a	O
consequence	O
of	O
the	O
early	O
life	O
reduction	O
in	O
vitamin	O
D	O
.	O
The	O
potential	O
links	O
between	O
vitamin	O
D	O
and	O
neuronal	O
calcium	O
binding	O
proteins	O
has	O
been	O
noted	O
in	O
a	O
recent	O
review	O
article	O
[	O
30	O
]	O
Two	O
members	O
of	O
the	O
dynamin	O
family	O
(	O
dynamin	O
1	O
and	O
dynamin	O
1	O
-	O
like	O
proteins	O
)	O
were	O
also	O
significantly	O
down	O
-	O
regulated	O
.	O

Results	O
In	O
total	O
,	O
2052	O
women	O
were	O
included	O
in	O
this	O
study	O
,	O
2046	O
with	O
a	O
blood	O
sample	O
at	O
T1	O
and	O
1816	O
at	O
T3	O
(	O
Fig	O
.	O
1	O
).	O

At	O
6	O
months	O
of	O
age	O
The	O
mean	O
KM	O
(	O
mean	O
±	O
SEM	O
,	O
n	O
=	O
6	O
animals	O
each	O
group	O
)	O
varied	O
from	O
390	O
.	O
2	O
±	O
27	O
.	O
0	O
mg	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
421	O
.	O
3	O
±	O
21	O
.	O
0	O
mg	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
403	O
.	O
9	O
±	O
29	O
.	O
0	O
mg	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
414	O
.	O
8	O
±	O
29	O
.	O
0	O
mg	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

This	O
indicates	O
the	O
efficacy	O
of	O
this	O
procedure	O
in	O
dramatic	O
improvement	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
mothers	O
,	O
especially	O
in	O
the	O
region	O
with	O
high	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
a	O
weak	O
correlation	O
was	O
found	O
between	O
poor	O
intrauterine	O
environments	O
and	O
ASD	O
with	O
intellectual	O
disabilities	O
,	O
there	O
was	O
no	O
relationship	O
found	O
between	O
ASD	O
without	O
intellectual	O
disabilities	O
and	O
perinatal	O
factors	O
[	O
12	O
].	O

One	O
study	O
observed	O
that	O
maternal	O
high	O
-	O
fat	O
diet	O
during	O
pregnancy	O
was	O
associated	O
with	O
meconium	O
microbial	O
composition	O
but	O
had	O
limited	O
maternal	O
diet	O
data	O
[	O
6	O
].	O

Results	O
From	O
2005	O
to	O
2009	O
,	O
370	O
women	O
called	O
Motherisk	O
regarding	O
SGA	O
counselling	O
.	O

Raised	O
ESR	O
values	O
(>	O
20mm	O
/	O
hr	O
)	O
were	O
less	O
frequent	O
in	O
supplemented	O
women	O
OR	O
0	O
.	O
71	O
(	O
0	O
.	O
55	O
,	O
0	O
.	O
91	O
).	O

Barker	O
and	O
Osmond	O
[	O
2	O
]	O
proposed	O
that	O
the	O
cardiovascular	O
disease	O
they	O
observed	O
in	O
an	O
adult	O
population	O
from	O
England	O
and	O
Wales	O
was	O
at	B
least	I
partly	O
associated	O
with	O
poor	O
early	O
nutrition	O
,	O
and	O
specifically	O
undernutrition	O
in	O
utero	O
[	O
3	O
].	O

With	O
regards	O
to	O
pharmacokinetics	O
,	O
oral	O
dosing	O
produces	O
therapeutic	O
effects	O
within	O
3	O
-	O
5	O
days	O
.	O

However	O
,	O
genes	O
related	O
to	O
cell	O
cycle	O
and	O
cellular	O
turnover	O
were	O
differentially	O
expressed	O
at	O
all	O
stages	O
except	O
stage	O
1	O
dpn	O
.	O

With	O
respect	O
to	O
health	O
education	O
,	O
the	O
most	O
mentioned	O
topic	O
was	O
“	O
hygiene	O
and	O
nutrition	O
”	O
followed	O
by	O
“	O
malaria	O
prevention	O
”	O
(	O
Figure	O
3	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
of	O
mother	O
’	O
s	O
personal	O
gestational	O
weight	O
gain	O
targets	O
and	O
their	O
pre	O
-	O
pregnancy	O
weight	O
categoryPre	O
-	O
pregnancy	O
BMINormalOverweightObeseTotalAccuracy	O
of	O
mother	O
’	O
s	O
weight	O
gain	O
targetUnder	O
IOM	O
rec18	O
(	O
40	O
.	O
9	O
%)	O
6	O
(	O
16	O
.	O
7	O
%)	O
7	O
(	O
23	O
.	O
26	O
%)	O
31	O
(	O
28	O
.	O
2	O
%)	O
Within	O
IOM	O
rec23	O
(	O
52	O
.	O
3	O
%)	O
23	O
(	O
63	O
.	O
9	O
%)	O
15	O
(	O
50	O
%)	O
61	O
(	O
55	O
.	O
5	O
%)	O
Above	O
IOM	O
rec3	O
(	O
6	O
.	O
8	O
%)	O
7	O
(	O
19	O
.	O
4	O
%)	O
8	O
(	O
26	O
.	O
7	O
%)	O
18	O
(	O
16	O
.	O
4	O
%)	O
44	O
(	O
100	O
%)	O
36	O
(	O
100	O
%)	O
30	O
(	O
100	O
%)	O
110	O
(	O
100	O
%)	O
Only	O
110	O
of	O
the	O
123	O
women	O
in	O
the	O
sample	O
responded	O
to	O
the	O
survey	O
question	O
about	O
personal	O
weight	O
gain	O
target	O
χ2	O
(	O
4	O
)	O
=	O
9	O
.	O
781	O
,	O
p	O
=	O
0	O
.	O
044	O
The	O
concordance	O
of	O
mothers	O
’	O
weight	O
gain	O
targets	O
with	O
IOM	O
recommendations	O
also	O
varied	O
by	O
receipt	O
of	O
professional	O
advice	O
.	O

Another	O
signaling	O
pathway	O
identified	O
to	O
be	O
regulated	O
in	O
a	O
diet	O
-	O
dependent	O
manner	O
is	O
the	O
'	O
VEGF	O
(	O
vascular	O
endothelial	O
growth	O
factor	O
)	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
known	O
from	O
gene	O
deletion	O
studies	O
to	O
be	O
essential	O
in	O
developmental	O
processes	O
[	O
36	O
,	O
37	O
].	O

PubMed	O
Central	O
:	O

A	O
novel	O
observation	O
of	O
our	O
study	O
is	O
that	O
the	O
hypothalamic	O
feeding	O
pathways	O
respond	O
to	O
the	O
vitamin	O
content	O
of	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Finally	O
,	O
proteomic	O
analyses	O
are	O
prone	B
to	O
Type	O
I	O
errors	O
.	O

Any	O
relationship	O
with	O
glioma	O
risk	O
is	O
probably	B
complex	O
and	O
must	O
be	O
interpreted	O
in	O
light	O
of	O
differences	O
in	O
farming	O
practices	O
and	O
the	O
protective	O
ability	O
of	O
farming	O
environments	O
,	O
especially	O
with	O
respect	O
to	O
microbial	O
exposures	O
[	O
102	O
,	O
103	O
,	O
114	O
].	O

Therefore	B
,	O
during	O
pregnancy	O
,	O
thyroxin	O
and	O
ferrous	O
sulphate	O
doses	O
should	O
be	O
spaced	O
by	O
at	B
least	I
4	O
hours	O
.	O

The	O
serum	O
calcium	O
and	O
phosphorus	O
were	O
respectively	O
measured	O
by	O
calorimetric	O
method	O
by	O
AutoAnalyzer	O
(	O
Echoplus	O
Corporation	O
,	O
Italy	O
),	O
Biosystems	O
kit	O
(	O
Spain	O
),	O
and	O
ELISA	O
method	O
.	O

Multiple	O
linear	O
regression	O
models	O
were	O
created	O
using	O
a	O
forced	O
-	O
enter	O
approach	O
and	O
were	O
adjusted	O
for	O
confounders	O
.	O

Importantly	O
,	O
our	O
study	O
illustrates	O
the	O
additive	O
effect	O
of	O
maternal	O
risk	O
factors	O
and	O
their	O
predictive	O
probabilities	O
for	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O

The	O
objective	O
of	O
this	O
analysis	O
was	O
to	O
determine	O
if	O
the	O
inverse	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
the	O
rate	O
of	O
PTB	O
found	O
in	O
the	O
earlier	O
randomized	O
controlled	O
trials	O
by	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Treatment	O
of	O
reflux	O
during	O
pregnancy	O
should	O
focus	O
on	O
nonpharmacological	O
measures	O
,	O
such	O
as	O
avoiding	O
large	O
meals	O
shortly	O
before	O
bedtime	O
,	O
sleeping	O
with	O
the	O
upper	O
body	O
elevated	O
,	O
and	O
avoiding	O
extensive	O
consumption	O
of	O
coffee	O
,	O
sweets	O
,	O
and	O
fatty	O
foods	O
.	O

Storage	O
temperature	O
is	O
monitored	O
and	O
logged	O
for	O
the	O
entire	O
duration	O
of	O
the	O
study	O
.	O

Newborn	O
weight	O
is	O
measured	O
with	O
a	O
calibrated	O
digital	O
infant	O
scale	O
to	O
the	O
nearest	O
10	O
g	O
.	O
In	O
order	O
to	O
minimize	O
intra	O
-	O
observer	O
variability	O
all	O
circumferences	O
and	O
CHL	O
are	O
measured	O
with	O
an	O
inelastic	O
tape	O
to	O
the	O
nearest	O
0	O
.	O
5	O
cm	O
(	O
metal	O
measuring	O
tape	O
not	O
used	O
to	O
prevent	O
possible	O
lacerations	O
).	O

Feed	O
comprising	O
about	O
80	O
%	O
concentrate	O
(	O
1	O
.	O
6	O
%	O
to	O
1	O
.	O
9	O
%	O
of	O
body	O
weight	O
;	O
CP	O
12	O
%	O
to	O
13	O
%,	O
TDN	O
72	O
%	O
to	O
73	O
%)	O
is	O
provided	O
during	O
the	O
early	O
fattening	O
stage	O
(	O
13	O
to	O
21	O
months	O
of	O
age	O
).	O

Vitamin	O
D	O
deficiency	O
in	O
Thailand	O
☆	O
Vitamin	O
D	O
deficiency	O
has	O
received	O
increased	O
attention	O
over	O
the	O
past	O
several	O
years	O
since	O
vitamin	O
D	O
may	O
play	O
an	O
important	O
role	O
not	O
only	O
in	O
bone	O
metabolism	O
but	O
also	O
in	O
a	O
variety	O
of	O
non	O
-	O
skeletal	O
diseases	O
such	O
as	O
diabetes	O
mellitus	O
,	O
autoimmune	O
diseases	O
,	O
infectious	O
diseases	O
,	O
cardiovascular	O
diseases	O
and	O
cancer1	O
,	O
2	O
,	O
3	O
.	O

A	O
draft	O
list	O
of	O
40	O
questions	O
was	O
revised	O
by	O
a	O
group	O
of	O
experts	O
.	O

In	O
vivo	O
studies	O
showed	O
increased	O
marbling	O
in	O
response	O
to	O
dietary	O
vitamin	O
C	O
supplementation	O
in	O
beef	O
cattle	O
;	O
dietary	O
supplementation	O
of	O
rumen	O
-	O
protected	O
l	O
-	O
ascorbic	O
acid	O
-	O
2	O
-	O
phosphate	O
during	O
the	O
final	O
fattening	O
period	O
increased	O
both	O
MS	O
and	O
fat	O
content	O
in	O
carcasses	O
of	O
Japanese	O
Black	O
cattle	O
[	O
150	O
].	O

Conclusions	O
Women	O
who	O
attend	O
their	O
first	O
antenatal	O
visit	O
during	O
the	O
months	O
of	O
extended	O
winter	O
were	O
more	O
likely	B
to	O
have	O
raised	O
insulin	O
resistance	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
and	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
status	O
.	O

Antidepressants	O
were	O
most	O
frequently	O
used	O
in	O
conjunction	O
with	O
an	O
SGA	O
(	O
54	O
.	O
1	O
%),	O
followed	O
by	O
benzodiazepines	O
(	O
15	O
.	O
8	O
%)	O
and	O
anticonvulsants	O
(	O
14	O
.	O
3	O
%),	O
primarily	O
lamotrigine	O
(	O
table	O
1	O
).	O

Finally	O
,	O
I	O
explain	B
my	O
reasons	B
why	O
this	O
theory	O
deserves	O
immediate	O
attempts	O
to	O
disprove	O
it	O
.	O

Additionally	O
,	O
some	O
previously	O
published	O
studies	O
[	O
14	O
,	O
15	O
]	O
found	O
associations	O
between	O
gestational	O
EDC	O
exposure	O
and	O
birth	O
weight	O
.	O

The	O
study	O
was	O
approved	O
by	O
the	O
Southampton	O
and	O
South	O
West	O
Hampshire	O
Research	O
Ethics	O
Committee	O
.	O

In	O
conclusion	O
,	O
it	O
appears	O
that	O
psychotropic	O
polytherapy	O
in	O
pregnant	O
women	O
with	O
mental	O
health	O
disorders	O
is	O
presently	O
a	O
common	O
practice	O
.	O

This	O
index	O
is	O
not	O
recorded	O
in	O
Romania	O
;	O
instead	O
,	O
we	O
evaluated	O
engagement	O
in	O
prenatal	O
care	O
according	O
to	O
Ministry	O
of	O
Health	O
recommendations	O
,	O
which	O
refer	O
to	O
the	O
total	O
number	O
of	O
prenatal	O
consultations	O
and	O
time	O
of	O
initiation	O
of	O
care	O
.	O

2010	O
;	O
Lin	O
et	O
al	O
.	O

Unfortunately	O
,	O
analysis	O
of	O
VDP	O
was	O
not	O
available	O
in	O
this	O
cohort	O
of	O
women	O
.	O

Post	O
-	O
hoc	O
analysis	O
of	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

In	O
a	O
separate	O
study	O
on	O
group	O
B	O
,	O
visfatin	O
levels	O
in	O
the	O
first	O
and	O
second	O
trimesters	O
showed	O
a	O
significant	O
negative	O
correlation	O
with	O
infant	O
’	O
s	O
weight	O
.	O

The	O
key	O
factor	O
which	O
results	O
in	O
the	O
development	O
of	O
gestational	O
diabetes	O
appears	O
to	O
be	O
a	O
failure	O
to	O
compensate	O
with	O
increased	O
insulin	O
secretion	O
.	O
3As	O
the	O
increase	O
in	O
insulin	O
resistance	O
is	O
greatest	O
in	O
the	O
third	O
trimester	O
,	O
GDM	O
usually	O
develops	O
going	O
into	O
this	O
period	O
.	O

A	O
nested	O
case	O
control	O
study	O
done	O
by	O
Lyall	O
et	O
al	O
.	O

This	O
is	O
the	O
first	O
time	O
that	O
a	O
gene	O
-	O
environment	O
interaction	O
between	O
a	O
GR	O
polymorphism	O
and	O
maternal	O
attitudes	O
towards	O
pregnancy	O
was	O
found	O
,	O
in	O
relation	O
to	O
fetal	O
weight	O
.	O

The	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
was	O
able	O
to	O
decrease	O
the	O
motivation	O
to	O
obtain	O
highly	O
palatable	O
food	O
in	O
a	O
free	O
choice	O
test	O
(	O
Mathes	O
et	O
al	O
.,	O
2008	O
;	O
Droste	O
et	O
al	O
.,	O
2010	O
;	O
Deshmukh	O
and	O
Sharma	O
,	O
2012	O
).	O

Cross	O
-	O
linking	O
is	O
more	O
likely	B
if	O
the	O
allergen	O
occurs	O
in	O
dimerized	O
or	O
multimerized	O
form	O
[	O
3	O
].	O

The	O
predominant	O
substrate	O
for	O
FA	O
synthesis	O
in	O
ruminants	O
is	O
acetate	O
,	O
which	O
is	O
mainly	O
derived	O
from	O
ruminal	O
fermentation	O
.	O

Where	O
dietary	O
measures	O
are	O
inadequate	O
to	O
achieve	O
glycemic	O
targets	O
,	O
insulin	O
should	O
be	O
introduced	O
.	O

We	O
dropped	O
three	O
samples	O
of	O
low	O
quality	O
,	O
with	O
read	O
counts	O
<	O
5000	O
,	O
yielding	O
a	O
final	O
sample	O
size	O
of	O
145	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S2	O
),	O
with	O
97	O
vaginally	O
delivered	O
infants	O
and	O
48	O
delivered	O
by	O
Cesarean	O
section	O
.	O

The	O
statistical	O
analysis	O
is	O
novel	O
,	O
using	O
mixed	O
-	O
model	O
techniques	O
that	O
enable	O
all	O
the	O
data	O
to	O
be	O
utilised	O
including	O
incomplete	O
families	O
.	O

Approximately	O
two	O
to	O
three	O
times	O
as	O
many	O
women	O
in	O
the	O
exposed	O
group	O
suffered	O
from	O
hypertension	O
,	O
gestational	O
diabetes	O
and	O
hypothyroidism	O
.	O

However	O
,	O
environmental	O
exposures	O
during	O
critical	O
windows	O
of	O
human	O
development	O
and	O
subsequent	O
non	O
-	O
genotoxic	O
/	O
epigenetic	O
changes	O
that	O
may	O
lead	O
to	O
later	O
life	O
adverse	O
health	O
outcomes	O
(	O
such	O
as	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
)	O
across	O
multiple	O
generations	O
continues	O
to	O
be	O
of	O
high	O
concern	O
for	O
all	O
the	O
Organization	O
for	O
Economic	O
Co	O
-	O
operation	O
and	O
Development	O
(	O
OECD	O
)	O
member	O
countries	O
,	O
the	O
International	O
Agency	O
on	O
Research	O
for	O
Cancer	O
(	O
IARC	O
)	O
and	O
the	O
European	O
Commission	O
(	O
EFSA2013	O
;	O
Greally	O
&	O
Jacobs2013	O
;	O
Herceg	O
et	O
al	O
.	O
2013	O
;	O
OECD2014	O
).	O

However	O
,	O
in	O
developed	O
countries	O
,	O
seasonal	O
availablity	O
of	O
food	O
has	O
a	O
limited	O
impact	O
on	O
diet	O
,	O
although	O
seasonal	O
differences	O
in	O
dietary	O
intakes	O
among	O
pregnant	O
women	O
have	O
been	O
observed	O
[	O
29	O
].	O

However	O
,	O
in	O
primary	O
human	O
adipose	O
stem	O
cells	O
,	O
both	O
BMP4	O
and	O
BMP7	O
induced	O
a	O
white	O
-	O
to	O
-	O
brown	O
adipocyte	O
transdifferentiation	O
(	O
Elsen	O
et	O
al	O
.,	O
2014b	O
),	O
pointing	O
to	O
the	O
occurrence	O
of	O
different	O
effects	O
,	O
depending	O
on	O
the	O
model	O
used	O
for	O
investigation	O
.	O

In	O
LP	O
offspring	O
1	O
,	O
042	O
probe	O
-	O
sets	O
showed	O
ontogenetic	O
regulation	O
(	O
384	O
1	O
dpn	O
≻	O
94	O
dpc	O
)	O
during	O
the	O
corresponding	O
time	O
period	O
that	O
was	O
group	O
-	O
specific	O
.	O

Similarly	O
,	O
vitamin	O
D3supplementation	O
did	O
not	O
affect	O
hospital	O
admissions	O
and	O
all	O
-	O
cause	O
mortality	O
.	O

Salmeterol	O
is	O
the	O
preferred	B
agent	O
when	O
long	O
-	O
acting	O
β2	O
agonists	O
are	O
indicated	O
in	O
pregnant	O
women	O
as	O
add	O
-	O
on	O
treatment	O
of	O
persistent	O
asthma	O
.	O

To	O
date	O
,	O
however	O
,	O
South	O
African	O
public	O
health	O
nutrition	O
interventions	O
for	O
pregnant	O
women	O
are	O
limited	O
to	O
folic	O
-	O
iron	O
and	O
calcium	O
supplementation	O
,	O
while	O
it	O
is	O
highly	O
likely	B
that	O
the	O
diet	O
of	O
pregnant	O
women	O
living	O
in	O
South	O
Africa	O
is	O
lacking	O
vital	O
micronutrients	O
and	O
essential	O
fatty	O
acids	O
beyond	O
those	O
supplied	O
,	O
or	O
is	O
even	O
containing	O
excessive	O
amounts	O
of	O
specific	O
micro	O
-	O
and	O
macro	O
-	O
nutrients	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
the	O
rate	O
of	O
major	O
malformations	O
reported	O
in	O
the	O
exposed	O
group	O
was	O
approximately	O
two	O
and	O
a	O
half	O
times	O
higher	O
than	O
in	O
the	O
comparison	O
group	O
(	O
6	O
.	O
2	O
%	O
vs	O
2	O
.	O
6	O
%).	O

They	O
did	O
not	O
differ	O
concerning	O
the	O
two	O
above	O
-	O
mentioned	O
variables	O
,	O
P	O
=	O
0	O
.	O
09	O
and	O
p	O
=	O
0	O
.	O
13	O
,	O
respectively	O
.	O

Using	O
a	O
life	O
-	O
history	O
interpretation	O
,	O
adaptive	O
developmental	O
responses	O
to	O
environmental	O
cues	O
may	O
be	O
graded	O
;	O
according	O
to	O
the	O
severity	O
of	O
the	O
stress	O
experienced	O
[	O
22	O
],[	O
54	O
]–[	O
56	O
].	O

Thus	B
,	O
migrating	O
women	O
or	O
those	O
unable	O
to	O
speak	O
local	O
languages	O
could	O
not	O
be	O
included	O
in	O
the	O
study	O
.	O

None	O
of	O
the	O
cell	O
lines	O
exhibited	O
dose	O
dependency	O
.	O

However	O
,	O
according	O
to	O
the	O
recent	O
studies	O
,	O
vitamin	O
D	O
deficiency	O
is	O
also	O
common	O
in	O
these	O
countries10	O
,	O
11	O
.	O

DISCUSSION	O
Our	O
findings	O
support	O
the	O
hypothesis	O
that	O
HV	O
or	O
HFol	O
pup	O
diet	O
prevents	O
the	O
increase	O
in	O
food	O
intake	O
,	O
body	O
weight	O
and	O
glucose	O
response	O
to	O
a	O
glucose	O
load	O
in	O
offspring	O
of	O
the	O
HV	O
dams	O
,	O
possibly	O
by	O
post	O
-	O
weaning	O
changes	O
in	O
food	O
intake	O
regulatory	O
systems	O
.	O

Little	O
is	O
known	O
about	O
the	O
actual	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
affects	O
children	O
’	O
s	O
health	O
;	O
we	O
hypothesize	O
that	O
maternal	O
diet	O
impacts	O
the	O
development	O
of	O
the	O
gut	O
microbiome	O
in	O
infancy	O
and	O
subsequently	O
influences	O
child	O
health	O
outcomes	O
.	O

Abstract	O
The	O
results	O
are	O
presented	O
of	O
a	O
case	O
-	O
control	O
study	O
conducted	O
in	O
the	O
north	O
of	O
Iran	O
.	O

Historic	O
influenza	O
surveillance	O
data	O
from	O
Nicaragua	O
shows	O
that	O
influenza	O
circulates	O
between	O
June	O
and	O
November	O
[	O
32	O
].	O

Further	O
adjustment	O
for	O
maternal	O
age	O
,	O
education	O
,	O
smoking	O
status	O
,	O
BMI	O
and	O
race	O
/	O
ethnicity	O
race	O
/	O
ethnicity	O
attenuated	O
these	O
estimates	O
but	O
women	O
reporting	O
no	O
PNV	O
use	O
still	O
had	O
significantly	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
(	O
OR	O
2	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
5	O
,	O
3	O
.	O
0	O
).	O

Importantly	O
,	O
this	O
evidence	O
supports	O
the	O
idea	O
that	O
the	O
contribution	O
of	O
the	O
endocannabinoid	O
system	O
in	O
the	O
early	O
life	O
programming	O
could	O
be	O
critical	O
.	O

However	O
,	O
those	O
who	O
did	O
receive	O
advice	O
were	O
more	O
likely	B
to	O
have	O
personal	O
weight	O
gain	O
targets	O
in	O
line	O
with	O
current	O
clinical	O
recommendations	O
.	O

Additionally	O
,	O
the	O
burden	O
is	O
not	O
shared	O
equally	O
,	O
with	O
the	O
impact	O
of	O
preterm	O
birth	O
falling	O
most	O
severely	O
on	O
the	O
poorest	O
families	O
and	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
health	O
systems	O
are	O
less	O
prepared	O
to	O
respond	O
.	O

Some	O
studies	O
have	O
attributed	O
seasonal	O
differences	O
in	O
gestational	O
diabetes	O
to	O
temperature	O
changes	O
.	O

[	O
10	O
]	O
The	O
synthesis	O
,	O
metabolism	O
and	O
function	O
of	O
vitamin	O
D	O
compounds	O
during	O
pregnancy	O
are	O
complex	O
.	O

PSM	O
matched	O
one	O
vaccinated	O
case	O
to	O
one	O
unvaccinated	O
case	O
for	O
the	O
probability	O
of	O
vaccination	O
.	O

Increasing	O
propionate	O
production	O
for	O
glucose	O
synthesis	O
is	O
also	O
important	O
for	O
IMF	O
deposition	O
,	O
especially	O
during	O
the	O
fattening	O
period	O
.	O

Genes	O
involved	O
in	O
'	O
fatty	O
acid	O
metabolism	O
',	O
'	O
biosynthesis	O
of	O
steroids	O
',	O
'	O
synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
',	O
'	O
glucocorticoid	O
receptor	O
signaling	O
'	O
as	O
well	O
as	O
the	O
'	O
degradation	O
of	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
'	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
LP	O
offspring	O
,	O
while	O
genes	O
associated	O
with	O
'	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
'	O
were	O
down	O
-	O
regulated	O
.	O

We	O
carried	O
out	O
interviews	O
and	O
reviewed	O
medical	O
records	O
post	O
-	O
partum	O
to	O
collect	O
data	O
on	O
demographics	O
,	O
influenza	O
vaccination	O
during	O
pregnancy	O
,	O
birth	O
outcomes	O
and	O
other	O
risk	O
factors	O
associated	O
with	O
adverse	O
neonatal	O
outcomes	O
.	O

It	O
was	O
also	O
used	O
previously	O
to	O
assess	O
individual	O
and	O
total	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
fatty	O
acid	O
intake	O
in	O
a	O
rural	O
and	O
urban	O
South	O
-	O
African	O
population	O
[	O
42	O
].	O

1	O
).	O

high	O
doses	O
of	O
vitamin	O
D	O
in	O
early	O
life	O
)	O
with	O
or	O
without	O
monitoring	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
or	O
whether	O
the	O
400	O
IU	O
/	O
day	O
dose	O
is	O
adequate	O
.	O

The	O
children	O
we	O
enrolled	O
into	O
our	O
study	O
largely	O
came	O
from	O
five	O
of	O
the	O
18	O
socioeconomically	O
deprived	O
inner	O
-	O
city	O
districts	O
.	O

Obesity	O
,	O
VD	O
accumulation	O
in	O
adipose	O
tissue	O
,	O
and	O
sunbathing	O
avoidance	O
due	O
to	O
hirsutism	O
results	O
in	O
65	O
%–	O
87	O
%	O
rate	O
of	O
VD	O
deficiency	O
in	O
PCOS	O
patients	O
[	O
27	O
].	O

Methods	O
Dietary	O
intake	O
was	O
estimated	O
using	O
a	O
food	O
frequency	O
questionnaire	O
among	O
33	O
623	O
women	O
aged	O
30	O
-	O
49	O
years	O
at	O
enrolment	O
(	O
1991	O
/	O
92	O
).	O

With	O
the	O
approval	O
from	O
the	O
IRB	O
,	O
pregnant	O
women	O
aged	O
less	O
than	O
the	O
legal	O
age	O
of	O
consent	O
in	O
Cameroon	O
(	O
21	O
years	O
)	O
and	O
attending	O
antenatal	O
care	O
services	O
were	O
considered	O
emancipated	O
minors	O
and	O
thus	O
allowed	O
to	O
provide	O
consent	O
for	O
themselves	O
.	O

investigated	O
the	O
role	O
of	O
supplemental	O
folate	O
,	O
zinc	O
and	O
antioxidants	O
(	O
vitamins	O
C	O
,	O
E	O
,	O
and	O
β	O
-	O
carotene	O
)	O
on	O
spermatocyte	O
aneuploidy	O
.	O

As	O
yet	O
there	O
have	O
been	O
no	O
reports	O
of	O
the	O
use	O
of	O
glulisine	O
in	O
pregnancy	O
.	O

This	O
study	O
found	O
that	O
four	O
calcium	O
binding	O
proteins	O
were	O
significantly	O
altered	O
in	O
the	O
nucleus	O
accumbens	O
of	O
the	O
adult	O
DVD	O
-	O
deficient	O
rat	O
(	O
calbindin	O
,	O
calbindin2	O
,	O
hippocalcin	O
and	O
calreticulin	O
).	O

Results	O
We	O
identified	O
637	O
spots	O
in	O
DVD	O
deplete	O
samples	O
and	O
655	O
spots	O
in	O
Control	O
samples	O
(	O
seeFigure	O
1for	O
a	O
representative	O
gel	O
).	O

Nonetheless	O
,	O
there	O
are	O
undisputed	B
benefits	O
to	O
healthy	O
eating	O
and	O
regular	O
physical	O
activity	O
so	O
these	O
activities	O
should	O
be	O
encouraged	O
.	O

Furthermore	O
,	O
regarding	O
the	O
role	O
of	O
allergies	O
and	O
immunity	O
,	O
there	O
is	O
no	O
clear	O
trend	O
toward	O
a	O
decreasing	O
risk	O
for	O
glioma	O
with	O
younger	O
ages	O
at	O
onset	O
of	O
the	O
allergic	O
condition	O
[	O
121	O
].	O

Sample	O
collection	O
At	O
21	O
–	O
23	O
postnatal	O
weeks	O
,	O
adult	O
offspring	O
were	O
sacrificed	O
by	O
decapitation	O
after	O
the	O
administration	O
of	O
Equitesin	O
®	O
(	O
3	O
mg	O
/	O
kg	O
).	O

At	O
adult	O
age	O
(	O
stage	O
188	O
dpn	O
)	O
2	O
,	O
084	O
probe	O
-	O
sets	O
were	O
significantly	O
different	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
and	O
**	O
p	O
<	O
0	O
.	O
01	O
comparing	O
“	O
High	O
cord	O
25	O
(	O
OH	O
)	O
D	O
”	O
group	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Demographic	O
data	O
,	O
family	O
and	O
environmental	O
data	O
,	O
outcomes	O
,	O
and	O
infant	O
lung	O
function	O
in	O
groups	O
with	O
different	O
25	O
(	O
OH	O
)	O
D	O
status	O
of	O
maternal	O
serum	O
.	O
Low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
36	O
)	O
High	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
35	O
)	O
Demographic	O
data	O
Gestational	O
age	O
(	O
weeks	O
)	O
38	O
.	O
4	O
±	O
1	O
.	O
238	O
.	O
8	O
±	O
1	O
.	O
3Male	O
(%)	O
5049Nature	O
delivery	O
(%)	O
6662Birth	O
BW	O
(	O
kg	O
)	O
3	O
.	O
1	O
±	O
0	O
.	O
33	O
.	O
2	O
±	O
0	O
.	O
4Birth	O
BL	O
(	O
cm	O
)	O
50	O
.	O
6	O
±	O
2	O
.	O
150	O
.	O
4	O
±	O
2	O
.	O
5BW	O
(	O
kg	O
)	O
8	O
.	O
3	O
±	O
1	O
.	O
18	O
.	O
1	O
±	O
1	O
.	O
0BL	O
(	O
cm	O
)	O
69	O
.	O
0	O
±	O
2	O
.	O
868	O
.	O
6	O
±	O
3	O
.	O
3	O
%	O
of	O
fall	O
/	O
winter	O
birth38	O
.	O
951	O
.	O
4	O
Family	O
and	O
environmental	O
data	O
Asthma	O
,	O
mother2	O
.	O
88	O
.	O
6Asthma	O
,	O
father2	O
.	O
80AR	O
mother22	O
.	O
231	O
.	O
4AR	O
,	O
father30	O
.	O
631	O
.	O
4AD	O
,	O
mother13	O
.	O
98	O
.	O
6AD	O
,	O
father02	O
.	O
8Daycare	O
attendance	O
(%)	O
11	O
.	O
114	O
.	O
3Maternal	O
smoke	O
in	O
pregnancy	O
(%)	O
8	O
.	O
32	O
.	O
8Postnatal	O
smoke	O
Exposure	O
(%)	O
41	O
.	O
637	O
.	O
1	O
Outcomes	O
NP	O
colonization	O
rate	O
(%)	O
69	O
.	O
766	O
.	O
7Ever	O
RTI	O
till	O
6	O
months	O
(%)	O
25	O
.	O
022	O
.	O
8Eczema	O
at	O
6	O
months	O
(%)	O
1720Ever	O
wheeze	O
at	O
6	O
months	O
(%)	O
2523	O
Infant	O
lung	O
function	O
%	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
2259Z	O
score	O
of	O
Rrs	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
33	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
39Z	O
score	O
of	O
Crs	O
-	O
0	O
.	O
03	O
±	O
1	O
.	O
13	O
-	O
0	O
.	O
39	O
±	O
1	O
.	O
08Z	O
score	O
of	O
VmaxFRC0	O
.	O
07	O
±	O
1	O
.	O
01	O
-	O
0	O
.	O
24	O
±	O
1	O
.	O
09	O
BW	O
,	O
body	O
weight	O
;	O
BL	O
,	O
body	O
length	O
;	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
AD	O
,	O
atopic	O
dermatitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
;	O
RTI	O
,	O
respiratory	O
tract	O
infection	O
,	O
Tpef	O
/	O
Te	O
,	O
ratio	O
of	O
time	O
to	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
;	O
Rrs	O
,	O
resistance	O
of	O
respiratory	O
system	O
;	O
Crs	O
,	O
compliance	O
of	O
respiratory	O
system	O
;	O
VmaxFRC	O
,	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
.	O

Researchers	O
compared	O
138	O
mothers	O
of	O
children	O
diagnosed	O
with	O
ALL	O
with	O
a	O
control	O
group	O
of	O
138	O
mothers	O
whose	O
children	O
did	O
not	O
have	O
cancer	O
.	O

Further	O
adjustment	O
for	O
race	O
did	O
not	O
substantially	O
change	O
these	O
estimates	O
(	O
Table	O
3	O
).	O

Our	O
findings	O
suggest	O
that	O
analysis	O
of	O
SNPs	O
may	O
have	O
an	O
important	O
role	O
in	O
identifying	O
high	O
-	O
risk	O
categories	O
of	O
individuals	O
who	O
are	O
likely	B
to	O
require	O
higher	O
doses	O
of	O
vitamin	O
D	O
to	O
achieve	O
repletion	O
,	O
and	O
studies	O
are	O
needed	O
to	O
establish	O
clinical	O
approaches	O
to	O
vitamin	O
D	O
supplementation	O
that	O
are	O
centered	O
on	O
individual	O
characteristics	O
.	O

Two	O
key	O
global	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
events	O
occur	O
,	O
one	O
after	O
fertilization	O
in	O
the	O
early	O
embryo	O
in	O
all	O
cells	O
,	O
and	O
the	O
second	O
in	O
germ	O
cells	O
only	O
during	O
primordial	O
germ	O
cell	O
(	O
PGC	O
)	O
development	O
(	O
Figure	O
1	O
).	O

The	O
results	O
of	O
original	O
articles	O
up	O
to	O
2015	O
have	O
been	O
summarized	O
and	O
discussed	O
in	O
a	O
critical	O
manner	O
to	O
provide	O
a	O
consistent	O
review	O
.	O

The	O
secondary	O
trial	O
outcomes	O
will	O
include	O
:	O
(	O
1	O
)	O
percentage	O
of	O
women	O
using	O
IFA	O
supplements	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
;	O
(	O
2	O
)	O
percentage	O
of	O
live	O
births	O
with	O
low	O
birth	O
weight	O
and	O
with	O
preterm	O
delivery	O
;	O
(	O
3	O
)	O
percentage	O
of	O
neonatal	O
deaths	O
attributable	O
to	O
preterm	O
delivery	O
,	O
and	O
to	O
birth	O
asphyxia	O
;	O
(	O
4	O
)	O
mean	O
marginal	O
additional	O
expenditure	O
associated	O
with	O
early	O
IFA	O
supplements	O
,	O
and	O
the	O
mean	O
cost	O
per	O
neonatal	O
death	O
prevented	O
;	O
(	O
5	O
)	O
the	O
percentage	O
of	O
pregnant	O
women	O
reporting	O
side	O
effects	O
including	O
nausea	O
and	O
vomiting	O
.	O

Future	O
mHealth	O
interventions	O
may	O
build	O
on	O
these	O
lessons	O
to	O
engage	O
audiences	O
in	O
health	O
programs	O
through	O
multiple	O
digital	O
channels	O
[	O
31	O
,	O
32	O
].	O

4	O
.	O

Genes	O
also	O
can	O
affect	O
vitamin	O
D	O
metabolism	O
,	O
skin	O
color	O
,	O
and	O
behavior	O
,	O
all	O
of	O
which	O
can	O
influence	O
circulating	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Relative	O
to	O
sun	O
exposure	O
,	O
diet	O
is	O
a	O
poor	O
source	O
of	O
colecalciferol	O
,	O
providing	O
only	O
40	O
-	O
400	O
IU	O
per	O
food	O
serving	O
,	O
12whereas	O
whole	O
-	O
body	O
UVB	O
exposure	O
for	O
20	O
min	O
for	O
a	O
light	O
-	O
skinned	O
person	O
during	O
the	O
summer	O
months	O
will	O
produce	O
at	B
least	I
10	O
,	O
000	O
IU	O
.	O
713However	O
,	O
increased	O
skin	O
pigmentation	O
,	O
age	O
,	O
use	O
of	O
sunscreen	O
,	O
built	O
environment	O
,	O
and	O
environmental	O
factors	O
that	O
reduce	O
the	O
strength	O
of	O
UVB	O
reaching	O
the	O
earth	O
’	O
s	O
surface	O
(	O
e	O
.	O
g	O
.,	O
winter	O
season	O
,	O
high	O
latitude	O
,	O
pollution	O
,	O
cloud	O
cover	O
,	O
and	O
ozone	O
levels	O
)	O
all	O
contribute	O
to	O
reduce	O
skin	O
colecalciferol	O
production	O
to	O
the	O
point	O
at	O
which	O
diet	O
might	O
become	O
the	O
primary	O
source	O
.	O
7	O
–	O
14Because	B
melanin	O
pigment	O
in	O
human	O
skin	O
absorbs	O
UVB	O
,	O
28black	O
people	O
have	O
lower	O
25	O
hydroxyvitamin	O
D	O
concentrations	O
than	O
white	O
people	O
,	O
and	O
are	O
often	B
vitamin	O
D	O
deficient	O
.	O
21However	O
,	O
the	O
risk	O
of	O
MS	O
in	O
black	O
people	O
is	O
lower	O
than	O
in	O
white	O
people	O
(	O
because	B
of	O
genetic	O
differences	O
).	O
28Analyses	O
of	O
the	O
relation	O
between	O
vitamin	O
D	O
status	O
and	O
MS	O
risk	O
are	O
therefore	B
better	O
done	O
separately	O
within	O
each	O
race	O
/	O
ethnic	O
group	O
.	O

Dean	O
et	O
al	O
.,	O
2013	O
[	O
4	O
];	O
Requejo	O
et	O
al	O
.,	O
2013	O
[	O
5	O
];	O
Lawn	O
et	O
al	O
.,	O
2013	O
[	O
6	O
].	O

In	O
the	O
present	O
study	O
,	O
maternal	O
vitamin	O
D	O
deficiency	O
in	O
mice	O
led	O
to	O
significant	O
changes	O
in	O
kidney	O
development	O
in	O
the	O
offspring	O
,	O
such	O
as	O
retardation	O
of	O
glomerular	O
maturation	O
and	O
an	O
increase	O
in	O
the	O
number	O
of	O
glomeruli	O
.	O

In	O
Models	O
1	O
and	O
4	O
,	O
there	O
was	O
also	O
a	O
trend	O
noted	O
with	O
the	O
child	O
’	O
s	O
percent	O
fat	O
being	O
positively	O
associated	O
with	O
cathelicidin	O
(	O
beta	O
=	O
0	O
.	O
028	O
,	O
p	O
=	O
0	O
.	O
052	O
and	O
beta	O
=	O
0	O
.	O
025	O
,	O
p	O
=	O
0	O
.	O
087	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multivariable	O
Linear	O
Regression	O
Models	O
Assessing	O
Factors	O
Associated	O
with	O
Natural	O
Logarithm	O
for	O
Cathelicidin	O
.	O
Model	O
1	O
Independent	O
VariablesBetaSE1p	O
valueRace	O
/	O
Ethnicity	O
Black	O
-	O
0	O
.	O
0390	O
.	O
230	O
.	O
864White	O
---------	O
Hispanic	O
-	O
0	O
.	O
1490	O
.	O
2000	O
.	O
459GenderFemale	O
---------	O
Male0	O
.	O
3180	O
.	O
16	O
0	O
.	O
047	O
Age0	O
.	O
1450	O
.	O
065	O
0	O
.	O
028	O
Percent	O
Fat0	O
.	O
0280	O
.	O
0140	O
.	O
052Child	O
'	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
-	O
0	O
.	O
0050	O
.	O
010	O
.	O
598	O
Model	O
2	O
Independent	O
VariablesBetaSEp	O
valueRace	O
/	O
EthnicityBlack0	O
.	O
0350	O
.	O
210	O
.	O
868White	O
---------	O
Hispanic	O
-	O
0	O
.	O
1490	O
.	O
210	O
.	O
470GenderFemale	O
---------	O
Male0	O
.	O
2750	O
.	O
170	O
.	O
104Age0	O
.	O
2120	O
.	O
07	O
0	O
.	O
004	O
Percent	O
Fat0	O
.	O
0250	O
.	O
020	O
.	O
087Child	O
'	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
birth	O
-	O
0	O
.	O
0030	O
.	O
010	O
.	O
748	O
Model	O
3	O
Independent	O
VariablesBetaSEp	O
valueRace	O
/	O
Ethnicity	O
Black0	O
.	O
0410	O
.	O
180	O
.	O
821White	O
---------	O
Hispanic	O
-	O
0	O
.	O
1220	O
.	O
160	O
.	O
458GenderFemale	O
---------	O
Male0	O
.	O
0910	O
.	O
140	O
.	O
507Age0	O
.	O
1550	O
.	O
07	O
0	O
.	O
023	O
Percent	O
Fat0	O
.	O
0120	O
.	O
010	O
.	O
359Maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
<-	O
0	O
.	O
000100	O
.	O
999	O
Model	O
4	O
Independent	O
VariablesBetaSEp	O
valueRace	O
/	O
Ethnicity	O
Black0	O
.	O
0460	O
.	O
1990	O
.	O
816White	O
---------	O
Hispanic	O
-	O
0	O
.	O
0800	O
.	O
1850	O
.	O
669GenderFemale	O
---------	O
Male0	O
.	O
3180	O
.	O
158	O
0	O
.	O
047	O
Age0	O
.	O
1510	O
.	O
064	O
0	O
.	O
021	O
Percent	O
Fat0	O
.	O
0260	O
.	O
010	O
.	O
069Maternal	O
25	O
(	O
OH	O
)	O
D	O
1	O
-	O
month	O
before	O
delivery0	O
.	O
0030	O
.	O
010	O
.	O
606	O
1SE	O
represents	O
Standard	O
Error	O
Discussion	O
In	O
this	O
study	O
of	O
healthy	O
children	O
whose	O
mothers	O
had	O
participated	O
in	O
a	O
vitamin	O
D	O
supplementation	O
trial	O
during	O
pregnancy	O
,	O
despite	O
differences	O
in	O
both	O
maternal	O
and	O
childhood	O
vitamin	O
D	O
status	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
cathelicidin	O
concentration	O
between	O
the	O
three	O
racial	O
/	O
ethnic	O
groups	O
studied	O
.	O

In	O
humans	O
,	O
the	O
only	O
physiological	O
recovery	O
of	O
insulin	O
sensitivity	O
after	O
a	O
period	O
of	O
insulin	O
resistance	O
,	O
partially	O
due	O
to	O
an	O
increase	O
in	O
food	O
intake	O
and	O
lipogenesis	O
,	O
is	O
observed	O
in	O
women	O
after	O
pregnancy	O
(	O
Barbour	O
et	O
al	O
.,	O
2007	O
).	O

This	O
review	O
,	O
therefore	B
,	O
examines	O
the	O
present	O
understanding	O
of	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
,	O
evaluates	O
the	O
current	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodent	O
models	O
and	O
highlights	O
the	O
research	O
considerations	O
and	O
implications	O
of	O
this	O
emerging	O
knowledge	O
for	O
public	O
health	O
and	O
regulatory	O
toxicology	O
.	O

P	O
-	O
values	O
(	O
significance	O
set	O
at	O
P	O
≤	O
0	O
.	O
05	O
)	O
for	O
each	O
stage	O
were	O
converted	O
to	O
a	O
set	O
of	O
q	O
-	O
values	O
(	O
q	O
≤	O
0	O
.	O
25	O
)	O
using	O
the	O
algorithm	O
proposed	O
by	O
Storey	O
and	O
Tibshirani	O
[	O
66	O
].	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

This	O
very	O
clever	O
approach	O
gave	O
the	O
authors	O
of	O
these	O
,	O
and	O
of	O
other	O
similar	O
studies	O
from	O
both	O
Europe	O
and	O
the	O
USA	O
,	O
reasons	B
to	O
state	O
that	O
their	O
data	O
strongly	B
suggest	O
that	O
the	O
effects	O
of	O
vitamin	O
D	O
may	O
be	O
mediated	O
through	O
the	O
endometrium	O
,	O
not	O
the	O
follicle	O
or	O
oocyte	O
[	O
56	O
,	O
57	O
].	O

African	O
American	O
women	O
accounted	O
for	O
a	O
majority	O
(	O
69	O
%)	O
of	O
the	O
non	O
-	O
white	O
births	O
and	O
had	O
a	O
19	O
%	O
PTB	O
rate	O
.	O

Thus	B
,	O
the	O
correlation	O
between	O
vitamin	O
D	O
intake	O
and	O
serum	O
levels	O
may	O
vary	O
.	O

We	O
provided	O
each	O
child	O
with	O
an	O
identification	O
card	O
,	O
which	O
included	O
a	O
photograph	O
of	O
the	O
child	O
,	O
to	O
enable	O
easy	O
access	O
to	O
outpatient	O
and	O
out	O
-	O
of	O
-	O
hours	O
paediatric	O
services	O
at	O
the	O
study	O
hospital	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
was	O
lower	O
.	O

It	O
also	O
secretes	O
several	O
batokines	O
,	O
allowing	O
for	O
inter	O
-	O
organ	O
communication	O
.	O

Maternal	O
nutrient	O
restriction	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
significantly	O
advanced	O
pubertal	O
age	O
in	O
female	O
offspring	O
to	O
a	O
similar	O
degree	O
(	O
p	O
<	O
0	O
.	O
01	O
,	O
figure	O
2A	O
;	O
Table	O
1	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Clouds	O
and	O
rain	O
retard	O
vitamin	O
D	O
-	O
producing	O
ultraviolet	O
B	O
light	O
from	O
penetrating	O
the	O
atmosphere	O
.	O

In	O
view	O
of	O
hypocalcemia	O
,	O
the	O
child	O
was	O
treated	O
with	O
2	O
ml	O
/	O
kg	O
of	O
10	O
%	O
calcium	O
gluconate	O
followed	O
by	O
maintenance	O
calcium	O
,	O
following	O
which	O
the	O
stridor	O
disappeared	O
and	O
there	O
were	O
no	O
further	O
seizures	O
.	O

Further	O
,	O
linear	O
regression	O
confirmed	O
the	O
inverse	O
association	O
between	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
and	O
head	O
circumference	O
(	O
B	O
-	O
1	O
.	O
74	O
;	O
95	O
%	O
CI	O
-	O
3	O
.	O
25	O
,	O
−	O
0	O
.	O
23	O
;	O
P	O
=	O
0	O
.	O
024	O
).	O

Their	O
medical	O
and	O
psychiatric	O
histories	O
,	O
medications	O
,	O
concomitant	O
disorders	O
and	O
demographic	O
characteristics	O
did	O
not	O
differ	O
from	O
those	O
of	O
the	O
included	O
cohort	O
.	O

These	O
recommendations	O
were	O
pooled	O
into	O
themes	O
of	O
which	O
the	O
most	O
prevalent	O
theme	O
concerned	O
health	O
centre	O
amenities	O
(	O
20	O
.	O
2	O
%)	O
such	O
as	O
good	O
toilet	O
facilities	O
,	O
cleanliness	O
,	O
reduced	O
congestion	O
and	O
preferential	O
care	O
towards	O
the	O
women	O
in	O
aspects	O
such	O
as	O
rapid	O
delivery	O
of	O
laboratory	O
results	O
.	O

evaluated	O
fertility	O
and	O
the	O
long	O
-	O
term	O
effects	O
of	O
I	O
-	O
131	O
therapy	O
in	O
815	O
women	O
.	O

006	O
26769	O
.	O
4	O
0	O
.	O
003	O
No320533	O
.	O
3533	O
.	O
3	O
Obstetrician	O
Yes18555	O
.	O
425576	O
.	O
325576	O
.	O
3	O
No710	O
.	O
61725	O
.	O
81725	O
.	O
8Total	O
number	O
or	O
prenatal	O
visits	O
≤	O
422	O
.	O
8	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
>	O
419057	O
.	O
925477	O
.	O
425477	O
.	O
4Gestational	O
age	O
at	O
registration	O
(	O
months	O
)	O
<	O
418053	O
.	O
7	O
<	O
0	O
.	O
001	O
19257	O
.	O
3	O
0	O
.	O
019	O
24472	O
.	O
8	O
<	O
0	O
.	O
001	O
≥	O
41218	O
.	O
52741	O
.	O
52843	O
.	O
1Nutritional	O
questionnaire	O
score	O
Low710	O
.	O
1	O
<	O
0	O
.	O
001	O
2333	O
.	O
3	O
<	O
0	O
.	O
001	O
2231	O
.	O
9	O
<	O
0	O
.	O
001	O
Medium13747	O
.	O
114756	O
.	O
819274	O
.	O
3	O
High4865	O
.	O
84967	O
.	O
65879	O
.	O
7	O
The	O
proportion	O
of	O
less	O
well	O
-	O
educated	O
women	O
(	O
less	O
than	O
8	O
years	O
of	O
school	O
completed	O
)	O
using	O
folic	O
acid	O
(	O
p	O
=	O
.	O
007	O
),	O
iron	O
(	O
p	O
<	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
)	O
increased	O
with	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

Japanese	O
Black	O
cattle	O
breed	O
has	O
the	O
highest	O
IMF	O
content	O
in	O
the	O
world	O
,	O
and	O
Korean	O
cattle	O
(	O
also	O
called	O
Hanwoo	O
)	O
the	O
second	O
highest	O
.	O

Patients	O
with	O
high	O
initial	O
VD	O
levels	O
(	O
267	O
.	O
8	O
±	O
66	O
.	O
4	O
nmol	O
/	O
L	O
)	O
had	O
a	O
four	O
time	O
better	O
chance	B
(	O
p	O
=	O
0	O
.	O
02	O
)	O
for	O
successful	O
IVF	O
procedure	O
compared	O
to	O
the	O
group	O
with	O
low	O
VD	O
levels	O
(	O
104	O
.	O
3	O
±	O
21	O
nmol	O
/	O
L	O
)	O
[	O
54	O
].	O

Moreover	O
,	O
by	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
DNA	O
methylation	O
and	O
genomewide	O
(	O
array	O
)	O
gene	O
-	O
associated	O
methylation	O
,	O
this	O
work	O
suggests	O
potential	O
epigenetic	O
mechanisms	O
underlying	O
changes	O
to	O
placental	O
function	O
that	O
may	O
lead	O
to	O
altered	O
fetal	O
development	O
and	O
programming	O
.	O

[	O
4142	O
]	O
Endocrine	O
Society	O
Issues	O
Practice	O
Guideline	O
on	O
Vitamin	O
D	O
and	O
the	O
guideline	B
recommend	O
that	O
clinicians	O
screen	O
for	O
vitamin	O
D	O
deficiency	O
in	O
people	O
at	O
risk	O
for	O
deficiency	O
,	O
including	O
obese	O
individuals	O
,	O
blacks	O
,	O
pregnant	O
and	O
lactating	O
women	O
,	O
and	O
patients	O
with	O
malabsorption	O
syndromes	O
.	O

The	O
study	O
population	O
were	O
pregnant	O
women	O
attending	O
ANC	O
facilities	O
in	O
any	O
of	O
the	O
selected	O
sites	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

This	O
overview	O
of	O
the	O
developmental	O
influences	O
on	O
childhood	O
overweight	O
and	O
obesity	O
suggests	O
opportunities	O
for	O
intervention	O
.	O

Toxins	O
delivered	O
by	O
water	O
or	O
air	O
pollution	O
appear	O
to	O
damage	O
the	O
genome	O
of	O
the	O
vitamin	O
D	O
deficient	O
(	O
14	O
).	O

no	O
.	O

Both	O
overweight	O
/	O
obesity	O
as	O
well	O
as	O
darker	O
skin	O
pigmentation	O
are	O
both	O
well	B
-	I
established	I
risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
the	O
dose	O
of	O
400	O
IU	O
daily	O
is	O
used	O
for	O
both	O
breast	O
-	O
fed	O
and	O
formula	O
-	O
fed	O
babies	O
,	O
vitamin	O
D	O
-	O
deficient	O
rickets	O
is	O
extremely	O
rare	O
in	O
formula	O
-	O
fed	O
infants	O
primarily	O
due	O
to	O
the	O
mandatory	O
addition	O
of	O
vitamin	O
D	O
to	O
infant	O
formulas	O
in	O
the	O
United	O
States	O
.	O

Summary	O
and	O
conclusions	O
Gestational	O
diabetes	O
is	O
a	O
common	O
disorder	O
which	O
in	O
the	O
majority	O
of	O
cases	O
,	O
should	O
initially	O
be	O
managed	O
by	O
dietary	O
measures	O
.	O

Of	O
the	O
total	O
(	O
n	O
=	O
128	O
)	O
of	O
participants	O
who	O
self	O
-	O
reported	O
not	O
receiving	O
influenza	O
vaccination	O
,	O
only	O
2	O
(	O
2	O
%),	O
had	O
evidence	O
of	O
influenza	O
vaccination	O
.	O

Conclusion	O
:	O
It	O
is	O
therefore	B
clear	O
that	O
the	O
diet	O
of	O
pregnant	O
woman	O
according	O
to	O
Ayurveda	O
will	O
prevent	O
many	O
complications	O
of	O
pregnancy	O
,	O
which	O
will	O
lead	O
to	O
healthy	O
pregnancy	O
&	O
healthy	O
fetus	O
&	O
finally	O
good	O
outcome	O
.	O

Increasing	O
the	O
percentage	O
of	O
concentrate	O
(	O
60	O
%,	O
75	O
%,	O
and	O
90	O
%	O
concentrate	O
)	O
in	O
growing	O
diets	O
increased	O
MS	O
in	O
steers	O
[	O
118	O
].	O

Alternately	O
,	O
any	O
reduction	O
in	O
cellular	O
energetics	O
within	O
this	O
region	O
may	O
delay	O
the	O
integration	O
of	O
cortical	O
and	O
/	O
or	O
sub	O
-	O
cortical	O
inputs	O
.	O

However	O
,	O
the	O
potential	O
side	O
effects	O
of	O
any	O
drug	O
must	O
be	O
balanced	O
against	O
the	O
risks	O
of	O
the	O
mother	O
or	O
the	O
infant	O
having	O
inadequately	O
treated	O
disease	O
.	O

An	O
active	O
form	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
in	O
sperm	O
proves	O
the	O
existence	O
of	O
local	O
synthesis	O
of	O
cholecalciferol	O
and	O
strongly	B
suggests	O
its	O
paracrine	O
effect	O
on	O
spermatogenesis	O
as	O
described	O
inFigure	O
1	O
[	O
19	O
,	O
20	O
].	O

Certain	O
foods	O
and	O
the	O
chemicals	O
contained	O
in	O
these	O
foods	O
may	O
be	O
more	O
or	O
less	O
available	O
at	O
particular	O
times	O
of	O
the	O
year	O
due	O
to	O
crop	O
cycles	O
,	O
storage	O
capability	O
,	O
transportation	O
access	O
,	O
and	O
cost	O
;	O
and	O
the	O
use	O
of	O
preservatives	O
in	O
foods	O
also	O
may	O
vary	O
accordingly	O
.	O

Two	O
hundred	O
and	O
seventy	O
(	O
69	O
.	O
9	O
%)	O
respondents	O
attended	O
ANC	O
at	O
the	O
health	O
centre	O
corresponding	O
to	O
their	O
catchment	O
health	O
area	O
while	O
30	O
.	O
1	O
%	O
attended	O
at	O
a	O
different	O
health	O
centre	O
out	O
of	O
their	O
catchment	O
health	O
area	O
(	O
Figure	O
2	O
).	O

All	O
reported	O
p	O
-	O
values	O
are	O
two	O
-	O
tailed	O
.	O

Lack	O
of	O
funding	O
to	O
obtain	O
fetal	O
weights	O
estimated	O
via	O
serial	O
ultrasound	O
is	O
an	O
issue	O
in	O
the	O
analyses	O
.	O

Management	O
of	O
these	O
patients	O
and	O
providing	O
evidencebased	O
advice	O
are	O
obviously	O
extremely	O
difficult	O
tasks	O
.	O

A	O
GR	O
Bcl	O
I	O
polymorphism	O
has	O
been	O
associated	O
with	O
increased	O
glucocorticoid	O
sensitivity	O
and	O
was	O
overrepresented	O
in	O
pregnant	O
women	O
with	O
pathological	O
,	O
fetomaternal	O
immune	O
adaptation	O
.	O

In	O
Mozambique	O
,	O
mobile	O
phones	O
are	O
used	O
to	O
link	O
inventory	O
,	O
distributors	O
,	O
and	O
marketers	O
of	O
socially	O
marketed	O
products	O
,	O
such	O
as	O
condoms	O
and	O
mosquito	O
bed	O
nets	O
,	O
to	O
reach	O
low	O
income	O
consumers	O
[	O
22	O
].	O

Interestingly	O
,	O
chronic	O
central	O
IL	O
-	O
6	O
stimulation	O
desensitized	O
IL	O
-	O
6	O
signal	O
transduction	O
characterized	O
by	O
reversal	O
of	O
elevated	O
pSTAT3	O
levels	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Mendez	O
et	O
al	O
.	O

We	O
fitted	O
generalized	O
linear	O
models	O
,	O
using	O
a	O
log	O
-	O
link	O
function	O
,	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
[	O
29	O
,	O
30	O
]	O
of	O
the	O
associations	O
between	O
sleep	O
duration	O
and	O
snoring	O
variables	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
risk	O
.	O

The	O
criteria	O
described	O
by	O
Vickers	O
were	O
adopted	O
to	O
refer	O
to	O
different	O
stages	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
).	O

Data	O
from	O
three	O
trials	O
involving	O
463	O
women	O
show	O
a	O
trend	O
for	O
women	O
who	O
receive	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
to	O
more	O
frequently	O
have	O
a	O
baby	O
with	O
a	O
birth	O
weight	O
below	O
2500	O
grams	O
than	O
those	O
women	O
receiving	O
no	O
treatment	O
or	O
placebo	O
,	O
although	O
the	O
statistical	O
significance	O
was	O
borderline	O
.	O

The	O
mean	O
difference	O
in	O
head	O
circumference	O
was	O
0	O
.	O
22	O
SD	O
units	O
between	O
the	O
groups	O
with	O
optimal	O
and	O
suboptimal	O
UCB	O
25OHD	O
.	O

Alcohol	O
dehydrogenase	O
1	O
(	O
ADH	O
)	O
is	O
the	O
primary	O
enzyme	O
that	O
oxidizes	O
retinol	O
to	O
retinaldehyde	O
[	O
138	O
],	O
and	O
retinaldehyde	O
inhibits	O
adipocyte	O
differentiation	O
[	O
139	O
].	O

When	O
a	O
woman	O
lactates	O
,	O
she	O
reduces	O
her	O
own	O
body	O
burden	O
of	O
certain	O
chemicals	O
by	O
transferring	O
them	O
to	O
her	O
nursing	O
child	O
via	O
milk	O
.	O

Even	O
after	O
controlling	O
for	O
seasonal	O
influence	O
on	O
endogenous	O
synthesis	O
,	O
low	O
household	O
income	O
,	O
and	O
infrequent	O
consumption	O
of	O
vitamin	O
D	O
drops	O
and	O
milk	O
,	O
the	O
significant	O
association	O
remained	O
.	O

“	O
Browning	O
”	O
of	O
WAT	O
could	O
be	O
one	O
of	O
the	O
mechanisms	O
underlying	O
the	O
increased	O
insulin	O
sensitivity	O
of	O
LPTENKO	O
mice	O
,	O
in	O
keeping	O
with	O
the	O
observation	O
of	O
increased	O
WAT	O
glucose	O
uptake	O
(	O
Peyrou	O
et	O
al	O
.,	O
2015	O
).	O

Although	O
many	O
proteins	O
were	O
found	O
to	O
be	O
significantly	O
altered	O
in	O
DVD	O
-	O
deficient	O
adults	O
,	O
the	O
fold	O
-	O
change	O
level	O
was	O
insufficient	O
for	O
confirmation	O
analysis	O
by	O
western	O
blot	O
.	O

OR	O
Odds	O
ratio	O
.	O

We	O
mitigated	O
against	O
this	O
possible	O
source	O
of	O
error	O
by	O
asking	O
additional	O
questions	O
about	O
the	O
type	O
of	O
supplement	O
and	O
its	O
commercial	O
name	O
.	O

Maternal	O
use	O
of	O
supplements	O
,	O
specific	O
brand	O
names	O
,	O
dosing	O
,	O
and	O
date	O
of	O
commencement	O
were	O
recorded	O
.	O

Decreases	O
in	O
the	O
HRV	O
parameters	O
were	O
noted	O
in	O
newborns	O
at	O
term	O
with	O
low	O
weight	O
[	O
34	O
],	O
while	O
other	O
studies	O
observed	O
a	O
normal	O
cardiac	O
autonomic	O
balance	O
in	O
these	O
neonates	O
[	O
17	O
,	O
35	O
].	O

Decreases	O
in	O
perceived	O
stress	O
during	O
pregnancy	O
were	O
also	O
independently	O
related	O
to	O
higher	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
OR	O
=	O
1	O
.	O
5	O
(	O
1	O
.	O
1	O
,	O
2	O
.	O
0	O
);	O
P	O
=	O
.	O
01	O
)	O
but	O
did	O
not	O
independently	O
predict	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
.	O

Among	O
the	O
factors	O
evaluated	O
in	O
our	O
study	O
,	O
area	O
of	O
residence	O
,	O
level	O
of	O
education	O
and	O
marital	O
status	O
were	O
associated	O
with	O
the	O
intake	O
of	O
folic	O
acid	O
during	O
pregnancy	O
,	O
independently	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

[	O
27	O
]	O
found	O
a	O
statistically	O
significant	O
inverse	O
association	O
between	O
PBDE	O
exposure	O
and	O
birth	O
weight	O
.	O

Vitamin	O
D	O
metabolism	O
in	O
the	O
placenta	O
has	O
been	O
shown	O
to	O
be	O
influenced	O
by	O
testosterone	O
production	O
and	O
thus	B
varies	O
by	O
fetal	O
sex	O
[	O
35	O
].	O

In	O
addition	O
,	O
fruits	O
,	O
vegetables	O
,	O
and	O
low	O
-	O
fat	O
dairy	O
intake	O
among	O
them	O
is	O
low	O
;	O
however	O
,	O
legumes	O
intake	O
is	O
good	O
in	O
the	O
mentioned	O
population	O
[	O
28	O
].	O

Insulin	O
is	O
still	O
the	O
mainstay	O
of	O
pharmacological	O
treatment	O
of	O
GDM	O
,	O
and	O
this	O
is	O
ideally	O
administered	O
in	O
a	O
basal	O
bolus	O
regimen	O
.	O

Visfatin	O
,	O
a	O
new	O
52KDa	O
adipokine	O
(	O
2	O
),	O
was	O
renamed	O
to	O
nicotinamide	O
phosphoribosyl	O
transferase	O
(	O
Nampt	O
)	O
in	O
2002	O
after	O
it	O
was	O
shown	O
that	O
it	O
encodes	O
an	O
enzyme	O
called	O
Nampt	O
,	O
which	O
is	O
involved	O
in	O
the	O
conversion	O
of	O
nicotinamide	O
into	O
nicotinamide	O
adenine	O
dinucleotide	O
(	O
NAD	O
)(	O
3	O
).	O

A	O
brief	O
questionnaire	O
on	O
prenatal	O
vitamins	O
,	O
including	O
name	O
and	O
frequency	O
,	O
and	O
intake	O
of	O
vitamin	O
D	O
rich	O
foods	O
was	O
completed	O
.	O

However	O
,	O
only	O
among	O
participants	O
vaccinated	O
in	O
the	O
first	O
trimester	O
,	O
the	O
percentage	O
with	O
preterm	O
birth	O
was	O
12	O
%,	O
significantly	O
higher	O
than	O
the	O
unvaccinated	O
group	O
(	O
6	O
%;	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
;	O
Supplementary	O
material	O
A2	O
).	O

Briefly	O
,	O
the	O
left	O
kidneys	O
were	O
fixed	O
in	O
freshly	O
prepared	O
fixative	O
(	O
1	O
.	O
27	O
M	O
formaldehyde	O
in	O
0	O
.	O
1	O
M	O
phosphate	O
buffer	O
,	O
pH	O
7	O
.	O
2	O
)	O
for	O
48	O
h	O
at	O
room	O
temperature	O
,	O
longitudinally	O
divided	O
into	O
two	O
halves	O
,	O
embedded	O
face	O
down	O
in	O
Paraplast	O
plus	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
Louis	O
,	O
MO	O
,	O
USA	O
),	O
serially	O
sectioned	O
at	O
a	O
nominal	O
thickness	O
of	O
5	O
µm	O
and	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

Additionally	O
,	O
differences	O
in	O
breast	O
milk	O
composition	O
due	O
to	O
maternal	O
diet	O
may	O
contribute	O
to	O
the	O
infant	O
gut	O
microbiome	O
in	O
breastfed	O
infants	O
.	O

Newborn	O
piglets	O
were	O
individually	O
weighed	O
immediately	O
after	O
birth	O
and	O
one	O
male	O
piglets	O
of	O
the	O
mean	O
body	O
weight	O
were	O
selected	O
per	O
litter	O
and	O
sacrificed	O
before	O
suckling	O
.	O

Lenters	O
et	O
al	O
.	O

has	O
shown	O
that	O
infants	O
with	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
have	O
a	O
higher	O
risk	O
of	O
respiratory	O
tract	O
infection	O
before	O
the	O
age	O
of	O
3	O
months	O
[	O
7	O
].	O

We	O
aimed	O
to	O
examine	O
the	O
association	O
of	O
maternal	O
diet	O
during	O
pregnancy	O
with	O
the	O
infant	O
gut	O
microbiome	O
6	O
weeks	O
post	O
-	O
delivery	O
in	O
mother	O
-	O
infant	O
dyads	O
enrolled	O
in	O
the	O
New	O
Hampshire	O
Birth	O
Cohort	O
Study	O
.	O

A	O
strong	O
,	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
VD	O
and	O
sperm	O
motility	O
and	O
morphology	O
was	O
also	O
found	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

This	B
means	I
that	I
for	O
each	O
dollar	O
invested	O
in	O
a	O
weekly	O
iron	O
supplementation	O
and	O
de	O
-	O
worming	O
program	O
the	O
monetary	O
value	O
in	O
terms	O
of	O
productivity	O
was	O
USD6	O
.	O
70	O
.	O

Furthermore	O
,	O
men	O
were	O
not	O
included	O
in	O
the	O
study	O
and	O
there	O
is	O
gender	O
difference	O
in	O
the	O
prevalence	O
of	O
psychosis	O
[	O
59	O
].	O

The	O
25OHD	O
concentration	O
has	O
been	O
shown	O
to	O
have	O
immunological	O
effects	O
in	O
women	O
with	O
a	O
history	O
of	O
recurrent	O
pregnancy	O
loss	O
[	O
12	O
].	O

In	O
other	O
words	O
,	O
the	O
respective	O
growth	O
of	O
the	O
BAT	O
and	O
WAT	O
depots	O
depends	O
on	O
the	O
maternal	O
diet	O
during	O
gestation	O
and	O
it	O
may	O
be	O
responsible	O
for	O
the	O
development	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
the	O
offspring	O
,	O
later	O
in	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

Overall	O
,	O
findings	O
from	O
the	O
current	O
study	O
support	O
a	O
stronger	O
role	O
for	O
maternal	O
intake	O
than	O
expenditure	O
in	O
predicting	O
offspring	O
weight	O
outcomes	O
,	O
but	O
additional	O
studies	O
with	O
objective	O
measures	O
of	O
physical	O
activity	O
(	O
e	O
.	O
g	O
.,	O
accelerometry	O
)	O
are	O
clearly	O
needed	O
.	O

Furthermore	O
,	O
individuals	O
with	O
sleep	O
disorders	O
may	O
be	O
predisposed	O
to	O
insulin	O
resistance	O
and	O
glucose	O
intolerance	O
due	O
to	O
sleep	O
-	O
related	O
dysregulation	O
of	O
the	O
HPA	O
axis	O
with	O
consequent	O
elevations	O
in	O
serum	O
cortisol	O
[	O
16	O
,	O
45	O
].	O

Knowledge	O
of	O
ANC	O
activities	O
done	O
at	O
the	O
ANC	O
The	O
responses	O
by	O
participants	O
concerning	O
routine	O
activities	O
at	O
antenatal	O
clinics	O
revealed	O
that	O
physical	O
examination	O
was	O
the	O
most	O
frequent	O
activity	O
and	O
the	O
least	O
was	O
vaccination	O
.	O

TG	O
synthesis	O
is	O
a	O
key	O
factor	O
for	O
IMF	O
deposition	O
[	O
69	O
].	O

Interventions	O
such	O
as	O
family	O
planning	O
;	O
prevention	O
and	O
management	O
of	O
sexually	O
transmitted	O
infections	O
(	O
STIs	O
);	O
use	O
of	O
insecticide	O
-	O
treated	O
bednets	O
and	O
intermittent	O
preventive	O
treatment	O
for	O
malaria	O
;	O
identification	O
and	O
treatment	O
of	O
pre	O
-	O
eclampsia	O
,	O
and	O
reduction	O
of	O
physical	O
workload	O
are	O
examples	O
of	O
strategies	O
that	O
could	O
improve	O
birth	O
outcomes	O
in	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settings	O
.	O

By	O
comparison	O
,	O
forced	O
expiration	O
maneuvers	O
more	O
closely	O
reflect	O
the	O
function	O
of	O
the	O
intrathoracic	O
airway	O
.	O

There	O
is	O
evidence	O
that	O
lifestyle	O
modification	O
,	O
aiming	O
for	O
a	O
5	O
%–	O
7	O
%	O
reduction	O
in	O
body	O
weight	O
,	O
is	O
effective	O
in	O
preventing	O
or	O
delaying	O
the	O
development	O
of	O
diabetes	O
in	O
people	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

Improving	O
the	O
nutritional	O
condition	O
of	O
cows	O
during	O
pregnancy	O
affects	O
growth	O
,	O
fat	O
deposition	O
,	O
and	O
beef	O
quality	O
in	O
steers	O
;	O
steers	O
from	O
cows	O
grazing	O
with	O
better	O
pasture	O
(	O
Thinopyrum	O
–	O
Elymus	O
–	O
Psathrystachus	O
,	O
CP	O
11	O
.	O
1	O
%	O
to	O
6	O
.	O
0	O
%)	O
during	O
mid	O
-	O
to	O
late	O
gestation	O
had	O
greater	O
live	O
body	O
weight	O
at	O
slaughter	O
,	O
HCW	O
,	O
and	O
tenderness	O
,	O
and	O
had	O
an	O
increased	O
tendency	O
for	O
IMF	O
deposition	O
compared	O
with	O
offspring	O
of	O
cows	O
grazing	O
on	O
native	O
range	O
(	O
Bouteloua	O
–	O
Hesperostipa	O
–	O
Pascopyron	O
,	O
CP	O
6	O
.	O
5	O
%	O
to	O
5	O
.	O
4	O
%)	O
[	O
155	O
].	O

Furthermore	O
,	O
the	O
propensity	O
score	O
analyses	O
minimized	O
biases	O
introduced	O
by	O
differences	O
in	O
baseline	O
characteristics	O
between	O
unvaccinated	O
and	O
vaccinated	O
pregnant	O
women	O
by	O
accounting	O
for	O
the	O
probability	O
of	O
vaccination	O
based	B
on	I
these	O
characteristics	O
[	O
43	O
].	O

Ethnicity	O
was	O
also	O
a	O
major	O
determinant	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
present	O
study	O
,	O
as	O
previously	O
reported	O
in	O
the	O
adult	O
population	O
[	O
32	O
]	O
and	O
in	O
pregnant	O
women	O
[	O
29	O
],[	O
48	O
],[	O
49	O
].	O

Irisin	O
,	O
obtained	O
by	O
cleavage	O
from	O
the	O
precursor	O
protein	O
,	O
fibronectin	O
type	O
III	O
domain	O
containing	O
5	O
(	O
FNDC5	O
),	O
was	O
described	O
as	O
promoting	O
the	O
appearance	O
/	O
recruitment	O
of	O
“	O
brite	O
”	O
cells	O
in	O
white	O
adipose	O
depots	O
(	O
Bostrom	O
et	O
al	O
.,	O
2012	O
;	O
Lee	O
et	O
al	O
.,	O
2014a	O
).	O

Finding	O
about	O
neonatal	O
weight	O
showed	O
that	O
those	O
in	O
the	O
top	O
quartile	O
of	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
marginally	O
significant	O
chance	B
of	O
having	O
low	O
weight	O
infant	O
compared	O
with	O
those	O
in	O
the	O
bottom	O
quartile	O
in	O
the	O
crude	O
model	O
[	O
OR	O
1	O
.	O
84	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
94	O
-	O
3	O
.	O
60	O
),	O
P	O
=	O
0	O
.	O
05	O
].	O

EPA	O
and	O
DHA	O
are	O
mainly	O
found	O
in	O
fatty	O
fish	O
,	O
with	O
levels	O
that	O
vary	O
by	O
the	O
species	O
of	O
the	O
fish	O
,	O
environmental	O
factors	O
and	O
geographic	O
area	O
[	O
27	O
].	O

Furthermore	O
,	O
a	O
GRS	O
including	O
rs10741657	O
and	O
rs2282679	O
showed	O
that	O
for	O
each	O
additional	O
risk	O
allele	O
,	O
late	O
pregnancy	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
after	O
supplementation	O
with	O
cholecalciferol	O
was	O
lower	O
by	O
4	O
.	O
4	O
nmol	O
/	O
L	O
(	O
95	O
%	O
CI	O
,	O
2	O
.	O
3	O
to	O
6	O
.	O
6	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Another	O
study	O
found	O
that	O
smoking	O
during	O
the	O
12	O
months	O
before	O
birth	O
of	O
a	O
child	O
was	O
associated	O
with	O
adolescent	O
overweight	O
(	O
21	O
).	O

The	O
service	O
launched	O
in	O
February	O
2010	O
and	O
delivers	O
text	O
messages	O
to	O
pregnant	O
women	O
and	O
new	O
mothers	O
.	O

Background	O
Early	O
Childhood	O
Caries	O
(	O
ECC	O
)	O
is	O
the	O
most	O
common	O
chronic	O
disease	O
of	O
childhood	O
and	O
is	O
defined	B
as	B
any	O
decay	O
in	O
the	O
primary	O
dentition	O
of	O
children	O
<	O
72	O
months	O
of	O
age	O
[	O
1	O
,	O
2	O
].	O

The	O
latitude	O
of	O
Houston	O
,	O
TX	O
is	O
29	O
degrees	O
,	O
more	O
southern	O
than	O
the	O
typically	O
used	O
latitude	O
cutoff	O
of	O
Atlanta	O
,	O
Georgia	O
of	O
33	O
degrees	O
for	O
sunlight	O
exposure	O
to	O
lead	O
to	O
vitamin	O
D	O
formation	O
in	O
the	O
dermis	O
to	O
occur	O
throughout	O
the	O
year	O
.	O

Not	B
surprisingly	I
,	O
they	O
found	O
that	O
children	O
who	O
breastfed	O
longer	O
had	O
higher	O
levels	O
of	O
PFASs	O
in	O
their	O
blood	O
.	O

The	O
microarrays	O
were	O
processed	O
at	O
the	O
University	O
of	O
California	O
–	O
San	O
Francisco	O
Institute	O
for	O
Human	O
Genetics	O
and	O
Genomics	O
Core	O
Facility	O
,	O
following	O
standard	O
protocols	O
.	O

These	O
mutant	O
mice	O
will	O
serve	O
as	O
useful	O
models	O
for	O
the	O
study	O
of	O
vertebral	O
malformations	O
.	O

For	B
this	I
reason	I
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	O
biochemical	O
markers	O
that	O
reflect	O
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	O
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

FGF21	O
deficiency	O
in	O
mice	O
was	O
shown	O
to	O
result	O
in	O
impaired	O
ability	O
to	O
adapt	O
to	O
long	O
-	O
term	O
cold	O
exposure	O
with	O
diminished	O
“	O
browning	O
”	O
of	O
WAT	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

This	O
limitation	O
has	O
to	O
be	O
considered	O
in	O
the	O
interpretation	O
of	O
the	O
data	O
and	O
further	O
research	O
will	O
be	O
addressed	O
to	O
evaluate	O
the	O
reasons	O
for	O
the	O
sex	O
-	O
dimorphic	O
alterations	O
.	O

In	O
Finland	O
,	O
Baum	O
et	O
al	O
.	O

Conclusions	O
Developmental	O
vitamin	O
D	O
deficiency	O
was	O
associated	O
with	O
subtle	O
changes	O
in	O
protein	O
expression	O
in	O
the	O
nucleus	O
accumbens	O
.	O

A	O
limitation	O
of	O
this	O
study	O
was	O
that	O
nearly	O
two	O
-	O
thirds	O
of	O
the	O
women	O
(	O
63	O
%)	O
had	O
only	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
during	O
pregnancy	O
,	O
which	O
prohibited	O
assessment	O
by	O
trimester	O
and	O
a	O
more	O
thorough	O
analysis	O
of	O
vitamin	O
D	O
benefit	O
among	O
those	O
with	O
low	O
initial	O
levels	O
.	O

When	O
a	O
simple	O
increase	O
in	O
serum	O
Htg	O
levels	O
is	O
observed	O
,	O
further	O
therapy	O
is	O
not	O
necessary	O
.	O

Food	O
restriction	O
in	O
dams	O
produced	O
a	O
decrease	O
in	O
caloric	O
intake	O
of	O
female	O
offspring	O
treated	O
with	O
AM251	O
(	O
Figure3H	O
).	O

It	O
is	O
important	O
that	O
providers	O
be	O
given	O
the	O
tools	O
to	O
empower	O
them	O
to	O
discuss	O
herbal	O
medicine	O
use	O
with	O
patients	O
,	O
and	O
are	O
encouraged	O
to	O
do	O
so	O
.	O

Methods	O
A	O
search	O
of	O
the	O
Canada	O
Vigilance	O
Database	O
from	O
April	O
1	O
,	O
2008	O
to	O
August	O
31	O
,	O
2013	O
identified	O
15	O
cases	O
of	O
anaphylaxis	O
and	O
16	O
reports	O
of	O
serious	O
non	O
-	O
anaphylactic	O
allergic	O
reactions	O
.	O

The	O
cohort	O
has	O
been	O
followed	O
since	O
birth	O
with	O
annual	O
questionnaires	O
and	O
,	O
since	O
age	O
7	O
years	O
,	O
with	O
objective	O
measures	O
in	O
annual	O
research	O
clinics	O
.	O

Approximately	O
40	O
-	O
80	O
%	O
of	O
the	O
oral	O
dose	O
is	O
absorbed	O
,	O
with	O
peak	O
serum	O
levels	O
measured	O
within	O
2	O
-	O
4	O
hour	O
,	O
and	O
the	O
half	O
-	O
life	O
of	O
the	O
administered	O
dose	O
is	O
approximately	O
1	O
week	O
.	O

3	O
.	O
7	O
.	O

The	O
mediators	O
of	O
such	O
beneficial	O
effects	O
seem	O
to	O
include	O
FGF21	O
,	O
interleukin	O
-	O
6	O
,	O
BMP8B	O
and	O
prostaglandin	O
D2	O
synthase	O
.	O

Body	O
weight	O
and	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
offspring	O
were	O
evaluated	O
during	O
the	O
lactation	O
and	O
/	O
or	O
post	O
-	O
weaning	O
periods	O
(	O
Figures2B	O
,	O
C	O
).	O

We	O
conducted	O
a	O
literature	O
review	O
to	O
assess	O
evidence	O
suggested	O
in	O
the	O
worldwide	O
literature	O
.	O

